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Abstract
Abstract
Non-prescription foot orthoses (FO) or inner-soles can be obtained “off the shelf’ 
from, for example, sports shops and chemists. They are available with different 
designs and materials, and are aimed at people who seek comfort and support for 
their feet. These FO can be found with similar components as prescription FO, 
however, the former are mass produced and therefore may not provide an appropriate 
fit for a particular subject’s foot morphology. There is therefore a need to assess the 
biomechanical effects of these FO to determine their immediate effects and to 
suggest implications following long term use.
Two “off the shelf’ FO were investigated. One was a flat insole with a heel pad, the 
other a flat insole with a heel pad and a medial arch support. Level walking kinetic 
and kinematic data were collected before, during and after use of the FO from 12 
healthy subjects (6 subjects per FO). A questionnaire was also developed to 
investigate the subject’s perception o f comfort and satisfaction with the FO. Healthy 
subjects were selected for the FO testing because these FO are intended for healthy 
subjects. The analysis was performed on a case by case basis such that each subject 
acted as his own reference.
Prior to the FO study, a comparison of two available kinematic marker sets, the Skin 
Marker set (SMS), and the Wand Marker set (WMS), was undertaken to select the 
one with best performance to use in the gait measurements. Using the selected WMS 
a data repeatability study was subsequently carried out with 6 healthy subjects. The 
results from this study were used to detect changes in gait parameters due to FO use.
The FO study showed that the orthoses used do not make a proper fit with all 
anatomical medial-longitudinal arches, may not reduce eversion in all users, and can 
cause an increased knee abduction moment, which may pose a potential health risk to 
the knee and surrounding structures.
The results suggest that greater guidance needs to be provided with “off the shelf’ 
orthoses, which may necessitate a more detailed clinical and biomechanical 
examination of the foot before purchase, and improved classification in terms o f the 
components and materials used, and the dimensions of such orthoses.
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Chapter 1
Introduction
1.1 Need for the study
There are many manufacturers who mass produce non-prescription FO in the UK and 
worldwide, for example A Algeo Ltd. (Liverpool, UK), Implus Corporation (NC, 
USA), and Vasyli International (Geneva, Switzerland). Such orthoses can be readily 
obtained off the shelf from retailers such as chemists and sports shops. Unfortunately, 
there a is lack of statistics on how many people use non-prescription FO and the 
reasons for using such FO, however, their wide availability in the market for sale 
indicates that people may buy and use such FO and a probable reason for their use is 
for comfort and pain relief which most non-prescription FO are advertised for.
When discomfort or pain develops in the feet, it can be disabling, making every step 
difficult and forcing a different walking strategy. This can lead to alterations in the 
normal kinematic, kinetic and muscle activation pattern of the lower limbs and pelvis. 
To obtain comfort or alleviate foot pain, people often seek medical advice and 
treatment, some seek non-medical support. Medically devised support can include 
weight reduction regimes, medication, physical therapy, and the use o f foot orthosis 
(FO) with specified design to suite particular conditions. The non-medically devised 
FO support include ready made “off the shelf’ FO that can be bought from retailers 
without the need for a medical prescription. The latter type of FO is the focus o f this 
study.
These, “off the shelf’ orthoses are (supposedly) made with the aim of giving comfort 
and support to the structure of the foot. Some FO claim to achieve that and even go as 
far as to suggest that use will lead to lower limb joint realignment, e.g. Orthaheel FO 
(Vasyli International, Geneva, Switzerland). However the biomechanical effects of 
non-prescription FO have rarely been explored.
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An inspection of “Off the shelf’ FO shows that the construction materials are similar 
to those of custom-made prescription FO. These materials include polymer gels and 
rubbers with varying mechanical properties. These FO can include one or more of the 
following components:
1. Flat insole
2. Heel pad
3. Longitudinal arch support
4. Metatarsal pad
A fundamental difference between custom-made and “off the shelf’ FO is that the 
former is made to the subject specific foot measurement and morphology, while the 
latter is often made in one universal size (for men 6-12 UK shoe size) and the users 
trim them to suit the foot size. This difference may lead to a FO components being 
disproportionate to the foot morphology.
A FO which includes all the above mentioned components could have a substantial 
effect on the function of the foot and more proximal segments and joints. This raises 
the need to investigate their immediate and short term biomechanical effects on the 
lower limbs and more proximal segments, and possibly to predict their long term 
effects. This is o f great importance for public health and safety. Furthermore, it could 
help clinicians in the decision making process for “off the shelf’ FO prescription.
1.2 Aim and hypothesis of the study
Able-bodied healthy subjects were selected for the study because “off the shelf’ FO 
are intended for this group of people to improve comfort and shock attenuation and 
not for treating specific foot problems or deformities. Hence the selected subjects for 
these FO presented with no physical problems.
This study aimed to assess pelvic and lower limb joint kinematic and kinetic changes 
due to the use of “off the shelf’ FO. Assessment was focused on the biomechanical 
changes in the non-sagittal planes particularly the transverse plane, as overuse injuries 
are often associated with pathomechanical motion in this plane [Seymour 2002].
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Assessment was performed on two types o f FO incorporating different components. 
Their biomechanical influence was measured within each subject and compared to 
each other, and to the no FO condition.
It was hypothesized that:
(i) Incorporation of the medial longitudinal arch in “off the shelf’ FO, will not add 
any additional advantages to gait as these lack a good orthotic fit to the arch of 
subjects.
(ii) Peak eversion angle during loading response will be reduced in both FO 
conditions but this reduction may not apply to all subjects. This hypothesis is based 
on the belief that a heel pad, which both tested FO incorporated, increases the laterally 
directed component o f the Ground Reaction Force (GRFy) and is subject specific.
(iii) Due to the use of FO, a decrease in subtalar eversion angle is expected; this will 
be accompanied with increased ankle and knee abduction internal moments. However, 
if  there was an increase in subtalar eversion, this would be accompanied by decreased 
ankle and knee abduction moments.
1.3 Structure of the thesis
This thesis is divided into nine chapters.
Chapter two describes the following aspects o f the foot:
a- Structure; an account of bones, joints and other supporting tissues forming the 
foot.
b- Morphology; description of foot shape, size, arches, foot types and classification 
methods (dimensional measurement, deviation from ‘neutral’, navicular drop and 
flexibility).
c- Function; role of the foot during locomotion and how its joints and other 
supporting tissues mechanically perform their roles, e.g. the windlass mechanism, 
joints and their axis orientation and the contribution of each joint to 3D motion, 
d- Pain and injury in or originating from the foot.
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Chapter three introduces normal gait and gait analysis methods. The chapter also 
presents and justifies the selection of equipment used in the thesis for the data 
collection. The chapter concludes by presenting the sources o f variability in gait data.
Chapter four introduces FO types, materials, and prescription and non-prescription 
FO. The chapter also presents a literature review on the biomechanical effects of FO; 
and highlights the areas where there is a lack of knowledge on the effects o f FO, 
especially non-prescription FO. The justification o f this FO study is reinstated, and 
the chapter concludes by introducing the study design and the steps taken before 
commencing gait measurement.
Chapter five aims to justify the selection of the kinematic marker set to be used for 
data collection. The selection was done by comparing two clinically used marker sets; 
the wand marker set (WMS) and the skin marker set (SMS). The comparison involved 
the collection of kinematic data while the two marker sets were applied 
simultaneously. The results and conclusions are presented.
Chapter six presents the repeatability of gait data, using the (selected) WMS model 
under the same test conditions to be used for the main FO study. Descriptive statistics 
are used to evaluate the repeatability o f the kinematic and kinetic data. The causes of 
imperfect data repeatability are discussed.
Chapter seven presents the experimental method for the study of “off the shelf’ FO. It 
explains how the data was collected and describes the types of FO tested.
Chapters eight presents the results and the statistical analysis performed on the data 
collected in chapter seven. Descriptive statistics were used to present the 
biomechanical effects of “off the shelf’ FO.
Chapter nine presents a brief discussion of the FO results, a summary of the key 
conclusions from all chapters in the thesis and links these to the original research 
hypothesis. The limitations and further work on “off the shelf’ FO are also presented.
1.4
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Foot and ankle: form and function
2.1 Introduction
The foot segment comes in direct contact with the FO. Therefore any effect a FO may 
have on the body will start at the foot, and a good understanding of foot/ankle 
complex is required. Foot function and the roles o f the various foot skeletal structures 
and skeletal supporting tissues are described. Foot morphology is accounted for; as 
this is of a particular importance as variation between foot configurations may 
necessarily require an individualised FO rather than one design for all feet. A brief 
account of common foot pathomechanical problems that may require FO treatment is 
given. As the ankle is in close proximity to the foot, its articulation and some common 
mechanically induced injuries to the foot and ankle are described, these injuries can 
relate to FO misuse, poor prescription of a FO, overuse injury that may be prevented 
by a FO, or manufacturing errors o f FO.
2.2 Structure of the foot
The foot is a complex structure of bones, joints, ligaments, muscles, soft tissue and a 
network of blood vessels and nerves. The foot contains intrinsic muscles and provide 
sites for extrinsic muscle insertion. While the bones constitute the framework o f the 
foot, the ligaments maintain joint stability and the muscles provide the pulling force 
and aid its stability. Contrary to popular belief, most muscles act eccentrically rather 
than concentrically during walking [Prior 1999].
The plantar aspect of the foot is of particular importance as it is the part of the foot in 
direct contact with the groimd during locomotion. This contact provides crucial 
sensory feedback about the ground and the pressure on various parts o f the foot. This 
feedback is integrated by the nervous system to modify muscular activity to suite 
variation in terrains thus enabling smooth locomotion.
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Prominent and palpable parts of the foot bones are used as anatomical landmarks for 
body anthropometric measurement and for placing tracking markers for movement 
capture for example during walking.
2.2.1 Foot skeleton
The foot is composed of 26 bones and several sesamoids. Sesamoids, with varying 
degrees of ossifications, are usually found around joints and attached to the muscle 
tendons. Their role is not precisely certain, however it is suggested that they reduce 
pressure, diminish friction and can modify the direction of muscle pull [Gray 1989],
As shown in figure 2.1, the foot is divided into four segments [Abboud 2002]; the 
rearfoot encompassing 2 bones (talus and calcaneus), the midfoot with 5 bones 
(navicular, cuboid and 3 cuneiforms), the forefoot with 5 bones (5 metatarsals), and 
phalanges (14 bones). The rearfoot and midfoot bones are known as the tarsals.
M e d ia l
MidfootForefootPhalanges Hindfoot
Posterior
Figure 2.1 Superior view of the right foot bones and regions. Image adapted from [Abboud 2002]
The talus is the only link bone between the shank and the foot, therefore all body 
weight is transmitted through the shank and must pass through this bone; hence, it 
must be strong enough to stand the compressive forces due to body weight and muscle 
tension. The talus is involved in three articulations at the ankle, talonavicular and 
subtalar joints. At the ankle, its upper and medial surfaces articulate with the distal 
end and medial malleolous of the tibia respectively. Its lateral surface articulate with 
the malleolous of the fibula (Figure 2.2). The upper articular surface o f the talus is
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cylindrical with the malleoli grasping its sides. This arrangement permits dorsiflexion 
and plantarflexion but prevents any side movement. This surface is broader at the 
front than at the back and during dorsiflexion the lateral malleolous is pushed 
outwards; this makes the malleoli grip more on the talus thus increasing ankle joint 
security. The ankle security is least during plantarflexion as the narrow part of the 
talus articular surface lie between the malleoli reducing the grasp force [Crouch 
1985], The medial malleolous is higher than the lateral malleolous and the ankle axis 
passes through the distal tip of the lateral malleolous (Figure 2.2) and below the 
medial malleolous. The axis lateral side is oriented posteriorly at around 6.8 degrees 
and inclined downward by about 7 degrees [van den Bogert et al. 1994]. It should be 
emphasized that there are variations in axis orientation between subjects and these 
values are just averages.
Lateral
malleolus
Axis of rotation o f ankle joint
Ankle mortice /
Subtalar "“ s  
joint Inferior
tibiofibular
joint
M _
Figure 2.2 Left, posterior aspect of the rearfoot complex. Adapted from 
[http//www.ntu.edu.tw/hmchai/SurfaceAnatomy/SUAlower/AnkleFoot 2006]
Right, lateral view showing the ankle axis position. Adapted from [Smith 1983]
The calcaneus (heel bone) is the largest tarsal bone, it extends downwards and 
posteriorly providing insertion for the achilles tendon on its posterior aspect. This 
posterior extension provides a long lever arm around the ankle joint. The calcaneus 
articulates with the talus forming the posterolateral compartment of the subtalar joint 
(Figure 2.3) the plane o f this joint is convex upwards. The second subtalar joint 
compartment lies anteromedial and is formed mainly by the articulation o f the 
calcaneonavicular socket with the head of talus. As a result o f this arrangement, 
motion at the subtalar joint occurs in these two compartments simultaneously around 
a common axis (Figures 2.3 and 2.4). This axis is directed upwards at a mean angle o f
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-42  degrees (range 20.5 to 68.5 degrees) to the transverse plane and at a mean angle 
o f -16  degrees (range 4 to 47 degrees) to the sagittal plane [Abboud 2002, Seymour 
2002], Again there is a variation in subtalar axis orientation across subjects.
Figure 2.3 Dorsal view of subtalar joint compartments. Adapted from [Smith 1983]
Calcaneus
Navicular
Articular surface 
for body of talus Plantar
calcaneonavicular
ligament
Calcaneonavicular
socket
Cuboid
Subtalar 
/  joint axis 
Range
20 .5 °
Transverse plane Range
Subtalar 
joint axis
Midline of foot
Figure 2.4 Subtalar joint axis orientation. The range refers to the variability of axis orientation 
across people . [Seymour 2002]
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The midfoot is the link between the forefoot and the rearfoot. It links with the rearfoot 
at the articulations of the calcaneus with the cuboid and the talus with the navicular. 
The midfoot is linked to the forefoot by articulations of the 1st, 2nd and 3rd cuneiforms 
with the 1st, 2nd and 3rd metatarsals (MT) bases respectively, and the cuboid with both 
the 4th and 5th MT bases. The midfoot bones are closely packed, joined by many 
ligaments, surrounded and crossed by many intrinsic and extrinsic muscles. The 
midfoot bones are wedge shaped forming an arch (Figure 2.5). The navicular has a 
palpable bony prominence (Sustanicalum Tali) which is often used as an anatomical 
landmark, for example for measuring arch height.
Medial cuneiform
Intermediate cuneiform
Lateral cuneiform
Cuboid
Figure 2.5 Midfoot bones: cross section. Adapted from [Smith 1983]
The forefoot and phalanges make about half the length of the foot. The MTs run along 
the foot and the second MT extends more distally than all other MTs. The first MT is 
the shortest and widest MT. When viewed from above, the MT heads form an 
inverted U shape, this shape is accounted for when designing a FO to permit rollover 
(3rd rocker). The phalanges (toes) have a large range of motion especially in the 
dorsiflexion/plantarflexion direction which is important for the windlass mechanism 
(see section 2.4).
Within the foot, there are three major articulations with functional significance these 
are; subtalar, midtarsal and metatarsophalangeal joints (Figure 2.6).
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midtarsal
Subtalar
metatarsophalangeal
Figure 2.6 Articulations of the foot with major functional significance during walking. Adapted 
from [Perry 1992]
Rotations around the subtalar joint axis produce pronation/supination of the foot. 
Because the subtalar axis is oblique, motion occurs in the three cardinal planes. 
Pronation is a combination o f dorsiflexion, abduction and eversion of the foot. 
Supination is exactly the opposite to pronation.
2.2.2 Foot arches
The hollow space in the plantar aspect of the foot that extends from the MT heads to 
the calcaneus encompasses the foot arches (Figure 2.7). This space is formed by the 
shape and arrangement of the rearfoot, midfoot and metatarsals bones. The arches 
make half a dome, and three arches are recognised. These are;
1. The medial longitudinal arch (blue)
2. The lateral longitudinal arch (green)
3. The transverse arch (red)
Medial longitudinal arch
ransverse arch
Lateral longitudinal arch
Figure 2.7 Foot arches, lateral view. [Marieb 1992]
2.6
Chapter 2 Foot and ankle: form and function
The medial longitudinal arch extends from the calcaneus to the heads of the three 
medial MTs. It rises to the talus and descends through the navicular to the three 
cuneiforms and ends in the 1st, 2nd and 3rd MT heads [Tortora 2000]. It is the longest 
and highest arch in the foot The navicular is considered as the keystone of this arch 
and functionally it is the most important arch [Kuhn et al. 1999].
The lateral longitudinal arch starts at the calcaneus, rises to the cuboid and ends at the 
4th and 5th MT heads. It is shorter and lower than medial longitudinal arch. The cuboid 
is the keystone of this arch. The transverse arch is formed by the navicular, three 
cuneiforms and the bases of the five MTs.
During standing the foot lies horizontally at approximately 90 degrees to the leg. This 
positioning means that vertical forces due to body mass are roughly parallel to the 
long axis o f the lower limb segments except the foot where it is at about 90 degrees to 
its long axis. The horizontal foot is segmented, therefore it can only hold weight if  it 
is arched [Marieb 1992]. Maintenance o f the foot arches is performed by the plantar 
fascia, foot intrinsic and extrinsic muscles and ligaments. Arches are built by the 
wedge shape and the arrangement of the cuneiform bones.
Factors that may influence the medial longitudinal arch structure and function include; 
age, gender, race, shoe type and age at which shoe wearing began [Razeghi et al. 
2002].
2.2.3 Plantar fascia
The plantar fascia (Figure 2.8) is a thick dense fibrous tissue. As the name suggests it 
is located on the plantar aspect of the foot. It runs from the calcaneus to the MT heads 
where it blends with the skin. It has a thick and strong central part known as the 
plantar aponeurosis; this radiates five slips, one to each toe. Each of these slips fuse 
with the deep transverse metatarsal ligaments.
2.7
Chapter 2 Foot and ankle: form and function
Aponeuros
Figure 2.8 Plantar fascia, showing the aponeurosis. Adapted from [Brotzman 1996]
Aquino et al. (1999) stated that; the plantar fascia has long been considered to have a 
significant purpose in the weight bearing foot, both in static and dynamic functions. 
This is particularly evident during the push-off phase of the gait cycle. Bartold (2004) 
described the plantar fascia as a unique anatomical feature that allows it to link the 
tarsal bones with the ligaments of the forefoot acting as a platform that passively 
stabilise the foot. The plantar fascia is an important stabilising structure o f the foot, it 
elongates (to a limited degree only) with increasing loads thus acting as shock 
absorber and energy store. These mechanical properties linked with its insertion into 
the medial calcaneus make it play a vital roll in foot resupination during the 
propulsion period of the gait cycle [Perry 1992].
Inflammation of this fascia leads to pain which will affect the normal walking pattern. 
For the non-athletes inflammation is seen most frequently among people whose 
occupations demand weight bearing especially factory workers, store men and nurses. 
In running athletes incidence of inflammation is about 10% [Bartold 2004]. Long 
distance runners have the greatest association with this condition. Occurrence o f this 
condition is most common after the fifth decade o f age; however it may occur at any 
age.
2.3 Foot morphology
Morphological studies try to characterise and classify foot shape. The classification is 
mainly focused on static anthropometric measurements taken from the foot, and to a 
lesser extent during walking. Different methods are used to classify feet, but there is 
no consensus on a particular method. However, high, normal and low arched feet are 
commonly used terms in the classification o f the medial longitudinal arch height.
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The shape of the foot depends on: the configuration of its skeleton, the intrinsic and 
extrinsic muscle tone, and the tension and elastic properties o f the supporting 
ligaments, plantar fascia and other soft tissues. Despite their common anatomical 
characteristics, feet shape and biomechanics differ greatly between people [Razeghi et 
al. 2002]. These are a natural variations among people, manifested as a range of 
subtalar and ankle joints axis orientations in which they fall (described in 2.2.1), also 
as different dimensional and mechanical properties of foot structures. Dimensional 
properties refer to the shape o f bones, and mechanical properties refer to the initial 
tension and elastic properties of muscle and ligaments.
The most obvious morphological feature of the foot is the medial longitudinal arch. 
Foot type classification is focused on characterisation of this arch in terms o f its 
height and flexibility. Characterisation also describes the pronation/supination angle 
of the subtalar j oint.
Methods used for morphological classification of the foot include;
1. Visual non-quantitative inspection of the foot. In this method, the foot is inspected 
from all four sides as well as the dorsal and plantar aspects. The observer looks for the 
presence or absence of foot arches in order to classify arch height. The ankle and heel 
valgus and varus deformity is also assessed, and any other deformity that can be seen. 
Assessment is performed during both weight bearing and non-weight bearing. This 
method is subjective and can vary among different examiners. It also does not provide 
quantitative values which are important for scientific analysis. However it may be 
clinically useful to direct attention into mere presence o f foot deformity.
2. Anthropometric foot measurement. This method provides values for the medial 
longitudinal arch height and flexibility, and on rear foot valgus/varus position. 
Measurement may be performed in the following ways:
>  Medial longitudinal arch height; this is measured from the navicular tuberosity 
to the floor during 10% and 90% weight bearing in the standing position. The 
absolute value of arch height may not be meaningful as the same value can 
indicate high arch in small feet and low arch for long feet. Therefore the arch 
height is normalised to foot length [Williams et al. 2000].
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>  Medial longitudinal arch angle; this method measures the angle between the 
medial malleolous-navicular tuberosity line and the tuberosity on the medial 
aspect of MT head [Razeghi et al. 2002]. It effectively combines the arch 
height and foot length.
>  Rearfoot angle; this method gives an indication on the valgus/varus position of 
the heel. It is measured as the angle between the line bisecting the calcaneus 
and the line bisecting the lower third of the tibia [Razeghi et al. 2002]. 
Because the bones referred to here are deeply embedded in tissues, it is 
subjective and can vary among investigators. However it is still a useful 
method, it can provide information on the subtalar joint.
>  Navicular drop; this measures the navicular vertical sagittal excursion in the 
sagittal plane at 0% and 50% weight bearing [Razeghi et al. 2002]. Excursion 
may indicate the degree of subtalar pronation. This method could be a useful 
for providing information on the flexibility of the arch under loading.
>  Ankle valgus index; this is a measure of ankle position in the frontal plane. In 
this method the malleoli line is projected into the footprint. The line joining 
the projection points is related to the line between the midpoint of those 
projections to the centre of the 3rd toe. This method only provides information 
on the ankle joint in static but incapable in dynamic foot function [Razeghi et 
al. 2002].
The common factor to characterise the shape of the medial longitudinal arch is the use 
of the navicular height. The change in navicular height at different body weights is 
used to evaluate the flexibility o f this arch.
3. Footprint indices; this method uses foot prints to assess the medial longitudinal arch 
during standing or walking. Footprints are taken on ink pads or pressure transducers 
mats. In either case the following indices may be assessed;
>  Arch index. This method may be used to assess the medial longitudinal 
arch in static or dynamic situations. It assumes that foot structural changes
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will be reflected on the imprint. The process involves dividing the foot into 
three areas-hindfoot, midfoot, and forefoot using a defined process. The 
arch index is calculated as the ratio of the middle area to the whole area in 
the footprint (Figure 2.9A) this method provides an objective measure for 
comparative purposes with >94% reliability [Cavanagh et al. 1987].
> Arch angle; this is the angle between a line connecting the most medial point 
of the metatarsal heads to the most medial point of the heel, with a line 
between the most medial point on the MT heads and the point which first 
touches MT line (Figure 2.9B) [Razeghi et al. 2002]. This method is used to 
assess the arch height and has a reliability coefficient o f 97%.
CB
Figure 2.9 Foot prints showing different method of assessing foot morphology. (A) arch 
index=B/(A+B+C). (B) arch angle. (C) footprint index= A/B. Adapted from [Razeghi et al. 2002]
>  Footprint index; this is defined as the ratio of the area of the non-contact to the 
contact area on the footprint excluding the toes (Figure 2.9C). This method 
showed high reliability coefficient of 98.2% [Razeghi et al. 2002]. It gives 
information on the medial longitudinal arch that is in contact with the ground; 
hence it could be useful especially in the assessment o f flat or low arched feet.
4. Radiographic use. From radiographs, measurement can be made directly on bone 
images. This can be useful especially in cases where soft tissues are embedding the 
bones of the foot, for example in children whose arches are difficult to define 
externally and in cases of oedematous feet.
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5. Classification of feet based on their function. In this method the outcomes of foot 
function are characterised. For example, the centre of pressure path, which can be 
obtained from forceplates data, pressure mats, and pressure insoles, can be used to 
classify foot function. Lateral displacement o f this path from the line joining the end 
points of the path can be a useful indicator on the distribution of pressure under the 
foot.
Clinical evidence indicate a relationship between foot structure and injury, for 
example, both low and high arched feet have been associated with high risk of injury 
[Razeghi et al. 2002], and in low arched feet, muscle fatigue is suggested as a cause 
that leads to MT fracture [Hunt et al. 2004], however, research findings on the 
relationship between foot structural deformity and injury produce conflicting results 
[Cowman et al. 1993]. This controversy is probably due to the use of different foot 
type classification methods, or the employed methods not taking into account all the 
factors that may influence the functional properties of the foot, for example arch 
flexibility, selection of subjects for the research with similar physical activity level, 
body mass index, and foot length and breadth.
It is important to know that different people have different foot configurations, arch 
height and flexibility, especially with regards to the use of FO. For example, “Off the 
shelf’ FO with a medial longitudinal arch support are made with one arch height, 
which may not be appropriate for all types o f feet.
2.4 Foot function
From an ambulation perspective, the foot has two principal functions: weight support 
and body propulsion. Those functions are achieved by the bones, muscles, ligaments 
and plantar fascia working as a ‘team’.
All body weight is transferred through the talus. In normally arched feet, the foot rests 
on the calcaneus and MT heads. The posterior aspect of the arches end rest on the 
floor at the calcaneus, this end is located posterior to the subtalar joint. The anterior 
end rests on the MT heads and is located anterior to the subtalar joint. As body weight 
is applied the arches depress downwards acting as shock absorbers. Shock absorption 
is performed by ligament stretch, muscle control and the acceleration of arch bones in
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the direction of force. The ligaments are elastic and they stretch as the arches are 
depressed and spring hack as the weight is reduced off the foot. The muscles 
concentrically and eccentrically produce and control the rate o f motion of foot joints.
Nyska et al. (1997) studied foot adaptation under different loading levels, they 
concluded that the human foot adapts itself under loading condition by maintaining 
the medial longitudinal arch, and increasing the loading further activates 
compensatory mechanisms which maintain the longitudinal arch and shifts the loads 
to the central and medial forefoot.
Motion at the subtalar joint has a considerable influence on the function o f the foot 
and influences the rest o f the lower limb and pelvis. It compliments the sagittal 
motion of the ankle and modifies mobility o f other foot joints. At heel initial contact 
the subtalar is in slight supination (~2 degrees), by the time the foot becomes flat on 
the ground, at about 25% of the gait cycle, the subtalar reaches its maximum 
pronation (8-12 degrees). This pronation results in ‘unlocking’ of the midfoot joints 
thus putting them at their maximum passive range of motion [Seymour 2002]. This 
‘unlocking’ mechanism gives two functional benefits; first it allows the foot to 
conform to uneven grounds, second it gives the foot arches flexibility to absorb the 
impact of transferring body weight to the foot. As the tibia advances forward in 
preparation for propulsion, the subtalar starts to supinate, this ‘locks’ the midfoot 
joints and make the whole foot, except the toe, a rigid lever for efficient push-off. 
During push off, the foot reaches its maximum supination of ~6 degrees [Seymour 
2002].
The plantar fascia is a major contributor to foot function and stability [Bartold 2004, 
Tak-Man Cheung et al. 2004]. During push-off, as the heel rises off the ground, the 
toes are forced to dorsiflex (reaching a maximum of 55 degrees at toe off); this leads 
to a tightening of the plantar fascia. This tightening accentuates the foot arches and 
resists motion of all rearfoot and midfoot joints. This action is known as the windlass 
mechanism (Figure 2.10).
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Intrinsic
muscles
Plantar fascia
Figure 2.10 Windlass mechanism, plantar fascia tensed by dorsiflexion of the metatarsophalangeal 
joints. Adapted from [Perry 1992]
Simultaneously with the windlass mechanism, the subtalar joint is inverting, causing 
the relative orientation o f the calcanocuboid and talonavicular joints axes to diverge, 
and thus locking motion of the midtarsal joints. The tarsometatarsal joints are also 
locked by this mechanism. Therefore tightening of the plantar fascia and locking the 
midtarsal and tarsal joints makes the weight bearing parts of the foot rigid for weight 
bearing and leverage to roll over the MT heads and propel the body.
In normal walking, during the period from initial contact to toe off, progression is 
aided by three rockers (Figure 2.11); the first is heel rocker in which the foot rotates 
around the heel helping the rest o f the foot to become in contact with the ground. 
Second is the ankle rocker, here the foot serves as stable horizontal plate and the body 
is hinged on the ankle, this rocker allows the body to advance. Finally is the forefoot 
rocker, in this rocker the body is advancing over the MT heads and the foot serves as 
rigid plate.
Heel rocker Ankle rocker Forefoot rocker
Figure 2.11 Foot rockers that assist body advancement. Adapted from [Perry 1992]
Lower limb segments influence each other. After heel contact, as the weight is 
transferred to the heel the calcaneus pronates, this makes the talus rotate inwards.
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Because the dome of the talus is enclosed tightly in the ankle joint mortise, the tibia 
and fibula are forced to rotate inwards as well. This rotation is also transferred to the 
knee, however because the knee has a limited degree of rotational mobility, certain 
amount o f the rotational force is also transferred to the thigh.
Therefore the amount of motion at the subtalar joint not only influence the foot and 
ankle but also the knee and hip. This principle of coupling is important towards the 
understanding of the mechanics of injury to the foot and ankle, and more proximal 
joints. Subtalar joint motion is not only due to bone structure and muscle action, but 
can also be influenced by external factors such as the use of FO, which is the focus of 
this research. The range of motion at the subtalar varies considerably between people 
but on average it is 20 degrees inversion and 10 degrees eversion [Valmassy 1996].
2.5 Pain and injury in/or originating from the foot
Compared to a straight path, walking (or running) along a curved path or uneven 
ground is likely to increase the twisting and bending forces acting at the ground-foot 
interface which in turn may increase the forces acting on the foot and more proximal 
joints. Ideally foot shock absorption should reduce the possible undesirable effects of 
the loads on the body. When the foot is not performing its task appropriately or if  the 
loads are too high, pain or injury may develop in the foot or more proximal structures.
The body’s shock absorption capacity is dependant on bone strength, joint range of 
motion in the direction of the moment and the restraining ability of the foot ligaments 
and intrinsic and extrinsic muscles. Ligament restraining capacity depends on its 
initial tension and elasticity. Whereas muscle restraining capacity depends on its tone, 
strength and flexibility.
Pain can often be an early warning of a pending mechanical failure (injury) o f a 
skeletal component. Pain may lead to gait pattern modification, which place undue 
stress on skeletal structures. Stresses, if  prolonged, can lead to structural failure. 
[Perry 1992] states that excessive tissue tension is the primary cause of 
musculoskeletal pain. Standing still for long periods of time puts excessive stress on 
the tendons and ligaments o f the feet because the muscles are inactive [Marieb 1992].
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In many cases where foot pain is present, a FO is often sought to decrease tissue 
stresses with the aim of reducing pain and avoiding injury.
Structurally related problems arise from poor alignment o f bones within the foot or at 
the ankle joints. A common foot problem is a flat or low medial longitudinal arch. 
Low arched feet have a poor shock absorption capacity and can be symptomatic or 
asymptomatic. Tachdjian 1985 (as referenced by [Kuhn et al. 1999]) states that low 
medial longitudinal arch result from inward rotation of any of three joints; the 
talocalcaneal, talonavicular or naviculocuniform joint. This malalignment is suggested 
by Simkin et al. 1989 (as referenced by [Hunt et al. 2004]) to contribute to fatigue of 
the controlling muscles which can lead to MT fractures during exercise. Muscle 
fatigue can cause pain in the foot and alter the gait pattern.
Controversy between researchers on the link between low arched feet and injury is 
likely to be for many reasons including foot musculoskeletal condition, type and level 
of subject activity and more importantly poor foot type classification. Poor foot type 
classification may group low arched feet in one category despite having different 
strength and shock absorption capacity. This raises the need for a widely accepted 
foot classification method. This method might be successful in gaining acceptance if  it 
takes into account the dimensional, structural and functional characteristics o f the 
foot. Furthermore, it will be helpful for clinicians and researchers judgement o f the 
results of their studies.
High arched foot (pes cavus) is another structural foot problem that impairs foot 
function. Aetiology o f this condition is idiopathic (unknown cause) or neurogenic. Its 
prevalence is 8-15% of the population according to Walker et al. 1998 and Welton 
1992 ( as referenced by [Bums et al. 2005]). The majority of cases are idiopathic; 
however, neurogenic causes are manifested as muscle force imbalance on the foot. In 
all cases pes cavus is characterised by a stiff medial longitudinal arch and reduced 
foot contact area with the ground. A stiff arch does not deform as body weight is 
transferred to the foot. Hence the shock absorption capacity is reduced and foot pain 
may result. Also pes cavus has a reduced foot-ground contact area which leads to an 
increase in the pressure under the foot.
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Another foot problem is cuboid bone subluxation. The cuboid, as mentioned before, is 
the lateral longitudinal arch keystone. Its subluxation causes lateral foot pain [Kuhn et 
al. 1999].
Overuse injuries due to pathomechanical movement in the transverse plane has long 
been associated with injuries [Seymour 2002]. Excessive subtalar pronation has been 
associated with low back pain [Bird et al. 1999], patelofemoral pain (Tiberio 1987, as 
referenced by [DeLeo et al. 2004]), injury around the ankle [Briggs 2005], plantar 
fasciitis (the most common cause of heel pain) [Bartold 2004], and achilles tendonitis 
(D’Amico 1986 as referenced by [Nicolopoulos et al. 1999]. These conditions are 
characterised by pain.
Plantar fasciitis is characterised by inflammation and pain. One of the treatment 
options for heel pain incurred by this condition is the use of custom and ready made 
FO [Bartold 2004].
Other sources of pain and injury in the lower limbs include leg length discrepancy 
which has been associated with low back pain, hip pain and stress fracture in the 
lower extremities [Gurney 2002].
For people who are highly active and undergo strenuous exercises like sports, the 
possibility is higher that they may be subjected to sudden high twisting or bending 
loads. These forces may ‘overwhelm’ the shock absorption capacity o f the foot, and 
thus may cause foot bone fracture, Lisfranc ligament sprain, ankle sprain or other 
forms of damage to foot structures. These loads may also have a damaging effect on 
more proximal structure like knee ligaments or cause low back pain. This category of 
people may opt for a FO as a prophylactic measure in an attempt to boost the shock 
absorption capacity and reduce the chance of injury.
Examples of injury due to pathomechanical movements in the transverse plane are 
inversion and eversion injuries due to forces that tend to excessively invert and evert 
the foot. Inversion injury is more common than eversion injury and occurs when a 
person, for example, stumbles and severely supinates his foot. This can lead to a 
fracture of the tip of the lateral malleolous and base of the medial malleolous, whereas
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eversion injury occurs when a medially directed force acts on the foot that tend to 
forcefully evert the foot beyond its normal range of motion; this may leads to fracture 
the tip of the medial malleolous and the shaft of the fibula (Figure 2.12).
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Figure 2.12 Inversion and eversion injury to the ankle joint. Adapted from [Smith 1983]
Summary. This chapter accounted for many aspects of the foot and ankle complex. 
The presented aspects are important towards understanding foot pain and injury that 
might occur. Pain and injury have been associated with foot deformity, such as low 
arched feet. Foot pain may be a cause that makes people use FO to obtain pain relief. 
Hence, understanding the biomechanical effects o f FO is important towards 
understanding the possible benefit/risks of the use of FO, particularly “off the shelf’ 
FO as these are not custom-made for specific individuals and may potentially 
introduce undesired biomechanical changes.
Because different people have different foot morphologies, foot type classification is 
an important issue in the determination of feet that are susceptible to injury, 
furthermore, controversy in some of the research on the susceptibility of the foot to 
injuries indicate that the differences between foot types that were taken into the 
research is an important cause for this controversy.
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Having looked at the foot and ankle form and function, the next chapter will presents 
gait analysis methods that can he used to assess the biomechanical effects of FO, it 
also presents sources of gait data variability that affect gait measurement and the 
detection of FO effects.
Chapter 3 Introduction to gait analysis
Chapter 3
Introduction to gait analysis
3.1 Introduction
This chapter reviews normal gait and gait analysis methods, it also accounts for the 
sources of variability in gait data and how these can be managed. These areas are 
covered to justify the research aim and method used to investigate the biomechanical 
effects of FO on gait.
Methods of gait analysis include: observational and direct measurement. 
Observational gait analysis uses the human eye to observe and analyse the subject 
gait. This method is subjective, only useful for kinematics, and provides limited 
information on gait; however, it is still a useful quick means for finding obvious gait 
deviations. Direct measurement, on the other hand, uses equipment to record gait data 
which can provide more accurate information on gait, and results can be recorded and 
viewed any time.
For gait data, sources of measurement variability are issues of concern for both the 
clinicians and researchers. High variability in gait data can mask small changes in gait 
parameters that need to be detected. For the clinician and researchers; the lower the 
variability due to the measurement method the more confidence there will be in the 
analysis results.
Empirical gait data variability may be seen in sequential steps, this variability is 
further increased by variability due to the measurement errors. It is not yet clear how 
much natural variability is a good for the wellbeing and what constitutes a harmful 
variability. However, it seems that small variability could be useful as it distributes 
forces over greater size of tissue thus avoiding overuse injury [Kurz and Stergiou 
2003], however, this distribution should not be coupled with excessive tissue stresses 
(e.g. torsion) as excessive variability may be harmful if it is accompanied with 
stresses higher than usual.
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3.2 Review of normal gait
Gait is the term used to describe the manner or style of walking [Whittle 1996]. The 
elements that constitute a complete description of gait are the kinematics, kinetics, 
electromyography (EMG), and energy consumption.
Walking and running are composed of repetitions of gait cycles (GC). The GC (figure
4.1) can be defined as the period between two successive occurrences o f one of the 
repetitive events of walking [Whittle 1996], for example, from heel contact to heel 
contact of the same limb. Any event throughout the gait cycle can be chosen to define 
the start and end o f the gait cycle; however, it is customary to take this event to be 
initial heel contact.
As shown in figure 4.1, the GC is divided into two main phases; stance (-60% of the 
GC), and swing phase (-40% of the GC and each phase is divided into sub-phases. 
Each sub-phase has a specific functional role, collectively all GC phases lead to 
propulsion of the body.
The GC sub-phases are: loading response (LR), mid-stance, terminal stance, pre­
swing, initial swing, mid-swing, and terminal swing (figure 3.1). Normal gait varies 
between normal subjects (inter-subject variability) and within the same subject at 
different times (intra-subject variability), therefore the durations o f the sub-phases 
given below are approximate and can vary among individuals. However, a normal gait 
has the following major events during the GC:
1. Initial contact
2. Opposite toe off
3. Heel rise
4. Opposite initial contact
5. Toe off
6. Feet adjacent
7. Tibia vertical
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Figure 3.1 The GC main phases and sub-phases, showing the leg position during a single gait 
cycle of the leg (shaded). Adapted from [Whittle 1996]
Loading response occupies the first 10-12% of the GC; this is from initial contact to 
opposite toe-off. During this period body weight is transferred to the advancing limb 
and the shock is absorbed. During this phase heel rocker takes place.
Mid-stance occupies the period 10-30% of the GC. It starts from opposite toe-off until 
heel-off. This represents half the period of single limb support during which the body 
is progressing over a stationaiy foot. Advancement is achieved over the ankle rocker. 
During this period, body weight is mainly borne on the heel and MT heads.
Terminal stance occupies the period 30-50% of the GC. It starts at toe-off and ends at 
contralateral initial contact. This represents the second half of single limb support 
during which the body continues to advance but over the forefoot-rocker. During this 
period the body weight is borne mainly on the MT heads.
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Pre-swing occupies the period between 50-60% of the GC. It begins at contralateral 
initial contact until ipsilateral toe-off. During this period body weight is transferred to 
the contralateral leg.
The swing phase occupies about 40% of the GC. It is composed of three sub-phases; 
initial-swing, mid-swing and terminal swing.
Initial swing occupies the interval between 60-73% of the GC. It starts at toe-off and 
ends when the feet are adjacent. During this phase the trailing limb advances forward 
and the foot is in a position to clear the ground.
Mid swing occupies the interval between 73-87% of the gait cycle. It starts at feet 
adjacent and ends when the tibia is vertical. Similar to initial swing, this phase serves 
limb advancement as the foot is clear off the ground.
Terminal swing occupies the interval between 87-100% of the GC. It begins when the 
tibia is vertical and ends at initial contact. This phase completes limb advancement 
and prepares the limb for the next GC. Table 3.1 summarizes the GC sub-phases 
timings and objectives.
Table 3.1 Timing and the objectives of gait cycle sub-phases (Timing and objectives taken from 
[Perry 1992]
Phase Timing Objectives
1. Loading response 0-10% GC
1. Shock absorption
2. Weight bearing stability
3. Preservation of progression
2. Mid stance 10-30% GC
1. Progression over the stationary foot
2. Limb and trunk stability
3. Terminal stance 30-50% GC 1. progression of the body beyond the supporting foot
4. Pre-swing 50-60% GC 1. Position the limb for swing
5. Initial swing 60-73% GC
1. Foot clearance of the floor
2. Advancement of the limb from its trailing position
6. Mid swing 73-87% GC
1. Limb advancement
2. Foot clearance from the floor
7. Terminal swing 87-100% GC
1. Complete limb swing
2.Prepare the limb for stance
3.4
Chapter 3 Introduction to gait analysis
3.3 Gait analysis methods
Gait analysis is a tool used to describe gait. The use of gait analysis provides useful 
information about gait that can be used to assess the effects of interventions such as 
physical therapy programs and FO. Methods of gait analysis can be simple using no 
equipments and relying on the expertise of the observer, or complex using gait 
measurement equipment. The selection of gait analysis method depends on the 
purpose for which gait is analysed. In the clinical setting the use of high technology 
equipment may not be suitable due to the cost and time required to obtain gait 
measurement results, however, observational gait analysis may be a more suitable in 
the clinic. TTiere is ongoing work to develop methods which can give gait results in 
real-time; however until this method is resolved, observational gait analysis remain 
the method of choice in the mean time.
3.3.1 Observational gait analysis
This method, as outlined above relies on the skill o f the observer. The observer looks 
for specific gait abnormalities while the subject is walking or makes a vedio recrding 
of gait and assess gait later. In either case the observer relies on his eye and mental 
judgment o f gait normality/abnormality.
Observers may document their observations o f gait using the Physician Rating Scale 
(PRS), the Edinburgh Visual Gait Analysis Interval Testing (EGAIT) scale, or the 
Rancho gait analysis system. These gait assessment scales divide the body into trunk, 
pelvis, hip, knee, and foot regions. The observer assesses specific events in these 
regions, for example, if there is normal heel-midfoot-forefoot contact sequence during 
stance.
Observational gait analysis can be useful especially in the clinic; it helps in 
identifying the functional task that require rectification and the sub-phase in which 
this problem occurs, however, it suffers from many limitations:
i. It is qualitative and subjective, thus can not provide numerical values on joint 
angles.
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ii. High occurring events can not be captured by the human eye; the eye can 
sample at about 16 Hz [Kirtley 2006]. Hence events occurring at higher 
frequency will not be captured by the eye.
iii. It can only provide information on body segment motion. Forces, however, 
can not be measured.
iv . It is entirely dependent on the skill of the observer.
The reproducibility of the results using this method of gait analysis is reported to be 
moderately reliable (Kerbs et al. 1985, cited in [Whittle 1996]).
This method of gait analysis involves observing the subject from the front, back and 
sides while the subject makes a number of walks. The observer will be looking for 
specific gait abnormalities (Table 3.2), each of these gait abnormality indicate a 
functional deficit that needs to be rectified.
Table 3.2 Common gait abnormalities and best direction for observation [Whittle 1996]
Gait abnormality Observing direction
Lateral trunk bending Side
Anterior trunk bending Side
Posterior trunk bending Side
Increased lumber lordosis Side
Circumduction Front or behind
Hip hiking Front or behind
Steppage Side or front
Vaulting Side
Abnormal hip rotation Front or behind
Excessive knee extension Side
Excessive knee flexion Side
Inadequate knee flexion control Side
Abnormal foot contact Front or behind
Abnormal foot rotation Front or behind
Insufficient push-off Side
Abnormal walking base Front or behind
Rhythmic disturbances Side
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It is also important to compare the range of motion of joint during walking with those 
found on the examination table, as this could help identify the source o f gait 
deviation.
The selection of either observational or direct measurement of gait is application 
dependent. Observational gait analysis is subjective, incapable of detecting small 
parameter changes, can not provide information on joint kinetics, and can not provide 
numerical values on gait parameters. Therefore, for the purpose of investigating the 
effects of “off the shelf’ FO, it is considered inappropriate. Hence direct measurement 
is the remaining option.
3.3.2 Gait analysis by direct measurement
Direct measurement provides data on gait that can be recorded and viewed any time. 
This method of gait analysis is used to obtain one or more of the following outcome 
measures: joint angles, body segment velocity and acceleration, pressure underneath 
the foot, muscle activity, energy consumption, and ground reaction force (GRF).
Because the effects of FO to be tested in this research are expected to be small; 
reliability and precision of the selected gait measurement equipment is o f paramount 
importance. Furthermore, to enable comparison with the literature, the aim o f this 
research was to investigate the temporal-spatial, 3D joint angle, and 3D joint moment 
changes due to the use of FO (justification for these is given in 4.3). This restricted 
the equipment selection options as follows:
Joint angles can be measured using a variety of methods including goniometers, 
gyroscopes, accelerometers or camera-based kinematic systems. The goniometers and 
camera-based approach are the most common. For example, the Biometric 
electrogoniometers (Biometrics Ltd., UK) are placed directly on the body such that 
each of its two arms is on one of two adjacent segments. Kinematic systems 
commonly use passive or active markers that are placed on the body segments and are 
tracked using special cameras. For simultaneous collection of multiple joint angles, 
the kinematic approach is perhaps the most convenient in the laboratory setting.
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Kinetic systems measure GRF using force plates or pressure insoles. GRF obtained 
from force plates has proved to be highly repeatable [Growney et al. 1997]. However, 
commercial pressure insole current technology can only provide the vertical 
component of GRF and no information on the shear forces can be obtained from such 
devices which may eliminate vital information on shear forces.
The combined kinematic and kinetic system integrates data of joint angles with GRF 
to estimate joint moment, power, and joint reaction force (JRF). This information is o f 
great value in determining the biomechanical effects of FO and is in the scope of this 
work. Yet, these systems have their limitations, e.g. they provide the net muscle 
moment and no information on individual muscle contribution, also joint angles are 
usually obtained from skin markers used to track embedded bone motion which can 
introduce some errors.
Pressure underneath the foot can be measured using pressure insoles, for example, 
Tekscan insoles (Tekscan, Inc. MA, USA). The centre of pressure may also be 
derived from force plate data. Pressure insoles suffer from many limitations such as 
drift which cause their output to increase as pressure of the foot is applied for longer 
time. The limitations o f these devices make them unsuitable for the FO test design.
Muscle activity can be measured using electromyographic equipment in which an 
electrode is placed on the skin or a needle is inserted into the muscle to record the 
electrical signals from muscles. The limitation of this method is that the obtained 
signal on muscle activity does not directly reflect muscle tension as the mathematical 
relationship between muscle tension and EMG signal is unknown particularly in non­
isometric contraction. Therefore, these equipments are of little benefit for assessing 
the effect of FO on muscle tension.
Energy consumption can be measured from the amount of oxygen the body consumes 
during a particular gait activity, however, there is no defined relationship between 
oxygen consumption and mechanical activity. Although energy consumption is very 
relevant to outcome measure in many clinical applications, in this project the 
biomechanical effects was to be investigated and therefore energy consumption was 
not considered further.
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3.4 Variability in gait data
3.4.1 Variability definition and outline
If variability in gait data was always zero then taking a single measurement from a 
subject or a patient will be enough to base significant clinical or research decisions. 
However, in reality this is not the case, and there is a need to investigate the sources 
of variability, assess its magnitude in the data, and find ways to minimize these 
sources and their effects on the computed parameters.
Gait variability may be defined as the fluctuation in the data of temporal-spatial, 
kinematic, kinetic, and electromyographic measurement [Chau et al. 2005]. 
Variability can be divided into three categories; intrinsic, pathological, and extrinsic 
factors (Figure 3.2). Intrinsic factors include the inherent natural variability, the effect 
of aging, and limb length. Pathological factors include the medical conditions such as 
diseases and injury that affect gait e.g. Parkinson’s disease or traumatic injury to the 
lower limb and nervous system* Extrinsic factors include instrumental error, 
measurement method, and random soft tissue artefact.
D iseases Trauma
PathologicalIntrinsic Extrinsic
Total variability
Inherent Aging Limb length Instrumentation Skin artefact M ethodological
Figure 3.2 Sources of gait data variability. Adapted from [Chau et al. 2005]
Human gait is inherently variable. This is not always a bad sign, in fact natural gait 
variability has been justified as an occurrence that overcomes repetitive impact forces 
by joint motion pattern and thereby spreading the joint forces over various tissues to 
prevent over use injury [Kurz and Stergiou 2003]. It may also be a key ingredient for 
energy efficient and stable gait [Chau et al. 2005]. Variability is also used as an out 
come measure for many health related issues, for example to assess fall risks in the
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elderly population [Hausdorff et al. 2001] and gait development in children Hausdorff 
et al. 1999 cited in [Chau et al. 2005].
Pathological variability is also used as an indicator to the presence o f medical 
conditions that affect gait such as Parkinson disease [Hausdorff et al. 2000 cited in 
[Chau et al. 2005] and offers an insight into neuromuscular control mechanism 
[Dingwell et al. 1999]. In these studies, assessment of variability in patients is usually 
performed against a control group that is considered to be normal.
In analysing gait data, high variability affects the quality and hence our confidence in 
this data. It can also mask important changes in gait pattern. Investigators try to 
minimize the effect of gait data variability by devising alternative gait measurement 
methods and using mathematical optimization techniques to manage data variability.
[Benedetti et al. 1998]) states that; clinical applicability of gait analysis depends on 
the precision, accuracy and reproducibility of the measures obtained. [Baker 2006] 
states that; measurement can be repeatable and stable without necessarily being 
accurate, these measurements may be clinically useful, but will be much easier to 
interpret if they were also accurate. Both o f these arguments are valid, however 
usability o f such data depends on the application for which it is intended to. Although 
no gait data can be perfectly repeatable (for the reasons stated above), it is still useful 
especially for within subject comparison purposes provided that it has high 
repeatability.
Variability is commonly assessed by computing the coefficient of variability (CV) 
[Winter 1991], the coefficient of multiple correlation (CMC) [Kadaba et al. 1989], 
and standard deviation (SD) [Perry 1992; Kurz and Stergiou 2003]. The former two 
statistical tools have the mean as the dominant factor in the denominator o f their 
formulas which may make the results unfairly high or low if the mean o f the 
waveform is large or small which may question their accuracy, however, they are 
useful for comparison within subject provided the measurement technique is 
repeatable.
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3.4.2 Intrinsic sources
Inherent variability is present in everybody even in young and healthy subjects 
[Danion et al. 2003]. This source of variability may be observed in all gait parameters.
Walking speed variability in normal adults is moderate showing a SD of 7% and 4% 
for indoor and outdoor respectively [Murray et al. 1964 and Waters et al. 1988 cited in 
[Perry 1992]. In turn, walking speed has an influence on joint angle [Benedetti et al. 
1998; Hanlon and Anderson 2005], hence leading to variability in joint angle 
parameters. Walking speed also influence the GRF, most joint moment amplitude as 
well as temporal-spatial parameters [Benedetti et al. 1998].
There is some controversy in the literature regarding the influence of walking speed 
on temporal-spatial variability; one study concluded that it has no statistically 
significant effect on step length, width, and step time variability [Owings and 
Grabiner 2004]. Another study [Danion et al. 2003] affirms a fundamental link 
between walking speed and variability in step length and step frequency. It seems that 
the first study although found a measurable increase in variability of step length, step 
width and step time (14%, 20% and 17% respectively), it relied solely on statistical 
significance to conclude a no effect state, however, in medical research, Altman 
recommends to measure the magnitude of change rather than its statistical 
significance [Altman 1990]. A reason for the former study not showing statistical 
significance could be methodological; the treadmill may reduce variability, and/or the 
averaging of multiple trials which could iron out variability differences.
Natural aging of healthy subjects affects the performance of the locomotor system 
which is reflected on the variability of step width [Grabiner et al. 2001; Owings and 
Grabiner 2004] and stride period (Hausdorff et al. 1997 cited in [Chau et al. 2005]) 
parameters.
Intrinsic variability may also arise from the subject selection criteria as different 
subjects have different intrinsic variability. These include BMI, leg length 
discrepancy (LLD), gender, and dominant side. In this research a strict subject 
selection criteria (explained in the method chapter) was set to minimize the possible 
effects of those factors on the collected data.
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Gait variability due to limb length is linked the child’s growth. Between the age of 1 
and 7 years the leg length increases by 194% and variability doubles, as measured by 
the SD, also increases from 2% to 4% (Sutherland et al. 1980 cited in [Perry 1992]). 
Similar relationship is assumed in adults although the correlation is weaker (Grieve 
and Gear 1966 cited in [Perry 1992]).
3.4.3 Pathological sources
Pathological sources due to diseases, like Parkinson’s disease, increases gait 
variability due to the impairment the disease inflicts on the neurological system 
function (Hausdorff et al. 2000 cited in [Chau et al. 2005]). A study [Merory et al. 
2006] on patients with Alzheimer disease showed that those patients had higher step 
length variability (measured by the CV) compared to a control group of normal 
subjects. Also step width variability was higher in this patient group at preferred and 
fast speeds, but not at low speed. A study by [Dingwell et al. 1999] of diabetic 
patients with and without peripheral neuropathy against a control group of age and 
weight matched healthy subjects showed trends (statistically not significant) of 
increased variability (measured by CV and SD) in step time and sagittal joint angles. 
The study showed that diabetics with peripheral neuropathy had the largest increase in 
variability which suggests that sensory feedback plays an important role in the control 
mechanism of locomotion. These studies on the effects of medical conditions 
concluded that these diseases increase the variability o f some gait parameters.
3.4.4 Extrinsic sources
Extrinsic sources due to instrumentation are those errors that come from the 
measurement equipment (e.g. cameras), noise from mains, marker flickering, and 
digitization which contaminate and cause error in the determining the real marker 
position. This can lead to systematic and random error in the processed data [Chiari et 
al. 2005].
For example, systematic errors are due to inadequacy in the model used to account for 
image distortion (Woltering 1990 cited in [Chiari et al. 2005]]). The magnitude of 
systematic error in marker position reconstruction depends on the size of the 
measurement volume and the position of the marker within this volume (Gazzani 
1993 cited in [Chiari et al. 2005]), a typical error in real marker location is 2-3mm in
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all three dimensions [Whittle 1982 cited in [Whittle 1996]. Cameras manufacturers 
report this error to be 1/3000 of the diagonal of the measurement volume [Chiari et al. 
2005]. Force plate calibration sets the zero base line without calibration an offset will 
be in the data and this may lead to errors in the calculations of joint moment, power, 
and joint forces.
Camera calibration sets the position of the camera with respect to the global 
coordinate system; this helps to reduce systematic errors due to image distortion 
[Chiari et al. 2005].
Random errors are due to mains noise, marker flickering, and marker digitization 
process [ Della Groce and Capozzo 2000; Fumee 1997 cited in [Chiari et al. 2005], 
marker shape distortion, partially obscured marker images, and markers merger 
[Fumee 1997; Pedotti 1995 cited in [Chiari et al. 2005].
The use of filtering techniques to smooth the data can reduce the random errors of 
noise in gait data. However, the low pass filtering process itself may remove 
important fast occurring (high frequency) events like heel strike transient [Whittle 
1996]. Interpolation of missing marker images represents the best estimate of marker 
position in the empty marker trajectory.
Methodological errors arise from the assumptions o f the model, for example, the 
estimation of joint centre, position of joint centre during locomotion, and segment 
dimensions; these are assumed to be fixed during locomotion. In reality there are 
always errors in joint centre estimation, and the joint centre of rotation moves as the 
joint flexes [Kirtley 2006]. These errors originate from differences in segment 
dimensions and weight between subjects.
Methodological errors may also arise from the laboratory setup; these mainly include 
the number of cameras used and the size of the measurement volume. To some extent, 
the more cameras are used to capture the data the more accurate marker position 
determination (digitization) will be; a study reported an error of 1:5000 when using 4 
cameras, and 1:15000 when using 36 cameras (Shortis 1988 cited in [Chiari et al. 
2005]). The closer the cameras are positioned to the measurement volume the smaller
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the measurement volume will be and hence a smaller diagonal, which means a 
reduced error in marker position estimation.
Another methodological source of variability is marker placement and alignment. 
This source is considered as the largest cause of gait data error and variability 
[Kadaba et al. 1989; Carson et al. 2001]. If a comparison is carried out between trial 
sessions where markers are placed then removed then placed again a few days later, 
then marker reapplication is very likely to be different between days. This causes 
variability in gait data due to differences in markers reapplication.
Methods dealing with variability due to marker placement and alignment include 
optimization techniques [Baker et al. 1999], knee alignment device (KAD) by 
(Motion Lab Systems, Inc., Baton Rouge LA), and transepicondylar axis (TEA) 
(Churchill et al. 1998 cited in [Schache et al. 2006]). The first method uses 
mathematical formulation to reduce variability due to crosstalk in knee joint angles by 
rotating the knee joint axis around the long axis of the thigh until crosstalk reaches its 
minimum value. The second method uses a three jaw device to align the knee joint 
axis independent of the thigh and shank markers. The third method orients the knee 
axis using the most prominent epicondyles of the femur. Out of those three methods, 
the optimization technique provided the best results [Schache et al. 2006]. However, 
optimization technique should be used as an aid not as a routine retrospective 
correction of data for erroneously placed markers [Baker et al. 1999].
Methodological source o f variability may also come from data averaging. Usually, 
when reporting data a parameter is an average of a few trials, this could affect the 
magnitude of peak values and may also shift their position (timing).
Obesity leads to changes in temporal-spatial and angular parameters [Spyropoulos et 
al. 1991], another study [Hills and Parker 1991] showed that those angular changes 
are largely not different from those of normal-weight subjects, however, compared to 
normal-weight subjects, obese subjects had lower stability and more variable pattern 
of rotations at all joints and for all speeds. Obesity causes an increase in rearfoot 
motion and forefoot abduction during walking greater than those in normal-weight
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subjects [Messier 1994]. The increase is possibly due to the higher loading of the 
rearfoot during the loading response phase of the GC.
LLD of more than 20mm (3.7% of leg length) in children can lead to gait asymmetry 
great than those observed in the normal population, and this asymmetry increases as 
LLD increases [Kaufman et al. 1996]. When LLD was more than 5.5% of leg length, 
a toe-walking gait was used as compensatory mechanism in normal children [Song et 
al. 1997]. A study found that LLD of more than 3.2mm causes increased rearfoot 
eversion during stance (Blake and Ferguson 1993 cited in [Gurney 2002]).
Laterality in able-bodied subjects has been referred to as an explanation for the 
functional differences in the lower extremities, those differences are natural, and 
probably reflect the contribution of each limb in carrying out the task of propulsion 
and control during walking, furthermore, gait symmetry has been assumed to simplify 
data collection and analysis [Sadeghi et al. 2000].
Females have significantly greater variability (measured by SD and CV) than males in 
the time-distance parameters at a given speed [Yamasaki et al. 1991], females tend to 
increase their speed by increasing their cadence rather than step length [Yamasaki et 
al. 1991; Cho et al. 2004]. Differences in gait pattern were also seen; females have 
significantly (P<0.0019) greater hip flexion and less knee extension before initial 
contact [kerrigan et al. 1998].
Force plate targeting may also be considered as a methodological source of error and 
variability in the collected data. A study by Wearing et al. o f 11 healthy subjects 
targeting a force plate at self-selected speed showed a significant (P<0.05) increase in 
the variability of step length, however, no significant (P<0.05) difference were seen in 
the GRF parameters [Wearing et al. 2000].
Finally, an extrinsic source of gait data error may come from soft tissue artefact. The 
gold standard is to track bone motion by placing markers on pins inserted into the 
bone, however, for obvious reasons this is not practical. Usually markers are placed 
on the skin to track bone motion. Because o f the relative motion between the 
skin/muscle and bone, this leads to what is known as soft tissue artefact.
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Soft tissue artefact is considered as the most critical factor in determination of 
segment position and orientation [Cappozzo et al. 1996], this is due to the relative 
inter-marker movement, and movement between markers and the underlying bones.
Largest skin artefact was found near joints, however mid-segments do not provide a 
rigid base for markers [Karlsson and Tranberg 1999]. In the lower limbs, skin 
movement artefacts were up to 40mm, largest at the greater trochanter, these artefacts 
became progressively smaller further down the leg, and the largest artefact was in the 
vicinity o f joints, hence, these sites are not suitable sites for markers [Cappozzo et al. 
1996]. Those artefacts are linearly associated with knee flexion [Lafortune and Lake 
1991 cited in [Leardini et al. 2005].
Other studies showed different artefacts values, however they were within 40mm 
[Karlsson and Tranberg 1999]. Artefacts are subject-specific, and discrepancies 
between reported researches may be due to different techniques used, large inter­
subject variability, differences in the tasks performed, and different locations for skin 
markers [Leardini et al. 2005].
To minimize the effect of artefacts, [Cappozzo et al. 1996] recommends that markers 
locations should be chosen where least skin movement occurs, and the use o f an 
optimisation technique to reduce its effect on the results.
Concluding remarks. This chapter justified the selection of the parameters which will 
be used to investigate the biomechanical effects o f FO on gait. It also justified the 
selection of the equipment which will be used for measuring these parameters.
Variability in gait data can mask gait parameter changes due to, for example, FO. It is 
important to adopt a strategy that can minimize the effects of methodological factors 
on gait data variability.
The next chapter gives an account of FO, the published research on their 
biomechanical effects, and the adopted method to investigate these effects.
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Chapter 4
Foot Orthoses: An introduction and literature review
4.1 Foot orthoses
The International Standards Organization (ISO) defines an orthosis as: An externally 
applied device used to modify the structural or functional characteristics o f the neuro- 
musculo-skeletal system [Pratt 1995].
4.1.1 Introduction
FO have been used to treat many conditions such as foot pain reduction in 
rheumatoid arthritis [Mejjad et al. 2004], low back pain [Ball and Afheldt 2002], and 
overuse injuries [McPoil and Cornwall 2000]. FO treatment has had varying degrees 
of success; for example, running injuries treated with FO report success in the range 
of 50-90% [Stacoff et al. 2000; Mundermann et al. 2003]. Some FO designs are 
successful in treating certain foot conditions, however, many FO do not have 
predictable results [Kogler et al. 1995]. Furthermore, there is no consensus on FO 
shape, material properties, and placement of components for any particular FO 
application [Stacoff et al. 2000].
The clinical use of FO is anecdotal and is not often based on a good understanding of 
which FO to use and how a FO will achieve the desired goals [Kogler et al. 1995; 
McPoil and Cornwall 2000; Nicolopoulos et al. 2000; Stacoff et al. 2000; Ball and 
Afheldt 2002]. However, an explanation of the role materials play in FO (given in
4.1.1) may help in the understanding of how FO achieve their goals.
The FO is placed at the interface between the sole of the foot and the shoe. The shape 
and the mechanical properties of FO modify the magnitude and timing of the loading 
on different areas underneath the foot to achieve the desired function of the foot and 
lower limb.
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There is no consensus on one classification of FO, however, in general, FO are 
classified according to their material properties as rigid, semirigid, and soft 
(accommodative) [Seymour 2002]. According to the design and purpose of these FO, 
they may be used as functional modifiers or accommodative. Functional FO are made 
of harder materials and offer a greater resistance to loading than the accommodative 
FO which are made of soft materials.
The success of a FO depends on clinical and biomechanical examination of the foot, 
the material properties, the fabrication technique, the casting technique and the 
education of the patient [Nicolopoulos et al. 2000].
4.1.2 FO material properties
Rigid FO are made of thermoplastic materials such as acrylic plastics, semirigid FO 
are made of materials such as leather or cork, and soft FO are made of rubber foams 
such as Plastizote (JMS Plastic Supply, New Jersey, USA). Although these are 
general categorization of material types, there is an overlap in their mechanical 
properties. For example, polymer resin comes in a range of rigidity between soft and 
very rigid, which overlaps with cork and rubber foams.
The mechanical properties of FO materials include their response to temperature, 
durability, elasticity, viscosity, and hardness.
Response to temperature is an important characteristic of FO material for 
manufacture. Low temperature setting materials, such as ‘Orthoplast’ (Johnson and 
Johnson, Raynham, Mass., USA), become soft and mouldable at around 70°C. 
Moulding of such material is easy and can be made using hot water.
The durability of FO material is the ability o f the material to maintain its mechanical 
characteristics under repeated cycles of loading over a period of time. Repeated 
loading compromises material strength and increases the risk of failure [Nielsen and 
Lusardi 2005]. High material durability ensures consistent FO performance.
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Elasticity is the ability o f a material to return to its original state, which is an 
important feature for the continued function of FO, as the shape and dimension of the 
FO, or any of its components, is very important for maintaining support during the 
repeated loading on the FO during gait. A highly elastic material will return stored 
energy to the foot.
The degree of viscosity determines the energy absorption capacity; highly viscous 
material requires force to be applied over a long period of time to cause material 
deformation. Viscous material absorbs most of the energy and will produce lower 
GRF than would be seen in an elastic material [Whittle 1999].
Hard materials have low or absent viscosity and thus will have a low exchange of 
momentum between the foot and the ground resulting in high GRF. The relationship 
between surface hardness and GRF is illustrated in Figure 4.1. This explanation of the 
effect o f material can help in the understanding of the mechanism by which FO 
achieves its goals by considering the material properties of FO and their effects on 
GRF.
»
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Figure 4.1 Relationship between surface hardness and the GRF; higher force occurs over a shorter 
period of time when interface is harder and vice versa. Momentum exchanged between the ground 
and the foot, represented by the area under the curve, is the same in each case [Whittle 1999].
4.3
Chapter 4 FO & literature review
In general, the selection of material type depends on the following factors pertinent to 
the subject or patient; age, level of activity, weight, and shoe style [Nicolopoulos et al. 
2000]. Furthermore, the medical condition is also a very important factor in the 
selection of material type. For example, a diabetic patient with peripheral neuropathy 
would normally be given a soft material FO as the skin of their feet is thin and fragile, 
and the patient will not be aware of foot injury if  it happens. The selection of soft 
material, as illustrated in Figure 4.1, reduces GRF and therefore reduces the risk of 
skin injury.
When considering the interaction between the FO and the foot, added to the role of 
elasticity and viscosity, thickness is an important factor in determining FO efficacy 
(Garcia et al. 1994, cited in [Whittle 1999]); as the foot is loaded and moving 
downwards, it will come to a halt in a finite distance, the longer this distance the more 
time is available to halt the foot and the less the force necessary to stop the foot.
Summary. The material viscoelastic property and thickness largely determine the 
effect of a FO. On contact with the foot, the material of FO may produce sensory 
feedback stimuli that can play a role to modify gait. The selection of FO material type 
and thickness should be determined according to the physical condition of the subject.
4.1.3 FO designs and types
Root et al. (1971, 1977) developed a FO paradigm for classifying joint disorders and 
directing treatment approaches that was based on having the subtalar joint function 
around its neutral position, however, clinical success is achieved both inside and 
outside this paradigm [Ball and Afheldt 2002]. Other authors agree with this principle 
and state that accurate capture and maintenance of the neutral subtalar joint position is 
a key for successful management o f running injuries using FO [Seymour 2002].
Non-prescription FO are found in shops, such as sports shops and chemists, in 
different shapes and made from different material types. Shapes range from lA length, 
% length, to full length. FO may also be just a component such as arch supports or a 
heel pad. The materials used in these FO are mostly polymers, for example, Gel or 
rubber foam, with varying range of mechanical characteristics. A wide variety of FO 
are made by manufacturers world wide, for example, Boots Pic (Nottingham, UK)
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have their own brand of FO in a range designs. Also world manufacturers, like Implus 
Corporation (Morrisville, NC, USA) make a wide range of FO with different designs 
and component incorporation. These products are distributed in the UK and world 
wide and can be easily ordered by the public at accessible prices (~£8 per FO pair).
Examples of some these types and designs o f FO are given in Figure 4.2. It should be 
noted that rigid and semirigid FO can only be % length or less and do not extend 
beyond the metatarsal heads. This is to permit the third foot rocker during ambulation.
Figure 4.2 Different FO materials and designs. Top left is a Root rigid FO and top right is the 
University of California Biomechanics Laboratory (UCBL) semirigid FO [Valmassy 1996]. 
Middle is a forefoot posting (A) and rearfoot posting (B) [Nielsen and Lusardi 2005].
The bottom two illustrate designs of dress shoes FO made from soft material [Seymour 2002].
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The Root functional FO (Figure 4.2) is designed to function in a dynamic way by 
initiating normal movement and function. It can be made from many rigid materials 
like Polypropylene, which is draped on a foot cast taken in a subtalar neutral position. 
It aims to maintain rearfoot eversion and midfoot stability [Valmassy 1996]. Note the 
slight heel dip in the FO which may be useful to control calcaneal eversion.
The UCBL device is designed to treat flexible flatfoot condition. This FO is made 
from a foot impression during weight bearing, and is made from light and thin 
semirigid Polypropylene. It has deep flanges and heel cup, which make it a choice for 
the treatment of pes planus [Valmassy 1996].
The soft dress shoes FO (Figure 4.2) are made from soft pliable materials and are 
mainly aimed for comfort and shock attenuation. These are made in a variety of 
deigns and dimensions. The two FO to be evaluated in this research fall in the later 
category of FO.
4.1.4 FO fabrication
According to [Goodwill and Chamberlain 1988] prescription of FO should be made 
with consideration to the followings:
1. The aims of the orthoses
2. What joints are to be treated
3. What materials are to be used
4. What pressure points must be avoided
5. How the patient will don and doff the FO
6. How the patient will fasten it in position
7. How the cosmetic appearance will be achieved
Further to these guide lines it may be useful to account for the patient foot tolerance 
and psychological acceptance of using a FO.
Both prescription and non-prescription FO may incorporate one or more of the 
following components;
1. Simple flat insole
2. Medial longitudinal arch support
3. Heel pad, heel cup, or Metatarsal pad
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4. Medial or lateral wedge
Custom-made FO may be produced from either a simple outline of the foot or a foot 
positive impression taken while the foot is in neutral position. In the former method 
the foot is placed on a paper and an outline is drawn around the foot. In this method 
only soft materials, e.g. Plastizote (JMS Plastic Supply, New Jersey, USA), that do 
not require moulding can be used to produce FO.
In the later FO production method, a positive impression of the foot is produced using 
one of two techniques; negative plaster cast of the foot, or foot impression box. In all 
methods the positive impression is rectified as required. In this method FO can be 
made from soft or rigid materials. Rigid materials are heated to high temperatures 
(e.g. Polypropylene at ~180°C) and then draped on the positive cast of the foot.
Production of negative plaster cast of the foot involves capturing the subtalar joint in 
the neutral position. This may be achieved by placing the subject in a prone position 
on the examination table with the hip in the neutral position and the foot hanging 
down beyond the examination table (Figure 4.3).
Figure 4.3 Determination of subtalar joint neutral position and casting. Left: the position of the 
patient, positioning 1st and 5th fingers on talus, and dorsiflexing the foot to neutral. Right: casting 
in this neutral position [Nielsen and Lusardi 2005].
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The 1st and 5th fingers o f one hand are placed medially on the talus head and laterally 
on the talus, then using the other hand, the foot is moved in pronation/supination to 
feel the talus by the two fingers. The foot is then moved in small motions until the 
talus can not be felt by either finger. In this position by using the other hand, the foot 
is dorsiflexed to neutral until resistance is felt; this will be the subtalar neutral position 
[Seymour 2002], The foot cast is taken in this position. The foot cast is then filled 
with plaster to obtain a positive cast; this cast is then used to produce the FO using the 
selected material.
A foot positive cast can be produced using the foot impression box (Figure 4.4), the 
box contains special foam which compresses with pressure and maintains its form 
when pressure is removed. The subject places his foot on the foam and presses until 
the foot is down in the foam to just below the lateral malleolous. The foot impression 
in the foam is filled with plaster to produce a positive foot cast which is then used to 
produce the FO. In this technique, both soft and rigid FO can be produced.
Figure 4.4 Foot impression box showing foot print on the foam. Image taken from [A. Algeo Ltd. 
catalog (Liverpool, UK)].
CAD CAM system (e.g Paracontour System) is used to produce a FO. The foot is 
scanned using cameras which produce a 3D image of the foot. The foot image is 
rectified on the computer and is then send to a CAD CAM system to mill out a FO for 
a chosen plastic material. In this technique only rigid material FO can be produced.
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The foot cast is taken in static (weight or non-weight bearing). In order to load 
pressure-tolerant areas and relief pressure-sensitive areas, an assessment of foot 
pressure areas is performed using a pressure measuring platform while the subject 
walks on an instrumented mat. The Orthotist uses the foot pressure image to modify 
the cast as required. Hence a FO can be produced to accommodate the foot dynamic 
pressure areas.
Comparing the casting and the simple foot outline methods for producing FO, one 
study examining the effectiveness of FO, produced by either method on feet with 
excessive pronation, found that casting was slightly better in controlling excessive 
eversion, however, this difference was not statistically significant [Stell and Buckley 
1998]. Unfortunately, this study did not account for the higher skill required to 
produce a FO using the simple foot outline method compared to the casting method. 
Furthermore, a FO produced by the foot outline method can not make a total contact 
with the sole of the foot which is a feature that improves the function of FO by 
providing a larger contact area between the foot and the FO [Kogler et al. 1996; 
Mundermann et al. 2003].
Comparing custom-made FO to “off the shelf’ FO, in the former the casting position 
of the foot is while the subtalar and ankle joints are in neutral, and cast rectification is 
done per subject’s foot, whereas with “off the shelf’ FO it is one design for all feet.
4.1.5 Effectiveness o f Prescription FO
Prescription FO are normally aimed for a particular individual following a medical 
examination. These FO are specified in terms of the components they incorporate and 
are custom-made to fit the subject foot shape and morphology.
Limited information on the characteristics of patients supplied by prescription FO 
from orthopaedic work shops in the Netherlands were published by Kruizinga et al. 
(2003). Their literature survey found that information about the characteristics of 
patients with foot orthoses in Western society seems to be completely lacking. Their 
study was limited to patients and found that: FO are worn by patients of all ages, 
including very young children. Most of the patients aged 18 or over had degenerative 
foot disorders. Patients had received the devices mainly for stabilisation and for
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correction. The main purpose of the FO in these patients was to correct varus/valgus 
ankle and knee, and to stabilise the rearfoot.
A report from the U.S. Health and Nutrition Survey, showed that 3.2% of the non­
institutionalised population aged 25-74 years complained of foot problems 
(Cunningham and Kelsey (1984) cited in [Kruizinga et al. 2003]).
Prescription FO are widely used to treat foot abnormal functions which commonly 
include excessive foot pronation, flatfeet, hindfoot and forefoot malalignment. The 
most commonly treated foot abnormality is excessive foot pronation [Nicolopoulos et 
al. 1999; McPoil and Cornwall 2000; Bartold 2004]. From the literature such 
interventions appear to have been remarkably successful in reducing excessive 
eversion but quantitative studies have produced contradictory results [Nicolopoulos et 
al. 1999]. Many factors may be responsible for these conflicting results, especially 
inappropriate prescription of foot orthoses [Nicolopoulos et al. 1999]. Good contact of 
FO to the foot structures is an important factor for its functional success [Kogler et al. 
1996; Mundermann et al. 2003].
Abnormal foot function is thought to be a primaiy factor causing increased tissue 
stress; increased tissue stress has been linked to soft tissue, osseous tissue, and 
contractile tissue inflammation [McPoil and Cornwall 2000]. Excessive pronation is 
thought to be associated with plantar fasciitis which accounts for 15% of all foot 
complaints and is the most common cause of heel pain [Bartold 2004].
4.1.6 Non-prescription FO
Non-prescription FO picked “off the shelf’ from shops are not subject-specific and 
are made in a universal size that can be trimmed to a range of foot sizes (for men this 
is usually 6-12 UK foot size). Furthermore, the proportionality o f the components 
which they incorporate is unlikely to suite a range of foot sizes. For example, a foot 
arch of foot size 6 will be different in length and width to that of size 12. Therefore, 
making one arch support size for different foot sizes in unlikely to appropriately fit all 
foot sizes within the 6-12 range, added to that is the differences in the foot arch 
heights among individuals which further adds to the problem of proper fit. These FO
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are intended by the manufacturers for people who seek comfort, pain relief, and 
support to the foot structures.
No resources on the type of people who use “off the shelf’ FO could be found. 
However, considering fact that information about the characteristics of patients using 
FO in western society seems to be completely lacking [Kruizinga et al. 2003], no 
specific characteristic of “off the shelf’ FO users could be given. However, given that 
such FO are found in many shops and retailers have websites to promote their sales, 
indicates that there is a market for these products and there are users. Manufacturers 
promote the comfort, pain relief, and even foot joint realignment qualities of their FO. 
An example of a FO promotion:
(Enhances comfort with excellent cushioning. Superior shock absorption) quoted from 
[http://www.foothealthcare.com/acatalog/sportwork.html visited 22/11/2006].
One of the criteria for FO treatment success is clinical and biomechanical examination 
of the foot [Nicolopoulos et al. 2000]. People who seek comfort and pain relief by 
using “off the shelf’ FO might have some form of tissue stress due to mild foot 
abnormal function or simply because they are using their feet for long hours per day. 
In any case, picking “off the shelf’ FO for comfort and pain relief without medical 
examination might not lead to improvement or could aggravate the problem if  the 
picked FO is inappropriate for the condition.
Non-prescription FO are usually made from soft materials (e.g. Polymer Gel); 
however, some are made from harder material, e.g. Orthaheel FO (Vasyli 
International, Geneva, Switzerland) [www.walkpainfree.com/uk/insertsregular.html]. 
With the increasing variety of non-prescription FO available in the market, there are 
no studies in the literature to validate the use of these FO straight from the shelf 
without medical prescription. Such practice holds a risk of adverse effects due to 
inappropriate use of FO.
Concluding remarks. A FO material mechanical properties determine its efficacy, and 
the subject physical condition should be considered when selecting a FO. 
Unfortunately, none of these factors is appropriately addressed when a member of the 
public selects a FO “off the shelf’.
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Because different people have different foot morphologies and different foot 
deformations during loading, taking into account that FO aim to support foot 
structures, necessitates that FO should make total contact with the foot during loading. 
This can only be achieved by manufacturing FO per subject. The manufacture of 
custom-made FO accommodates the individual’s foot morphology by providing the 
correct dimensions of FO to the foot shape. In the “off the shelf’ FO case, these are 
made in one dimension and shape for a range of foot sizes (usually 6-11 UK size) and 
morphologies. Therefore it is unlikely that “off the shelf’ FO will make a good fit for 
all foot sizes and shapes, which could reduce its functional efficiency and may lead to 
undesirable effects due to improper fit and function.
The mechanism by which FO achieves its goals is poorly understood, the use of FO in 
the treatment of many conditions is largely anecdotal, and treatment success rates are 
not always 100% across subjects. This makes it even less likely that “off the shelf’ 
FO will succeed in providing the desired function.
There is limited information on the users of prescription and complete lack on non­
prescription FO. “Off the shelf’ FO lack validation for safe use by the public which 
may put the public health at risk.
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4.2 Literature review: Biomechanical effects of FO
This section is focused on two aspects of FO; first it reviews the research published on 
the biomechanical effects of FO, second it reviews the impact of FO on perceived 
comfort.
A number of methods can be used to evaluate the biomechanical effects of FO. These 
include foot pressure distribution, comfort, temporal-spatial effects, joint angle 
changes particularly eversion, GRF, joint moments and reaction force changes. In this 
chapter only comfort, eversion angle, GRF and moments are reviewed for their 
relevance to this work. Details of the selection of these parameters to evaluate the 
biomechanical effects of FO were given in chapter 3.
4.2.1 Effects o f FO on subtalar eversion angle
Excessive pronation has been associated with foot and lower limb injuries [McPoil 
and Cornwall 2000; Ferber et al. 2005]. FO are used to control excessive pronation, 
and excessive pronation is the most commonly treated foot disorder [Nicolopoulos et 
al. 1999; Stacoff et al. 2000].
Studies have shown the success of FO in the treatment of many foot and lower limb 
problems, however, the mechanism in which FO achieves this success remain illusive 
[Ball and Afheldt 2002; Ferber et al. 2005]. Furthermore, the prescription of these FO 
is subjective and lacks scientific evidence [Landorf and Keenan 1998]. This section 
discusses previous research on the biomechanical effects of FO on: subtalar 
inversion/eversion, GRF, joint moment, the effect of different posting methods.
The majority of running injuries occur at the knee (Taunton et al. 2002 cited in 
[Ferber et al. 2005]), and a strong correlation (r = 0.953) between subtalar 
inversion/eversion and tibial rotation has been shown [Cornwall and McPoil 1995].
Pronation is a combination of subtalar eversion, ankle dorsiflexion and forefoot 
abduction. Excessive foot pronation has been implicated as a factor for overuse injury 
in the lower limbs [Miller et al. 1996]. Rearfoot orthotic devices are used to correct 
biomechanical abnormalities primarily by reducing the pronation compensatory
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mechanism thus reducing stress on joints ligaments and tendons (Drez 1980 cited in 
[Miller etal. 1996]).
Whereas many researchers believe that biomechanical FO reduce maximum eversion 
[Mundermann et al. 2003; Nester et al. 2003; MacLean et al. 2006], others challenge 
these findings and conclude that the FO influence on eversion reduction is small (0-3 
degrees) and is subject-specific [Brown et al. 1995; Stacoff et al. 2000]. The 
differences between these studies could be due to differences in one or more o f the 
methodological factors of: subject selection criteria, FO type, experiment design (e.g. 
FO adaptation period), gait measurement method, and shoe type. Methodological 
differences and the effects of the investigated FO of these five studies are summarized 
in Table 4.1.
Mundermann et al. (2003) conducted their experiment on 21 adult healthy subjects 
(12 females, 9 males), LLD<5mm, and with 13 degrees of pronation and other 
unspecified subject inclusion criteria determined by podiatrists. The researchers used 
sandals to enable markers to be placed directly on the foot, and the testing procedure 
involved testing the effects of three FO conditions (Figure 4.5): (1) intrinsically 
moulded medially wedged FO; (2) moulded to foot shape FO, (3) a combined 
moulded shell with medial wedge FO during running after two weeks adaptation 
using a flat neutral control FO. The FO shell was made of hard Polypropylene and the 
posting from 3mm EVA.
Figure 4.5 FO conditions. (A) control neutral FO (left), intrinsic medially wedged FO (right). (B) 
moulded shell FO (top) and extrinsic medially wedged FO (bottom) [Mundermann et al. 2003].
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Table 4.1 Summaiy of different FO effects on eversion angle and the methods used by five 
different studies. All studies took adult subjects (F=female, M=male).
Subjects Selection
criteria
Experiment
method
Shoe
type
FO Effect on 
Eversion
Mundermann 
et al. 2003
21
(12F,9M)
LLD<5mm
pronation>13
Running Sandals Medial wedge post 
on flat base FO
Reduction
Healthy degrees
during
running
Moulded neutral 
shell FO
Increased 
eversion and 
inversion
(pronators) Moulded neutral 
shell FO with 
medial wedge post
Increased 
eversion and 
inversion
Nester 
et al. 2003
15
(7F,8M)
Healthy
Unspecified walking Own
shoes
Medially wedged+ 
arch support FO on 
3mm flat base
Reduction
Laterally wedged 
FO on 3mm flat 
base
Increase
MacLean 
et al. 2006
15 F 
Healthy
Unspecified Running Trainers, 
no heel 
counter
Medial heel wedge 
on moulded FO
Reduction
Brown 
et al. 1995
24
(16F,8M)
Patients
Pronation-
related
dysfunctions
Walking
on
treadmill
Trainers Biomechanical FO 
with heel and 
forefoot varus posts
No change
(forefoot 
varus >8deg.)
(video
+markers)
“Off the shelf’ arch 
support
No change
Stacoff 
et al. 2000
5 M 
Healthy
No
overpronation
Running 
Pin makers
Trainers “Off the shelf’ 
simple insole plus 
cork arch support
Small 
reduction 
and is 
subject- 
specific
“Off the shelf’ 
simple insole plus 
medial wedge
Small 
reduction 
and is 
subject- 
specific
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Their study found that the medially wedged FO reduced maximum eversion; the 
moulded shell FO increased both eversion and inversion, and the combined FO with 
medial wedge had similar effect as the moulded shell alone. Increase in eversion with 
the second and third FO is not explicitly stated by the authors; however, it can be 
clearly seen in their average graphs.
Nester et al. (2003) used 15 adult healthy subjects (8 males and 7 females), with 
unspecified subject selection criteria, subjects wore their own shoes (unspecified), and 
the testing involved walking at controlled cadence (108steps/min) in two orthotic 
conditions; (1) 3mm thickness flat base with 10 degrees high density EVA medial 
wedge placed under the heel and running to before the 1st metatarsal head, and a 
medium density EVA medial arch support; (2) FO was similar to the first FO 
condition, however, the wedge was placed laterally and ran from the heel to just distal 
to the base of the 5 metatarsal head, and this FO did not have a medial arch support. 
They found that medially wedged FO reduced maximum eversion angle and the 
laterally wedged FO increased it.
MacLean et al. (2006) carried out their experiments on 15 adult healthy female 
athletic runners. The subject selection criteria were unspecified, trainer shoes were 
worn, and the testing was performed during running with 5 degrees medial extrinsic 
heel wedge made of EVA placed on moulded polypropylene rigid FO shell. They 
found that this FO reduced maximum eversion angle.
On the other side of the argument, Brown et al. (1995) conducted their experiment on 
24 adults patients (16 females, 8 males (43 feet)) with lower limb excessive pronation 
(>13 deg), forefoot varus>8deg, modified running training shoes (heel counter 
removed and replaced by transparent plastic). Patients walked at a self-selected speed 
on a treadmill and testing was for two types of FO; (1) a custom-made semi-rigid 
biomechanical FO with forefoot and rearfoot extrinsic rubber varus posts, (2) was 
Spenco “off the shelf’ full length arch support (Spenco Medical Corporation, Waco, 
Tx, USA). They found that both FO did not change the maximum eversion angle in 
this patient group.
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Stacoff et al. (2000) performed their tests on 5 healthy male subjects. No 
overpronation is the only given subject-selection criteria. Markers were mounted on 
cortical pins, trainer shoe (cut at the back for pins) were worn, and the testing was 
preformed during running trials using three type of soft FO; (1), “off the shelf’ flat 
insole, soft, about 2mm thick rubber foam, (2) FO had the same insole as the first FO, 
however with added medial arch support, (3) FO was the like the first FO, however, a 
medial (under the heel) wedge was added to it (Figure 4.6). They found that “off the 
shelf’ flat insole leads to a decreased maximum eversion angle, and the same was for 
the second and third FO. However, the study emphasizes that the changes found in 
eversion angle were small (0-3 degrees), and unsystematic across all subjects.
0W
mm
m a-
m
4M
m
4M
Cut-out for
ealcMm&l
bout pin
Figure 4.6 The shoe and FO used in the study, left; medial wedged FO, right; medial longitudinal 
arch support [Stacoff et al. 2000].
In addition to the methodological differences presented in Table 3, differences could 
be due to differences between the FO types used in these investigations, e.g. material, 
design, the components they incorporate, construction, and their fit to the participants.
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The work by Stacoff et al. (2000) was conducted using markers mounted on cortical 
pins. This could mean that variability due to marker re-application was eliminated and 
the differences in their study are due to intra-subject variability and the effect of FO. 
Their study found the effects of these FO unsystematic and subject-specific. However, 
overall, it seems that although the FO can reduce excessive eversion, this may not be 
the case for all normal healthy subjects, which highlights the need to establish an 
experimentally proven criteria for the subjects who could benefit from the use of FO, 
and a criteria for FO prescription that details the design and specifications of these 
FO.
4.2.2 Effects ofFO on GRF and joint moment
Mundermann et al. (2003) found that medial wedge posting on a flat base FO 
increased vertical impact peak and maximum loading rate of GRFz, reduced the 
maximum inversion moment at the ankle joint, increased the maximum external 
rotational moment at the knee, and delayed the maximum abduction moment at the 
knee in stance. The neutrally moulded FO reduced the vertical impact peak and 
maximum loading rate of GRFz, reduced maximum inversion moment at the ankle, 
increased maximum external rotation moment at the knee, and delayed both 
maximum abduction moment and external rotation moment at the knee. The neutrally 
moulded shell FO with medial wedge post had similar effect (as the neutrally moulded 
shell alone) on the GRF and joint moments. It can be inferred from their results that 
the magnitude of the knee abduction moment was not affected by the FO with medial 
posting on a simple flat insole.
Nester et al. (2003) found that medially or laterally wedged FO principally affect the 
medial-lateral component of the GRF, and found no evidence of their effects on the 
vertical and anterior-posterior components of the GRF. At the ankle, the medially 
wedged FO increased the magnitude of the laterally directed GRF, increased the 
external rotation and abduction moments, whilst the laterally wedged FO reduced 
those moments and reduced the lateral GRF. At the knee, the medially wedged FO 
increased the adduction moment and the peak external rotation moment.
MacLean et al. (2006) found that FO with a medial heel wedge placed on a moulded 
shell had the following effects; did not change the maxima of the vertical impact peak
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or loading rate, decreased maximum ankle inversion moment, and increased internal 
knee flexion and extension maxima.
Flaieh et al. (2005) carried out a pilot study on one healthy adult subject (M). The 
subject had no history of lower limb injury that might affect gait, with no visible 
lower limb joint malalignment, and satisfied a special physical examination chart 
(designed for this research). The chart dealt with the neurological, musculoskeletal, 
and anthropometric aspects of subjects. The subject walked at self-selected speed. The 
tested FO was a flat “off the shelf’ FO made of Polymer Gel and incorporated a heel 
cushioning pad made from the same material (later used as FOl in this research). 
They found that this FO led to a reduction in the knee and ankle abduction moment, 
abduction power, and the magnitude of the resultant of the joint reaction force. Also, 
the study found that the FO had very small effect on the temporal-spatial parameters; 
the stance/swing ration was mainly unchanged, however, walking speed increased by 
2.4% with the use of the FO. GRFz was reduced, GRFy increased and GRFx showed 
no evidence of change. The results of this pilot study was not used in the expanded 
subject group in which FOl was tested, this was due to changes introduced to the 
marker application method and the testing schedule, however, the results of this pilot 
study guided the adopted research direction.
Miller et al. (1996) conducted experiments on 25 adult healthy subjects (12F, 13M), 
normal lower limb joint ROM, but with 5-10 degrees of calcaneal eversion during 
standing, used “Street Shoes” with no special cushioning or motion-restriction 
features. Maximum heel height was 25mm, and subjects walked at self-selected 
speed. They investigated the effects of functional FO made of plastic polymer 
(unspecified firmness) and medial heel wedge of firm Plastizote. They found that this 
FO decreased GRF in the vertical and anterior-posterior directions during the early 
stage of stance phase. They gave no account of the FO effect on joint moments.
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Jorgensen and Eskstrand (1988) tested the effect of heel pad confinement (Figure 4.7) 
of selected sports shoes on shock absorption. Seven healthy adults (3F, 4M) took part 
in the testing. Two types of shoes were tested; one with high shock absorption and the 
other with low shock absorption. The testing was performed as a “Human drop test” 
method using an AMTI forceplate (Figure 4.7). They found that rearfoot confinement 
increases the shock absorption capacity as measured by the reduction of the vertical 
peak impact force (GRFz).
Fz
heel
confinement
Figure 4.7 Left; heel pad confinement using shoe heel counter. Right; “human drop test”
[Jorgensen and Eskstrand 1988].
The clinical significance of GRF increase or decrease during loading response is that 
it reflects the shock absorption capacity of a FO; a decrease indicates an improved 
shock absorption and vice versa. The issue of shock absorption is important in the 
understanding of the development of shock-related injuries. According to Nigg (1985) 
cited in [Jorgensen and Eskstrand 1988] impact loading lead to the development of 
overuse/overload injuries, however, according to Radin et al. (1973) cited in 
[Jorgensen and Eskstrand 1988], the development of these injuries is due to the 
accumulation of micro traumas.
Nester et al. (2003) indicates that contrary to the general expectation in which shock 
attenuation will be more clearly reflected in the vertical and anterior-posterior 
components of GRF, they found that most shock attenuation occur in the frontal and 
transverse planes (GRFy and GRFx). This could be because most subtalar motion 
occurs in these planes.
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Generally, FO effects on joint moments depend on the components the FO incorporate 
[Mundermann et al. 2003]. The different findings of these studies on the effects of FO 
on GRF and joint moments may also be due to different methodologies used by these 
investigators as discussed earlier. Notably there is some contradiction on the effects 
on GRFz where some studies found no effect and other studies found evidence of FO 
effect on this GRF component.
Mejjad et al. (2004) studied the effect of a FO on pain and temporal-spatial 
parameters. The testing was performed on 16 patients (13F, 3M) with RA and 
metatarsalgia pain. The FO was 10mm thick, semi-flexible, formed on foot projection 
during standing with no postings. Gait measurement was during walking at self­
selected speed. Pain was assessed by visual analogue scale (VAS).They found that the 
FO reduced pain, but did not significantly improve (increase) gait in terms of stride 
length, cadence and walking speed despite the numerical increase in walking speed 
(7%) with the use of FO.
Studies [Mejjad et al. 2004; Flaieh et al. 2005] found that FO use resulted in an 
increase in walking speed (by 7% and 2.4% respectively). The increase in speed may 
be due to the energy storing capacity of FO material; as the FO is compressed it stores 
energy and its release in late stance may give an added propulsion force during the 
push-off phase. Speed change can cause a change in the joint angle parameters 
[Hanlon and Anderson 2006] and therefore joint moments and kinetic parameters.
4.2.3 The perceived comfort due to the FO
Comfort can not be measured objectively, however, subjective methods are used to 
evaluate the perceived comfort by FO users in which the subject can assess his 
comfort/discomfort, for example, on a scaled line of a VAS [Goodwill and 
Chamberlain 1988], or a questionnaire with graded levels of comfort/pain [Finestone 
etal. 2004].
FO are often used to support foot structure [Kogler et al. 1995] and to treat existing 
pathological conditions, relief pain, and prevent overuse injuries [Conrad et al. 1996; 
Finestone et al. 2004].
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Comfort sensation can be improved if pain is decreased and this can be achieved by a 
FO [Mejjad et al. 2004], in their study VAS was used to assess pain in RA patients. 
Pain is a sign of tissue stress, and studies have showed that FO can reduced pain in 
RA patients with metatarsalgia [Conrad et al. 1996; Mejjad et al. 2004; Mejjad et al. 
2004], and soft FO has been shown to have a higher comfort score than semi-rigid FO 
[Finestone et al. 2004]. Canard et al. (1996) and Finestone et al. (2004) used a scaled 
questionnaire to assess pain levels.
The medial longitudinal arch plays an important role in shock absorption as it ‘gives 
in’ to absorb the impact of body weight transfer from the contralateral limb. 
Maintenance of the arch function is partially performed by the plantar fascia. 
Excessive tension and repeated loading in the plantar fascia can lead to calcaneal heel 
spur and plantar fasciitis, which is accompanied by heel pain and inflammation 
(Andrews 1983, cited in [Kogler et al. 1995]). The plantar fascia and other soft 
tissues, controlling arch depression and elevation during walking, can be aided by FO 
that incorporates an arch support, as such a FO acts as an external mechanical support 
device [Kogler et al. 1995].
Kogler et al. (1995) studied the effectiveness of FO with medial arch support on the 
medial longitudinal arch. Their study was conducted on the feet of cadavers which 
were examined for normality prior to testing. A strain gauge was inserted in the 
plantar facia to record its tension during the mechanical testing. They found that this 
FO significantly reduced strain in the plantar fascia.
Mechanical shock absorption is a method that is used to reduce body load, thereby, 
preventing and treating injuries [Jorgensen and Eskstrand 1988]. At the end of swing 
phase, as the foot contact the ground, the foot generates a transient force, due to the 
exchange of momentum between the foot and the ground [Whittle 1999]. This 
transient force can be seen in the forceplate data curve as a spike occurring before 
GRFz peakl. This results in a shock wave that travels up the body and is thought to be 
associated with degenerative joint disease, headaches, prosthetic joint loosening, 
plantar fasciitis, achilles tendonitis, muscle tear, and stress fracture [Folman et al. 
1986; Pratt 1989, cited in [Whittle 1999]. Reduction of transient forces contribute to 
the prevention of these medical conditions and these can be reduced by viscoelastic
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materials incorporated in the shoe construction or in FO (Lafortune and Henning 
1992, cited in [Whittle 1999]).
Heel pads in FO aim to absorb the shock of weight transfer during the loading 
response phase of the GC. Jorgensen and Ekstrand (1988) investigated the effect of 
heel pads confinement on shock absorption at heel strike, they found that heel 
confinement improved shock absorption capacity.
Turlik et al. (1999) studied pain relief in patients with calcaneal heel spur, using a 
generic heel pad and functional FO. Assessment was performed using a 5 pain levels 
questionnaire. The study found that both FO reduced pain severity and duration, 
however, the functional FO performed better in achieving this task.
Another study also found heel pads and customised soft FO to be effective in heel 
pain relief associated with plantar fasciitis [Seligman and Dawson 2003]. This study 
assessed pain using two methods; verbal, and a Likert-type scale; the former reports 
moderate pain as a rank of 5, mild pain a rank of 2, and no pain a rank of 1. The later 
method assess pain levels on a scale of 1-10 pain levels, 1 (no pain) and 10 (extreme 
pain).
Conclusions. Clinical and biomechanical examination of the foot, FO material 
properties, and FO manufacturing method play a key role in the success of FO for its 
intended purpose. Unfortunately, for “off the shelf’ FO users, none of these factors is 
addressed, and this raises concern on the health safety of the users of these FO.
Different types of custom-made FO have been investigated and showed that they can 
support the foot arches thus reliving pain by reducing stress on the soft tissues of the 
foot particularly the plantar fascia. Also heel pads improve shock attenuation by 
reducing GRFz, thus reducing heel pain.
Controversy surrounds the effect of FO on many kinematic and kinetic parameters 
particularly foot pronation. This could be for a number of reasons; (1) differences in 
subjects selection criteria, for example, BMI, LLD, age, and joints alignment. (2) 
differences in the data collection protocol. This study on healthy subjects, examining
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two types of “off the shelf5 FO, sets a tight subject selection criteria to ensure 
consistency among all participants, it also sets a data collection protocol with timed 
sequence of events to ensure high repeatability. “Off the shelf’ FO investigation is 
aimed to help to pave the way to appropriate FO use in non-prescription, prescription, 
and FO specifications.
Therefore, the aim of this work was to investigate the biomechanical effects of “off 
the shelf’ FO on the foot and lower limbs. Particular attention was given to the effect 
of FO on foot pronation for its importance towards healthy foot and lower limb 
function as was seen in the published literature.
4.3 Introduction to the FO testing methodology
Investigating the biomechanical effects of FO followed three main steps which were 
taken in sequential order. These steps were performed to optimize the reliability and 
gain confidence in the FO investigation method. The steps were; (1) selection of the 
better available marker set for gait analysis, (2) testing the repeatability of gait data 
using the intended FO data collection method, (3) FO testing using the determined 
subject selection criteria, data collection protocol, and data analysis method.
(1) Marker set selection. Examination of FO biomechanical effects requires (as 
demonstrated in chapter 3) quantitative gait data. Data collection is often performed 
using markers applied to the pelvis and lower limb segments. Many marker sets are 
available for this task, with different methods of attachment and determination of 
segment positions in space. Because the expected effects of FO on gait kinematics and 
kinetics are small, it is important that the selected marker set is reliable and has 
minimal variability in tracking body segments during walking. Explanation of the 
experimental method, results, and conclusion for the process of marker set selection is 
given in chapter 5.
(2) Gait data repeatability. Gait data acceptance largely depends on the repeatability
of gait data [Kadaba et al. 1989]. A highly repeatable method of obtaining gait data
gives greater confidence in the results and implies that methodological variability in
gait data between the sessions (under the same testing conditions) is minimised. If gait 
data variability is minimised it can provide a better chance of detecting small gait
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parameter changes like those expected of FO use. Therefore, a repeatability study was 
conducted to determine the differences in each kinematic and kinetic parameter within 
a test session and between test sessions. Those differences were later used in the 
determination of the gait parameter changes that were due to the FO use. Gait 
parameter changes that are greater than those seen in the repeatability study were 
considered to be due to the effect of FO. The repeatability study is described in 
chapter 6.
(3) FO testing. After selecting the marker set to be used in the FO testing and 
determining the repeatability of gait data using the selected marker set, the testing of 
the kinematic and kinetic effects of FO was carried out. FO testing involved subject 
selection, data collection, and data analysis. This procedure was conducted according 
to a set protocol. Details of the FO tests are given in chapter 7.
Joint angles changes due to the use of FO were selected as an outcome measure for 
FO effects because excessive joint motion has been associated with increased tissue 
stress [McPoil and Cornwall 2000], and specifically excessive foot pronation has been 
associated with lower limb injuries [Seymour 2002]. Furthermore, because the lower 
limb is composed of segments linked at joints, coupling between these segments 
indicate an inter-segmental biomechanical influence; for example, foot eversion and 
tibial rotation coupling is empirically proven (r=0.953) [Cornwall and McPoil 1995], 
Also, temporal-spatial was opted for because o f the close relationship between 
walking speed and joint angles [Hanlon and Anderson 2005] and GRF [Keller et al. 
1996; Taylor et al. 2004].
Joint moments were selected for two reasons; first an increase in joint moments may 
cause harm to the joint particularly in directions where joint motion is limited, and 
where the joint depends on ligaments and muscles for its stability, for example knee 
abduction. Second, to enable comparison with results in the literature.
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Chapter 5
Kinematic Marker Set Selection
5.1 Introduction
Gait analysis has progressed from the academic discipline into practical applications and is 
becoming an important tool in the clinical management. Gait analysts remain divided and 
uncertain over the marker set of choice for their particular gait measurement activity.
A number of marker sets are available for the determination of kinematic data; these include 
the Helen Hayes (HH) [Kadaba et al. 1990], the Newington Children’s Hospital [Davis et al. 
1991], the Helen Hayes Hospital marker set in GaitLab [Vaughan et al. 1999], and the HH 
derived Skin Marker Set (SMS) and the conventional modified HH Wand Marker Set (WMS) 
[Q Gait].
The choice of marker set as well as the methods employed in computing joint angles are 
believed to affect the results of gait analysis [Castagno et al. 1995; Cappozzo et al. 2005]. To 
date, there is no ‘gold standard’ for routine and practical gait analysis, even though attempts 
have been made to propose standardizations in the community [Wu and Cavanagh 1995].
A bone-fixed marker set will produce real and accurate joint kinematics that can be used as a 
reference. However; this method is invasive and not practical for routine clinical investigations. 
Since there was no reference marker system, it was not possible to measure the absolute 
accuracy of any marker set; however, it is possible to compare the performance of marker sets 
relative to each other.
Marker sets often use different number of markers, method of attachment, and anatomical 
landmarks and sites for marker placement. They usually differ in their definition of local 
segment coordinate axes and algorithms used for joint kinematics. Earlier marker sets were 
restricted in the possible number of markers and relative location that could be recorded by the 
technical limitations of camera systems. As a result, some of these sets have assumptions and
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inter-segment dependence, for example, the HH marker set defines the thigh segment using a 
mid-thigh marker placed on a wand, the knee joint centre and the hip joint centre (HJC). The 
HJC, calculated from the position of the anterior superior iliac spine markers and pelvic 
orientation, creates a dependency between the thigh and pelvic segments. Recent advances in 
hardware and software for motion capture systems has allowed for an improvement in the 
measurement capabilities, and has led to the development of true six degrees o f freedom 
marker sets and the implementation of optimization methods, among other advances [Benedetti 
et al. 1998], for example, marker sets can use 3 markers or more per segment (Figure 5.1).
Figure 5.1 Antero-medial (left) and antero-lateral (right) views of the marker set at die distal shank and foot. 
Adapted from [Leardini et al. 2006].
The SMS and WMS (Figure 5.2), are practical to use for routine clinical gait analysis, and are 
in common use despite the theoretical advantages of the six degrees of freedom models. The 
SMS has an advantage over the WMS in that it is easier to apply, does not require any 
alignment of the thigh and shank markers and does not use a thigh wand which may get moved 
and misaligned by the hand of the subject during arm swing. For these reasons, the SMS offers 
a potential for ease of use in routine gait analysis. However, there is very little data in the 
literature on the SMS repeatability. One study [Liu 2002] was performed on 6 able-bodied 
subjects and found the SMS repeatability to be excellent in the sagittal, good in the frontal and 
poor in the transverse plane parameters. In addition, there is lack of data on SMS comparison to 
any conventional marker set. Hence a comparison with a more conventional set was considered 
to be sensible.
The WMS is a slightly modified version of the conventional HH described by Kadaba et al. 
(1990). Marker locations for the WMS are very similar to the conventional FIH marker set.
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However the HH does not use a heel marker and its sacral marker is mounted on a wand 
whereas the WMS uses a heel marker and the sacral marker is applied directly on the skin. The 
HH repeatability is reported to be excellent in the sagittal plane, good in the frontal and 
transverse planes within a test day and poor between test days [Kadaba et al. 1989].
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Figure 5.2 SMS and WMS - Markers location. Adapted from [Qualisys Medical AB]
The SMS and WMS are clinically used for routine gait measurement, however, the SMS is 
believed to be easier to apply and use especially for patients with physical disabilities. The aim 
of this study was to shed light on the strengths and weaknesses of the SMS compared to the 
more established WMS. To this end, the kinematic performance of these marker sets was 
evaluated and compared. Statistical analysis was carried out on each marker set separately.
5.2 Method
5.2.1 Marker system description and joint angle calculations
The SMS was developed at the Lundberg Laboratory for Qualisys Medical AB, 
Guthenburg/Sweden. It uses 15 markers placed directly on the skin over lower body anatomical 
landmarks (Figure 5.2). The WMS also uses 15 markers (Figure 5.2) and uses similar 
anatomical landmarks to the SMS, but the supra patella and tibial tuberosity markers are 
replaced by mid thigh and mid shank markers mounted on wands (100 mm and 50 mm long 
respectively). Marker location and alignment are described in appendix A.1A.
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Joint centre positions are calculated from marker positions based on the data published by 
Vaughan et al. (1999). The hip joint centre is calculated from pelvic markers within a local 
pelvis coordinate system. The knee and ankle joints are calculated within a local shank 
coordinate system. Appendix A. IB describes the local segment coordinate system definitions 
as used by each marker set. The right-handed segment coordinate systems are approximately 
oriented in the same way in the standing position, with the X-axis pointing forward, the Y-axis 
pointing to the left, and the Z-axis pointing upwards. The 3D angles are calculated using the 
Euler-angle approach as described by Kadaba et al. (1990), with the ordered Cardan sequence 
Y, X, Z, and the proximal segment coordinate system acting as the reference.
5.2.2 Subject selection criteria
Twelve able-bodied subjects (8 males and 4 females) with no history of gait problems were 
recruited for this study. Mean age was 30.5 years (range 22-60 years, SD 11.2), mean body 
mass index (BMI) of 22.6 (range 21-24.9, SD 1.2) and leg length discrepancy (LLD) <15mm. 
BMI was used to detect both over and under weight subjects as obesity has an effect on gait 
kinematics including changes of walking joint angles [Hawary 1998]. LLD can cause gait 
asymmetry as it requires gait compensatory mechanisms [Blake and Ferguson 1993; Kaufman 
et al. 1996]. Kaufmann (1996) describes LLD greater than 20 mm to cause gait asymmetry, 
whilst Liu [Liu et al. 1998] suggests LLD greater than 23 mm to cause gait asymmetry. 
Researchers have disagreement over the magnitude of LLD that causes gait asymmetry, which 
warrants treatment and some accept up to 30 mm [Gurney 2002]. For this study LLD of 15 mm 
was chosen as a limit to reduce inter-subject gait variability.
5.2.3 Data collection protocols
Informed consent was obtained from each subject prior to the gait trials. Subjects walked at 
their self-selected speed, bare-foot and wore Lycra shorts. Marker alignment was performed 
with the subject standing, feet parallel pointing straight forward and adjacent to each other. The 
SMS and WMS were applied simultaneously and bilaterally. Subjects performed sufficient 
traverses until they felt comfortable prior to any data collection. After each set of gait trials 
marker alignment and positions were checked for displacement.
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5.2.4 Equipment, data collection and processing
Data was collected using a 7-camera system (Qualisys Medical AB, Sweden). The data was 
captured, tracked and labelled using the Qualisys motion analysis software Q Trac 2.5, and 
joint kinematic calculations performed using Q Gait 2.0 [Qualisys Medical AB, Sweden]. 19 
mm diameter retro-reflective markers were used.
Data was sampled at 100 Hz. To guide the subjects through the walking path two pieces of 
tape were placed on the floor 10 meters apart marking the start and end points of the walking 
path; these were placed such that an imaginary line joining these marks passes through the 
centre of the measurement volume. Ten walking and one standing trials were collected for 
each subject in the same session, and one session was used to collect the data. The term 
session refers to the set of walking trials under the same marker application condition.
For each subject, one standing and three walking trials were selected for analysis. The 3 
walking trials selected were those with the least marker trajectory breakage. The selected trials 
for analysis were the first best 3 trials of the session, this was done to ensure consistency across 
the sessions and the fact that the subject is most likely to walk more consistently at the 
beginning of the session rather at the end of it as he may get tired. Q Trac was then used to 
track the data. A second order curve was fitted to the three dimensional coordinates using a 
least square method (part of Q Gait software) in order to filter the data. Q Gait utilized the 
smoothed marker coordinates in order to calculate the joint and segment angles for each marker 
set bilaterally. Using the auto-normalization function in Q Gait, the computed joint angles were 
normalized to one complete gait cycle (GC), containing 200 intervals, each interval 
representing 0.5 % of the GC.
5.2.5 Data analysis
This study did not combine the data from the right and left sides in order to separate variability 
due to the right-left asymmetry and inter-subject variability. The results section will therefore 
present a comparison between the two marker sets for the right side only.
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(i) Determination of mean values
For each marker set, the three trials per subject were averaged to compute a subject mean. The 
average and standard deviation (SD) were then computed from a total of twelve individual 
subject means per kinematic parameter. The parameters were 3D joint angles for the hip, knee, 
and ankle, in addition to the pelvic segment angles. The group averages from the two marker 
sets were visually compared for differences.
In addition, for each walking trial (3 trials per subject and 12 subjects), the absolute difference 
(ABSD) (magnitude of wand -  skin) between the two marker sets was computed for each 
kinematic parameter for each GC were then averaged over the 12 subjects to compute the mean 
ABSD. The ABSD reflects the magnitude of disagreement between the two marker sets; the 
lower the value, the better the agreement.
(ii) Variability
The CV was used in order to assess the variability in joint angles waveforms within each 
marker set. The CV as defined by Winter [Winter D 1991], was calculated for each marker set 
per subject. The CV was then averaged (n = 12) for the twelve kinematic parameters.
(Equation 5.1)
CV = (Equation 5.2)
Where: N  is the number of intervals over the stride.
thXf is the mean value of the variable at the i interval.
o f  is the standard deviation of variable x about x.
The CV is commonly used to assess the measurement variability. Care must be taken when 
interpreting the CV results, particularly when the means of two groups are not equal.
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(iii) Comparison of gait parameters
The two marker sets were also compared in their calculation of joint angle excursion (range) 
and joint angles at key points of phases in the GC. The excursion angles were calculated per 
subject (an average of 3 trials). These were then averaged (n = 12) to compute the mean and 
standard deviation per parameter.
The hip, knee and ankle joint angles were computed at heel contact (HC), peak angles during 
the loading response (LR defined as 0-10% of the GC), and swing phase (SP defined as 60- 
100% of the GC) [Whittle 1996]. Joint excursions and peak angles were chosen for the 
comparison, as higher errors are likely to show when the joint angles are furthest from the 
neutral orientation. The joint angles at HC are clinically relevant, for example as a measure of 
the efficacy of orthotic interventions or electrical orthoses for foot drop.
(iv) Statistical comparison
The Wilcoxon test (P 0.05) was used to test the statistical significance of differences between 
the SMS and WMS seen in the CVs, excursions, and the chosen gait parameters. This test was 
selected because the data was paired but could not be assumed parametric.
5.3 Results
Individual walking speeds and cycle times fell within their respective normal ranges for free- 
speed walking as reported by Whittle (1996). Walking speed was (mean 1.2m/s, SD 0.2, range 
1.0-1.6), cadence (mean 113.1step/min, SD 1.1, range 102-128) and cycle time (meanl.Os SD 
0.1, range 0.9-1.2).
The pelvic angles were exactly the same for both marker sets. This is expected as both the SMS 
and WMS use the same markers and definition for the segment coordinate system and segment 
angles. Thus the comparison graphs do not include the pelvic segment angles.
5.3.1 Visual comparison
Figures 5.3, 5.4, and 5.5, group average of the joint angles for the right side, the standing joint 
angles for the 12 subjects are also shown. Sagittal plane joint angle waveforms (both standing 
and walking) showed the least visible differences when compared to the frontal and transverse
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plane joint angles. Frontal plane joint angles showed very little differences for hip adduction, 
and greater differences for knee adduction (greater range in the SMS). For ankle inversion the 
SMS and WMS showed visible waveform differences. During the terminal stance and pre­
swing phases, the SMS showed a neutral angle as opposed to an everted ankle in the WMS. 
Transverse plane waveforms showed visible differences for all joints. The knee rotation angles
o
were both visually dissimilar and offset (approximately 15 ) between the WMS and SMS. The
o 9
ankle rotations had a similar pattern but with an offset of approximately 15 . The hip rotation 
waveforms were visually dissimilar in the two marker sets.
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Figure 5.3 Hip joint angles mean (bold) and standard deviation (n = 12) from both the SMS (skin) and 
WMS (wand). Dotted line denotes standing angles. Flexion, adduction and internal rotation are positive, 
(dorsi = dorsiflexion; inrotation = internal rotation; GC = gait cycle)
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Figure 5.4 knee joint angles mean (bold) and standard deviation (n = 12) from both the SMS (skin) and 
WMS (wand). Dotted line denotes standing angles. Flexion, adduction and internal rotation are positive, 
(dorsi = dorsiflexion; inrotation = internal rotation; GC = gait cycle)
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Figure 5.5 Ankle joint angles mean (bold) and standard deviation (n = 12) from both the SMS (skin) and 
WMS (wand). Dotted line denotes standing angles. Flexion, adduction and internal rotation are positive, 
(dorsi = dorsiflexion; inrotation = internal rotation; GC = gait cycle)
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5.3.2 Absolute differences ABSDs
Figure 5.6 shows the averaged ABSD between the two marker sets for all joint angles from the
o o
right leg. The transverse plane joint angles showed the highest disagreement (9 -25 range) 
between the two marker sets. The sagittal and frontal plane angles showed better agreement 
(0.5°-8° range) throughout the GC. Ankle inversion angle showed disagreements (maximum of 
6°) between the two marker sets during the stance phase. Knee adduction angle showed
disagreements during both the stance (3°) and swing phases (8°). Ankle dorsiflexion showed
0 * n 0some disagreement throughout the GC (minimum difference of 1.5 and a maximum of 6
occurring during the SP).
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Figure 5.6 Mean of the ABSDs between the SMS and WMS for the twelve joint parameters (rot = rotation; 
flex = flexion; inv = inversion; dorsi = dorsiflexion; add = adduction; GC = gait cycle) n=12.
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5.3.3 CV results
Table 5.1 shows the averaged CV values for the right lower limb joint angles from both marker 
sets. The CV was generally similar for both marker sets, with a difference varying between 0 
and 3% for most joint angles; these differences were not statistically significant. For knee 
rotation, however, the WMS had a higher CV compared to the SMS (32 to 12 %), which was 
statistically significant.
For the three joints, both the WMS and SMS showed the lowest CV in the sagittal angles. For 
the hip angles, the CV was highest for transverse angles in both the WMS and SMS. For the 
knee the CV was highest in the transverse angles for the WMS and frontal angles for the SMS. 
For the ankle the inversion/eversion angles had the highest CV for both the SMS and WMS. 
For the sagittal and frontal angles, the ankle had the highest CV. In the transverse plane, the CV 
was highest for the hip joint. This was true for both marker sets. The lowest CV was in the hip 
and knee flexion (~7%) for both marker sets.
Table 5.1 CV (%) and excursion, mean and standard deviation for the pelvic angles and right leg 
joint angles (* indicates a statistically significant difference between SMS and WMS)
CV (%) Excursion (degrees)
Parameter
SMS WMS SMS WMS
Mean (SD) Mean(SD) Mean(SD) Mean(SD)
Pelvic tilt 25(27) 25(27) 3(1) 3(1)
Pelvic obliquity 30(11) 30(11) 7(2) 7(2)
Pelvic rotation 55(29) 55(29) 8(2) 8(2)
Hip flexion 7(3) 8(4) 44(6) 44(5)
Hip adduction 25(9) 24(9) 11(3) 11(3)
Hip internal rotation 32(25) 35(48) 14(3) 10(3)
Knee flexion 7(2) 7(2) 63(3)* 61(3)
Knee adduction 19(9) 22(12) 12(4)* 8(3)
Knee internal rotation 12(6)* 32(16) 13(3)* 16(4)
Ankle dorsiflexion 17(7) 17(5) 25(6) 26(5)
Ankle inversion 44(21) 42(30) 15(4) 14(5)
Ankle internal rotation 27(23) 24(13) 17(4) 16(3)
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5.3.4 Gait parameters comparison
Table 5.1 shows the right joint angle excursions averaged for all subjects. For the sagittal plane, 
the differences between the SMS and WMS were within 2°. The difference was within 4° for the 
transverse and frontal planes. The differences in excursions between the two marker sets were 
not statistically insignificant with the exception of the three knee joint excursions.
Table 5.2 shows a comparison between the two marker sets in determining peak sagittal joint 
angles at defined events and phases of the GC. The differences between the two marker sets 
were generally small (range 0-3 ). These differences were statistically insignificant, with the 
exception of hip and knee flexion at HC, and peak knee flexion and ankle dorsiflexion during 
SP.
Table 5.2 Right sagittal joint angles at HC and peak angles (degrees) during LR and SP 
(* indicates statistically significant difference between SMS and WMS)
Angle at HC Peak angle LR Peak angle SP
Parameter SMS WMS SMS WMS SMS WMS
Mean
(SD)
Mean
(SD)
Mean
(SD)
Mean
(SD)
Mean Mean 
(SD) (SD)
Hip 28(3)* 29(3) 29(3) 30(3) 30(3) 30(3)
Knee 5(3)* 7(3) 20(4) 20(4) 66(2)* 65(3)
Ankle 5(3) 3(2) 5(3) 3(2) 10(3)* 7(2)
5.4 Discussion
Conventional marker sets suffer from a number of errors that include soft tissue artifact (STA), 
marker misplacement and inter-segment dependency. STA are largest close to joints and 
proximal segments show higher STA than distal ones [Karlsson and Tranberg 1999]. This 
suggests that the SMS is more prone to STA errors than the WMS because of its marker 
locations near the knee, namely the supra patella and tibial tuberosity markers. These errors are 
expected to influence the thigh and shank orientation hence the hip, knee and ankle parameters. 
Inter-segment dependency can propagate the errors from proximal to distal joints. Therefore, 
errors due to STA and joint centre estimation are accumulated.
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Generally, the results showed an overall agreement between the SMS and WMS. The observed 
differences were mainly in the frontal and transverse planes, which are more sensitive to errors 
due to the relatively smaller movements in these two planes. These differences are the result of 
a combination of factors that includes joint centre definitions and a position dependent STA. 
The SMS uses markers positioned close to the joints and does not use wand markers, and is 
hence independent of the wand alignment. The wands are affected by both skin and soft tissue 
movement due to muscular activity. This is particularly so for the thigh and shank wands’ 
positions adopted with the significant muscle volume underneath.
Compared to the WMS, the SMS suffered from a high inter-subject variation (higher SD 
around the mean) in the determination of knee abduction, and hip, knee, and ankle rotations. It 
is suggested that this might be caused by the supra patella marker, which is used to define the 
thigh segment axes. Medial or lateral errors in the positioning of this marker affect the thigh 
segment coordinate system that might lead to flexion/extension crosstalk increasing the amount 
abduction/adduction seen at the knee which can be seen to coincide with the peaks of knee 
flexion (Figure 5.4). Both the hip and knee rotations are affected considerably by this marker. 
In addition, subject dependent location and orientation of the patella relative to the femur, both 
when standing and walking, might have contributed to this variation. Care must be taken when 
applying the supra patella marker, such that the standing position of the subjects as well as 
quadriceps activity is standardized during the marker application process. It is believed that this 
will reduce the amount of variation and the offsets for the transverse and frontal angles.
Higher ABSDs were observed the fiirther the joint angle is from the neutral (e.g. joint rotations 
during LR and SP and ankle inversion during late stance). This is likely to be the result of 
higher errors and differences between the two marker sets occurring at the limits of the joint 
motion as reported previously [Castagno et al. 1995].
The SMS and WMS showed similar CV results. The WMS showed a statistically significant 
higher CV for knee rotation. The CV values for the sagittal plane were comparable with 
previously reported data [Winter D 1991]. Care must be taken when comparing the CVs of 
groups with unequal means. When the CV values are considered in combination with the group 
means and SDs (Table 5.1, Figures 5.3-5.5), the SMS and WMS had very similar variability in
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the sagittal plane, the WMS was slightly less variable for all frontal and transverse planes 
parameters. The two marker sets were in total agreement for all pelvic parameters.
o
The differences observed in the calculated 3D excursion and peak angles were within 4 .  
Statistical significance seen in the sagittal parameters differences is due to the low variability in
o
these parameters (e.g. SD for knee flexion excursion is 3 ). The clinical implications of these 
differences are application dependent and parameter dependent. However, these differences are 
within 1 SD for these parameters.
The results from both marker sets were visually compared with previously reported data, 
showing general waveform pattern agreement [Kadaba et al. 1989; Benedetti et al. 1998]. 
However, frontal and transverse knee angles showed some differences in the overall pattern 
from both marker sets (abduction during swing). Studies using bone fixed markers showed that 
there is variability across subjects in the knee rotation and adduction angle patterns as well as 
high errors when using skin-based marker sets for the determination of transverse and frontal 
plane angles at the knee [Reinschmidt et al. 1997]. Thus the comparison with other studies for 
these parameters is difficult. The ankle joint showed an eversion angle followed by an 
inversion towards the end of stance, different from [Kadaba et al. 1989; Benedetti et al. 1998]. 
This is in agreement, however, with Reinschmidt’s study that used both skin and bone markers 
[Reinschmidt et al. 1997].
5.5 Conclusion
Sources of errors including STA, marker application, joint centre estimation and intra and inter­
subject variability are the main contributing factors to the differences found. The decision to 
select one of these marker sets could be viewed to be parameter-specific and application- 
dependant, depending on the parameter(s) of interest and the type of patient to be measured the 
selection of the SMS or the WMS could be made. The slight frontal and transverse planes 
WMS advantage does not discredit the SMS in these planes. Frontal and transverse plane joint 
angle differences between the two marker sets were within few degrees (taking into account 
waveforms offsets). Disagreements in joint angles for those two planes are also seen among 
reported studies in the literature.
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The use of the supra patella marker can be seen to reduce the reliability and accuracy of the 
SMS in the measurement of the hip and knee, and ankle rotation angles.
Therefore careful application of this marker is required. However, the SMS is believed to have 
some practical advantages over the WMS for clinical use. This is especially true with children 
as it does not require marker alignment nor obstruct arm swing. It also avoid the wands being 
knocked when subjects are using an ambulation aid such as crutches or walking frames. A 
study [Kalogridi et al. 2006] of the SMS comparison with the 6DOF showed ABSD within 3 
degrees at the pelvis and hip in the three planes; the differences were accumulating distally 
because of error propagation which is also a character of the WMS as these two marker sets 
have inter-segment dependency unlike the 6DOF.
The WMS was selected for use in the FO investigation for two reasons:
(1) In the SMS, marker placement variability of the supra patellar marker can affect the non- 
sagittal joints angles especially at the knee, and this can negatively affect gait data repeatability 
in these planes.
(2) The subjects taken for FO investigation are normal healthy adults and therefore wand 
marker alignment can be performed and there is no risk of wand being knocked by crutches or 
walking aids.
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Chapter 6
Repeatability of gait data
6.1 Introduction
The ability to carry out gait measurement in a highly reproducible method is crucial to 
any gait study. This is particularly important if the purpose is to detect relatively small 
changes in gait parameters. High repeatability minimizes data variability due to 
methodological data collection approach and impacts positively on the detection of 
smaller changes in gait data.
Repeatability as measured by the Coefficient of Multiple Correlation (CMC) [Kadaba 
et al. 1989], has been investigated by many researchers. The CMC is used to compare 
waveform similarity for within (CMCW) and between (CMCb) sessions. The CMC is 
calculated as follows:
For between sessions (CMCb), equation 6.1 is used.
(Equation 6.1)
M N T _
1 2 1  (Y,J( - Y,)2/ T(MN-I)
CMC"= 1 -
M N T _
1 2  2  (Yijt - Y )2/ (M NT-l)
i=l pl t=l
Where Yytis the fth time point of the jth  run on the rth test session. 
Where Yt is the average at time point t over NM gait cycles,
_  1 M N
Y,=   2 2 Y»
MN J_1
Y is the grand mean over time and is given by;
_  1 M N T
Yi,= —  2  2 2  Yijt
MNT 1-1 t_1
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M is the number of models,
N is the number of runs 
T time points within a GC
For within session repeatability (CMCW), equation 6.2 is used.
(Equation 6.2)
M N T _
I  £  I  (Yjjt - Yii )2 / MT(N-1)
CMC2= 1 - 1=1 J~‘ _____________________
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Yit is the average at time point t on the ith test day and is given by;
_ I n
y,=  — y  Yijt
N 11
Yi is the grand mean on the ith day and is given by;
_  1 N T
Yt= ------ I I  Y^
NT J_1 1-1
Kadaba et al. (1989) investigated the repeatability of kinetic, kinematic and 
electromyography gait data. Their investigation focused on the repeatability within 
day (CMCW) and between days (CMCb) for those gait parameters. They found that 
CMCW was higher than CMCb (3D) and sagittal CMCs were higher than frontal and 
transverse plane CMCs. They attributed repeatability discrepancies to the inherent 
physiological variability and to marker reapplication and alignment errors.
Growney et al. (1997) investigated the kinetic and kinematic repeatability. They 
found similar repeatability trends as Kadaba et al. (1989). They attributed non-sagittal 
repeatability discrepancies to the smaller joint excursions in these planes and to errors 
in the re-application of mid thigh and mid shank wand markers.
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Carson et al. (2001) concluded that kinematic repeatability is subject to errors arising 
from marker placement rather than inter-tester and skin movement.
Other investigators have used the repeatability to understand the inherent variability 
in gait data from a neurological view point [Chau et al. 2005].
These studies agree that CMCW is generally higher than CMCb and marker re­
application and alignment is very important for gait data repeatability. However, none 
of these studies explicitly accounted for the protocol employed to apply and align the 
markers for the production of their data.
Markers are usually attached to the skin with respect to bony anatomical landmarks. 
Some anatomical landmarks are more difficult to locate than others especially those 
which do not have bony prominences but surfaces like the greater trochanter. Della 
Croce et al. (2005) estimated the precision of locating anatomical landmarks among 
examining physiotherapists, they found a mean precision error of 9.8mm (range 4.8- 
21mm). The highest error was 21mm at the right ASIS, the left ASIS error was only 
12.2mm. The large difference between the right and left ASIS raises a question about 
the reason for this large discrepancy especially as they are both palpable prominences 
should help to accurately and precisely pin point their position, and it is expected that 
this difference be small, however, this indicate that variability in gait data can be 
raised thus making it difficult to compare data which was collected by different raters.
A data collection protocol can act as a guide to the selection, preparation, marker 
application and alignment of the subject and data collection. The rationale for 
employing a data collection protocol is to improve data reproducibility by minimising 
the possible sources of gait data variability that may mask changes in gait parameters 
which investigators try to quantify.
The aim of this study was to assess the kinematic and kinetic repeatability, as 
measured by the CMC, using WMS application and alignment protocol. The WMS 
was used, as from Chapter 5, this was to be the marker set of choice for the main FO 
study. Therefore, the results of this study would be used to determine the differences 
seen when data is analysed with and without FO.
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6.2 Method
Six healthy male subjects were recruited for the study. The testing was done over two 
days one week apart, in each test day two sessions were performed 15minutes apart.
The principle of the subject selection criteria were that all subjects belong to the same 
age band as devised by Whittle (1996), physical condition and ability, gender and 
BMI as this helps to reduce inter-subject variability. Details of the anthropometry of 
the selected subjects are given in Appendix B. 1. The subject selection criteria were:
1. Satisfy the set physical examination chart for able bodied subjects (Appendix B.2). 
The chart examines the neuro-musculo-skeletal condition of the subject which all has 
to be sound.
2. The selected subjects were in the 18-49 years age band [Whittle 1996]; This is to 
avoid the effects of age differences on gait among the participants.
3. BMI; within a normal range (18.9-24.9).
4. LLD of no more than 15mm. The 15mm LLD was selected to limit the effect of 
LLD on gait data variability as described in (5.2.2).
5. All subjects have the right as their dominant side.
In each session the WMS was applied using the protocol described above. In each 
data collection sessions the WMS was applied and aligned, and data was collected 
then the markers removed and applied again after 15 minutes to collect another set of 
data. The subjects walked shod at their self-selected speed.
6.2.1 Equipment
Data was captured using a 7-camera system ProReflex MCU500 (Qualisys Medical 
AB, Gothenburg, Sweden), and two AMTI force platforms (Advanced Mechanical 
Technology Inc. Watertown, MA, USA.); version BP400600HF, sensing element is a 
strain gauge bridge, and dimensions 400x600x82.5 mm. The data was tracked and 
labelled using the motion analysis software QTM (Qualisys Medical AB, Gothenburg, 
Sweden) and joint kinematic and kinetic calculations performed using Visual 3D (C- 
Motion Inc., Rockville MD, USA).
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6.2.2 Foot motion measurement
Because the experiment was done while the subjects were shod; the foot had to be 
considered as one segment and foot motion was calculated as the 3D motion of the 
ankle joint. It will be better, if it was possible, to measure and study the rearfoot 
(subtalar joint), midfoot and forefoot segments motion separately. As this will give an 
insight into foot inter-segments motion particularly the rearfoot.
Another method, less commonly used, of assessing subtalar inversion/eversion is by 
measuring tibial rotation. A study [Cornwall and McPoil 1995] found strong 
correlation (r = 0.953) between subtalar motion and tibial rotation. However care 
must be taken when evaluating subtalar motion through tibial rotation, as the later 
represents the collective motion o f the ankle, subtalar, and mid-foot joints. 
Furthermore the correlation between tibial rotation and subtalar motion is imperfect.
Currently there are multi-segmented foot models that divide the foot into three or 
more segments [Leardini et al. 1999; Carson et al. 2001; Leardini et al. 2006], thus 
enabling an insight into intra-foot segment motion. However, because these models 
are applied to barefoot, it is not possible to use such models in the shod condition.
6.2.3 Data collection and processing
The protocol was applied and the subjects were asked to walk along the walkway in 
the gait laboratory. The walking trials were performed in one direction along the gait 
laboratory. The start point was adjusted so that the subject steps on the force plate 
cleanly, however the subjects were not told the reason for this adjustment to avoid 
targeting. The term session refers to the set of walking trials under the same marker 
application condition.
Kinematic and kinetic data were collected at 200Hz sampling rate. For each subject, 1 
standing and 5 “clean” force plate contact per leg for walking trials were collected. The 
selected trials for analysis were the first best 5 trials of the session, this was done to 
ensure consistency across the sessions and the subject is most likely to walk more 
consistently at the beginning of the session rather at the end of it as he may get tired.
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Comparing the number of trials selected (3 trials in the marker sets comparison versus 
5 trials in the repeatability study) can be explained as follows: in the marker sets 
comparison study the purpose was to compare angles between two adjacent segments 
as measured by the SMS and WMS as they were applied simultaneously, here a single 
trial would have been sufficient to compare the differences between the 2 marker sets, 
but a mean of 3 trials was used as this is a common figure in clinical practice. Whereas 
in the repeatability study, variability in gait pattern plays an important role in 
determining the means and SD of the joint angles, hence a greater number of trials are 
needed to obtain a representative mean and SD of the joint angles and kinetic 
parameters thereby reducing the effects of out layers.
From QTM the files were exported in a c3d form. The c3d files were processed in 
Visual 3D, the markers position data was filtered at 10Hz and the force plate data at 
30Hz. A 10 frame maximum spline fill was applied to the marker data.
The calculated parameters were:
i. Temporal-spatial data of walking speed, cadence and step length.
ii. 3D joints angles.
iii. 3D moments and powers of the hip, knee and ankle joints.
iv. Resultant joint reaction force magnitude of the hip, knee and ankle joints.
The computed gait parameters were means of 5 trials, normalized to one complete gait 
cycle (GC) and exported in p2d text file (contains a simple header and data section) 
form containing 101 data points encompassing 100 intervals, each interval representing 
1 % of the GC.
The sample rate in this study was 200Hz compared to the 100Hz in the earlier marker 
sets comparison (chapter 5 study). 200Hz was selected because the highest frequency 
content of GRF is ~75Hz (in principle the sampling rate should be at least twice the 
highest frequency content) whereas the earlier study did not contain GRF data and 
100Hz was adequate to capture kinematic data. The exported data in this study 
contained 101 data points per GC, this was 201 data points in the earlier study. The 
reason for this is that the software (Q Gait) used in the earlier study only allows for 
201 data point export whereas the software (Visual 3D) used in this study allow the 
selection of any number of data points per GC, and it was thought that 101 data points
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were sufficient to represent the GC.
Only the right side was taken for analysis and every subject was his own control. For 
each subject for every parameter the CMCW and CMCb were computed and the 
outcome was averaged across the six subjects to produce a parameter mean for CMCW 
and CMCb. The CMC was calculated without removing the waveform means because 
it becomes higher as the waveforms are brought closer to the x axis and can be 
misleading. CMCb were calculated from session means and then averaged across the 
six subjects. CMCW were calculated from individual session trials then averaged across 
the six subjects.
66.2.4 Calculation of the absolute difference (ABSD)
The ABSD between days was calculated between session means and within day 
between the session individual trials.
For every parameter the ABSD between corresponding data points on the waveforms 
were calculated for all gait cycle data points (n=101). These ABSDs were then 
averaged to compute a parameter ABSD. The ABSDs were then averaged across the 
six subjects to compute the mean of ABSDs. The ABSD was calculated rather than an 
increase or decrease between sessions because some parts within a GC can be higher 
while others are lower than corresponding parts of the compared GC which when 
averaged can give a misleading result (e.g. zero mean difference). This ABSD reflects 
the magnitude of change in a gait parameter over the gait cycle.
6.2.5 Waveform comparison
The CMC was used to evaluate waveform similarity for within and between sessions. 
The CMC was calculated for each subject then averaged across the six subjects.
6.2.6 Excursions
Between days excursions were calculated from session means and then averaged 
across the six subjects. Within day excursions were calculated from individual session 
trials then averaged across the six subjects. Within session and between sessions 
excursion differences were calculated for joint angles and the kinetic parameters. 
Finally to express the clinical weight of the ABSD it was expressed as a percent of its 
excursion.
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6.3 Data collection protocol
The following procedure was followed for subject preparation, marker application and 
alignment prior to data collection.
(A)- Marker application
1. Have the subject wear shorts which are closely fitting, elastic and conforming to the 
body shape (e.g. Lycra shorts). This ensures minimal movement between markers on 
the shorts and the underlying soft tissue and bone without restricting body segments 
motion. It also ensures the markers on the shorts are as close as possible to the 
anatomical landmark.
2. Gait walking trials; apply the markers with the subject standing naturally with 
his/her feet adjacent (medial aspects of feet touching each other) and parallel and also 
facing forward. It is believed that this position will lead to more repeatable placement 
and alignment.
3. Correctly locating the anatomical landmarks is a key point for accurate marker 
application. The marker should be applied so that its centre coincides with the centre 
of the found anatomical landmark in the horizontal plane. In cases where the marker 
is at a described location with respect to a specified anatomical landmark, precisely 
measure the distance of the marker position to the anatomical land mark (e.g. Sacral 
marker).
(B)- Marker alignment
To align the thigh and shank wand markers, have the subject standing with feet 
parallel and adjacent as described above. Figure 6.1 and Figure 6.2 illustrates this 
method; Line BB is the assumed line of progression, it passes through the contact 
points of the medial edges of the feet. Line AA is an imaginary line through the lateral 
malleoli; it lies at 90 degrees to line BB. The person aligning the wand markers stands 
on line AA at about two meters from the subject. Alignment is done visually using the 
edge of a lm rule. Using a ruler edge with one eye open align the thigh wand marker 
with the knee and the greater trochanter markers. Also align the shank wand marker 
with the knee and lateral malleolous markers. Do the same for the other side o f the 
body in the case of bilateral marker application.
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Figure 6.1 Marker alignment concept (foot plate)
(C)- Shoe type
It was important to ensure a unified shoe type across all participants. This included 
shoe design, material, heel height and size. Shoes were firmly laced around the foot 
without restricting foot motion. It is believed that this would help to reduce variability 
due to differences in shoe types among the participants.
Figure 6.2 Marker alignment concept (subject standing on foot plate)
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6.4 Results
The results from this study showed a trend for better within day repeatability than 
between days. The trend was true for temporal-spatial, joint angle, joint moments, 
joint powers and joint reaction force resultant magnitude parameters.
6.4.1 Temporal-spatial parameters
Individual walking speeds (ranged 1.30 -  1.62 m/s), cadence (ranged 103.5 -  120.0 
steps/min) and step length (ranged 0.700 -  0.857 m) all fell within the normal ranges 
for males aged between 18-49 years in free speed walking [Whittle 1996], Within day 
ABSD was lower than that between days for the measured temporal-spatial 
parameters (Table 6.1). Expressed as percentages o f their means; the ABSD for 
walking speed, cadence and step length was lower within a test day than between test 
days.
Table 6.1 Changes in temporal-spatial parameters within and between days. Results are from 4 
sessions (n=12). (W=within, b=between)
parameter Overall ABSD mean (SD) ABSD/overall mean
Mean (SD) w b w b
Walking speed (m/s) 1.451 (0.083) 0.043 (0.030) 0.068 (0.039) 3.0% 4.7%
Cadence (steps/min) 112.1 (4.3) 2.0 (1.8) 3.1 (1.4) 1.8% 2.7%
Step length (m) 0.792 (0.043) 0.013 (0.011) 0.024 (0.016) 1.7% 3.0%
6.4.2 Joint angles
Sagittal CMCs were greater than 97% and were higher than frontal and transverse 
plane CMCs for all parameters except for pelvic tilt which had the lowest CMC value 
(77.9%) (Table 6.2). Relatively low pelvic tilt is probably because o f the small pelvic 
tilt excursion (3.6 degrees), which is the lowest excursion among all measured 
parameters. For most parameters; CMCW was higher than CMCb.
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Table 6.2 Changes in joint angle parameters within and between days (n = 6). (W=within,
b=between)
CMC (%) Excursion Excursion ABSD Walking ABSD/Exc
Mean (SD) Mean (SD) diff Mean (SD) (Walking)
w b w b w b w b w b
Pelvic
tilt 80.7 (7.2) 68.3 (24.2) 3.6 (1.3) 3.2 (1.1) 0.6 0.4 0.7 (0.2) 2.6 (1.7) 20.6% 80.2%
Pelvic
obliq 97.5(1.5) 92.5 (6.2) 9.4 (2.9) 9.3 (2.7) 0.6 0.8 0.6 (0.1) 1.1 (0.5) 6.5% 12.1%
Pelvic
rot 93.0 (5.2) 92.8 (5.2) 12.2 (4.8) 11.4(4.6) 1.3 1.4 1.4 (0.5) 1.5 (0.7) 11.8% 13.0%
Hip 1.4 1.1 2.2% 7.0%flex 99.8(0.1) 98.7 (1.3) 50.4 (5.0) 50.3 (4.6) 1.1 (0.3) 3.5 (2.1)
Hip
abd 97.7 (1.6) 93.9(7.1) 12.4 (3.9) 11.9(3.7) 0.8 1.5 0.8 (0.2) 1.4 (0.9) 6.8% 11.5%
Hip
inrot 96.3 (2.9) 75.0(26.6) 16.6 (5.2) 15.6 (4.5) 1.2 2.6 1.1 (0.3) 3.4 (2.6) 6.7% 22.0%
Knee
flex 99.7(0.1) 99.6 (0.2) 66.5(6.1) 66.4 (5.4) 1.8 1.3 1.6 (0.3) 2.2 (0.6) 2.3% 3.3%
Knee
abd 97.9 (0.9) 90.0 (9.8) 15.5 (3.6) 14.6 (3.2) 1.7 2.8 0.8 (0.2) 1.6 (0.9) 5.1% 10.9%
Knee
inrot 92.3 (4.4) 69.9(24.8) 17.2 (5.6) 16.6 (5.0) 1.8 1.5 1.7 (0.4) 3.9 (2.1) 9.7% 23.5%
Ankle
dosi 99.1 (0.3) 97.3 (3.8) 32.1 (7.7) 31.4 (7.2) 1.7 1.5 1.2 (0.3) 2.0 (1.8) 6.4% 6.4%
Ankle
abd 96.0 (1.7) 82.9(28.0) 22.5 (2.4) 21.6 (2.7) 2.4 2.2 2.0 (0.6) 4.8 (4.5) 8.7% 22.4%
Ankle
inv 94.0 (1.7) 84.4(13.9) 13.4 (3.5) 13.2 (3.9) 1.5 1.2 1.2 (0.3) 3.5 (4.1) 8.6% 26.5%
Compared to the published literature [Kadaba et al. 1989; Growney et al. 1997], 
sagittal CMCs were similar, however, the results from this study showed higher 
CMCs in the non-sagittal planes indicating an improved “between day” repeatability. 
Furthermore the differences between CMCb and CMCW in the frontal and transverse 
planes were substantially reduced from maximums o f 21% and 41% to within 13% 
and 21% respectively (Table 6.3).
Table 6.3 the differences between CMCW and CMCb (n = 6)
Kadaba Growney Thisstudy
Frontal Pelvic 7 11 5
Plane Hip 7 8 4
Knee 18 21 8
Ankle NA 3 13
Transverse Pelvic 11 4 1
Plane Hip 41 21 21
Knee 38 37 22
Ankle 27 24 10
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For all angle parameters, the mean excursions were very similar for within and 
between test days. Comparing within day to between days excursions; these were very 
similar and the difference between them was within 1 degree for all angles, also the 
SDs was also very similar in both of them with a difference within 1 degree (Table 
6 .2).
The ABSDs during walking were within 5 degrees in both within and between days 
mean (ranged 0.6 - 4.8 degrees), SD (ranged 0.1 -4 .5 )  (Table 6.2). Within day ABSD 
were less than between days for all angles and were between 0.6-2.0 degrees. The 
ABSDs for between days were between 1.1-4.8 degrees. The value of the ABSD was 
not dependent on the joint excursion magnitude.
The ABSD percentage (Table 6.2) of the excursion was lower within a test day than 
between test days for all measured joint angle parameters. The highest percentage was 
seen in the between day pelvic tilt (80.2%) and the lowest were in the sagittal plane at 
all joints.
6.4.3 Joint moment and ground reaction forces (GRF)
Most moment CMCs were greater than 97%. The lowest were for ankle abduction 
CMCb which was 81.6%. Both CMCw and CMCb were higher than those in the 
literature [Kadaba et al. 1989; Growney et al. 1997] for all parameter except the 
CMCb of ankle abduction.
The within and between day excursions were very similar for all GRF and moment 
components. The ABSD (range 1.4 -  27.4 Nm) in joint moments were lower within a 
test day than between test days for all parameters. When expressed as a percent o f the 
excursion the ABSDs were within 10% except for ankle abduction moment where it 
was 28.3%.
Table 6.4 shows the ABSD, CMC, excursion and ABSD/excursion percentage o f the 
GRF and joint moments. GRF CMCs were greater than 99% except for GRFy 
(CMCw = 94.2%). In previous studies, GRFy was also found to be more variable than 
GRFz and GRFx [Kadaba et al. 1989; Growney et al. 1997], The GRF absolute 
differences were lower for within day than between days for x, y, z components.
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Most moment CMCs were greater than 97%. The lowest were for ankle abduction 
CMCb which was 81.6%. Both CMCw and CMCb were higher than those in the 
literature [Kadaba et al. 1989; Growney et al. 1997] for all parameter except the 
CMCb of ankle abduction.
The within and between day excursions were very similar for all GRF and moment 
components. The ABSD (range 1.4 -  27.4 Nm) in joint moments were lower within a 
test day than between test days for all parameters. When expressed as a percent of the 
excursion the ABSDs were within 10% except for ankle abduction moment where it 
was 28.3%.
Table 6.4 GRF and joint moments variability (n = 6). (W=within, b=between)
CMC (%)
Mean (SD)
Excursion
Mean (SD)
Excursion
diff
ABSD Walking
Mean (SD)
ABSD/Exc
(Walking) 
% of EXC
w b w b w b w b w b
G RFz
99.2(0.2) 99.5 (0.2) 816.1(126.3) 817.0(123.0) 19.0 30.8 27.4(7.4)
23.6(6.9) 3.4% 2.9%
GRFx
99.5 (0.2) 99.7 (0.2) 320.4 (69.2) 319.6(63.2) 6.8 9.0 9.0 (2.0) 7.1 (3.0)
2.8% 2.2%
GRFy
94.8 (2.2) 98.1 (1.3) 71.1 (15.3) 69 .4(14.1) 9.0 2.0 6.3 (1.6) 3 .5 (1 4 ) 8.9%
5.0%
HIP
FLEX 98.9(0 .2) 98.8 (0.6) 163.0 (46.4) 159.8(45.4)
10.6 11.0 5 .9(1 .4) 6 .4 (1 8 ) 3.6% 4.0%
HIP
ABD 98.7(0.4) 98.7(1 .2) 75.5(18.4) 65.9(16.9) 5.9 7.8 3.9 (0.9) 4.4 (2.6) 5.2%
6.6%
HIP
ROT 98.0(0 .7) 95.6 (3.5) 31.4(8.3) 29.0 (7.2) 1.9 4.9 1.4(0 .2) 2 .6 (1 3 ) 4.5%
9.1%
KNEE
FLEX 98.8 (0.5) 97.6 (2.5) 87.1 (21.6) 82.8(18.7) 6.2 6.7 3.1 (0.5)
5 .2 (2 8 ) 3.6% 6.2%
KNEE
ABD 99.2 (0.2) 98.8(0 .8) 50.3(10.0) 45.9(12.3) 2.9 5.2 2.1 (0.2) 3 .2 (1 4 )
4.1% 7.0%
KNEE
ROT 98.9(0 .2) 98.7(0 .9) 26.5 (5.7) 25 .6(5 .0) 1.6 2.5 1 0 (0 .2 ) 1.1 (0.5) 3.8%
4.4%
ANKLE
DF
ANKLE
ABD
99.6 (0.2) 
97.7(1.6)
99.7 (0.2) 
81.6(16.1)
116.3(28.6)
19.6(4.2)
115.4(26.8)
19.0(5.0)
3.2
2.3
3.7
4.4
2.5 (0.4) 
1.1 (0.1)
3.3 (1.3)
5.4 (3.5)
2.2%
5.4%
2.8%
28.3
%
ANKLE
INV 99.3 (0.2) 99.1 (0.7) 19.3(2.7) 18.5(3.0) 1.7 1.8 0.6 (0.1) 1 0 (0 .5 )
3.3% 5.5%
6.4.4 Joint power
Power is the product of moment and angular velocity. Therefore it is expected that the 
changes in walking speed and joint moment would be seen in the calculated powers. 
This is the case; the ankle abduction CMCb w was the lowest among all power 
parameters (Table 6.5).
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Table 6.5 Joint power variability (n=6). (W=within, b=between)
C M C  (%)
Mean (SD)
Excursion
Mean (SD)
Excursion
diff
ABSD Walking
Mean (SD)
ABSD/Exc
(Walking) 
% of EXC
w b w b w b w b w b
HIP
FLEX
97.3 (0.3) 97.1 (1.1) 214.8(32.3) 199.2(32.4) 19.8 21.3 11.8(1.9) 11.1(2.7) 5.5% 5.6%
HIP
ABD
89.8(6 .0) 84.5(10.1) 145.3 (80.0) 133.9(70.7) 26.1 55.9 7.0(2.1) 7 .0(23) 4.8% 5.2%
HIP
ROT
93.1 (4.4) 90.1 (5.6) 101.1 (74.5) 93.9(59.9) 13.9 41.2 3 .2 (11) 3 .6(18) 3.2% 3.8%
KNEE
FLEX
97.4 (0.7) 96.9 (2.6) 233.0(70.4) 219.7(66.4) 24.0 24.6 98(2 .2) 9.7(4.0) 4.2% 4.4%
KNEE
ABD
94.6 (0.9) 94.3(2 .7) 82.1 (32.2) 87.0(36.3) 17.8 20.4 3.9(1.3) 3 .8(14) 4.7% 4.3%
KNEE
ROT
91.2(5 .4) 88.4(8 .8) 67 .9(40.2) 61.4(32.6) 14.0 13.7 3 .2(11) 2 .9 (11) 4.7% 4.8%
ANKLE
DF
97.8 (0.6) 98.9(1 .1) 326.5 (62.7) 305.8 (63.0) 28.2 25.4 9 .0 (11) 5.8(2.1) 2.8% 1.9%
ANKLE
ABD
87.1 (5.6) 78.1 (18.8) 66.1 (22.1) 56.3(17.4) 14.6 23.8 3 .4(10) 3 .4(16) 5.1% 6.0%
ANKLE
INV
88.3(3 .9) 90.7(4.9) 4 1 .0 (1 9 .4 ) 34.5(16.9) 8.5 9.3 2.5(0.8) 19(0.8) 6.1% 5.4%
6.4.5 Joint reaction force magnitude (JRF)
The JRF results, shown in Table 6.6, reflect the trend seen in the previous results. The 
within day ABSD, CMCs and excursions were lower than that between days; 
however, the JRF magnitude is extremely repeatable (CMCs were greater than 99%). 
The ABSD percentage of JRF excursion is within 4%.
Table 6.6 Joint reaction force variability (n = 6)
CM C (%)
Mean (SD)
Excursion
Mean (SD) Excursion diff
ABSD Walking
Mean (SD)
ABSD/Exc
(Walking) 
% of EXC
w b w b w b w b w b
HIP 99.6(0 .1) 99.5(0 .8) 729(120) 725(120) 32.8 42.2 21(4.3) 24.2(24.6) 2.9% 3.3%
KNEE 99.7(0 .1) 99.8(0.2) 825(132) 824(127) 28.0 37.7 20(4.9) 18.7(10.5) 2.4% 2.3%
ANKLE 99.7(0.1) 99.8(0 .1) 863(135) 864(130) 25.7 33.0 19(5.1) 16.1(5.6) 2.2% 1.9%
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6.5 Discussion
A highly reproducible gait measurement protocol can aid gait data repeatability which 
in turn can help the detection of small changes in gait parameter. This can give 
clinicians greater confidence in comparing gait data between days for patient 
monitoring and treatment decisions.
Sources of measurement errors include instrumental inaccuracies, skin artefacts and 
marker misplacement, the latter is greater than the other two [Della Croce. Ugo 1995]. 
This study dealt with the latter source of error which is widely believed to be the main 
cause of the lower gait measurement repeatability [Kadaba et al. 1989; Ugo Dlla 
Croce 1995; Growney et al. 1997; Della Croce et al. 2005]. It is believed that soft 
tissue artefact is subject-specific [Leardini et al. 2005], hence its effect on 
repeatability is expected to be minimal. These probably have small variability and 
hence have smaller influence on repeatability.
In healthy subjects, during standing, the whole leg almost rotates as one segment at 
the hip joint. Foot rotation and position on the floor determine the leg segment 
orientation in space, it also determine the hip joint position. Hip joint motion changes 
the palpable location o f the greater trochanter (GT). The GT is an anatomical 
landmark used for the determination of the thigh segment frontal plane, hence by 
placing the feet in a repeatable position the palpable location of GT will be in the 
same spot every time the markers are applied and aligned.
During thigh and shank wand markers alignment the position of the investigator with 
respect to the subject is important, as different positions lead to different alignments 
and hence different determinations of the thigh and shank frontal planes. During wand 
markers alignment, any alteration in the GT position, segment orientation or 
investigator position can alter the thigh and shank frontal plane orientation. It is 
believed that the alignment method used in this study has impacted positively on the 
3D kinematic and kinetic repeatability particularly in the non-sagittal planes.
Compared to the published literature, the results from this study showed an improved 
“between day” repeatability, and a substantial reduction in the differences between 
CMCW and CMCb for joint angles in the frontal and transverse planes. These
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differences were reduced from maxima of 21% and 41% to 13% and 21% 
respectively (Table 6.2). This is attributed to the highly reproducible marker 
application and alignment protocol.
Sagittal joint angles CMCs were very similar to those reported in previous studies 
[Kadaba et al. 1989; Growney et al. 1997] for both CMCW and CMCb. Sagittal 
repeatability was excellent (CMCs>97%), the only exception is the pelvic tilt which 
showed a slightly lower CMC, this is widely believed [Kadaba et al. 1989; Growney 
et al. 1997] to be caused by the limited pelvic tilt excursion (3.6 degrees) which 
makes its CMC sensitive to errors. CMCW is not always higher than CMCb; this is 
similar to the results from [Growney et al. 1997] who suggests the this caused by the 
step of averaging the data in which the random variation may cancel out leading to 
CMCb being higher than CMCW. CMCb higher than CMCW is also seen in some 
kinetic parameters.
The majority of joint angle mean ABSDs were around 2 degrees (maximum 4.8 
degrees). The walking ABSDs, as was revealed by the sensitivity analysis (Appendix 
B.3), were variable over the GC and dependent on the flexion angle of the joint. This 
kind of variability is due to error in the definition o f joint axis orientation which is 
caused by marker placement error [Kadaba M P et al. 1990]. Despite the presence of  
ABSDs, the excursions were not affected, this was similar to previous findings 
[Kadaba et al. 1990].
The ABSD in joint angle parameters as a percentage of the excursion was calculated 
to reflect its clinical importance. It is observed that the higher this percentage the 
lower the CMC (table 6.2). In the clinical environment a measurement error of, for 
example, 2 degrees in pelvic tilt (excursion 3.6 degrees) is more significant than 2 
degrees error in knee flexion measurement (excursion 66.5 degrees).
The knee and ankle joint axes of rotations lie in the thigh and shank frontal planes 
respectively. Errors in marker application can lead to joint angle errors and introduce 
joint crosstalk which particularly affects small angular components (rotations) [Della 
Croce 1995], It can also lead to joint centre mislocation which in turn affects joint 
angles and moments [Stagni et al. 2000]. Crosstalk arises from differences between
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the anatomical joint axis of rotation and the defined joint axis, the latter is based on 
marker positions on the segments.
The presence of a common marker between two adjacent segments leads to inter­
segment dependency and errors at proximal joints propagate distally, which may 
affect the repeatability of distal joints parameters [Kalogridi et al. 2006].
Natural intra-subject variability is displayed as a change in speed, step length and step 
frequency. To separate the contribution of marker placement and alignment errors 
from subject natural variability, the calculated within session changes in gait 
parameters (while marker position were unchanged) represent the intra-subject 
variability. Whereas the calculated between day variability is mainly due to intra­
subject and marker reapplication and alignment variability.
The results from this study showed greater variability in walking speed between days 
than within day (4.7% and 3% respectively), this is consistent with findings from 
previous studies by Kadaba et al. (1989) and Growney et al. (1997). Walking speed is 
the composition of stride frequency and stride length, the change in walking speed 
result more from stride length than stride frequency (relationship =1.664m/Hz) 
[Danion et al. 2003].
The literature lacks evidence on the relationship between walking speed and joint 
angles. The study by Lelas et al. (2003) confirms the presence of a relationship 
between walking speed and joint angles; they found the relationship poor to predict. 
Benedetti et al. (1998) found that speed only had an effect on hip coronal plane angles 
and ankle plantar flexion at toe off and during swing whereas the knee was not 
affected. A more recent study by Hanlon and Anderson (2006) found that an increase 
of 0.5m/s in walking speed leads to different changes at different joints and these 
changes are variable throughout the GC. However, these were within 6 degrees.
In this study the maximum change in walking speed was 0.068 m/s, considering 
Hanlon and Anderson (2006) results, this change is expected have a small 
contribution to the ABSD in joint angles. Therefore it is reasonable to assume that 
speed-related changes in joint angles seen in this study are relatively small.
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A change in walking speed affects joint moments [Benedetti et al. 1998; Lelas et al. 
2003] and powers [Chen et al. 1997; Lelas et al. 2003]. The GRF differences in this 
study were probably mainly due to the change in walking speed; these were within 
7% of the total GRF excursion. The differences in moments, powers and JRF can be 
partly attributed to the GRF changes, which are not related to marker application 
errors.
In terms of within and between days repeatability in joint moments and powers; they 
followed a similar pattern to that of joint angles. However, because the GRF had a 
very high repeatability (mainly CMC>98%), this reflected positively on the CMCs of 
those parameters. However there was relatively low ankle abduction repeatability. 
This was partly because of its small excursion and the large ABSD in this parameter.
The joint reaction force magnitude followed a similar pattern for within and between 
days and was extremely repeatable (CMC>99.5%). This is probably because of the 
excellent repeatability seen in the GRF.
6.6 Summary
Sagittal CMC results from this study were in agreement with those from previous 
studies. Sagittal repeatability was the highest followed by the frontal then transverse 
plane. Within day repeatability (as measured by the CMCs) was better than between 
days.
Compared to the published studies, the results from this study showed higher 
repeatability in the non-sagittal planes for both within and between test days. The 
improved repeatability seen in this study is attributed to the adopted marker 
application and alignment protocol.
The factors which have the greatest influence on reproducibility are the natural intra­
subject variability, and marker application and alignment errors. The within day 
repeatability assesses the intra-subject data variability. Whereas the between days 
repeatability assesses gait data variability due to intra-subject and marker application
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and alignment variability. The least factor affecting repeatability is probably the 
variability in walking speed.
6.7 Conclusion
Compared to the published literature, the adopted marker application and alignment 
protocol for gait measurement in this study lead to similar sagittal and better frontal 
and transverse planes data reproducibility. Perfect gait data repeatability is probably 
not achievable due to the natural human gait variability.
Great care should be taken when locating the anatomical landmarks, applying and 
aligning the WMS markers.
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Chapter 7
FO test method and protocol
“The justification for the analysis lies not in the data collected but in the manner in 
which the data was collected” (Schoolman et al., 1968 cited in [Altman 1990])
7.1 Introduction
Wearing a FO can be regarded as an intervention at the shoe/foot interface. The FO 
testing aimed at finding changes in gait parameters that are due to this intervention. When 
the FO is worn the body need to respond and adapt to this change, hence, the gait changes 
that might be seen immediately might not represent the final gait pattern that the body 
will adopt in response to the FO intervention. The final gait pattern which the body adopt 
is what needs to be considered in investigating the long term effects of FO.
Several approaches were adopted in the literature for investigating the effects of FO. 
Some investigated the immediate effects of FO [Stacoff et al. 2000; MacLean et al. 
2006], while others assessed the effects of FO after a periods of ~ 1 week adaptation 
[McPoil and Cornwall 2000; Finestone et al. 2004].
This study was considered to be a prospective one to provide data on the changes 
observed with “off the shelf’ FO in able-bodied subjects. Given this and the relatively 
small number of subjects used (6 per FO) the FO effect on gait was done for each subject 
separately: every subject acted as his own control. Although for indicative purposes only 
mean changes across each group were determined.
Since the biomechanical effects of “off the shelf’ FO have limited studies on them in the 
literature, the approach taken was to first determine all lower limb joints angle and 
moments to find any variability that is greater than what would be expected naturally 
based on the variability results from a separate work undertaken in the repeatability study 
(chapter 6).
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7.2 Selection of foot orthoses
Two “off the shelf’ foot orthoses (FO) were selected for the testing. The two orthoses 
incorporated different number of components. These orthoses will be named here FOl 
and F02.
FOl is the “advanced footcare Gel insole” (figure 7.1) made in the USA for Boots (Boots 
Group PLC, Nottingham, UK). It is a full length insole and incorporates a simple flat 
insole and a heel pad. This FO is designed for men and made in one universal size that 
can be trimmed to fit in shoe size in the range of 6-12. The Gel material o f this FO is very 
durable and a pair cost ~£8.
Polymer insole
Gel heel pad
Figure 7.1 FOl manufactured in the USA and endorsed by Boots chiropodist (Boots Pic Group, UK)
These insoles aim, according to the provider, is to give comfort by redistribution o f foot 
pressure and shock absorption by utilising the mechanical properties o f the Gel. As part 
o f the instructions provided with the insoles, it recommends to seek advice from a 
chiropodist if symptoms persist.
The sole is 3 mm in thickness except around the heel region where it becomes thicker 
with a maximum of 9mm at the furthest point on the back o f the heel. The upper surface 
is covered by a fabric cloth.
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F02 (Figure 7.2) is the “Airplus sports and work insole”. It is made in the USA for 
Implus Corporation (Implus Corporation, NC, USA). It is a full length insole and 
incorporates a simple flat insole, heel pad and a medial longitudinal arch support. This 
FO is designed for men and made in a universal size that can be trimmed to fit shoe size 
in the range of 7-12. This FO cost ~£8.
Antimicrobal fabric
Gel heel drop Arch and heel support
Figure 7.2 F02 manufactured in the USA for Implus Corporation (Implus Corporation, NC, USA)
F 0 2  is made for the same comfort aims as F O l ,  however, it does not make the 
recommendations to seek advice from a chiropodist if symptoms persist which the 
provider of F O l  make.
The sole is 2.5mm thick at the toes and gradually increase to reach a maximum of 9mm at 
the furthest point on the back o f the heel. Like F O l ,  the upper surface is covered by a 
fabric cloth, however, the sole is made of rubber material and the heel is made of 
Polymer Gel.
The selection o f these F O  was based on their component incorporation, as the aim o f this 
research was to investigate and compare the biomechanical effects o f F O  with different 
number of components.
Both F O l  and F 0 2  are readily available “off the shelf’, F O l  is the simplest and F 0 2  is 
similar to F O l  but it has an added arch support.
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7.3 Subjects recruitment and selection
Prior to recruiting subjects an approval for carrying out the FO tests was obtained from 
the University of Surrey Ethics Committee. The approval, research protocol, volunteer 
information sheets, and volunteer consent form are given in Appendices C.l, C.2, C.3, 
and C.4 respectively.
Twelve healthy able-bodied male subjects were selected for the FO testing; six subjects 
for each FO. Anthropometry of the selected subjects is given in Appendix C 5. Subject 
recruitment was limited to these numbers as this was a prospective study to give 
indications on what to focus on when conducting further examination of the effects of 
these FO with larger number of subjects. Subjects were sought from students and staff at 
the University of Surrey by placing adverts on campus notice boards. Subjects who were 
interested in taking part in the FO tests were provided with the following documents:
• Information Sheet, which describe the aims and procedure of the experiment, and 
a simple description of the subject selection criteria.
• Application form and Self Assessment Questionnaire of their physical condition 
and activity.
• Consent form.
Potential participants were asked to arrange an appointment for an introductory meeting 
in the Gait Laboratory at the University of Surrey. In this meeting the following were 
carried out in order to determine eligible subjects and complete the recruitment process.
1. Participants were given an explanation of the FO experiment plan and the reason for 
carrying it out, and their questions were answered.
2. Medical history and physical examination of the neurological and musculoskeletal 
condition was performed to determine the subject’s eligibility to participate in the 
experiments. The examination was done according to a specially designed chart (Chart 
A).
In particular; foot deformity was assessed for flat feet, subtalar valgus/varus deformity, 
and forefoot abduction/adduction; these examinations were performed visually while the 
subject was standing with equal weight bearing on both feet, however the navicular 
height was measured and divided by foot length as an aid to arch height normality. The 
examination of the knee focused on its ligament condition stability, especially in the
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Chart A
Physical Examination and Anthropometry Chart
SUBJECT ID: Date: Dominant side: Gender:
Age: Height: Weight BMI:
MEDICAL CONDII[TONS OR INJURIES AFFECTING GAIT
1. Neurological:
2. Musculoskeletal:
3. Other conditions:
J OINT-MUSCLES WEAKNESS
RT LT
Hip: Hip:
Knee: Knee:
Ankle: Ankle:
Foot: Foot:
3D JOINT ROM RESTRICTION
RT LT
Hip: Hip:
Knee: Knee:
Ankle: Ankle:
Foot: Foot
BONE AND JOINT DEFORMITY
RT LT
Hip: Hip:
Knee: Knee:
Ankle: Ankle:
Foot: Foot
MUSCULOSKELETAL PAIN
RT LT
Hip: Hip:
Knee: Knee:
Ankle: Ankle:
Foot: Foot:
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FOOT SENSATION TO LIGHT TOUCH
RT /  LT □ Intact RT /  LT □ Impaired
3D KNEE LIGAMENT CONDITION
RT □POSITIVE □NEGATIVE LT □POSITIVE nNEGATIVE
KNEE REFLEX
RT/LT □Normal RT /  LT □Abnormal
BALANCE (ROMBERG TEST)
RT/LT □Normal RT /  LT □Abnormal
TISSUE
FIRMNESS
□ Soft □Average □ Firm
MUSCLE
TONE
□Normal RT /  LT □Hyper R T /L T □Hypo RT /  LT
GAIT DEVIATION (OBSERVATIONAL)
BARE FOOT:
SHOD:
NOTES:
Type of Shoes:
A nthropom etry for V isual 3D  Software
Subject ID: Date:
Body mass (kg)
Height (mm)
ASIS breadth (mm)
R Leg length (mm) L Leg length (mm)
R knee width (mm) L Knee width (mm)
R Ankle width (mm) L Ankle width (mm)
R Foot height (mm) L Foot height (mm)
R Foot width (mm) L Foot width (mm)
Shoe heel height (mm)
R Navic. ht (mm) R Foot length (mm) ratio:
L Navic. ht (mm) L Foot length (mm) ratio:
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medial-lateral direction, and the shank alignment with respect to the thigh. This was 
performed manually and visually. The aim of these physical examinations was to find any 
deformity or abnormality that may abnormally increase subject-variability and not allow 
the FO to show its effect on normal healthy subjects.
3. Body anthropometry was taken for those who passed the above examination also 
(Chart A). The following measurements were taken:
Body mass (kg)
Height (mm)
ASIS breadth (mm)
R Leg length (mm), L Leg length (mm)
R knee width (mm), L Knee width (mm)
R Ankle width (mm), L Ankle width (mm)
R Foot height (mm), L Foot height (mm)
R Foot width (mm), L Foot width (mm)
R Navicular height (mm), L Navicular height (mm)
R Foot length (mm), L Foot length (mm
Shoe heel height (mm)
4. The consent form was signed by the participant in the presence of a witness.
Subject selection criteria were similar to that in the repeatability study with tighter age 
band and height; the following subject selection criteria were applied; these were 
designed to maintain consistency among participants and reduce inter-subject gait 
variability:
i. The subject is in good health and satisfies the physical examination chart.
ii. Leg length discrepancy (LLD) of no more than 15mm.
iii. Subjects are between 20-30 years old.
iv. Males.
v. Right handed and right footed.
vi. Height between 16500-1800mm.
vii. BMI in the range of 18.5-24.9.
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7.4 Subject shoes
The subjects were instructed to keep wearing their own shoes for the duration of the FO 
testing (3 weeks) and maintain their normal daily activity. Shoes used for the experiment 
were:
(i) Subject’s own trainers. This was chosen in order to avoid periods of foot/shoes 
adaptation. However, checks were made to ensure that the shoes has been worn and 
adapted to by the participants.
(ii) No ‘play’ between the foot and the shoes and the shoes were tight enough without 
compromising foot motion and comfort. This applied with and without FO conditions. 
This goal was achieved with tightening and loosening the shoe laces as appropriate. 
Appropriate shoe size to foot size was checked ( as in normal clinical practice for the 
auther) by making sure that the distance between the longest toe end and toe box end was 
between l-2cm when the heel was in contact with the shoe heel counter.
(iii) The upper surface of the sole was flat and not shaped to accommodate foot contours. 
Because the FO is meant to support foot contours, and if these contours are already 
present in the shoes it may mask FO function.
(iv) The shoe did not overlap the malleoli. This was to allow the marker on the lateral 
malleolous to be applied without being disturbed by the shoe edge.
7.5 Experiment schedule
The 12 participants were divided into two groups of six subjects each. FOl was tested 
with one group who were assigned numbers S1-S6 and F02 was tested with the second 
group who were assigned S7-S12.
After the screening, FO tests were performed over 4 sessions with one week interval 
between every two consecutive sessions, making the total testing period 3 weeks. FO 
wearing period was one week starting in session A l and ending in session B2. The term 
session refers to the set of walking trials under the same FO conditions. The term session 
refers to the set of walking trials under the same marker application condition.
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Session A was composed of two sessions (Al and A2), session B was also composed of 
two sessions (B1 and B2), and sessions C and D were one session each. For every 
session, 5 trials were used for analysis, making the total number of trials 360 for the 12 
subjects. The tests were timed and designed as shown in Table 7.1. The selected trials for 
analysis were the first best 5 trials of the session, this was done to ensure consistency 
across the sessions and the subject is most likely to walk more consistently at the 
beginning of the session rather at the end of it as he may get tired.
Table 7.1 FO test schedule; 1 week is the separation period between sessions 
_________________ (NO = no FO, WO = with FO)_________________
First meeting Session A Session B Session C Session D
Screening & 
anthropometry
Al - Data NO 
A2- Data WO
Bl-Data WO 
B2- Data NO
C- Data NO D- Data NO
First meeting, as mentioned above, was designated for screening and taking body 
anthropometric data. For sessions A-D the collected data was at self-selected speed.
Session A. Prior to collecting data in this session as with all sessions, the subject took a 
sufficient number of steps until he felt comfortable to walk with the markers on. In this 
session two sets of data were collected (Al and A2). The first set of data (Al) was 
collected without the FO, then the designated FO was trimmed and inserted bilaterally 
inside the subject’s shoes to collect another set of data (A2). The subjects were instructed 
to keep wearing the shoes with the FO in and perform their normal daily activities until 
the next session (one week later).
Session B. Subject preparation was done as in session A. Two sets of data were collected 
in this session (B1 and B2). The first set (Bl) was collected with the FO in the shoes, 
then the FO was removed from the shoes to collect another set of data (B2). After session 
Bl the FO were not worn any more, however, the subjects kept wearing the same shoes 
and maintained their normal daily activity until the end of the testing period. At the end 
of this session a questionnaire was given to the participants to complete. The 
questionnaire aimed to assess the comfort/discomfort and performance of the FO during 
the wearing period.
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Session C. One week after session B, the subject was prepared as in the previous sessions 
and one set of data was collected (C).
Session D. One week after session C, an exact repeat of session C. Session D is the last 
session in the testing, and nothing further was required from the participants.
Sessions C and D are considered as wash out periods from the effects of the FO, whereas 
session A2 is considered as the immediate effect of the FO and session Bl as the learned 
effect of the FO.
It was decided that 1 week of wearing FO is a reasonable break-in period to allow the 
foot and lower limbs to adapt to the FO intervention, this decision was based on the 
method adopted by [McPoil and Cornwall 2000] in which they took 40hrs of FO use as 
the break-in period for the FO. However, the immediate and final effects of FO were 
calculated. Also, after wearing the FO for 1 week, a two week washout period was taken 
to monitor changes in gait.
As the schedule shows, in session A two sets of data were collected (Al and A2). A l was 
without FO. When FO was applied A2 set was collected, A2 represent the immediate 
effect of using FO. In session B, also two sets of data were collected (Bl and B2). Bl 
was with FO and represent the adopted gait in response to the FO intervention. When FO 
was removed B2 set was collected, B2 represent the immediate effect of disusing the FO.
7.6 Data collection protocol
7.6.1 Equipment and system calibration
Data was captured in the Gait laboratory at the University of Surrey (Figure 7.3) using a 
7-camera system Qualisys ProReflex MCU500 (Qualisys Medical AB, Sweden), and two 
AMTI version BP400600HF force platforms (Advanced Mechanical Technology Inc. 
Watertown, MA, USA). 18mm diameter passive markers for the WMS, and a computer 
system running Windows XP Professional were used.
The measurement volume and the force plates were calibrated for every test day before 
the data collection sessions. The camera system and force plates were synchronised.
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Figure 7.3 Gait laboratory of the University of Surrey
7.6.2 Data collection protocol
A protocol was developed to guide the sequence o f steps to be taken from the moment the 
subject arrives to gait laboratory until the data is collected. The following rules were 
applied in every data collection session;
S  In every day test day the WMS was applied and aligned once.
S  After collecting each set of data, marker alignment was checked.
S  Each session’s set o f data consisted of 10 walking and one standing trials,
however, for analysis only 5 trials were used.
S  Data is collected at normal self-selected speed while shod.
S  The kinematic and kinetic data collection was at 100Hz. This was adequate for
marker position capture, however, for force plate data some transients (occurring 
at frequencies higher than 50Hz) might have been missed out. This is dicussed 
further in further work (9.8).
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S  Data was collected in one direction in the Gait Laboratory at the University of 
Surrey. The walking trials start point was determined for each subject so that he 
hits the force plates ‘cleanly’, however the subjects were not told the reason for 
determining and adjusting the start point. This is done to maintain natural gait 
pattern by avoid targeting the force plates.
S  The length of the walking path was 10m with the start and finish points marked 
on the floor, a straight line joining those marks went through the centre of the 
measurement volume.
S  Photographs and video capture of the trials were taken laterally (right) and 
anteriorly.
S  No gait trials were performed if the subject was feeling unwell or tired as this may 
affect his gait.
S  The questionnaire (Chart B) was given to the participants to complete at the end 
of session B when wearing the FO is completed.
S  To ensure high between days repeatability of the ankle 3D parameters, the 
locations of the markers applied to the shoe are marked with a pen, so that the 
markers can be placed on the same points in every session.
S  The shoe laces were tightened without restricting foot motion.
S  To ensure the freedom of arms swing without being obstructed by the thigh wand 
markers, the wands are placed at 25mm below the finger tips while the hands are 
relaxed and fingers are extended.
The sequence of data collection was;
1. Subject preparation.
2. Marker application and alignment.
3. Walking and standing data collection trials.
7.6.3 Subject preparation
1. The subjects wore closely fitting elastic Lycra shorts.
2. Subjects did not wear any article (like watches) which could reflect light and can be
‘regarded’ by the camera system as a marker.
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3. The WMS was applied and aligned (Figure 7.4) using the alignment method which was 
described in the repeatability study in chapter 6.
4. Once the makers were applied and aligned the subject was asked not to bend or sit 
down until all the data collection was completed. This was done to ensure that the marker 
placement and alignment was unaltered.
Figure 7.4 Marker application and alignment (Subject standing on alignment foot plate)
7.7 Data processing and analysis
In medical studies, investigators should usually be interested in determining the size of  
the difference of a measured outcome between groups, rather than a simple indication of  
whether it is statistically significant or not [Altman et a l 2000].
7.7.1 Data processing
The data was tracked and labelled using Qualisys Track Manager QTM version 1.9.254 
(Qualisys Medical AB, Gothenburg, Sweden).
Joint kinematic and kinetic calculations were performed using Visual 3D, version 3.28 (C- 
Motion Inc., Rockville MD, USA). Only the right side was taken for analysis. In Visual 
3D, the marker data was filtered using a 10Hz cut-off frequency, and force plate signals 
were filtered at 30Hz cut-off frequency. Marker trajectory interpolation was performed at 
10 frame maximum gap fill trajectory; this was performed after the data was filtered. The
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calculated parameters were means of 5 trials; means were then exported as p2d text file 
(contains a simple header and data section) files normalized to one complete gait cycle 
(GC), containing 101 data points encompassing 100 intervals, each interval representing 
1% of the GC.
Comparing the number of trials selected (3 trials in the marker sets comparison versus 5 
trials in both the repeatability and the FO studies) can be explained as follows: in the 
marker sets comparison study the purpose was to compare angles between two adjacent 
segments as measured by the SMS and WMS as they were applied simultaneously, here a 
single trial would have been sufficient to compare the differences between the 2 marker 
sets, still a mean of 3 trials were used as this is a common figure in clinical practice. 
Whereas in the repeatability and FO studies variability in gait pattern plays an important 
role in determining the means and SD of the joint angles, hence a greater number of trials 
are needed to obtain a representative mean and SD of the joint angles and kinetic 
parameters thereby minimizing the effects of out layers.
7.7.2 Data analysis
As this was a prospective study, the analysis was made general to survey the areas where 
FO effects might be seen, however, a focused analysis on the FO effect on eversion 
during LR was made as the literature reports various effects of FO on eversion. This will 
enable comparison of this FO investigation with the literature.
Session A1 data was considered to represent the original gait characteristics against 
which all other sessions were compared to. In order to understand the effects of FO on 
gait, comparison of session means was performed as follows;
A1 vs A2 
A1 vsB l 
B1 vsB2  
A1 vs B2 
A1 vs C 
A1 vs D
Comparison of the means of A2 against A1 represents the immediate (learning effect) 
effect of the FO. B1 against A1 represents the effect of the FO after using it for one week
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(learnt effect). B1 vs B2 represent the immediate change in gait when the FO is removed 
after being worn for one week. B2 against A1 represents the readiness to go back to the 
original gait pattern. C against A1 represents the effect of one week washout period on 
regaining the original gait pattern. D against A1 is similar to C against Al; however, the 
washout period is two weeks.
The following parameters were calculated for each session;
1. Temporal-spatial; walking speed (m/s), cadence (steps/min), and right step length (m).
2. 3D pelvic, hip, knee and ankle joint angles.
3. 3D ground reaction force (GRF).
4. 3D moment for the hip, knee and ankle joints.
All calculations were for the whole GC except the GRF where it was for the stance phase 
only, and maximum eversion and maximum excursion angles were calculated during the 
loading response of the GC. Also, GRF and inv/ev peak angles were calculated during LR 
for all session means. LR period 1-10%GC (Perry 1992].
The principle behind the selection of the following method for analysing the data was that 
the Coefficient of Multiple Correlation (CMC) tells that there is a change in the gait 
characteristic of a parameter and the Absolute Difference (ABSD) gives a magnitude for 
this change. Furthermore, comparison of the CMC and ABSDs with their counterparts 
from the repeatability study confirms that these changes are due to the FO if  they are 
greater than the expected variability determined in the repeatability study.
i. The CMC [Kadaba et al. 1989] was selected to assess waveform similarity and 
spread between sessions. The CMCs of FO testing results were compared to their 
counterparts obtained from the repeatability study. For CMC formulas see 
repeatability study (chapter 6). The assumption made here is that normal 
variability between the groups in the repeatability study is the same as that for the 
subjects selected for the FO study.
If the CMC for the FO sessions is lower than its corresponding CMC in the 
repeatability study, it indicates that the waveforms are more dissimilar and/or more 
spread than what would normally be expected, and this is likely to be a change in 
gait pattern due to the FO.
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CMCs of A l against A2 and B1 against B2 of the FO study correspond to within 
session repeatability (CMCW) from the repeatability study, because the marker set 
application and alignment was unchanged. CMCs of Al against B l, Al against 
B2, Al against C, and Al against D correspond to between session repeatability 
(CMCb) because a new marker application and alignment was performed for each 
of these sessions as they occurred in different test days.
ii. The ABSD was calculated between corresponding data points on the waveforms, 
then averaged over the GC to compute a parameter ABSD mean. The ABSD 
mean was calculated for all parameters. ABSDs were compared to their 
corresponding ABSDs in the repeatability study in the same way used for the 
CMCs. If the ABSD was higher than the corresponding ABSD in the repeatability 
study, this was considered to indicate a change in a gait parameter due to the 
effect of the FO.
The ABSD was selected rather than the positive or negative change between 
session means because these may cancel each other out and can give a misleading 
result (e.g. zero mean difference). The ABSD reflects the magnitude of change in 
a gait parameter over the gait cycle.
iii. Maximum eversion and maximum excursion during LR. This was only performed 
for the joint angle parameter and GRF. Calculation of those parameters was 
between session means.
Loading response was considered to occur between 0-10%GC [Perry 1992]. The 
change in maximum eversion is an important consideration for understanding the 
effect of FO, as excessive eversion is widely considered to be a cause of injury 
[Seymour 2002].
Maximum eversion and maximum excursion are considered as two closely linked 
parameters because they determine the subtalar excursion. This link is important 
when attempting to understand what is happening during the LR of the GC. If a 
reduction in eversion is accompanied by corresponding reduction in excursion, 
this will mean that the FO has reduced eversion and limited inversion/eversion
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motion at the subtalar joint. If a reduction in eversion was not accompanied by a 
reduction in excursion, this will mean that the FO has increased inversion at the 
same time as it reduced eversion (provided these values exceed their counterparts 
in the repeatability study).
iv. Excursion differences were calculated between session means over the GC, this 
was done for all parameters. Like the CMC, excursion differences were compared 
to those found in the repeatability study. If the excursion differences were higher 
than their corresponding differences in the repeatability study, then this indicates 
that they are probably due to the effect of FO, if lower then this is unlikely to be 
due to the FO. Excursion is a method of detecting whether the FO restricts or 
increases joint range of motion.
v. Finally to express the clinical weight of any differences found due to the FO, the 
absolute difference and the excursion differences were expressed as percentages 
of the excursion for all parameters, however, for the temporal-spatial parameters, 
they were expressed as percentages of their respective means.
7.8 Questionnaire
“Off the shelf’ FO claim to provide comfort. The questionnaire was intended to test the 
performance of the FO from the participants viewpoint. Because comfort can not be 
quantified, a subjective assessment of the interaction between the FO and the participants 
was developed in a form of a questionnaire (chart B). It should be emphasized that 
feedback from the participants is subjective and what one person may perceive, for 
example, as excellent comfort, may be just good comfort for another person.
The questionnaire focused on four aspects of FO, these were;
1. Comfort. Acceptability of a FO by the user is influenced by how much comfort a FO 
can provide.
2. Plantar foot cushioning. Pressure redistribution may be used to relief sensitive areas 
and load tolerant areas under the foot. Pressure redistribution is a feature that FO 
manufacturers promote to boost their FO sales.
3. Gait Stability. A comfortable FO will not be used if it causes unstable gait.
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4. Overall satisfaction. This question was asked to have the subject feedback on his 
readiness to use the assigned FO.
The method of obtaining the participants feedback used; questions to be answered by yes 
or no and a VAS on a 110mm horizontal line. The VAS is labelled with extreme states at 
its ends with a mid point on the line representing the neutral or the no change state. The 
participants were asked to mark the point on the line which they perceive to represent 
their state.
Analysis of the results from the VAS was by comparing the number of responses around 
the neutral point. Also a mean of the estimated points values from the neutral point was 
produced and compared between FOl and F02. Analysis of the yes or no questions was 
by the number of yes and no as a ratio to the number of participants.
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Chapter 8
Results of FO tests
“Not everything that counts ccm he counted and not everything that can he 
counted counts ” (Sign hanging in Einstein's office at Princeton)
This chapter presents the results of the FO tests. These include the results from the 
questionnaire, temporal-spatial, kinematics, and kinetics. The kinematics and kinetics 
effects of FO were calculated during two periods; first during the LR period, second 
over the whole GC.
The principle used to assess the temporal-spatial, kinematic, and kinetic effects of FO 
was that; any change in a parameter greater or less than the mean CMC +1 SD, mean 
excursion difference ±1SD, and mean ABSD +1SD which were computed in the 
repeatability study (chapter 6), was considered to be due to the effect of FO.
8.1 Questionnaire
The questionnaire was designed to examine the participants perception of the FO. A 
common point among all the participants for both FO is that none of them wanted to 
stop using the FO; however, they expressed varying degrees of comfort and 
acceptance to their assigned FO. A summary of the main aspects of the questionnaire, 
for both FOl and F02, are presented in Table 8.1. Details of the questionnaire are 
given in Chart A.
Table 8.1 Summary of the main aspects on FO questionnaire on both FOl and F02 (n = 6 per FO)
Category FOl F02
Fit Has adding the FO to the shoes 
caused discomfort?
Yes;l No;5 Yes;l No;5
Gait Did the FO made your walking 
better?
Yes 3 No 3 Yes;l No;5
Comfort How comfortable were the FO? 24% above neutral comfort 34% above neutral comfort
Acceptance How happy were you wearing the 
FO?
33% above neutral 
acceptance
17% above neutral 
acceptance
Satisfaction Overall satisfaction with your FO? 44% above neutral 
satisfaction
26% above neutral 
satisfaction
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Chart A. FOl and F02 questionnaire results. Assessment using VAS. Inclined arrows 
indicate neutral, minimum, or maximum, (n = 6)
FOl QUESTIONNAIRE 
THE EFFECTS OF “OFF THE SHELF” INNERSOLES ON GAIT
This questionnaire is for your evaluation of the performance and comfort experienced 
while using the innersoles.
A. Fit of innersoles
1. Did the innersoles move or crease inside the shoe during walking? Yes; 0 No; 6
2. Did the innersoles make the shoes tight? Yes; 6 No;0
3. Did the innersoles cause any discomfort during standing or walking? Yes; 1 No;5
4. Did you feel a difference in your walking pattern with the innersoles? Yes; 5 No; 1
IF YES TO ANY OF THE ABOVE PLEASE DESCRIBE...........................................
B. Performance of the innersoles
1. How comfortable were the innersoles while standing? (Place a cross or a line)
As uncomfortable as I can imagine Neutral As comfortable as I can imagine
I ±----- 1 -1 --4+I- 1------- 1
2. How comfortable were the innersoles during walking? (Place a cross or a line) 24% 
comfort increase
As uncomfortable as I can imagine Neutral As comfortable as I can imagine
I *----------- — i ------------ H H
3. How do you rate the cushioning of the innersoles during standing? (Place a cross or a 
line)
As bad as I can imagine Neutral As good I can imagine
I---------------------- — W- 4 ---------------- 1
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4. How do you rate the cushioning of the innersoles during walking? (Place a cross or a 
line)
As bad as I can imagine Neutral As good as I can imagine
-t F  — 1
5. How happy were you wearing the innersoles? (Place a cross or a line) 33%
As unhappy as I can imagine As happy as I can imagineNeutral
6. How stable did you feel with the innersoles during standing? (Place a cross or a line)
As unstable as I can imagine Neutral As stable as I can imagine
4 ----------—
7. How stable did you feel with the innersoles during walking? (Place a cross or a line)
As unstable as I can imagine Neutral As stable as I can imagine
*-4-h
C. Satisfaction with the innersoles
1. Do you feel your posture has improved with the innersoles? Yes 0 No 6
2. Did the innersoles made your walking better? Yes 3 No 3
3. Since you started, was there a loss in the bounce of the innersoles? (Place a cross or a 
line)
No loss at all Total loss
i-
4. Overall satisfaction with your innersoles? (Place a cross or a line)
As unsatisfied as I can imagine Neutral t As satisfied as I can imagine
■ H -
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Chart A contd.
F02 QUESTIONNAIRE 
THE EFFECTS OF “OFF THE SHELF” INNERSOLES ON GAIT
This questionnaire is for your evaluation of the performance and comfort experienced 
while using the innersoles.
A. Fit of innersoles
1. Did the innersoles move or crease inside the shoe during walking? Yes; 0 No; 6
2. Did the innersoles make the shoes tight? Yes; 2 No; 4
3. Did the innersoles cause any discomfort during standing or walking? Yes; 1 No; 5
4. Did you feel a difference in your walking pattern with the innersoles? Yes; 0 No;6
IF YES TO ANY OF THE ABOVE PLEASE DESCRIBE..........................................
B. Performance of the innersoles
1. How comfortable were the innersoles while standing? (Place a cross or a line)
As uncomfortable as I can imagine Neutral As comfortable as I can imagine
I--------------------- — 4 4 ------------------ 1
2. How comfortable were the innersoles during walking? (Place a cross or a line)
As uncomfortable as I can imagine Neutral As comfortable as I can imagine
I--------------- 4-------#  W------!— A
3. How do you rate the cushioning of the innersoles during standing? (Place a cross or a 
line)
As bad as I can imagine Neutral As good I can imagine
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4. How do you rate the cushioning of the innersoles during walking? (Place a cross or a 
line)
s bad as I can imagine Neutral As good as I can imagine
----------------1----H444------ 1
5. How happy were you wearing the innersoles? (Place a cross or a line)
As unhappy as I can imagine Neutral As happy as I can imagine
1 1 1
6. How stable did you feel with the innersoles during standing? (Place a cross or a line)
As unstable as I can imagine Neutral As stable as I can imagine
 *r i ii at
7. How stable did you feel with the innersoles during walking? (Place a cross or a line)
As unstable as I can imagine Neutral As stable as I can imagine
4— *r i ii— 4
C. Satisfaction with the innersoles
1. Do you feel your posture has improved with the innersoles? Yes 1 No 5
2. Did the innersoles made your walking better? Yes 5 No 1
3. Since you started, was there a loss in the bounce of the innersoles? (Place a cross or a 
line)
No loss at all Total loss
M U  4 4 -----------
4. Overall satisfaction with your innersoles? (Place a cross or a line)
Neutral
1 1 K I1 1 *\ r i r i [ *
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The summary in table 8.1 is based on the points considered as the most important in 
each section of the questionnaire. Fit was related to discomfort due to adding the FO 
in the shoes (section A, Q 3 in the questionnaire), comfort was related to walking 
comfort (section B, Q 2 in the questionnaire), gait improvement was related to the 
participant perception of walking improvement (section C, Q 2 in the questionnaire), 
FO acceptance was related to how happy the participants were to use a FO (section B, 
Q 5 in the questionnaire), and satisfaction was related to the overall satisfaction 
(section C Q 4 in the questionnaire). The various categories are interlinked with each 
other and are difficult to separate; for example, when a participant expresses high 
satisfaction with the FO this is normally related to comfort perception, gait 
improvement, or/and good fit of the FO. Furthermore, perception is subjective and 
plays an important role in the accuracy of the assessment, and hence the percentages 
produced from the questionnaire. The percentages produced in the above table are the 
arithmetic mean values of the marks distances from neutral which the participant 
made on the VAS of the questionnaire; values to the right (above) of the neutral point 
were positive and values to the left (below) of the neutral point were negative.
Equal number (5/6) in both FOl and F02 groups expressed positive f it  of the FO 
(section A, Q 3 in the questionnaire). Only one participant from either group felt 
discomfort because the FO made the shoe tight, however, this was not bad enough to 
make him stop wearing the FO.
Equal number of participants (4/6) in both FOl and F02 groups expressed an 
improvement in comfort with the use of FO (section B, Q 2 in the questionnaire). 
However, the level of the expressed comfort was higher in the F02 group (35%) than 
FOl group (24%) (Table 8.1). Only one participant in each group felt the FO caused 
discomfort, however, this was not enough to make him stop using the FO, and also 
one in each group felt no difference in comfort with the use of FO.
In the FOl group, 3/6 of the participants felt their gait has improved and 3/6 of the 
participants did not feel any improvement (section C, Q 2 in the questionnaire). These 
numbers were 1/6 and 5/6 respectively for F02.
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Acceptance of FOl was slightly better than F02. 4/6 of the participant in each FO 
group expressed acceptance of their assigned FO (section B, Q 5 in the questionnaire). 
However, 2 participants using FOl felt neutral towards using the assigned FO 
whereas 1 participant in F02 group felt neutral and 1 participant felt unhappy using 
F02. The calculated mean level of acceptance was higher for FOl (33%) whereas this 
was 17% for F02.
Overall satisfaction was greater for FOl (44% above neutral) than F02 (26% above 
neutral). All 6/6 participants using FOl expressed some degree of satisfaction with 
their FO, whereas only 4/6 participants using F02 expressed satisfaction, 1 was 
neutral and 1 was unsatisfied with F02 (section C Q 4 in the questionnaire).
The lower F02 acceptance and satisfaction scores could be, at least in part, due to one 
person (subject No 7) in F02 group who scored these aspects as negative, and the 
reason his low score could be because his shoes had a thick and flexible sole which 
could with the addition of F02 have made the flexible sole too thick that it rebounds 
during loading which might have made him feel unstable, and therefore feeling 
comfortable with the FO but unhappy and dissatisfied using it. If this person was 
eliminated from the group, then scores for acceptance and satisfaction would have 
been similar in FOl and F02. Furthermore, it is expected that if this participant used 
FOl instead of F02 he would have experienced the same problem. Therefore it can be 
said that both FO had a similar effect on these aspects in the questionnaire.
For both FO, for the miscellaneous comments in the first section of the questionnaire, 
5/6 of the responses describing the FO ranged from uncomfortable at the beginning 
then getting gradually better with time, to comfortable and very comfortable from the 
start. The responses from the participants show that both FO had good acceptance; 
however, judging by the number of negative responses per FO; FOl was slightly 
better than F02.
The participants did not comment directly on shock attenuation, however, they 
reported good comfort in the comments sections of the questionnaire from which 
shock attenuation could perhaps be inferred. In summary, both FO had similar 
perception by the participants on comfort with small subject-specific variations.
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8.2 Temporal-spatial
In this and all subsequent sections, the following points apply;
(1) The number of subjects who have shown ‘changes’, presented in tables, are colour 
coded as follows; red increase, blue decrease, and black no change.
(2) An increase (decrease) denotes that the change was larger than those values found 
in the repeatability study by at least ±  1 SD.
(3) Within refers to the measured variability in a parameter values between two 
collection sessions conducted in the same day. Between refers to the measured 
variability in a parameter values between two collection sessions conducted over two 
different days.
Table 8.2 presents the mean speed, cadence, and step length o f sessions and the 
changes in these parameters due to the use of FO. Details o f individual subjects results 
of speed, cadence, and step length changes can be found in appendix D l.
Table 8.2 Temporal-spatial parameters for FOl and F02 tests. +ve percentage indicate increase 
and -ve percentage indicate decrease, (n = 6 per FO condition).
FOl
sp eed  
overall m ean
A1-A2
5 , 0 , 1 
3.2%
B1-B2
1 , 1 , 4  
-1.6%
A1-B1
4 , 0 , 2  
4.9%
A1-B2
3 , 0 , 3  
3.1%
A1-C
4 , 0 , 2 
4.9%
A1-D
3 , 1 , 2  
4.4%
normal variability: m ean(SD)%  
within 1.7(1.4)%  
between 2.1(1)%
cadence  
overall m ean
0 , 0  6  
0.0%
1 , 1 , 4  
-1.1%
3 , 0 ,3  
3.0%
2 , 1 , 3 
1.8%
3 , 1 , 2 
3.7%
4 , 0 . 2  
3.2%
within 1.2(1.2)%  
between 1.5(0.5)%
step length 
overall m ean
5 , 0 , 1 
3.2%
1 , 3 , 2 
-1.3%
4 , 0 , 2 
2.5%
2 , 0 , 4 
1.2%
2 , 2 , 2 
0.6%
2 , 1 , 3 
0.6%
within 0.7(0.5)%  
between 1.5(0.8)%
F 0 2
sp eed  
overall m ean
A1-A2
2 , 0 , 4  
4.7%
B1-B2
1 , 1 , 4
0.1%
A1-B1
2 , 1 , 3 
2.5%
A1-B2
4 , 1 , 1 
2.6%
A1-C
4 , 1 , 1 
3.9%
A1-D
2 , 1 , 3 
1.8%
normal variability: m ean(SD)%  
within 1.7(1.4)%  
between 2.1(1)%
cadence  
overall m ean
2 , 0 , 4 
1.6%
1 , 0 , 5 
1.0%
2 , 1 , 3 
-0.1%
3 , 1 , 2 
1.0%
5 , 1 , 0 
2.2%
3 , 1 , 2  
1.9%
within 1.2(1.2)%  
between 1.5(0.5)%
step length 
overall m ean
5 , 0 , 1 
2.6%
1 , 2 , 3 
-0.5%
2 , 1 , 3 
3.0%
3 , 1 , 2 
2.4%
2 , 1 , 3 
2.3%
2 , 3 , 1 
-0.1%
within 0 .7 (0  5)% 
between 1.5(0.8)%
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(i) Speed. In the first session (session A), when FO was applied, it caused an 
immediate increase in walking speed in 5/6 of FOl and 2/6 of F02 of the participants 
with mean increase of 3.2% and 4.7% respectively. However, one participant (No 6) 
in FOl group showed a speed drop of 2.5%, and when this participant mean was 
removed from the FOl group the mean speed increase became 4.3%.
Compared to the initial no FO condition (Al), after one week of wearing the FO 
(session B l), in FOl group 4/6 of the participants had a speed increase, the group 
overall mean increase was 4.9%. In F02 group, 2/6 showed a speed increase, 
however, the overall mean was within speed normal variability.
These speed increases were greater than their natural variability and therefore are 
considered to be due to the effect of FO; this confirms the research pilot study finding 
which used FOl and found an increase in the walking speed by 2.4% [Flaieh et al. 
2005]. This speed increase could be attributed to the energy storing property of the FO 
material which when released can give assistance during the push off phase of the GC, 
so leading to an increase in the walking speed.
Comparing B2 to B l, when FO was removed (session B), 1 participant in both FOl 
and F02 groups had an immediate speed decrease greater than normal variability.
The immediate removal of FO had a lower impact on speed than applying the same 
FO indicating a rather quicker ability to Team’ and a slower response to return to the 
original state after using the FO for 1 week in those subjects.
By the end of the 2 weeks washout period after disusing the FO (session D), greater 
number of F02 users than FOl (3/6 compared to 2/6) had a speed within its normal 
variability. This indicate a rather greater effect of FOl on speed.
(ii) Cadence. There was no specific trend of the effect of FO on cadence; the 
fluctuation of cadence was generally small (mainly around 1%), and this was mostly 
within the natural variability of this parameter. This indicates that speed changes due 
to the effect of FO did not manifest a corresponding cadence change.
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(iii) Step length. This parameter showed an increase when FO was applied, this was in 
both FOl and F02 groups (Table 8.2); 5/6 of FOl and 5/6 of F02 participants had an 
overall increase by 3.2% and 2.6% respectively. One subject in FOl group (No 6 
again) had no step length change, and when he was removed from the group mean, it 
became 4% step length increase. One subject in F02 group did not have any change 
in his step length; therefore he did not affect the group mean.
One week after wearing the FO, 4/6 of FOl and 2/6 of F02 participants had an 
increase in their step length, and the group overall increase was 2.5% and 3% 
respectively, and this speed increase was greater than the normal within session 
variability. Two participants in FOl group did not show step length change, and this 
was three in F02 group.
Comparing B2 to B l, when FO was removed, 3/6 of FOl and 2/6 of participants had a 
decrease in their step length; the overall change was a decrease by 1.3% and 0.5% 
respectively, and this decrease was within normal “within session” variability.
The overall mean step length changes for sessions C and D was within the normal 
variability of speed.
Most increases in step length were greater than their natural variability. Step length 
changed in a similar fashion to speed; this should be expected as, according to 
[Danion et al. 2003]), speed is the composition of stride frequency and stride length, 
and the change in walking speed result more from stride length than stride frequency 
(relationship =1.664m/Hz). The speed relationship with cadence and step length could 
explain the greater change in step length than cadence to manifest the speed increase, 
assuming right and left leg walking symmetry.
Gait improvement due to the use of a FO can be assessed if FO increase the temporal- 
spatial parameters [Mejjad et al. 2004]. Comparing the effects of FOl to those of F02  
within the above temporal-spatial parameters, there is no evidence of a clear 
advantage of one FO over the other, indicating that the addition of the medial 
longitudinal arch into “off the shelf’ F02 was not effective did not improve gait (as 
measured by increasing those parameters), hence, these results can partially support
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hypothesis (i) which indicate that such arch supports will not fit the natural medial 
longitudinal arch of the foot, and hence will be either too high, too low, too long, or 
too short to suit all feet morphologies.
Conclusion. Both FOl and F02 increased walking speed and step length, but less 
effect was seen in cadence increase. There was no better temporal-spatial performance 
of either FOl or F02 compared to each other, hence, hypothesis (i) can be supported.
8.3 Kinematics
8.3.1 Maximum eversion and inversion angles LR
LR was calculated as the 10%GC period starting at IC [Perry 1992], Table 8.3 
presents the data of the effects of FOl and F02 (during LR) on maximum eversion, 
maximum inversion angles, and the normal variability o f these parameters for within 
and between sessions are also presented. Details of individual participants parameter 
changes are presented in Appendix D 2.
Table 8.3 Maximum eversion and inversion angle changes during LR. For eversion +ve indicate 
decrease and -ve indicate increase. For inversion overall mean +ve indicate increase and -ve 
indicate decrease, (n = 6 per FO condition).
F01 inv and ev angles (LR)
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D normal variability: mean(SD)
max ev 3, 1 ,2 4, 0 ,2 0, 2, 4 3, 0 ,3 2, 0 4 0, 0 ,6 within 0.9(0.5)
overall mean 0.3 -3.2 -1.3 1.8 2.3 1.2 between 2.1(1.3)
max inv 1, 0, 5 0, 2, 4 2, 1, 3 1, 2, 3 0, 2 ,4 0, 1 ,5 within 1.6(1.8)
overall mean -1.1 -2.4 -1.7 0.7 0.8 1.3 between 1 .7(11)
FQ2 inv and ev  angles (LR)
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D normal variability: mean(SD)
max ev 1, 2 ,3 4, 0, 2 2, 0 ,4 0, 1 ,5 0, 0, 6 0, 1, 5 within 0.9(0.5)
overall mean 0.0 2.2 -1.5 0.8 0.9 0.5 between 2 .1 (13)
max inv 1 ,0 ,5 0, 1, 5 1, 1 ,4 1, 3, 2 1 ,0 , 5 1 ,0 ,5 within 1 .6(18)
overall mean -1.1 0.9 -0.4 0.5 -0.9 -0.5 between 1.7(11)
Visual examination o f the maximum eversion angles graphs during LR (appendix D 
3) showed that when FOl was applied 3/6 of the participants showed a maximum 
eversion reduction and the rest of the participants showed an increase, the same 3/6 o f 
the participants showed eversion reduction 1 week after wearing this FO. When FOl 
was removed 5/6 of the participants showed an immediate eversion increase.
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Also the visual examination showed that when F02 was applied only 2/6 of the 
participants showed an eversion reduction, 3/6 showed eversion reduction 1 week 
after wearing this FO, and when F02 was removed 6/6 of the participants showed an 
immediate eversion increase. Participants who did not show an eversion reduction had 
an eversion increase.
Based on these visual graphs examinations, the percentage of subjects who responded 
to the FO, and had maximum eversion reduction, were generally low (<50% in both 
FOl and F02), however, FOl had a slightly more effect than F02 in this respect.
Maximum eversion angles LR. When the FO were applied (session A), FOl and F02 
reduced maximum eversion in 1/6 and 2/6 of participants by a range o f (1.1-3.1) and 
(1.1-5.7) degrees respectively, and these reductions were greater than their normal 
variability. For the remaining participants of FOl; 3/6 had an eversion increase and 
2/6 had no change, and for F02; 1/6 had an eversion increase and 3/6 had no change.
One week after wearing the FO, the angle reductions were increased in 2/6 o f the 
participants using FOl and the reductions were in the range of 4.3-7.8 degrees. For 
F02 none o f the participants had an eversion reduction.
Sessions C and D showed a trend towards a gradual return to within their normal 
variability; for session D the mean peak eversion was very similar to that o f the 
normal variability in most subjects in the two FO groups.
After wearing the FO for 1 week, some eversion reductions were doubled; indicating 
that with the use of FO the foot adapts and modifies its function with time to the new 
imposed interface under the foot sole. Hence, the first part of hypothesis (ii) is 
supported by these results.
The removal of the FO caused an immediate increase in peak eversion angle in the 
affected participants in each FO group; this increase continued over the 2 week 
washout period and returned to within its normal variability by the end of the washout 
period. This indicates that the 2 weeks washout period is long enough to clear the 
effects of 1 week of FO use.
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The discrepancy between visual examination and the calculated eversion change is 
because in the latter the normal variability range specifies which changes are due to 
the FO, whereas in visual examination any decrease is considered as a change.
Eversion occurs normally during the LR of the GC, and this motion is frequently 
considered as one of the components of shock absorption mechanism [Nester et al. 
2003]. The limited number of participants who had eversion reduction in both FOl 
and F02 groups leads to the belief that both FO may not be suitable for every person 
and there was no clear advantage of one FO over the other. Therefore for F02, the 
addition o f the medial longitudinal arch did not improve its function more than FOl; 
this further supports hypothesis (i).
Maximum inversion angle LR. When FO were applied (session A2), none of the 
participants in FOl and F02 groups had a reduction, however, 1 in each group had an 
inversion increase greater than the normal variability (Table 8.3).
One week after wearing the FOl, 1 participant in each FO group had an inversion 
reduction and the majority of participants had no change.
One week after wearing the FO, considering the number of participant and the value 
of increase and decrease in this parameter, there was no tendency to a change in the 
inversion angle at IC (maximum LR inversion occurs at IC), and this was the case for 
both FO groups. By session D most participant inversion angles were within their 
normal variability.
It was noticed that none of the participants in both FOl and F02 groups who had 
eversion reduction also had inversion reduction; if  eversion is reduced and inversion 
is also reduced then the total subtalar excursion is reduced. This kind of reduction 
may be useful for people who have the harmful excessive subtalar eversion [Seymour 
2002], however, for normal people, this could mean that the total joint area which 
bears the force is reduced and this can be harmful [McPoil and Cornwall 2000; Kurz 
and Stergiou 2003].
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The different responses among the participant groups to the same FO agree with the 
findings of [Stacoff et al. 2000], who investigated the effects of FO on normal 
subjects and used markers mounted on cortical pins, they concluded that the effects of 
FO is subject-specific.
Conclusion. Both FOl and F02 had similar effect on reducing maximum eversion 
angle during LR, and this was in no more than 33% of the participants; this indicates 
that “off the shelf’ FO may not be useful for every body. Hence, these results support 
hypothesis (i) and (ii).
8.3.2 Joint angles GC
8.3.2.1 Gait pattern changes (CMC) GC
Tables 8.4a and 8.4b show the CMC means of subjects groups for the pelvis and 
lower limb joint angles for FOl and F02 respectively. The normal between and 
within session repeatability is also shown in the tables. Full details of subjects CMC 
can be found in Appendix D 4.
For FOl (Table 8.4a), most changes in the gait pattern CMC were seen in the pelvic 
tilt, hip rotation, knee abduction, and knee rotation. These parameters were reduced in 
the greatest number of participants and most of the group mean CMCs were less than 
the corresponding CMCs mean ± 1SD of the repeatability study. These parameters 
were considered as showing a change in their motion pattern due to the use of this FO. 
Among all parameters and after 2 weeks washout period, knee abduction showed the 
greatest reluctance to return to within its normal variability.
For F02 (Table 8.4b), most changes in the gait pattern CMC were seen in the pelvic 
tilt, knee flexion, and knee abduction. These parameters were reduced in the greatest 
number of participants and some of the group mean CMCs were less than the 
corresponding CMCs mean + 1SD of the repeatability study. These parameters were 
considered as showing a change in their motion pattern due to the use of this FO. 
Compared to FOl, non-sagittal parameters in F02 showed better readiness to return to 
within their normal variability.
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Table 8.4a FOl mean angle CMC of the pelvis and lower limb joint angles (GC). CMCw= within 
session repeatability, CMCb= between sessions repeatability, (n = 6 per FO condition)
F01 Angles CMC
pelvic tilt CMC 
mean CMC
A1-A2
2, 3 , 1 
64.9%
B1-B2
3, 3 ,0  
75.6%
A1-B1
1 ,5 , 0 
31.1%
A1-B2
1, 1 ,4  
29.9%
A1-C
0, 4, 2 
38.6%
A1-D
2, 3, 1 
56.4%
normal variability: mean(SD) 
CMCw = 80.7(7.2)%
CMCb = 68.3(24.2)%
pelvic obliq CMC 
mean CMC
5, 0, 1 
99.3%
6, 0 ,0  
99.4%
0, 2, 4  
88.5%
0, 2 ,4  
88.5%
1, 2 ,4  
83.8%
1 ,0 ,5
93.7%
CMCw = 97.5(1.5)%  
CMCb = 92.5(6.2)%
pelvic rot CMC 
mean CMC
4, 0 ,2  
97.4%
2, 0 ,4  
96.8%
1 ,3  2 
83.8%
1, 4, 1 
77.8%
0, 2 .4  
87.9%
1, 3 ,2  
66.6%
CMCw = 93(5.2)% 
CMCb = 92.8(5.2)%
hip flex CMC 
mean CMC
0, 1 ,5  
99.8%
0, 0 ,6  
99.8%
0, 0, 6 
99.1%
0, 0 ,6  
99.0%
0, 1 ,5  
98.5%
0, 0 ,6  
99.2%
CMCw = 99.8(0.1)%  
CMCb = 98.7(1.3)%
hip abd CMC 
mean CMC
4, 0 ,2  
99.5%
3, 0 ,3  
99.4%
0, 2. 4 
93.4%
0, 2 ,4  
92.6%
0, 1 ,5  
90.6%
0, 1 ,5  
93.7%
CMCw = 97.7(1.6)%  
CMCb = 93.9(7.1)%
hip rot CMC 
mean CMC
2, 2 ,2  
75.8%
1, 0, 5 
97.2%
0, 2, 4  
57.6%
0, 2 ,4  
53.8%
0, 3 ,3  
42.8%
0, 2 ,4  
56.0%
CMCw = 96.3(2.9)%  
CMCb = 75(26.5)%
knee flex CMC 
mean CMC
2, 0 ,4  
99.8%
1, 1 ,4  
99.6%
0, 0 6 
99.4%
2, 1 ,3  
99.5%
0, 2, 4  
99.3%
1 ,0 ,5
99.0%
CMCw = 99.7(0.1)%  
CMCb = 99.6(0.2)%
knee abd CMC 
mean CMC
2, 2 ,2  
88.1%
1 ,2 ,3
96.4%
0, 3 3 
69.3%
0, 3 ,3  
75.2%
0, 5, 1 
52.1%
0, 5, 1 
56.4%
CMCw = 97.9(0.9)%  
CMCb = 90(9.8)%
knee rot CMC 
mean CMC
3, 2, 1 
87.5%
3, 1, 2 
94.8%
0 ,2  4 
64.1%
0, 2 ,4  
66.6%
0, 1 5 
70.9%
1 ,3 ,2
45.8%
CMCw = 92.3(4.4)%  
CMCb =69.9(24.8)%
ankle dorsi CMC 
mean CMC
1, 1 ,4  
97.7%
1 ,5 ,0
89.6%
0 , 1 ,5  
90.3%
0, 0 ,6  
97.9%
0, 1 5 
94.8%
0, 1 ,5  
94.1%
CMCw = 99.1 (0.3)% 
CMCb = 97.3(3.8)%
ankle abd CMC 
mean CMC
2, 2 ,2  
91.0%
3, 1 ,2  
89.6%
0 ,0  6 
86.9%
0, 0 ,6  
89.7%
0, 0 ,6  
75.6%
0 ,0 ,6
86.4%
CMCw = 96(1.7)%  
CMCb = 82.9(28)%
anklle inv CMC 
mean CMC
2, 1 ,3  
90.5%
1 ,4 , 1 
79.3%
0, 1 5 
78.6%
0, 2 ,4  
74.6%
0, 3 ,3  
68.4%
0, 2, 4 
70.6%
CMCw = 94(1.7)%  
CMCb = 84.4(13.9)%
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Table 8.4b F02 mean angle CMC of the pelvis and lower limb joints (GC). CMCW= within 
session repeatability, CMCb= between sessions repeatability, (n = 6 per FO condition)
F 0 2  A ngles CMC
pelvic tilt CMC 
mean CMC
A1-A2
3, 2 , 1 
80.8%
B1-B2
4, 1, 1 
76.8%
A1-B1
0, 4 ,2  
22.2%
A1-B2
0, 4 ,2  
22.9%
A1-C
0, 4 ,2  
23.5%
A1-D
0, 4, 2  
23.7%
normal variability: mean(SD) 
CMCw = 80.7(7.2)%
CMCb = 68.3(24.2)%
pelvic obliq CMC 
mean CMC
3, 0 ,3  
98.9%
5, 0, 1 
99.4%
0, 1 ,5  
93.3%
0, 1 ,5  
92.7%
0, 3 ,3  
82.2%
2, 3 , 1 
89.8%
CMCw =97.5(1.5)%  
CMCb = 92.5(6.2)%
pelvic rot CMC 
mean CMC
4, 0 ,2  
98.7%
2, 0 ,4  
94.8%
1, 1 ,4  
92.6%
0, 1 ,5  
91.0%
1, 1 ,4  
95.6%
1, 1 ,4  
94.1%
CMCw = 93(5.2)%  
CMCb = 92.8(5.2)%
hip flex CMC 
mean CMC
2, 0 ,4  
99.9%
3, 0 ,3  
99.9%
0, 1 ,5  
97.4%
1 ,2 ,3
97.8%
3, 2, 1 
97.2%
3, 1 ,2  
98.6%
CMCw =99.8(0.1)%  
CMCb = 98.7(1.3)%
hip abd CMC 
mean CMC
3, 0 ,3  
99.0%
6, 0 ,0  
99.5%
0, 0 ,6  
97.0%
0, 0, 6 
97.0%
0, 2 ,4  
84.1%
0, 1 ,5  
92.2%
CMCw =97.7(1.6)%  
CMCb = 93.9(7.1)%
hip rot CMC 
mean CMC
1 ,0 ,5
98.6%
1 , 1 ,4  
97.2%
0, 2 4 
62.5%
0, 1 ,5  
62.3%
0 ,1 ,5
67.9%
0, 0 ,6  
82.2%
CMCw =96.3(2.9)%  
CMCb = 75(26.5)%
knee flex CMC 
mean CMC
3, 1 ,2  
99.8%
4, 0 ,2  
99.9%
1 ,3 ,2
99.5%
1, 2 ,3  
99.5%
1 , 4 , 1 
99.4%
1, 4, 1 
99.5%
CMCw = 99.7(0.1)%  
CMCb = 99.6(0.2)%
knee abd CMC 
mean CMC
4, 1, 1 
98.4%
1 ,3 ,2
95.5%
0, 3 ,3  
49.5%
0, 4 ,2  
54.1%
0, 3 ,3  
84.4%
0, 2 ,4  
88.1%
CMCw = 97.9(0.9)%  
CMCb = 90(9.8)%
knee rot CMC 
mean CMC
4, 0 ,2  
96.3%
2, 0 ,4  
96.0%
0, 2, 4 
64.8%
0, 1 ,5  
64.0%
0, 3 ,3  
57.4%
1, 2 ,3  
51.3%
CMCw = 92.3(4.4)%  
CMCb =69.9(24.8)%
ankle dorsi CMC 
mean CMC
0, 4 ,2  
97.0%
0, 4 ,2  
97.9%
0, 1, 5 
94.6%
0, 0 ,6  
96.5%
0, 1 5 
94.2%
0, 1 ,5  
95.8%
CMCw = 99.1(0.3)%  
CMCb = 97.3(3.8)%
ankle abd CMC 
mean CMC
2, 1 ,3  
96.6%
4, 1 , 1 
96.9%
0, 0 ,6  
85.9%
0, 0 ,6  
85.1%
0, 0 ,6  
87.3%
0, 0, 6 
87.9%
CMCw = 96(1.7)%  
CMCb = 82.9(28)%
anklle inv CMC 
mean CMC
5, 1 ,0  
81.6%
3, 3 ,0  
89.7%
0, 1, 5 
72.5%
0, 2 ,4  
76.1%
0 ,0  6  
92.6%
0, 0 ,6  
92.5%
CMCw =94(1.7)%  
CMCb = 84.4(13.9)%
Conclusion. Both FOl and F02 have an effect on the motion pattern o f the pelvic tilt 
and knee abduction. It is possible that because of the high SD for some CMCb some o f 
the real gait pattern changes due to FO in all pelvis and lower limb parameters may 
have been masked. FOl had a greater influence on the motion pattern for most of the 
lower limb parameters than F02. An explanation o f this could be because o f the 
differences in insole thickness; FOl had a thicker sole which could have a greater
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‘give in’ time than F02, therefore it will not suddenly stop compressing during 
loading and ‘upset’ the subtalar motion pattern; however, this speculation needs 
further work on the effect of sole thickness and perhaps with different material 
properties (discussed in the chapter on FO) to understand the behaviour of the subtalar 
motion pattern. Understanding this pattern is important as it may affect motion at 
other joints particularly tibial rotation due to the established coupling mechanisms 
between those two motions [Cornwall and McPoil 1995].
83.2.2 Angle differences (ABSD) GC
Tables 8.5a and 8.5b present the number of participants who had ABSD changes 
greater than the normal variability; it also presents the mean of the group ABSD 
change. All subjects ABSD values between sessions can be found in Appendix D 5.
For FOl, the largest number of participants who had an increase in the ABSDs were 
in the hip rotation, knee abduction, and knee rotations. The increase the mean of the 
group for these parameters that was greater than the normal ABSDs variability ranges 
found in the repeatability occurred in about 50% of the session comparisons (Table 
8.5a).
For F02, the largest number of participants who had an increase in the ABSDs were 
in the hip flexion, hip rotation, knee flexion, and knee abduction. The increase the 
mean of the group for these parameters was mostly within the normal ABSDs 
variability ranges found in the repeatability study (Table 8.5b).
Generally, from the ABSD results, it appears that;
> Hip rotation and knee abduction were affected by both FO.
>  FOl affected larger number of participants and larger number of parameters.
> The number of participants affected by either FO was around 50%.
> The greatest magnitude of mean ABSD was 10.8 degrees by FOl which 
occurred in hip rotation.
> Although some of the induced ankle abduction and ankle ABSD were as high 
as 4 and 3 degrees respectively, these were not detectable because of the high 
between days normal ABSD variability ranges, which could mask changes 
due to the FO.
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The greatest effects of FOl and F02 were on the hip rotation and knee abduction, 
because within these parameters; for FOl the 2 weeks washout period did not remove 
the effects of this FO on hip rotation and knee abduction, however, F02 2 weeks 
washout was enough to remove any effect of this FO from these parameters.
Conclusion. Both FOl and F02 affected knee abduction angle. These results suggest 
that FOl had a greater effect than F02; this provides further supports to hypothesis 
0).
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Table 8.5a FOl Angle ABSD of the pelvis and lower limb joints (GC). ABSD = Absolute 
difference, (n = 6 per FO condition)
F01 A ngles ABSD
pelvic tilt ABSD 
mean change
A1-A2
1 , 1 ,4  
0.9
B1-B2
2, 2 ,2  
0.7
A1-B1
4, 1, 1 
2.3
A1-B2
4, 2 ,0  
2.3
A1-C
4, 0 ,2  
2.4
A1-D
3, 2, 1 
1.9
normal variability: mean(SD) 
within 0.7(0.2) 
between 2.6(1.7)
pelvic obliq ABSD 
mean change
1 ,5 ,0
0.4
0, 6 ,0  
0.3
3, 0 3 
1.8
3, 0 ,3  
1.8
4, 1, 1 
2.0
1 ,2 ,3
1.1
within 0.6(0.1) 
between 1.1(0.5)
pelvic rot ABSD 
mean change
0, 5 , 1 
0.6
0, 3 ,3  
0.9
3, 0. 3  
2.3
3, 0 ,3  
2.8
2, 0 4 
2.0
2, 1, 3 
2.6
within 1.4(0.5) 
between 1.5(0.7)
hip flex ABSD 
mean change
2, 1 ,3  
1.2
2, 2 ,2  
1.1
0, 5, 1 
2.7
0, 5, 1 
2.9
1 ,4 , 1 
3.5
0, 5, 1 
2.3
within 11(0 .3)  
between 3.5(2.1)
hip abd ABSD 
mean change
0, 5 , 1 
0.5
0, 2 ,4  
0.5
2, 0 4  
1.9
2, 0 ,4  
2.1
3, 0 ,3  
2.3
2, 0, 4 
1.7
within 0.8(0.2) 
between 14(0 .9)
hip rot ABSD 
mean change
2, 3 ,1  
2.8
0, 1 ,5  
1.2
2 ,0  4 
5.3
3, 0 ,3  
5.6
3 ,0  3  
7.1
1, 0, 5 
6.3
within 11(0 .3) 
between 3.4(2.6)
knee flex ABSD 
mean change
0, 1 ,5  
1.5
2, 1, 3 
2.1
3, 0 ,3  
2.9
3, 1 ,2  
2.5
3, 1 ,2  
3.0
2, 1, 3 
3.2
within 1.6(0.3) 
between 2.2(0.6)
knee abd ABSD 
mean change
2, 2 ,2  
1.1
0, 1 ,5  
0.6
3, 0 ,3  
2.6
3, 1 ,2  
2.6
4, 1, 1 
3.4
1 ,2 ,3
3.5
within 0.8(0.2) 
between 16(0 .9)
knee rot ABSD 
mean change
2, 2 ,2  
2.1
0, 4 ,2  
1.3
2 , 1 ,3  
3.7
1 ,0 ,5
3.8
0, 0 ,6  
3.6
2, 1, 3 
5.4
within 17(0 .4) 
between 3.9(2.1)
ankle dorsi ABSD 
mean change
2 , 1 ,3  
1.4
5, 1 ,0  
3.4
1 ,0 , 5 
3.5
0, 0 ,6  
1.6
1, 0, 5  
2.5
1 ,0 ,5
2.8
within 12(0 .3)  
between 2(1.8)
ankle abd ABSD 
mean change
1 ,2 ,3
2.2
2, 3, 1 
2.5
0, 3 ,3  
3.5
0, 3 ,3  
3.0
1 ,0 ,5
5.1
1 ,2 ,3
3.6
within 2(0.6) 
between 4.8(2.5)
ankle inv ABSD 
mean change
3 , 1 ,2  
1.6
4, 1 , 1 
2.7
0, 0 ,6  
2.6
0, 0 ,6  
2.9
0, 0 ,6  
3.0
0, 0 ,6  
2.6
within 1.2(0.2) 
between 3.5(4.1)
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Table 8.5b F02 Angle ABSD of the pelvis and lower limb joints (GC). ABSD = Absolute 
difference, (n = 6 per FO condition)
F 0 2  A n gles ABSD
pelvic tilt ABSD 
m ean change
A1-A2
0, 4 ,2  
0.4
B1-B2
1 ,4 ,1  
0.7
A1-B1
2, 1, 3 
3.2
A1-B2
2, 0 ,4  
2.9
A1-C
2, 2 ,2  
3.3
A1-D
2, 2, 2  
3.0
normal variability: m ean(SD) 
within 0.7(0.2) 
between 2.6(1.7)
pelvic obliq ABSD 
m ean change
0, 4 ,2  
0.4
0, 6, 0 
0.3
1, 0, 5 
1.2
1 ,0 ,5
1.2
3, 0 ,3  
2.0
2, 2 ,2  
1.4
within 0.6(0.1) 
between 1.1 (0.5)
pelvic rot ABSD  
m ean change
0, 5, 1 
0.6
0, 2 ,4  
1.1
2, 0, 4 
1.5
2, 0  4 
1.6
0, 1 ,5  
1.2
0, 1 5 
1.3
within 1.4(0.5) 
between 1.5(0.7)
hip flex ABSD 
m ean change
1 ,3 ,2
0.9
0, 4 ,2  
0.8
2, 0, 4 
4.9
2, 0 ,4  
4.5
2, 0  4 
4.5
1 ,0 ,5
3.3
within 1.1(0.3) 
between 3.5(2.1)
hip abd ABSD  
m ean change
0, 2 ,4  
0.7
0, 6, 0 
0.4
0, 0, 6  
1.2
0, 0 .6  
1.1
4, 0 ,2  
2.7
2, 1, 3 
2.0
within 0.8(0.2) 
between 1.4(0.9)
hip rot ABSD 
m ean change
0, 2 ,4  
0.9
2, 0 4  
1.1
4, 1, 1 
6.1
4, 1 , 1 
6.1
0, 1, 5 
3.9
0, 0 ,6  
3.3
within 1.1(0.3) 
between 3.4(2.6)
knee flex ABSD 
m ean change
1 , 1 ,4
1.3
0, 3 ,3  
1.2
2, 2 ,2  
2.7
2 ,2  2 
2.7
3, 1 ,2  
3.0
1, 1, 4 
2.6
within 1 6 (0 .3 )  
between 2.2(0.6)
knee abd ABSD  
m ean change
0, 4, 2 
0.5
1 ,2 ,3
0.7
3, 0 ,3  
2.5
2, 0 ,4  
2.5
0, 0 ,6  
1.6
0 , 0 ,6
1.6
within 0.8(0.2) 
between 1.6(0.9)
knee rot ABSD 
m ean change
0, 4 ,2  
1.2
0, 3 ,3  
1.2
1 ,0 ,5
3.5
1, 1 ,4  
3.8
2 , 1 ,3  
4.7
2, 0, 4 
5.2
within 17 (0 .4 )  
between 3 .9(2 .1)
ankle dorsi ABSD  
m ean change
4, 0, 2 
1.9
3, 0 ,3  
1.8
0, 0, 6 
2.8
0, 0 ,6  
2.3
1 ,0 ,5
2 .7
0, 0 ,6  
2.3
within 12 (0 .3 )  
between 2(1.8)
ankle abd ABSD 
m ean change
0, 2 ,4  
1.5
1 ,4 ,1  
1.5
1 ,2 ,3
4.0
0 , 1 ,5  
4.1
0, 2 ,4  
3.5
0, 3 ,3  
3.1
within 2(0.6) 
between 4.8(2.5)
ankle inv ABSD 
m ean change
2, 2 ,2  
1.9
3 , 1 ,2  
1.7
0, 0, 6 
3.1
0, 0 ,6  
3.3
0, 0 ,6  
1.9
0, 0 ,6  
1.8
within 1 2 (0 .2 )  
between 3.5(4.1)
8.20
Chapter 8 Results of FO tests
8.3.2.3 Angle excursion difference GC
Tables 8.6a and 8.6b present the number of participants who had angle excursion 
changes greater or less than the normal variability; it also presents the mean o f the 
group excursion change. All subjects between sessions changes of this parameter can 
be found in Appendix D 6.
Table 8.6a FOl Angle excursion differences (GC). (n = 6 per FO condition)
F 01 A n gles exc  diff
pelvic tilt exc  diff 
mean change
A1-A2 
0, 0 ,6  
-0.5
B1-B2
0 ,1, 5 
0.4
A1-B1
1,0, 5 
-0.3
A1-B2
0, 0, 6 
0.1
A1-C
1,0, 5 
-0.3
A1-D
1,0,5
-0.2
normal variability: mean(SD) 
within 0.6(0.2) 
between 0.4(0.2)
pelvic obliq exc  diff 
mean change
1,1 ,4  
-0.3
1,0,5
-0.3
1,1 ,4  
-0.5
3, 0, 3 
-0.8
2, 0, 4 
-0.8
2, 1, 3 
-0.7
within 0.6(0.2) 
between 0.8(0.2)
pelvic rot exc  diff 
mean change
1,0, 5 
0.0
1,2,3
0.4
0, 0, 6 
-1.5
1,0, 5 
-1.1
2, 0, 4 
-2.0
1, 0, 5 
-0.1
within 1(0.6) 
between 1.4(1.2)
hip flex exc  diff 
mean change
1,0,5
-0.3
1,0,5
0.3
2 ,1, 3 
0.0
1,1, 4 
0.2
0, 2,4 
0.8
2, 2,2 
0.6
within 1.4(0.5) 
between 1.1 (0.5)
hip abd exc  diff 
mean change
1, 1,4 
-0.1
1,0,5
-0.5
1,1, 4 
0.1
1,0, 5 
-0.4
2, 0, 4 
-1.0
2, 1, 3 
-0 .9
within 0.8(0.3) 
between 1.5(0.8)
hip rot exc  diff 
mean change
0, 2,4 
0.9
0 ,1,5 
0.2
0,1,5
0.9
0 ,1, 5  
1.1
0,1,5
1.4
2, 1, 3 
0.8
within 1.2(0.3) 
between 2.6(1.5)
knee flex ex c  diff 
mean change
0, 0,6 
-0.4
0, 0,6 
0.3
2, 2,2 
-0.4
2,1,3
-0.1
0,1,5
0.0
3, 1, 2 
-0 .8
within 1.8(0.5) 
between 1.3(0.3)
knee abd exc  diff 
mean change
0, 0,6 
0.2
1,0,5
-1.4
0,0, 6 
-0.1
0,0. 6 
-1.5
1,1,4
-1.5
0, 0 6 
0.0
within 1.7(0.7) 
between 2.8(1.4)
knee rot exc  diff 
mean change
1,0,5
-1.6
0, 0,6 
0.9
3 ,1 ,2  
-2.3
3 ,1, 2  
-1.4
2, 0, 4 
-1.2
2, 1,3 
-1.4
within 1.7(0.7) 
between 1.5(0.5)
ankle dorsi exc  diff 
mean change
0, 1, 5 
0.7
0, 1,5 
0.2
0, 0,6 
-0.2
0, 0, 6  
0.0
0, 2,4 
0.3
1, 1, 4 
0.6
within 17 (0 .9 )  
between 1 .5 (1 1 )
ankle abd exc  diff 
mean change
0, 2,4 
2.1
0, 0,6 
-0.5
0,1 5 
1.1
0,0 6  
0.6
1,2, 3 
1.0
0, 1,5 
0.5
within 2 .4 (1 2 )  
between 2.2(0.9)
ankle inv exc  diff 
mean change
2, 0,4 
-1.7
1,0,5
-0.6
2,1,3
0.0
2,1,3
-0.7
2 ,1,3 
-0.9
2, 2,2 
-0 .2
within 1.5(0.6) 
between 1.3(0.9)
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For FOl (Table 8.6a), the largest number of participants who had an increase or 
decrease in their excursion were in the hip rotation, knee rotation, ankle abduction, 
and ankle inversion. However, the group overall mean o f most of these parameters 
were within their normal variability.
Table 8.6b F02 Angle excursion differences (GC). (n = 6 per FO condition)
F02 Angles
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D normal variability: mean(SD)
pelvic tilt exc diff 1, 0, 5 0, 0,6 2, 2,2 0, 0, 6 2, 3, 1 1, 2, 3 within 0.6(0.2)
mean change -0.1 0.3 -0.1 0.2 0.4 -0.1 between 0.4(0.2)
pelvic obliq exc diff 3, 0,3 1, 0,5 2, 2,2 2, 1, 3 1,2, 3 1, 2, 3 within 0.6(0.2)
mean change -1.0 -0.1 0.0 -0.1 0.1 0.8 between 0.8(0.2)
pelvic rot exc diff 0, 0,6 1, 1,4 1,0,5 0, 1, 5 1, 0, 5 1, 1, 4 within 1(0.6)
mean change 0.1 -0.4 0.4 0.0 -0.4 0.4 between 1.4(1.2)
hip flex exc diff 2, 0,4 1,0,5 2, 2,2 2, 1, 3 2, 3, 1 2, 2,2 within 1.4(0.5)
mean change -0.8 -0.7 -0.5 -1.2 0.0 0.4 between 1.1(0.5)
hip abd exc diff 2, 0, 4 1,0,5 2, 0.4 0, 1, 5 0, 1, 5 0, 2, 4 within 0.8(0.3)
m ean change -0.7 -0.7 0.4 -0.3 0.5 0.9 between 1.5(0.8)
hip rot exc diff 0, 0,6 1, 1,4 0, 0, 6 0, 0, 6 1, 1, 4 1, 1, 4 within 12(0 .3 )
mean change -0.1 0.4 -0.3 0.1 0.8 0.5 between 2.6(1.5)
knee flex exc diff 0, 0,6 2, 0,4 0, 0,6 2, 0, 4 3, 0, 3 2, 2, 2 within 1.8(0.5)
mean change 0.4 -1.4 0.1 -1.2 -2.0 -0.8 between 1.3(0.3)
knee abd exc diff 0, 0, 6 0, 0,6 1, 0, 5 1,1,4 0, 0, 6 0, 0, 6 within 17(0 .7 )
mean change -0.5 -0.2 1.1 0.9 0.2 -0.5 between 2.8(1.4)
knee rot exc diff 1, 1,4 1, 1,4 1, 1,4 2, 3, 1 2, 3, 1 2, 2, 2 within 17(0 .7 )
mean change -0.7 -0.2 0.5 0.3 -0.1 -0.4 between 1.5(0.5)
ankle dorsi exc diff 1, 0,5 3, 0,3 2, 0,4 3, 0, 3 2, 1, 3 2, 1, 3 within 17 (0 .9)
mean change -0.2 -2.2 -1.6 -3.8 -1.1 -0.5 between 1 .5 (1 1 )
ankle abd exc diff 0 ,1,5 1,0,5 1,0,5 2, 0, 4 1, 0, 5 1, 1,4 within 2 .4 (1 2 )
mean change 0.5 -0.8 -1.1 -1.9 -0.4 0.8 between 2.2(0.9)
ankle inv exc  diff 0, 2,4 3, 0,3 0, 4,2 2, 3, 1 3, 1,2 3, 1, 2 within 15(0 .6 )
mean change 1.1 -2.4 3.3 0.9 -1.9 -1.4 between 1.3(0.9)
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For F02 (Table 8.6b), the largest number of participants who had an increase or 
decrease in their excursion were in the pelvic obliquity, hip flexion, hip abduction, 
ankle dorsiflexion, and ankle inversion. However, the group overall mean of most of 
these parameters were within their normal variability.
Generally, from the excursion differences results, it appears that;
>  The largest percentages of participants affected by FOl were 50% increase in 
knee rotation, and for F02 was 66% in ankle inversion/eversion excursion.
> The greatest magnitude of mean excursion reduction by FOl was seen in knee 
rotation (8.3 degrees), and for F02 it was in hip flexion (7.5 degrees).
>  Neither FO had any effect on pelvic tilt and pelvic rotation excursions.
>  The effects of FOl and F02 were variable in magnitude and inconsistent in 
direction.
It was not unusual that the same FO causes an increase in excursion for some 
participants and a decrease in others; this was seen in hip flexion, knee rotation, and 
ankle inversion. Previous research on the effects of FO on eversion reduction found 
contradicting results [Ferber et al. 2005], and this lead to a belief that some FO 
designs have unpredictable results [Kogler et al. 1995].
Conclusion. There is a need to classify FO according to their material type and 
dimensions, and subjects according to their musculoskeletal structure and function.
8.3.2.4 Grouping the CMC, ABSD, and excursion effects
Table 8.7 presents a summary of the parameters that had one or more of the CMC, 
ABSD, and excursion difference. The most affected parameters were hip rotation and 
knee abduction. The later had a change in its CMC and ABSD and these were seen in 
both FOl and F02 conditions.
Visual examination of the graphs show that; for most subjects the waveform pattern 
change had an irregular change in angle amplitude between waveforms throughout the 
GC rather than a constant shift between waveforms.
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An explanation of the effect of FO on knee abduction could be that while 
inversion/eversion is affected, the base of limb support (foot) motion change in the 
frontal plane could have influenced knee motion as well in this plane. This may help 
to understand if hypothesis (iii) is true, however, more evidence is needed from the 
kinetic analysis to confirm or reject this hypothesis.
Table 8.7 Summary of the greatest changes (2 or more subjects showing a change in both A1-A2 
and Al-Bl) in joint angles as assessed by the CMC, ABSD, and excursion differences (GC).
Pelvic
tilt
Pelvic
obliq
Hip
flex
Hip
abd
Hip
rot
Knee
flex
Knee
abd
Knee
rot
Ankle
dorsi
Ankle
abd
Ankle
inv
CMC FOl
F02 FOl
F02
FOl
F02
FOl F02
ABSD
F02
FOl
F02
F02
FOl
F02
FOl
Exc
diff
F02 F02 F02 FOl FOl F02 FOl
FOl
F02
Ankle inversion CMC and excursion was affected by both FOl and F02 conditions, 
for the participants who had inversion/eversion movement pattern change (CMC) this 
was coupled by an excursion changes, indicating a change in this parameter due to the 
effect of FO.
8.4 Kinetics
8.4.1 Peak ground reaction force (GRF) during LR
Table 8.8 presents the excursion differences of the GRFz, GRFx, and GRFy between 
sessions for FOl and F02 tests. Details of individual subjects change can be found in 
Appendix D 7.
For both FOl and F02, GRFz showed the least change in the number of participants 
and the groups overall mean change was within normal variability of this parameter. 
The greatest change (increase) was seen in GRFy in which the groups overall mean 
change were mostly greater than the normal variability of this parameter. GRFx also 
showed similar changes to GRFy in the number of participants, however, the groups 
overall mean changes were within the normal variability of this parameter.
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Table 8.8 GRF excursion differences components during LR. +ve =decrease, -ve = increase (n = 6 
per FO condition)
F01 GRF (LR)
GRFz exc  
overall mean
A1-A2
0, 1, 5 
-10.4
B1-B2
0, 0 ,6  
-0.4
A1-B1
0, 0 ,6  
-0.6
A1-B2
0, 0 ,6  
-1.1
A1-C
0, 1 ,5  
-7.5
A1-D
1, 0, 5 
-12.4
normal variability: mean(SD) 
within 19(10.6) 
between 30.8(20.2)
GRFx exc  
overall mean
2, 0 ,4  
-5.7
1, 0 ,5  
-6.0
0, 0 ,6  
-2.6
1, 0, 5 
-8.6
2, 1 ,3  
-7.5
3, 0 ,3  
-9.5
within 6.8(6.6) 
between 9(6.4)
GRFy exc  
overall mean
0, 0 ,6  
-4.8
0, 0 ,6  
-1.6
3, 0 ,3  
-5.8
4, 1, 1 
-7.3
5, 0, 1 
-8.6
2, 1, 3 
-3.5
within 9(5.8) 
between 2(1.4)
F 0 2  GRF (LR)
GRFz exc  
overall mean
A1-A2
1 .1 ,4
2.8
B1-B2
1, 1 ,4  
-8.8
A1-B1
0, 0, 6 
9.9
A1-B2
0, 0 ,6  
1.2
A1-C
0, 0 ,6  
-20.7
A1-D
0, 0 ,6  
-2.1
normal variability: mean(SD) 
within 19(10.6) 
between 30.8(20.2)
GRFx exc  
overall mean
2 ,0 ,4
-7.7
1, 0 ,5  
-6.7
2, 0 ,4  
-7.9
3, 0 ,3  
-14.6
2 ,0 ,4
-12.0
2, 1 ,3  
-6.4
within 6.8(6.6) 
between 9(6.4)
GRFy exc 2, 0, 4 0, 0 ,6 2, 1, 3 5, 1 ,0 3, 1 ,2 3, 1 ,2 within 9(5.8)
overall mean -7.4 -5.9 -0.8 -6.7 -6.1 -5.8 between 2(1.4)
8.4.2 Moment excursion during LR
Table 8.8 presents the moment excursion changes during LR. Details o f all subjects 
and for all sessions are given in appendix D 8.
For FO l, the greatest number o f subjects who had moment change (increase or 
decrease) was in hip flexion, knee abduction, and ankle dorsiflexion. However, all 
group means of these parameters were within their respective normal variability.
For F02, the greatest number o f subjects who had moment change was in hip and 
knee flexion. However, all group means o f these parameters were within their 
respective normal variability.
Conclusion. Knee abduction moment and GRFy during LR was seen to increase. This 
is concerning because of the nature of knee medial-lateral stability.
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Table 8.8 moment excursion difference during LR. (n = 6 per FO)
Results of FO tests
F01 Moments exc diff LR
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D normal variability: mean(SD)
hip flex 1. 0, 5 1 ,0 ,5 3, 1, 2 3, 1, 2 1, 1 ,4 1 ,0 ,5 within 13.6(1.3)
mean change -4.2 -1.6 -5.1 -6.7 1.6 -0.3 between 8.6(2.3)
hip abd 0, 0 ,6 0, 0, 6 1, 0, 5 2, 0 ,4 1 ,0 ,5 1 ,0 ,5 within 3.8(1.2)
mean change -2.4 0.0 -5.0 -5.1 -4.6 -2.8 between 5.1 (3.9)
hip rot 0, 0, 6 0, 1, 5 1 ,0 ,5 1 ,0 ,5 0, 0 ,6 1 ,0 ,5 within 2.2(1.2)
mean change -0.9 0.8 -3.3 -2.5 -1.9 -3.5 between 5.9(3.7)
knee flex 1 ,0 ,5 1, 0, 5 1, 1 ,4 1 ,0 ,5 0, 0 ,6 1, 1 ,4 within 5.7(3.8)
mean change -3.4 -3.1 0.9 -2.2 -1.8 2.8 between 6.9(2.4)
knee abd 1, 0, 5 0, 0, 6 2, 0 ,4 2, 0 ,4 3, 0 .3 3, 0 ,3 within 4.8(1.8)
mean change -3.7 1.1 -8.2 -7.1 -5.5 -8.7 between 6(2.8)
knee rot 0, 0, 6 1, 0, 5 0, 0 ,6 1 ,0 ,5 0, 0 .6 0, 1 ,5 within 1.3(0.7)
mean change -0.6 -1.0 0.3 -0.7 -0.3 0.6 between 2.2(1.1)
ankle dorsi 0, 1 ,5 2, 0, 4 0, 3, 3 1 ,0 ,5 1, 2, 3 2, 1, 3 within 3(0.8)
mean change 0.5 -2.7 1.5 -1.1 0.3 -0.8 between 2.7(0.8)
ankle abd 1, 0, 5 0, 0 ,6 0, 0 ,6 0, 0 ,6 0, 0, 6 0, 0, 6 within 1.9(0.8)
mean change -0.1 0.5 -1.9 -1.4 -1.0 -0.1 between 4.4(2.7)
ankle inv 1 ,0 ,5 0, 0, 6 1 ,0 ,5 1, 0, 5 1 ,0 ,5 2, 0 ,4 within 0.9(0.6)
mean change -0.8 0.0 -1.3 -1.3 -1.2 -1.9 between 1.3(0.8)
F 02 Moments exc diff LR
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D normal variability: mean(SD)
hip flex 2, 0 ,4 0, 0, 6 2, 0 ,4 1 ,0 ,5 2, 0, 4 2, 0 ,4 within 13.6(1.3)
mean change -7.2 -2.3 -5.6 -7.8 -12.0 -5.6 between 8.6(2.3)
hip abd 1, 0, 5 2, 0 ,4 1 ,0 ,5 2, 0 ,4 2, 0, 4 1, 1 ,4 within 3.8(1.2)
mean change -4.2 -2.7 -2.5 -5.3 -5.6 0.1 between 5.1(3.9)
hip rot 2 ,0 ,4 0, 1 ,5 1 ,0 ,5 1 ,0 , 5 1, 0, 5 1 ,0 ,5 within 2.2(1.2)
mean change -2.8 0.2 -6.0 -5.7 -5.0 -3.2 between 5.9(3.7)
knee flex 2, 0 .4 0, 0, 6 3, 1, 2 4, 0, 2 3, 1, 2 2, 1 ,3 within 5.7(3.8)
mean change -7.2 -3.2 -8.4 -11.5 -4.9 -4.3 between 6.9(2.4)
knee abd 1 ,0 ,5 0, 0 ,6 0, 1, 5 0, 1, 5 0, 0 ,6 0, 1 ,5 within 4.8(1.8)
mean change -3.7 1.1 -8.2 -7.1 -5.5 -8.7 between 6(2.8)
knee rot 0, 0 ,6 0. 0 ,6 0, 0 ,6 1 ,0 ,5 0, 0, 6 0, 2, 4 within 1.3(0.7)
mean change -0.7 -0.5 -0.9 -1.4 -0.5 0.8 between 2.2(1.1)
ankle dorsi 0, 0, 6 1 ,0 ,5 1 ,0 ,5 3, 0 ,3 2, 0, 4 1, 1, 4 within 3(0.8)
mean change -0.9 -1.2 -1.9 -3.1 -2.8 -1.1 between 2.7(0.8)
ankle abd 1,0 , 5 0, 1, 5 0, 0, 6 0, 0 ,6 0, 0, 6 0, 1, 5 within 1.9(0.8)
mean change -1.7 1.1 -2.3 -1.3 0.1 2.8 between 4.4(2.7)
ankle inv 0, 0, 6 0, 0 ,6 0, 0 ,6 1 ,0 ,5 0, 0 ,6 2, 0 ,4 within 0.9(0.6)
mean change -0.4 0.1 1.1 1.2 0.8 1.1 between 1.3(0.8)
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8.4.3 Ground reaction force (GRF) over all GC
Table 8.9 presents the CMC, ABSD, and excursion differences of all GRF 
components over the GC. Details of these parameters for all subjects can be found in 
Appendix D 9.
GRFz. Both FOl and F02 had similar effect on this parameter; the CMC showed a 
decrease in 4/6 of FOl and 5/6 in F02 participants. The ABSD decreased in 2/6 of the 
participants in both FO. The least effect (1/6 of participants) was in the excursion 
difference by both FO. However, the group means of most of these variables were 
within their normal variability.
The return to the normal variability range after the 2 weeks washout period was in 
more subjects using F02 than FOl, this could be due to inter-subject differences in 
the ability to ‘learn’ the effects of FO during use and return to the original state after 
FO disuse.
GRFx. Both FOl and F02 had similar effect on the CMC and ABSD (no more than 
3/6 of participants), however, the excursion changes (generally an increase) were in 
greater number of participants in F02 and also in no more than 3/6 o f participants. 
Compared to the effects on GRFz, the CMC and ABSD were in less participants, 
however, the effect of F02 on the excursion of GRFx was seen in greater number of 
participants than FOl. The group mean changes were mostly within the normal 
variability of this parameter.
The 2 weeks washout period did not show a noticeable effect in returning the GRFx to 
within its normal variability.
GRFy. For the CMC and ABSD, the changes were in similar number of participants 
as those in GRFx. For the excursion differences, GRFy was affected (mostly 
increasing) in more participants than in GRFx and these effects were mainly an 
increase in GRFy. However, most group means for CMC, ABSD, and excursions for 
both FOl and F02 were within their normal variability. Similar to GRFx, the 2 weeks 
washout period did not show a noticeable effect in returning the GRFy to within its 
normal variability.
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Table 8.9 CMC, ABSD, and excursion differences for all GRF (GC). (n = 6 per FO)
FOl GRF GC
GRFz
CMC 
overall mean
A1-A2
3, 1, 2 
99.3%
B1-B2
3, 2, 1 
98.9%
A1-B1
2, 2, 2 
99.5%
A1-B2
1, 3, 2 
99.4%
A1-C
1, 3 ,2  
99.1%
A1-D
0, 4 ,2  
98.8%
normal variability: mean(SD) 
within 99.1(0.2) 
between 99.5(0.2)
ABSD 
overall mean
0, 2, 4 
23.3
1, 3, 2 
23.5
0, 2, 4 
19.9
1, 0, 5 
23.0
3, 1 ,2  
28.1
4, 1, 1 
33.2
within
between
27.4(7.4)
23.6(6.9)
exc diff 
overall mean
1. 0, 5 
-8.1
0, 0, 6 
0.4
0, 0, 6 
6.0
0, 0, 6 
6.4
0, 0 ,6  
-0.4
1, 1 ,4  
6.7
within
between
19(10.6)
30.8(20.2)
GRFx
CMC 
overall mean
0, 1 ,5  
99.5%
1, 1, 4  
99.1%
0, 2 4 
99.6%
0, 2, 4  
99.6%
0, 2. 4 
99.4%
0, 3 ,3  
99.2%
within
between
99.5(0.2)
99.7(0.2)%
ABSD 
overall mean
0, 3 ,3  
7.3
2, 3, 1 
7.4
0, 2 4 
5.8
0, 0 ,6  
6.6
2, 0 4 
7.6
3, 0 ,3  
9.0
within
between
9.0(2.0) 
7.1 (3.0)
exc diff 
overall mean
1, 0, 5 
-5.8
0, 1, 5 
-3.1
0, 0, 6 
2.0
1, 1 ,4  
-1.1
1 ,0 .5
-7.4
2, 2 ,2  
-5.1
within
between
6.8(6.6)
9(6.4)
GRFy
CMC 
overall mean
4, 0, 2 
97.5%
3, 0, 3 
97.2%
1, 2, 3 
95.5%
0, 2 ,4  
96.4%
0, 4 ,2  
96.8%
0, 3 ,3  
96.1%
within
between
94.8(2.2) 
98.1(1.3)
ABSD 
overall mean
0, 1, 5 
3.6
0, 5, 1 
3.9
1 ,0 , 5 
4.3
2, 0 ,4  
4.7
1, 0, 5 
4.4
1, 0, 5 
4.5
within
between
6.3(1.6) 
3.5(1.4)
exc diff 
overall mean
0, 0, 6 
-4.3
0, 0, 6 
-3.1
2, 1, 3 
-4.0
3, 1, 2 
-7.1
5, 0, 1 
-7.9
3, 1, 2 
-4.3
within
between
9(5.8)
2(1.4)
F02GRF GC
GRFz
CMC 
overall mean
A1-A2
5, 0, 1 
99.6%
B1-B2
4, 0, 2 
99.5%
A1-B1
2, 3, 1 
99.2%
A1-B2
2, 2 ,2  
99.2%
A1-C
1, 2, 3 
99.3%
A1-D
0, 2 ,4  
98.9%
normal variability: mean(SD) 
within 99.1(0.2) 
between 99.5(0.2)
ABSD 
overall mean
0, 3, 3 
18.9
0, 4 ,2  
19.3
2, 2 ,2  
26.0
2, 2, 2 
24.6
2, 2 ,2  
23.6
2, 0, 4 
29.3
within
between
27.4(7.4)
23.6(6.9)
exc diff 
overall mean
1, 0, 5 
-14.1
2, 0, 4 
-10.2
0, 0 ,6  
0.5
1, 0, 5 
-9.8
0, 0 ,6  
-17.8
0, 0 ,6  
-12.1
within
between
19(10.6)
30.8(20.2)
GRFx
CMC 
overall mean
2, 0, 4 
99.7%
2, 0, 4 
99.7%
0, 2, 4 
99.3%
0, 2, 4 
99.4%
0, 1 ,5  
99.4%
0, 2 ,4  
98.8%
within
between
99.5(0.2)
99.7(0.2)%
ABSD 
overall mean
0, 4, 2 
6.4
0, 4 ,2  
6.1
2, 2, 2 
8.0
2, 1 ,3  
7.6
1, 0, 5 
7.8
2, 0, 4 
10.7
within
between
9.0(2.0) 
7.1 (3.0)
exc diff 
overall mean
3, 0 ,3  
-12.7
1, 1 ,4  
-2.4
1, 1, 4 
-5.1
2, 1 ,3  
-7.5
3, 1 ,2  
-10.7
1, 2 ,3  
-1.3
within
between
6.8(6.6)
9(6.4)
GRFy
CMC 
overall mean
2, 0, 4 
96.9%
4, 0 ,2  
98.1%
0, 3, 3 
97.1%
0, 3, 3 
97.2%
0, 2 ,4  
96.6%
0, 2, 4 
96.6%
within
between
94.8(2.2)
98.1(1.3)
ABSD 
overall mean
0, 4, 2 
4.0
0, 4, 2 
3.1
1, 0, 5 
3.8
2, 0, 4 
3.7
2, 0 ,4  
4.2
2, 0, 4 
4.1
within
between
6.3(1.6) 
3.5(1.4)
exc diff 
overall mean
0, 0, 6 
-6.4
0, 0, 6 
-6.9
2, 1, 3 
0.3
5, 0, 1 
-6.6
3, 0 ,3  
-6.2
3, 0 ,3  
-5.5
within
between
9(5.8)
2(1.4)
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The foot is the base where the biomechanical interaction between the body and the 
ground occurs. Shock propagates along the linked lower limb segments and gets 
attenuated by the joints and segments.
Shock attenuation is the amount of force reduction, an increase in excursion was seen 
in the lateral GRFy and anterior GRFx components; this suggests that eversion angle 
reduction increased shock attenuation and thus increased the GRFy and GRFx and 
greater increase in GRFy than GRFx as seen in the results. A possible reason for this 
is because of the subtalar axis orientation which makes eversion motion occurs mainly 
in the frontal planes and partly in the transverse and sagittal planes. GRFz was mainly 
unchanged; this may be because the increase in GRFz that might have happened was 
attenuated at more proximal joints.
Conclusion Both FOl and F02 had similar effects on GRF over the GC as during the 
LR. Both FOl and F02 were similar of their effect on GRF components (mainly 
increasing GRFy and to a lesser degree GRFx). These effects are similar to previously 
published results on FO [Nester et al. 2003]. These changes suggest a motion pattern 
change in some of the FO users. The similarity of the effects of FOl to F02 indicates 
that the addition of the medial longitudinal arch to F02 was not an effective 
improvement compared to FOl which did not have this arch; this provides further 
support to hypothesis (i).
8.4.4 Moment over the GC
Joint moment changes were evaluated over both the LR and GC. During the LR 
moment changes was assessed in terms of its excursion changes. Over the GC, joint 
moments were evaluated by the waveform CMC, ABSD, and excursion changes. The 
CMC was used as an indicator for joint moment pattern changes which gives an 
indication to the normality of joint loading pattern. The ABSD was used as an 
indicator for the magnitude of moment change due to the effect of FO, and the 
excursion differences was used to assess the changes in moment maximums.
Tables 8.10a and 8.10b present the CMC, ABSD, and excursion differences in 
moments for FOl and F02 respectively. Details of sessions for all subjects are given 
in Appendix DIO.
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A common observation in Tables 8.10a and 8.10b is that: for FOl and F02 most of 
the group mean changes were within their respective normal variability ranges.
FOl (Table 8.10aT All joint moments CMC and ABSD were affected by this FO. 
These effects were in different number of participants (generally around 50%) in 
different joint parameters. The least affected were all the ankle parameters and knee 
rotation. However, the excursion magnitude was mainly unchanged. This indicates 
that a motion pattern change over the GC is affected rather than a moment magnitude. 
An abnormal moment pattern could mean that moments are increasing at times when 
it should be low, and this is of particular concern for the knee where most injuries 
occur [MacLean et al. 2006].
The 2 weeks washout period showed an excellent return to within the normal 
variability range for the CMC, ABSD, and the excursion differences. This return was 
mostly seen in more than 66% of the participants.
FQ2 (Table 8.10b). A generally similar effect of this FO to FOl was seen on joint 
moments. The least affected were all the ankle parameters. However, F02 had a 
greater than FOl effect (mainly increased in more subjects) on the moment excursion 
magnitude.
Similar to FOl, the 2 weeks washout period showed an excellent return to within the 
normal variability range for the CMC, ABSD, and the excursion differences. This 
return was mostly seen in more than 66% of the participants.
Conclusions.
(1) The limited change in moment excursions amplitude over the GC may be 
attributed to participants adopting new gait strategy (pattern) over the GC that does 
not require extra muscular effort.
(2) The greater change of the CMC and ABSD than excursion magnitude indicates 
that a motion pattern change over the GC is affected rather than a moment magnitude. 
An abnormal moment pattern could mean that moments are increasing at times when
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it should be low, and this is of particular concern for the knee where most injuries 
occur [MacLean et al. 2006].
(3) The results of GRF and moment over the GC were less reviling than those during 
the LR; however, the general trend was similar to that during the LR in that the 
observed changes were seen at proximal joints rather than at the ankle and subtalar 
joints. Therefore by grouping the evidence from the changes during LR and over GC 
on knee and ankle abduction; hypothesis (iii) only hold true for knee abduction angle 
and moment.
(4) Changes in any of the parameters did not occur in all participants and some times 
under the same conditions different subjects may have opposite results. This indicates 
a great inter-subject variability that warrants further investigation and biomechanical 
classification of feet and lower limb joints.
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Table 8.10a. FOl moment during GC. CMC, ABSD, and excursion difference (n = 6)
F 0 1  M om ents GC
hip flex CMC 
m ean CMC
A1-A2
3, 1 ,2  
99.1%
B1-B2
3, 2, 1 
97.9%
A1-B1
1, 1 ,4  
98.6%
A1-B2
1 ,3 , 2 
98.5%
A1-C
1, 3, 2  
98.0%
A1-D
0, 1, 5 
98.7%
normal variability: m ean(SD) 
CMCw = 99.9(0.2)%
CMCb = 98.8(0.6)%
hip flex ABSD  
m ean change
0, 5, 1 
3.2
0, 4, 2 
3.8
0, 4 ,2  
3.9
0, 5, 1 
3.7
0, 4 ,2  
4 .6
0, 4, 2 
4.1
within 5 .9(1.4) 
between 6 .4(1 .8)
hip flex exc  diff 
m ean change
1, 0 ,5  
-4.1
0, 0, 6  
1.3
1, 0, 5  
-8 .9
2, 0 ,4  
-7 .6
0, 0 ,6  
-2 .8
0, 0 ,6  
-1 .6
within 10.6(3.8) 
between 11.1(7.8)
hip abd CMC 
m ean CMC
4, 0 ,2  
99.4%
4, 0, 2 
99.3%
0, 0 ,6  
99.0%
0, 0, 6  
98.8%
0, 0, 6 
99.0%
0, 2, 4 
98.4%
CMCw =98.7(0.4)%  
CMCb = 98.7(1.2)%
hip abd ABSD 
m ean change
0, 5, 1 
2.0
0, 5, 1 
2.1
0, 2 ,4  
2.8
0, 1, 5 
3.2
0, 4, 2 
2.8
0, 0 ,6  
3.6
within 3 9(0.9) 
between 4 .4(2 .6)
hip abd exc  diff 
m ean change
0, 0 ,6  
-1 .8
0, 0, 6 
-1.1
0, 0, 6 
-2 .9
0, 0 ,6  
-4.0
0, 0 ,6  
-3 .3
0, 0 ,6  
-2.9
within 5 .9(1.7) 
between 7 .8(10.2)
hip rot CMC 
m ean CMC
4, 1, 1 
98.3%
3, 3, 0  
98.7%
0, 1, 5  
95.7%
0, 2, 4  
94.4%
0, 0, 6  
96.3%
1 ,0 ,5
95.3%
CMCw = 98(0.7)%  
CMCb = 95.6(3.5)%
hip rot ABSD  
m ean change
0, 5, 1 
0 .8
0, 5, 1 
0.9
0, 5, 1 
1.5
0, 2, 4  
1.6
0, 4 ,2  
1.7
0, 0 ,6  
1.7
within 1.4(0.2) 
between 2 .6 (1 .3)
hip rot ex c  diff 
m ean change
0, 0, 6 
-1 .3
0, 0, 6  
0.9
1, 0 ,5  
-4 .0
1, 0, 5 
-3 .2
1, 0 ,5  
-3 .5
1 ,0 ,5
-3.6
within 1.9(0.7) 
between 4 .9(2 .7)
knee flex CMC 
m ean CMC
0, 1 ,5  
98.5%
2, 2, 2  
97.7%
0, 3 3 
92.3%
0, 2 4 
94.4%
0, 3, 3  
92.4%
0, 3 3  
87.6%
CMCw = 98.8(0.5)%  
CMCb = 97.6(2.5)%
knee flex ABSD  
m ean change
2, 4, 0  
2 .5
2 , 1, 3 
2.2
3, 1 ,2  
4.8
2, 2, 2  
4.2
2, 1 ,3  
4 .7
4, 0 ,2  
6.2
within 3 .1(0 .5) 
between 5 .2(2 .8)
knee flex ex c  diff 
m ean change
1, 0, 5 
-2 .8
1 ,0 , 5 
-3.8
0, 1 ,5  
1.5
1 ,2 , 3 
-2.2
1, 0, 5 
-1 .3
0, 1, 5 
2.4
within 6 .2(2 .6) 
between 6 .7(2 .9)
knee abd CMC 
m ean CMC
2, 2, 2 
98.8%
3, 1, 2  
99.5%
1, 5 0 
97.0%
0, 5, 1 
96.9%
0, 2 4 
98.4%
0, 4 ,2  
96.6%
CMCw = 99.2(0.2)%  
CMCb = 98.8(0.8)%
knee abd ABSD  
m ean change
0, 3 ,3  
1.6
0, 6, 0  
1.3
1, 1, 4 
3.1
0, 1, 5 
3.1
0, 0, 6 
2.3
0 , 1, 5 
3.0
within 2.1 (0.2) 
between 3 .2 (1 .4 )
knee abd e x c  diff 
m ean change
2, 0 ,4  
-2 .3
0, 0, 6 
-0.4
0, 0, 6 
-4 .9
0, 0, 6 
-5.3
0, 0, 6 
-2 .7
1, 0,  5  
-3.1
within 2 .9 (1 1 )  
between 5.2(7.7)
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Table 8.10a. FOl moment during GC contd.
F 0 1  M om ents GC contd.
knee rot CMC 
m ean CMC
A1-A2
4, 1, 1 
99.1%
B1-B2
4, 2 ,0  
99.0%
A1-B1
0, 0 ,6  
98.5%
A1-B2
0, 0, 6 
98.7%
A1-C
0, 2, 4 
98.1%
A1-D
0, 2 ,4  
97.8%
normal variability: m ean(SD ) 
CMCw = 98 .9(0 .2)%
CMCb = 9 8 .7 (0 .9 )%
knee rot ABSD  
m ean change
0. 4, 2 
0.6
0, 4, 2 
0.6
0, 0 ,6  
0.8
0, 1, 5 
0.8
0, 1, 5 
1.0
0, 1 ,5  
1.0
within 1(0.2) 
between 1.1 (0.5)
knee rot ex c  diff 
m ean change
0, 1, 5 
-0.5
0, 0, 6 
-0.4
0, 0 ,6  
-1.1
1 , 0 ,  5 
-1 .6
0, 0 ,6  
-1.8
0, 0 ,6  
-0.8
within 1.6(0.5) 
between 2 .5(1 .9)
ankle dorsi CMC 
m ean CMC
0, 0, 6 
99.6%
0 , 1 , 5  
99.6%
0, 1, 5  
99.6%
0, 0, 6  
99.7%
0 , 3 , 2
99.4%
0, 4 ,2  
99.2%
CMCw = 99.6(0.2)%  
CMCb = 99.7(0.2)%
ankle dorsi ABSD  
m ean change
3, 1, 2  
2.7
2, 2 ,2  
2 .3
1, 4, 1 
2.4
0, 6, 0 
2.2
3, 2, 1 
3 .5
3, 3 ,0  
3.8
within 2 .5(0.4) 
betw een 3 .3(0 .3)
ankle dorsi e x c  diff 
m ean change
1, 0 ,  5 
-2.1
0, 1 ,5  
-0.6
0, 0 ,6  
1.2
0, 0 ,6  
0.6
0, 1, 5 
1.7
0, 1 ,5  
1.8
within 3 .2(1.8) 
between 3.1(22)
ankle abd CMC 
m ean CMC
0, 2 4 
89.0%
0, 2 ,4  
97.0%
0, 3, 3 
55.7%
1 , 3 , 2
62.0%
0, 4 ,2  
54.7%
0, 2 ,4  
78.8%
CMCw = 97.7(1.4)%  
CMCb = 81.6(16.1)%
ankle abd ABSD 
m ean change
2, 4, 0 
1.0
0, 5, 1 
0.7
0, 2 ,4  
2.5
0, 3, 3  
2.1
0, 2, 4  
2 .7
0, 2 ,4  
2.6
within 1.1 (0.1) 
betw een 5 .4(3 .5)
ankle abd ex c  diff 
mean change
0, 1, 5 
0.9
0, 0 ,6  
0 .4
0, 0 ,6  
0.9
0, 0 ,6  
1.3
0, 1 ,5  
-0 .3
0 , 1 , 5  
0.3
within 2 .3(0 .7) 
between 4 .4(2 .7)
anklle inv CMC 
m ean CMC
1, h  4 
99.0%
3, 0 ,3  
99.5%
0, 1  5 
98.9%
0, 2 ,4  
98.6%
0, 1 5 
98.7%
0, 2 ,4  
98.4%
CMCw = 99.3(0.2)%  
CMCb = 99(0.8)%
ankle inv ABSD  
m ean change
1, 1, 4 
0.5
0, 2 ,4  
0.5
0, 1 ,5  
0.7
0, 2  4 
0.7
0, 1 5 
0 .7
0, 0 ,6  
0.9
within 0 .6(0 .1) 
betw een 1(0.5)
ankle inv ex c  diff 
m ean change
0, 0, 6 
-0.1
0, 1 ,5  
-0.2
0, 0, 6 
-0.5
0, 0 ,6  
-0.7
0, 0 , 6  
-1.2
0, 0 ,6  
-1.0
within 1.3(0.8) 
between 1 .8(1.4)
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Table 8.10b. F02 moment during GC. CMC, ABSD, and excursion difference (n = 6)
F 0 2  M om ents GC
hip flex CMC 
mean CMC
A1-A2
2, 2, 2 
99.0%
B1-B2
3, 2, 1 
99.3%
A1-B1
2 ,2 ,2
98.7%
A1-B2
1 ,2 ,3
98.7%
A1-C
1 ,3 ,2
98.1%
A1-D
0 ,1  5  
98.4%
normal variability: mean(SD) 
CMCw = 99.9(0.2)%
CMCb = 98.8(0.6)%
hip flex ABSD 
mean change
0, 5, 1 
3.3
0, 6 0 
2.9
0, 4 ,2  
4.1
0, 4 ,2  
4.1
0 ,3 ,3
5.0
0, 3, 3 
4.3
within 5.9(1.4) 
between 6.4(1.8)
hip flex exc diff 
mean change
3, 0, 3 
-9.8
0, 0 6 
0.3
2 ,0 ,4
-3.8
1 ,1 ,4
-3.5
2, 1 ,3  
-7.8
1, 1, 4 
-1.8
within 10.6(3.8) 
between 11.1(7.8)
hip abd CMC 
mean CMC
6, 0 ,0  
99.6%
6, 0 ,0  
99.6%
0 ,0 ,6
99.3%
0, 0, 6 
99.3%
0, 0, 6 
99.2%
0, 0, 6 
99.0%
CMCw =98.7(0.4)%  
CMCb = 98.7(1.2)%
hip abd ABSD 
mean change
0, 6 ,0  
2.1
0, 6 ,0  
2.0
0, 1, 5 
2.7
0, 2 ,4  
2.5
0, 0 6 
2.9
0 ,0 , 6 
3.2
within 3.9(0.9) 
between 4.4(2.6)
hip abd exc diff 
mean change
0, 0, 6 
-2.4
0, 0 ,6  
-0.1
0 ,0 ,6
-0.4
0, 0 6 
-0.5
0, 0 6 
-5.8
0, 0 6 
-0.8
within 5.9(1.7) 
between 7.8(10.2)
hip rot CMC 
mean CMC
5, 1, 0 
98.5%
4, 1, 1 
98.9%
1 ,2 ,3
94.2%
1 ,1 ,4
95.5%
0 ,1 .5
93.2%
0, 1 5 
94.0%
CMCw = 98(0.7)%  
CMCb = 95.6(3.5)%
hip rot ABSD 
mean change
0, 6, 0 
0.8
1, 5 ,0  
0.9
1 ,3 , 2 
2.0
0, 2 4 
1.8
1, 1 ,4  
2.1
1 ,3  2 
1.9
within 1.4(0.2) 
between 2.6(1.3)
hip rot exc diff 
mean change
2, 0 4 
-2.1
0, 0 ,6  
0.5
2 ,0  4 
-5.5
2 ,0  4 
-5.1
1 ,0  5 
-4.4
1 ,0 , 5 
-3.0
within 1.9(0.7) 
between 4.9(2.7)
knee flex CMC 
mean CMC
3, 0 3 
99.2%
2, 2, 2 
98.9%
0, 2, 4 
92.6%
0, 2, 4  
93.5%
0, 2, 4  
96.8%
0, 1, 5 
97.3%
CMCw = 98.8(0.5)%  
CMCb = 97.6(2.5)%
knee flex ABSD 
mean change
0, 5, 1 
2.1
2, 4 ,0  
2.2
1 ,0 ,5
5.2
1 , 1 , 4
4.4
0, 0 , 6  
3.9
0, 0, 6 
3.5
within 3.1 (0.5) 
between 5.2(2.8)
knee flex exc diff 
mean change
1 , 0 , 5
-5.8
1, 0 , 5  
-4.3
2, 1 , 3  
-4.3
4, 0 ,2  
-8.6
4, 1, 1 
-3.7
2, 1, 3 
-4.5
within 6.2(2.6) 
between 6.7(2.9)
knee abd CMC 
mean CMC
4, 0, 2 
99.6%
5, 0, 1 
99.7%
0, 0 ,6  
98.9%
0, 0 ,6  
99.0%
1, 0, 5 
99.2%
1, 1, 4 
98.8%
CMCw = 99.2(0.2)%  
CMCb = 98.8(0.8)%
knee abd ABSD 
mean change
0 , 6 ,  0 
1.3
0, 6 , 0  
1.2
0, 1 , 5  
2.4
0, 1 , 5  
2.2
0, 1, 5 
2.0
1, 2, 3 
2.6
within 2.1(0.2) 
between 3.2(1.4)
knee abd exc diff 
mean change
1, 0, 5 
-2.0
1, 0, 5 
-0.1
0, 0 , 6  
1.4
0, 0 , 6  
1.3
0, 0 , 6  
-1.5
0, 0, 6 
3.6
within 2.9(1.1) 
between 5.2(7.7)
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Table 8.10b. F02 moment during GC contd.
Results of FO tests
F 0 2  M om ents GC contd.
knee rot CMC 
m ean CMC
A1-A2
4, 1, 1 
99.2%
B1-B2
4, 1, 1 
99.3%
A1-B1
0, 3, 3 
98.2%
A1-B2
0, 1, 5 
98.6%
A1-C
0, 2, 4  
98.2%
A1-D
0, 2, 4  
97.8%
normal variability: m ean(SD ) 
CMCw = 98.9(0.2)%
CM Cb = 9 8 .7 (0 .9 )%
knee rot ABSD  
m ean change
0, 4, 2 
0.7
0, 4 ,2  
0.6
0, 0, 6 
1.0
0, 0, 6  
0.9
1, 1, 4 
1.0
0, 0, 6 
1.0
within 1(0.2) 
betw een 1.1 (0.5)
knee rot exc  diff 
m ean change
2, 1, 3 
-1.1
1, 0, 5 
-0 .2
0, 1, 5 
0.3
1, 0, 5 
0.1
0, 0, 6  
-0 .5
0, 2, 4 
1.6
within 1.6(0.5) 
betw een 2 .5(1 .9)
ankle dorsi CMC 
m ean CMC
4, 0, 2 
94.7%
3, 0, 3 
97.5%
0, 2 ,4  
83.6%
1, 1, 4  
86.2%
0, 0 ,6  
75.4%
0, 1, 5 
87.8%
CMCw = 99.6(0.2)%  
CMCb = 99.7(0.2)%
ankle dorsi ABSD  
m ean change
3, 2, 1 
2.0
2, 2 , 2  
2.1
2, 4, 0 
3.1
0, 6, 0 
2.5
3, 2, 1 
2.1
3, 3, 0 
2.9
within 2 .5(0 .4)  
betw een 3 .3 (0 .3)
ankle dorsi ex c  diff 
m ean change
1, 0 5 
-2 .4
0, 0, 6 
0.4
0, 0, 6  
0.6
0, 1; 5 
1.0
1, 1, 4  
0.2
1, 1 4 
0.8
within 3 .2 (1 8 )  
betw een 3 .7(2 .2)
ankle abd CMC 
m ean CMC
1, 3, 2  
94.7%
2, 1, 3 
97.5%
0, 0, 6 
83.6%
0, 0, 6  
86.2%
2, 1, 3 
75.4%
1, 0, 5 
87.8%
CMCw = 97.7(1.4)%  
CMCb = 81.6(16.1)%
ankle abd ABSD  
m ean change
3, 2, 1 
1.3
2, 3, 1 
1.1
0, 1 5 
2 .5
0, 2, 4  
2.1
0, 3, 3 
2.0
0, 3, 3 
1.9
within 1 1 (0 .1 )  
betw een 5 .4(3 .5)
ankle abd exc  diff 
m ean change
2, 0 4 
-1 .8
0, 0, 6  
-0.1
2, 0, 4 
-4 .3
1, 0, 5 
-4 .4
0, 0, 6  
0.0
0, 1 5 
3.1
within 2 .3(0 .7) 
betw een 4 .4 (2 .7 )
anklle inv CMC 
m ean CMC
4, 0, 2 
99.6%
4, 0 ,2  
99.6%
1, 0, 5 
99.3%
0, 0 ,6  
99.4%
0, 0, 6  
99.4%
0, 0, 6 
99.0%
CMCw = 99.3(0.2)%  
CMCb = 99(0.8)%
ankle inv ABSD  
m ean change
0, 2 : 4 
0.5
0, 3, 3 
0.5
0, 1, 5 
0.6
0, 2 4 
0.6
0, 4, 2  
0.6
0, 1 5 
0.8
within 0 .6(0 .1) 
betw een 1(0.5)
ankle inv exc  diff 
m ean change
0, 0, 6 
-0 .4
0, 0, 6  
0.1
0, 1, 5 
1.1
0, 0, 6  
1.2
0, 1, 5  
0.8
0, 1 5 
1.1
within 1 3 (0 .8 )  
betw een 1 .8(1.4)
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8.5 Summary
L oading  R esponse
1. Eversion angle reduction was seen in 2/6 cases in FOl and 0/6 in F02 condition.
2. Greatest increase seen with the number of subjects was in GRFy (3/6 for FOl, 2/6 
for F02,) followed by GRFx (0/6 for FO, 2/6 for F02). GRFz showed no evidence o f  
change (0/6 for both FOl and F02).
3. The result which stands out for its health implications was the increase in knee 
abduction moment in FOl condition (2/6 of the participants).
G ait Cycle
1. The largest number o f subjects showing changes in joint angles was seen in the 
knee abduction angles (CMC and ABSD), knee and hip rotation angles (CMC, 
ABSD, and Excursions).
2. Effects on GRF components were similar to that during LR.
3. All joint moments showed a change in their CMC, ABSD, and excursion 
differences (3D).
G eneral observations
> Many parameters were increasing in some subjects and decreasing in others for 
the same FO under the same test conditions.
> Walking speed increase (-3% in FOl and F02) were manifested as a result of an 
increase in step length rather than step frequency.
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Chapter 9
Discussion, conclusions, limitations and further work
This chapter briefly discusses the important results of FOl and F02 investigation. It 
then introduces the key conclusions in the thesis covering all chapters. Then accounts 
for the limitations of this work. Finally, it presents the needed further work that was 
based on the findings of FO tests.
9.1 Discussion
Many people with foot alignment problems (e.g. low arched feet) causing pain or 
discomfort have never sought medical help. Instead, they may opt for “off the shelf’ 
FO to relief their foot, low back and lower limb pain caused by the foot malalignment. 
This group of healthy people may not be aware of the possibility of adverse effects of 
these easy to obtain FO. This work on 2 types of “off the shelf’ FO is aimed to shed 
light on the short term effects of those FO and predict the possible long term effects.
Generally, the results show that FOl affected more subjects than F02 for most of the 
investigated parameters with marked differences between FOl and F02 in some 
parameters. The most important difference in the effects between FOl and F02 is the 
increase in knee abduction moment by FOl (2/6 of the participants). This knee 
moment increase stands out for its clinical importance and possible health 
implications. An increase in knee abduction moment may hold potential risk of knee 
injury [Nester et al. 2003]. This is because the knee has limited motion in the medial- 
lateral direction and a moment increase can place stress on its ligaments and 
supporting soft tissue that might lead, in the long term, to damage those tissues or 
knee arthritis. Furthermore, this problem may be aggravated in people with high BMI 
or joint deformities as this may raise the magnitude of the increase in the knee 
abduction moment.
Therefore, according to the results of this study, FOl is not recommended for use 
“off the shelf’, instead its use should be prescribed after a detailed clinical and
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biomechanical examination of the foot to weigh the risks and benefits of using FOl 
and prescribe it accordingly.
It is speculated that the increase in knee abduction moment by FOl is due to two 
reasons: first the material type of FOl (Polymer Gel), which is highly elastic, and 
second its sole thickness. Those two factors can increase its shock absorption capacity 
and hence increase the GRF shears in the direction where the FO can spring back to 
exert a counter force namely the medial-lateral and anterior-posterior shears. This 
increase was evident in the GRFx and GRFy. The increase in those shears rather than 
the vertical GRFz is probably because of their relatively smaller magnitude as 
compared to GRFz
Hence, as the shear forces increase, a corresponding increase in the moments in the 
frontal and transverse planes of the lower limb joints is expected. However, this 
expected moment increase was only seen in the knee abduction but not in the ankle 
abduction which could be because of the high measurement variability of the ankle 
abduction moment that masked the moment increase.
Another important observation in the results was that not all subjects responded in the 
same manor to the same FO under the same test conditions. The results of previously 
published studied are controversial on the effects of FO on gait parameters 
particularly inversion/eversion angle, GRF, and joint moments. This is probably due 
to inter-subject anatomical and functional variations in the foot joints alignment 
making every foot respond differently to the FO. In principal, the outcome of the 
struggle between the extrinsic (GRF) and intrinsic (muscle) forces determines joint 
motion and thereby their motion pattern.
The different inter-subject responses to FO raise the need to classify feet according to 
their structure and function to match them with the appropriate FO design and 
material properties. At the same time as creating subject classification, FO design and 
components should be related to this classification such that a formula can be worked 
out to specify the FO in details for the particular class of feet. The published literature
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on FO does not seem to give enough importance to the FO specifications particularly 
their material mechanical properties.
The proposed subject and FO classification and subject-FO matching may not be easy 
to develop and will require a great deal of research work, however, it will be 
important to optimize the use of FO and avoid adverse effect that may develop with 
FO misuse.
Only FOl reduced eversion. The mechanism by which FO reduce eversion is poorly 
understood. A possible explanation of this mechanism is the elastic property of the FO 
material, which exerts a rebounding force on the calcaneus as it everts to resist its 
lateral motion during LR. This mechanism of elastic materials increasing the reaction 
force is well explained by Whittle (1999).
Gait improvement due to the use of a FO can be assessed if  FO increase the temporal- 
spatial parameters [Mejjad et al. 2004]. Comparing the effects of FOl to those of F02 
within the temporal-spatial parameters, both FOl and F02 caused an increase in 
walking speed, however, there is no evidence of a clear advantage of one FO over the 
other.
The immediate removal of FO had a lower impact on speed than applying the same 
FO indicating a rather quicker ability to Team’ and a slower ability to return to the 
original state after using the FO for 1 week in those subjects.
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9.2 Conclusions
9.2.1 Literature review
The literature reports on the effects of FO on eversion reduction are controversial 
[Stacoff et al. 2000; Ferber et al. 2005]; while some researchers found that FO reduce 
eversion others found that this reduction is unsystematic and subject-specific. 
Excessive eversion has been associated with foot and lower limb injury [Seymour 
2002]. Most runners injuries occur at the knee [MacLean et al. 2006].
Some types of FO are more successful than others in supporting the anatomical 
medial longitudinal arch; a successful FO must effectively stabilize the apical bony 
prominence of this arch [Kogler et al. 1996]. Some FO are more effective than others 
in treating foot disorder and some do not have predictable results [Kogler et al. 1995].
9.2.2 Gait model
Compared to the WMS, the SMS suffered from larger soft tissue artefact (STA) which 
affected angle measurement of the non-sagittal plane. The cause of this artefact is 
believed to be due to the supra-patella marker placed over a region with high skin and 
muscle movement. However, the SMS performed similar to WMS in the sagittal 
plane. Hence, the SMS can be satisfactorily used for measuring sagittal motion. The 
SMS does not require marker alignment which makes it easy to apply, and does not 
use wand which can be knocked by arm swing and walking aids such as frames and 
crutches. This makes it a choice for children and patients where only sagittal motion is 
of interest. For this research, however, measurement of 3D motion was required, and 
healthy adults were taken into the FO investigation; therefore WMS was considered 
the better choice and was selected for all subsequent gait measurements.
In the context of this research, sources of gait data variability are mainly due to 
inherent and methodological factors. The latter include the type of marker set used for 
collecting kinematic data and the repeatability level of the method used for gait 
measurement. High gait data repeatability is an important factor for the detection of  
relatively smaller changes in gait parameters.
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Compared to the published literature, and as measured by the CMC, the adopted 
marker application and alignment method had considerably improved gait data 
repeatability in the non-sagittal planes, while the sagittal plane repeatability was 
similar to that in the published literature.
9.2.3 Effect of FO on gait
Hypothesis (D Incorporation of the medial longitudinal arch in “off the shelf’ FO, will 
not add any additional advantages to gait as these lack a good orthoses fit to the arch 
of subjects.
The results of FOl and F02 investigation showed that both FO had similar effects on: 
walking speed (increased), step length (increased), maximum eversion angle during 
LR (reduced), and CMC of the GRFy over the GC (increased). These results suggest 
that the addition of the medial longitudinal arch to F02 was ineffective and therefore 
hypothesis (i) is supported.
Hypothesis (iil Peak eversion angle during LR will be reduced in both FO conditions 
but this reduction may not apply to all subjects. This hypothesis is based on the belief 
that a heel pad, which both tested FO incorporated, increase the laterally directed 
component of the Ground Reaction Force (GRFy) and inter-subject response 
variability.
Both FOl and F02 similarly reduced maximum eversion angle during LR. This 
reduction was inconsistent across either subject group and was in 2/6 o f the 
participants. This showed that “off the shelf’ FO may not produce the same effect for 
every body, hence, these results support hypothesis (ii).
Hypothesis (iii) Due to the use of FO, a decrease in subtalar eversion angle is 
expected; this will be accompanied with increased ankle and knee abduction internal 
moments. However, if there was an increase in subtalar eversion, this would be 
accompanied by decreased ankle and knee abduction moments.
The general trend of GRF and moment changes over the GC was similar to that during 
LR, and the changes in moments were seen at the knee joint but not at the ankle and
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subtalar joints. Only FOl can cause an increase in knee abduction moment in some 
participants (2/6), but showed no effect on ankle abduction moment, therefore, 
hypothesis (iii) can only be supported for knee abduction moment in FOl condition.
Important findings. Although the increase in the knee abduction moment was detected 
in a low propotion (2/6 in FOl) of the participants, it is of concern, as an increase can 
pose a potential health risk to the knee and surrounding structures. This concern is for 
two reasons: (1) the knee is the site where most lower limb injuries occur [MacLean et 
al. 2006], (2) the type of participants taken into this prospective study were normal 
healthy subjects with normal BMI and with no joint knee and foot joint alignment 
problems. If the users of such FO had lower limb joint alignment problems and/or 
higher BMI, it is likely that the knee abduction moment increase will be higher and 
the number of affected participants may be higher than found in this prospective 
study.
The different responses by different subjects to the same FO under the same test 
conditions (in some parameters opposite responses were seen) indicate an inter­
subject variability that warrants further research to appropriate the FO-subject 
matching.
Considering the small number of participants taken into this FO investigation (6 per 
FO) and the potential risk of knee injury, further work is necessary to investigate”off 
the shelf’ FO with larger groups and subjects with certain foot alignment problems to 
further investigate the knee abduction moment changes in subjects with a spectrum of 
physical conditions, for example, high BMI and subtalar eversion deformity.
The CMC and ABSD variability over the GC indicate motion pattern changes 
occurring within the GC sub-phases. These changes warrant further assessment of the 
effect of FO within those sub-phases, particularly during the LR and push-off periods 
where the GRF reaches its peaks. The changes within these sub-phases can be 
investigated in the time domain as this will be important to see how the timing of 
major events can affect, for example, the coupling of eversion with tibial rotation and 
the effects on the knee and more proximal joints.
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9.3 Limitations of this research
• The number of participants taken into this prospective study is limited (6 
subjects per FO), thus, inferential statistics will have little power and 
descriptive statistics was used instead. Therefore, investigation of the found 
biomechanical changes with a larger number of subjects is needed.
• The model used to calculate the 3D foot motion uses only two markers placed 
on the shoe and one on the ankle. The determination of subtalar motion will be 
limited or inaccurate by this model. Recently, multi-segmented foot models 
that divide the foot into three or more segments [Leardini et al. 1999; Carson 
et al. 2001; Leardini et al. 2006] have been developed, thus enabling an insight 
into intra-foot segment motion. However, because the FO testing had to be 
done shod, it was not possible to use such models. A hybrid model, with more 
than two foot markers, is currently under development at the University of 
Surrey this model aims to improve the accuracy of 3D foot motion 
determination and to provide better foot motion measurement in the frontal 
plane. The model might have tracking markers placed directly or indirectly on 
the foot through shoes cutaways.
• Joint kinematics were determined from markers attached directly on the skin 
and on wands, these are subject to skin artefacts. Skin artefact is subject- 
specific [Leardini et al. 2005] and the calculated angles from skin markers do 
not always reflect well the underlying bone motion jReinschmidt et al. 1997], 
hence, some of the computed natural variability of joint angle (which was used 
to determine FO effects) may be due skin artefacts. An ideal solution to this 
problem will be the use of markers mounted on pin inserted into bone; 
however, this procedure is invasive and not practical for routine use.
• The difference in the sampling rate used to capture data in the repeatability 
study (200Hz) and that in the FO study (100Hz) is acknowledged. A 100Hz 
sampling rate might not be high enough to capture all GRF transients as some 
of these are around 75Hz; hence, some transients might have been missed out. 
Subsequently, this could have influenced the calculated GRF and moment, but
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it should not affect the temporal-spatial and joint angle calculations as these, 
for normal walking have frequency content within 10 Hz (95%).
• It is accepted that in retrospect further analysis of the number of trial used for 
to determine parameter means would have been appropriate.
• It is possible that the FO could have caused small changes in gait parameters 
that fell within the parameter natural measurement variability and therefore 
could not be detected.
• The use of shoes to evaluate the effect of FO presents a limitation as the 
effects of the shoe and FO can not be separated, however, the shoe only 
condition was used as a reference base (session A l) to which all subsequent 
data were compared.
• The material mechanical properties and dimensions differences between FOl 
and F02 limit the comparison of these FO.
• Motion between the foot and the shoes is not accounted for.
9.4 Further work
1. Further investigation of the biomechanical effects of these FO with larger number 
of subjects is needed. Special attention should be given to knee abduction moment, 
joint reaction force, and motion. The investigation needs to be carried out with larger 
number of subjects with the same subject selection criteria as in the current research. 
Also the proposed investigation needs to be carried on subjects with selected foot 
deformities. As mentioned in the limitations, a larger subject group will enable 
inferential statistical analysis to extrapolate the findings to the general population.
2. Investigate other biomechanical effects of these FO particularly the centre of 
pressure path behaviour and the joint reaction forces (JRF). Centre of pressure path 
data can be obtained from force plates. JRF can be computed from the kinetic data.
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3. To investigate the biomechanical changes within the sub-phases of the GC 
particularly during the LR and push-off periods where the GRF reaches its peaks. 
Changes within these sub-phases can be investigated in the time domain as this will 
be important to see how the timing of major events can affect, for example, the 
coupling of eversion with tibial rotation and the effects on the knee and more 
proximal joints.
4. Investigation of the FO effects on running and on different terrains at different 
speeds to cover the effects of FO in a greater range of physical activity and terrains 
(terrains may be reproduced in the laboratory).
5. To establish the periods of washout that are necessary to clear the changes in gait 
parameter due to wearing the FO and to establish time by which most changes has 
occurred with FO.
6. Investigate the effect of FO sole thickness and perhaps with different material 
properties to understand the relationship between subtalar motion pattern and material 
type and thickness.
7. Because different people have different ankle and subtalar axes orientations; this 
may be a factor that can help explain why some people are more responsive to FO 
than others. Therefore, investigation of the axes orientation with the FO to match feet 
with FO would be appropriate.
8. The marker set model (WMS) used only two markers on the foot segment. The 
determination of subtalar motion will be limited by this model. It may be useful to 
perform the analysis using a hybrid model that has more than two markers to track the 
foot. Recently, there are multi-segmented foot models that divide the foot into three or 
more segments which allow computing motion between foot segments. Such models 
might be useful if cuts in the shoes to place markers on the foot prove to be 
repeatable. Hence, if this method is viable, this can improve foot motion measurement 
and overcome the limitations of the shoe.
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9. The effect of the number of data points per GC may require further analysis to 
determine the appropriate number.
10. Investigate the effects of FO on muscle activity (EMG).
11. Investigate the effects of FO on pressure distribution.
12. Investigate the kinematic and kinetic changes in the time domain.
9.5 Recommendation
A subject-FO matching guidelines need to be established. This may be achieved by 
determining an experimentally proven neuro-musculo-skeletal classification of 
subjects and a classification of FO that can detail the specifications of FO in terms of 
material type, FO design, and dimensions of the components it incorporates. If this 
can be accomplished then it will be possible to match subjects with the appropriate 
FO. This will be cost-effective and minimise possible adverse effects. The proposed 
guidelines should act as a FO prescription criteria.
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Appendix A.1 the Skin marker Set (SMS) and Wand Marker Set (WMS) definitions 
A- Markers location and alignment
RASIS
U
Supra patella
Lateral knee 
Tibial tefoerosity
Lateral malleolus 
Heel
2nd & 3rd NTT Heads -
Sacrum
.ASIS
Supra patella
•  •(7 s P—  Lateral knee
P Tibial tuberosity
Lateral malleolus 
Heel
2nd & 3rd MT Heads
Sacmm
WMS
-LASIS
Mid thi^i wand 
Lateral knee
Mid shank wand
Lateral malleolus 
Heel
2nd & 3rd MT Heads
Mid thigh wand 
Lateral knee 
Mid shank wand
Lateral malleolus 
Heel
2nd & 3rd MT Heads
The SMS (left) and WMS (right)- Markers location. Adapted from [Qualisys Medical AB]
Markers are applied and aligned were performed with the subject standing, feet parallel 
pointing straight forward and adjacent to each other. Application; ASIS (right/left): At the 
anterior superior iliac spine. Sacrum: 10 mm below the mid-point of the posterior superior iliac 
spines. Supra patella: 10 mm proximal to the superior border of the patella when the knee is 
extended and halfway of the patellar width. Lateral knee: Lateral on the knee joint line, 
halfway of the lateral aspect of the knee excluding the patella thickness. Tibial tuberosity: At 
the tibial tuberosity. Lateral malleolous: At the lateral malleolous. Toe: At the foot between the 
2nd and 3rd metatarsals and 10-15 mm proximal to the 2nd and 3rd metatarsal heads. Heel: At the 
heel, posterior of calcaneus, and at the toe marker level. Alignment; Mid thigh wand: Middle of 
the thigh mounted on a 100mm wand is aligned with the lateral knee and greater trochanter. 
Mid shank wand: Middle of the shank mounted on a 50mm wand is aligned with the lateral 
knee and lateral malleolous markers.
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B- Segment local coordinate system definition
Joint centre definition, briefly; SMS, Hip centre is defined from the ASIS marker, knee centre 
is from the lateral knee marker using a formula that defines the joint centre position relative to 
the plane of (oiee-tibial tuberosity-malleolous markers, ankle centre from the lateral 
malleplous marker using a formula that defines the joint centre position relative to the plane of 
knee-tibial tuberosity-malleolous markers.
For the WMS, hip centre same as SMS, knee from the lateral knee marker at half the knee 
width in the tibial tuberosity-malleolous-lateral knee markers plane, ankle cenjrp is defined 
from the malleolous marker at half the ankle width in the tibial tuberosity-mallpolous-lateral 
knee markers plane.
Axis definition followed the right hand rule, the X axis pointing forward the Y axis pointing to 
the left and the Z axis pointing upwards. Two axes are defined and the third axis is orthogonal 
to them.
For the SMS the pelvis origin is at the midpoint of right & left ASIS, X axis is sacrum to origin, 
Y axis is through the origin in the ASIS and sacrum plane pointing to the Jejj:. Thigh: X axis is 
orthogonal to Z, in plane (knee, hip, supra patella) and Z axis is Knee to hip joint centre. Shank: 
X axis is orthogonal to Z in plane (knee, ankle, tibial tuberosity) and Z axis is ankle to knee 
joint centres. Foot: X axis is heel to 2nd-3rd metatarsal heads and Z axis is orthogonal to X, in 
plane (heel, ankle, 2nd-3rd metatarsal heads).
For the WMS: Thigh: Z axis is knee to hip centre, Y orthogonal to Z in plane (knee, hip and 
mid thigh wand) and X axis is defined as orthogonal to Y, Z. Shank: Z axis is knee to ankle 
centre, Y orthogonal to Z in plane (knee, ankle and mid shank wand) and X axis is defined as 
orthogonal to Y, Z. Pelvis and Foot: same as SMS.
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Appendix B .l Anthropometry o f the selected subjects (S = Subject)
Mass
(kg)
Height
(mm)
BMI LLD
(mm)
Age
(Y)
Gender Dominant
side
SI 67.5 1780 21.3 10 42 M Rt
S2 58 1770 18.5 10 27 M Rt
S3 72.5 1720 24.5 10 28 M Rt
S4 86 1860 24.9 10 27 M Rt
S5 60 1650 22.0 5 28 M Rt
S6 79 1810 24.1 5 24 M Rt
MEAN
(Range)
70.5
(58-86)
1765
(1650-1860)
22.55
(18.5-24.9)
8.3
(5-10)
29.3
(24-42)
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Appendix B.2 Physical Examination and Anthropometry Chart
SUBJECT ID: Date: Dominant side: Gender:
Age: Height: Weight: BMI:
MEDICAL CONDI1CIONS OR INJURIES AFFECTING GAIT
1. Neurological:
2. Musculoskeletal:
3. Other conditions:
JOINT-MUSCLES WEAKNESS
RT LT
Hip: Hip:
Knee: Knee:
Ankle: Ankle:
Foot: Foot:
3D JOINT ROM RESTRICTION
RT LT
Hip: Hip:
Knee: Knee:
Ankle: Ankle:
Foot: Foot:
BONE AND JOINT DEFORMITY
RT LT
Hip: Hip:
Knee: Knee:
Ankle: Ankle:
Foot: Foot:
MUSCULOSKELETAL PAIN
RT LT
Hip: Hip:
Knee: Knee:
Ankle: Ankle:
Foot: Foot:
FOOT SENSATION TO LIGHT TOUCH
B.2
Appendices B
RT /  LT nlntact RT /  LT nlmpaired
3D KNEE LIGAMENT CONDITION
RT □POSITIVE □NEGATIVE LTnPOSITIVE ^NEGATIVE
KNEE REFLEX
RT/LT nNormal RT /  LT □Abnormal
BALANCE (ROMBERG TEST)
RT/LT nNormal RT /  LT □Abnormal
TISSUE
FIRMNESS
□ Soft □Average □ Firm
MUSCLE
TONE
□Normal RT /  LT □Hyper R T /L T □Hypo R T /L T
GAIT DEVIATION (OBSERVATIONAL)
BARE FOOT:
SHOD:
NOTES:
Type of Shoes:
Anthropometry for Visual 3D  Software
Subject ID: Date:
Body mass (kg)
Height (mm)
ASIS breadth (mm)
R Leg length (mm) L Leg length (mm)
R knee width (mm) L Knee width (mm)
R Ankle width (mm) L Ankle width (mm)
R Foot height (mm) L Foot height (mm)
R Foot width (mm) L Foot width (mm)
Shoe heel height (mm)
R Navic. ht (mm) R Foot length (mm) ratio:
L Navic. ht (mm) L Foot length (mm) ratio:
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Appendix B.3 Sensitivity analysis 
B. 3.1 Aim and method
In order to asses the effect of marker misplacement on joint angles; a sensitivity 
analysis was performed using one standing trial. Assessment was performed for all 
WMS markers. The effect of each marker was assessed separately.
Markers were displaced by 10mm along any of the axis o f the laboratory coordinate 
system that marker misplacement might occur. This was done in both the positive and 
negative directions o f the determined axis. For example the ASIS marker was 
determined to have a possible misplacement error in the Y and Z directions and it is 
not possible to have misplacement error in the X direction (X axis is anatomically in 
the anterior- posterior direction).
The sensitivity study aims at giving a sense o f the magnitude of error in the computed 
joint angles due to likely marker reapplication errors. To estimate the likely alignment 
errors of the wand markers a special test was performed using two skin markers and 
one wand maker. These were set up to simulate the thigh and shank wand markers 
alignment. The skin markers were placed on a standing board and aligned vertically 
using a plum line (Figure 1).
The wand marker was then placed between the tow markers and aligned with the two 
skin markers using a ruler by the same person who performed WMS marker 
application and alignment. Then the plum line was dropped again between the two skin 
markers and its distance to the centre of the wand marker was measured.
Figure 1 Thigh and shank marker alignment test
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The waveforms of the displaced markers were compared to the original waveform to 
calculate the angles differences due to the marker disposition for all angles parameters.
Comparisons were made at the corresponding data points on the angle waveforms. The 
differences were calculated in both the negative and positive axis then averaged to 
produce a mean difference.
Assessment of the effect of marker misplacement during walking was performed on 
the thigh and lateral knee markers separately on a walking trial.
B.3.2 Results
10mm marker displacement resulted in a constant shift of the waveforms along the Y 
axis. This was the case for all markers in the standing trial.
The maximum shift was 5.2 degrees, which occurred in the knee rotation when the 
shank marker was moved in the X direction (Table 1). The least shift was seen in the 
malleolous and lateral knee markers displacement in the Z direction which it had very 
small effect on any joint angle parameters (range 0-0.6 degrees).
Table 1 The average change (degrees) in angle parameters when the marker was displaced by 
10mm along the indicated direction in both the positive and negative directions.
Marker Pelvic
tilt
Pelvic
obliq
Pelvic
rot
Hip
flex
Hip
abd
Hip
rot
Knee
flex
Knee
abd
Knee
rot
Ankle
dorsi
Ankle
abd
Ankle
inv
Sacrum Y 0 0 1.5 0.4 0.4 2.0 0.1 0.5 0.3 0 0.2 0
Sacrum Z 2.7 0.1 0 3.2 0 0.9 0.3 0 0.8 0 0.4 0.2
ASIS Y 0 0 0.8 0.2 0.5 1.0 0 0.5 0 0 0 0
ASIS Z 1.5 2.6 0.1 1.6 3.4 0.7 0.2 0.8 0.4 0 0.2 0.1
Thigh X 0 0 0 0.6 0.1 4.3 1.5 0.4 3.0 0.3 1.5 0.5
Lat.knee X 0 0 0 1.7 0 1.9 3.1 0.7 2.0 0.9 4.1 1.2
Lat.knee Z 0 0 0 0.1 0.1 0.1 0.3 0.1 0.4 0.2 0.6 0.3
Shank X 0 0 0 0 0 0 0.5 0 5.2 0.9 4.9 1.8
Malleolus X 0 0 0 0 0 0 1.5 0.2 1.8 3.3 1.1 0.7
Malleolus Z 0 0 0 0 0 0 0.3 0 0.3 3.0 0.4 0.2
ToeX 0 0 0 0 0 0 0 0 0 1.7 0.4 0.1
ToeY 0 0 0 0 0 0 0 0 0 0.2 3.6 1.9
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Joint angles were most sensitive to the thigh, shank and lateral knee markers in the X 
direction. Marker shift in this direction caused rotation of the frontal planes of the 
segments which those markers lei in. Subsequently rotating and shifting the joints axis 
at the ends of these segments. The lateral knee marker shift in the X direction causes a 
shift in the knee axis whereas a shift o f the thigh marker leads to rotation o f the knee 
and hip axis in the transverse plane, a shift in the shank marker leads to rotation of the 
knee and ankle axis in the transverse plane.
The lateral knee marker is a central marker in the WMS set up; it is used for the 
determination of knee joint axis and the alignment of the thigh and shank segments. Its 
shift in the X direction affected knee flexion and ankle abduction most (3.1 and 4.1 
degrees respectively), however it had much less effect on ankle dorsiflexion (0.9 
degrees), however, its shift in the Z direction had very little effect on any joint 
parameter (0.6 degrees max).
The results showed that distal markers do not have effects on more proximal joint 
angles, however, proximal markers have effects on more distal joints angles, although 
generally small but still present.
The special test showed, in tow tests, an alignment error of 3 mm and 4mm on the 
same side of the wand. This makes the alignment variability 1mm; this value will be 
used in further analysis.
B. 3.3 Discussion
Accurate and precise marker application and alignment have been found to be crucial 
for data reproducibility [Kadaba et al. 1989; Growney et al. 1997]. Marker positions 
are used in the calculation of joint centres, for example the ASIS marker is used to 
locate the hip joint centre. Errors in marker location can lead to an offset in the joint 
centre location which in turn can over or under estimates joint motions due to joint 
crosstalk.
The results demonstrated varying sensitivity to different markers and to the direction of 
marker disposition. The relatively large effect of the lateral knee, thigh and shank 
markers on segment transverse plane rotations may be partly explained geometrically;
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10mm marker displacement produces greater angle on a short radius than that on a 
longer radius.
This is seen by comparing the effects of the thigh and shank markers shifts on knee 
rotations (3.0 and 5.2 degrees respectively); the thigh marker is much farther from the 
thigh Z rotation axes than the shank marker from the shank Z rotation axes.
This phenomenon is also seen in the hip where a shift in the ASIS marker in the Z 
direction (relatively short radius) had a large effects on hip abduction (3.4 degrees) and 
the effect of lateral knee marker in the X direction on ankle dorsiflexion (longer radius) 
only produced 0.9 degrees change.
The concept of the effect of the distance of the marker from the joint centre of rotation 
was observed in the results. A solution to reduce sensitivity is to increase this 
distance, however this should not be overdone for reasons of practicality o f marker 
application, alignment and walking while wearing extra long wands. In addition too 
long wands may introduce high marker vibration problems, however a balance 
between wand length and vibration can be found to improve marker performance.
In connection with this issue, body anthropometry is expected to have an influence on 
marker sensitivity; for subjects with larger physical dimensions, sensitivity is 
anticipated to be lower. This makes marker application and alignment for children a 
more sensitive matter, therefore more accuracy and precision will be required for 
subjects with relatively smaller bodies.
The non-sagittal higher sensitivity to the thigh and shank wand markers misplacement 
may partly explain the higher between days CMC variability seen in these planes in 
the literature [Kadaba et al. 1989; Growney et al. 1997].
A study by [Kadaba M P et al. 1990] showed that a change in the orientation of joint 
axis (defined from surface markers) lead to a nonuniform shift in the joint angles 
waveforms.
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The waveform offsets were constant during the standing trial; however, for the 
walking trial these differences were constant near the joint neutral position and varied 
as the joint moves away from neutral which is consistent with [Kadaba et al. 1989] 
findings.
Geometrically the further the joint from neutral the less the effect of marker offset on 
the resulting joint angle which may partly explain this variability. Figure 2 illustrates 
the effect of lateral knee joint marker on the hip flexion angle when it was displaced 
posteriorly in the X direction. This indicates a non-linearity in the change in joint 
angle.
Figure 2 The angles produced in the hip joint by the same marker displacement. In this triangle 
DE=EF=FG, however angle a > b > c (this figure is to demonstrate the non-linearity of marker 
displacement error).
hip joint centre
-4 knee joint centre
This was also demonstrated by the waveform offset of the lateral knee marker (X 
direction) during walking (
Figure 1). However this may not be always the case as other factors like subject 
variability and multiple markers offset come into play.
Figure 1 Effect of Lateral knee marker 10mm shift in the X direction on a walking trial; Blue line 
after the shift.
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knee flex
0.0
0.0
Time
The largest change in ankle inversion was 1.9 degrees which occurred when the toe 
marker was displaced in the Y direction. It was also changed by 1.8 degrees when the 
lateral shank marker was shifted in the X direction. Inversion/eversion is of a 
particular interest in this research due to the close association of excessive eversion 
with foot and lower limb injuries [Seymour 2002]. A method will be designed to 
ensure high repeatability of the toe marker; this will be explained further on in the 
thesis.
B.3.4 Conclusion
The magnitude of joint angle sensitivity is marker-specific and direction-dependant in 
marker misplacement. 10mm marker displacement resulted in within 6 degrees ABSD 
in joint angles. The likely error for marker misplacement, demonstrated by the special 
test, was 1mm. Hence the expected errors in joint angles due to 1mm marker 
misalignment are ~0.5 degrees (assuming linearity).
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Appendix C 1. Ethical approval document / Ethics Committee/ University of Surrey
21 December 2005
Mr Issam Flaieh 
School of Engineering
Dear Mr Flaieh
The effects o l “off the shelf” foot orthoses finnersoles) on gait (EC/2005/130/Enol
On behalf of the Ethics Committee, I am pleased to confirm a favourable ethical opinion for 
the above research on the basis described in the submitted protocol and supporting 
documentation,
Date of confirmation of ethical opinion: 21 December 2005
The list of documents reviewed and approved by the Committee is as follows:-
Document Type: Application 
Dated: 11/11/05 
Received: 15/11/05
Document Type: Risk Assessment Form 
Dated: 05/11/05 
Received: 15/11/05
Document Type: Advert 
Dated: 05/11/05 
Received: 15/11/05
Document Type: Consent Form 
Dated; 05/11/05 
Received: 15/11/05
Document Type: Project Application Form 
Dated: 05/11/05 
Received: 15/11/05
Document Type: Project Summary 
Dated; 05/11/05 
Received: 15/11/05
Document Type: Self Assessment Questionnaire 
Dated: 05/11/05 
Received: 15/11/05
Ethics Committee
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Document Type: Questionnaire 
Dated: 05/11/05 
Received: 15/11/05
Document Type: Project Protocol 
Dated: 05/11/05 
Received: 15/11/05
Document Type: Physical Examination Chart 
Dated: D5/11/05 
Received: 15/11/05
Document Type: Insurance Proforma 
Dated: 05/11/05 
Received: 15/11/05
Document Type: Volunteer Information Sheet 
Dated: 05/11/05 
Received: 15/11/05
Document Type: Your Response to the Committee’s Comments 
Dated: 09/12/05 
Received: 12/12/05
Document Type; Amended Information Sheet and Consent Form 
Dated: 09/12/05 
Received: 12/12/05
This opinion is given on the understanding that you will comply with the University's Ethical 
Guidelines for Teaching and Research.
The Committee should be notified of any amendments to the protocol, any adverse 
reactions suffered by research participants, and if the study is terminated earlier than 
expected, with reasons.
You are asked to note that a further submission to the Ethics Committee will be required in 
the event that the study is not completed within five years of the above date.
Piease inform me when the research has been completed.
Yours sincerely
Catherine Ashbee (Mrs)
Secretary, University Ethics Committee 
Registry
cc: Professor T Desombre, Chairman, Ethics Committee 
Dr D Ewins, Supervisor, School of Engineering
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Appendix C 2. Project protocol 
University of Surrey
Please Contact: Mr Issam Flaieh, Rm 7DK 03, Centre for Biomedical Engineering 
School of Engineering
Tel 01483 684573; e-mail i.flaieh@surrev.ac.uk
THE EFFECTS OF “OFF THE SHELF” INNERSOLES ON GAIT 
PROJECT PROTOCOL 
1. Background
“Off the shelf’ innersoles are currently available, e.g. from sports shops and chemists, 
without the need for a medical prescription. These orthoses have different designs, 
however, there is very limited information on the effect of these innersoles on the 
body. This may lead to inappropriate use/self prescription.
2. Hypothesis and aim of the project
It is hypothesized that:
(i) Innersoles introduce biomechanical changes in gait that will be seen in temporal- 
spatial, joint angle, moment and power data.
(ii) These changes will tend to increase in magnitude as more components are 
incorporated into the innersoles.
(iii) These changes are expected to be within 10%.
The aim of this study is to investigate those changes and conduct statistical tests to 
identify significant changes.
3. Ethical considerations
(i) An information sheet explaining the trial procedure will be provided and a written 
consent form will be signed.
(ii) Volunteers will be students and staff from the University of Surrey. They will be 
asked to participate on the understanding that; a- The procedure is explained and is 
entirely voluntary, b- The participants have the right to decline to participate or, 
having accepted, to withdraw at any time
(iii) Pain and discomfort: If at any time during the gait trials pain develops, then 
wearing should be stopped immediately.
UniS
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4. Selection of Volunteers
Volunteers will be sought from students and staff of the University by posting an 
advertisement for volunteers on appropriate campus notice boards. A sample advert is 
included in this submission. The advert will direct enquirers to the investigator for:
•  Information Sheet, which will describe what will be expected of participants
• Application Form and Self Assessment Questionnaire
• Consent Form
Samples of each are included in this submission. Potential participants will be asked 
to arrange an appointment for an introductory session at the Gait Laboratory, where 
they will hand in their forms and take the screening test. There they will be given a 
demonstration of what they will be expected to do, and their questions will be 
answered.
If the tests are over-subscribed, priority will be given to participants who meet the 
selection criteria on a first come first served basis. The following selection criteria 
will be applied, these are designed to reduce gait variability in the collected data;
(i) The subject is in good health and satisfies the physical examination chart
(ii) Leg length discrepancy of no more than 15mm
(iii) Subjects are between 20-30 years old
(iv) Be males
(v) An advert will made containing the general selection conditions of:
a) A male
b) Age range 20-30 years
c) All subjects have the right side as their dominant for both leg and hand
d) Height between 1700-1800mm
5. Shoe type
(i) The subject’s normal shoes will be used for the experiments
(ii) There is no play between the foot and the shoes yet maintaining foot comfort. This 
applies to with and without the innersoles.
(iii) It is acceptable to use different types of shoes to accommodate the two types of 
innersoles
(iv) The sole of the shoes should be flat
(v) The shoe must not overlap the malleoli
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6. Gait data collection
(i) Two types of innersoles SI and S2 (fig.l) will be tested.
(ii) Twelve subjects will participate in the study. These will be divided randomly into 
two equal groups. One group will be tested with S 1 and the other group will be tested 
with S2.
Figure 1; SI S2
SI: is made of polymer gel and incorporates a heel pad and a simple flat insole, 
supplied by Boots Group P ic (Nottingham, UK)
S2: is made of composite flexible material and incorporating a gel heel pad, insole, 
arch support and metatarsal pad, supplied by A A lgeo L td  (Liverpool, UK)
(iii) Data collection sessions will be one week apart
(iv) Each innersole test will be conducted over five weeks as shown in the following
table: NS = no innersoles, WS = with innersoles
Week 1 Week 2 Week 3 Week 4 Week 5
Day 1
Subjects 1,2&3 
FOl
Screening & 
anthropometry
A l-D ataN S 
A2- DataWS
B l-D ataW S 
B2- DataNS
C- DataNS D- DataNS
Day 2
Subjects 4,5&6 
FOl
Screening & 
anthropometry
A l-D ataN S 
A2- DataWS
B l-D ataW S 
B2- Data NS
C- DataNS D- DataNS
Day 3
Subjects 7,8&9 
F02
Screening & 
anthropometry
A l-D ataN S 
A2- DataWS
B l-D ataW S 
B2- DataNS
C- DataNS D- DataNS
Day 4
Subjects 
10,11&12 F02
Screening & 
anthropometry
A l-D ataN S 
A2- Data WS
B l-D ataW S 
B2- Data NS
C- DataNS D- DataNS
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Week 1: This will be an introductoiy session prior to the data collection sessions. 
This session will be used to screen the participants for normal BMI, history of injury, 
measurement of the arch height and joint range of motion (ROM), appropriate shoe 
type and physical examination. The experimental procedure will be explained to the 
volunteers and their questions answered.
Week 2: SI and S2 will be tested using the same procedure. Two trial conditions 
(without and with innersoles) will be conducted in the same session. The gait trials 
will be video taped and photographs of the marker setup will be taken.
First trial. Using hypo allergic double-sided tape, fifteen retro-reflective markers will 
be placed on specific anatomical landmarks on the pelvis and lower limbs (figure 2). 
Data will be collected with the subject shod and without the innersoles, then data will 
be collected immediately after fitting the innersoles.
The subject will walk at self-selected speed along the gait laboratory until he feels 
accustomed to walking with the markers on.
One set of data will be collected while the subject is standing on one of the force 
platforms (FP).
A number of walking trials will be performed to determine the position of the starting 
point so that the subject hits the force platforms “cleanly” and with minimal targeting.
Data from 5 right and 5 left “clean” foot contacts on one FP will be collected. All 
walking trials will be collected in the same direction along the gait laboratory.
Second trial: Innersoles will be inserted bilaterally inside the volunteer’s shoes and 
data will be collected using the same method as in the first trial. The subject will be 
asked to keep wearing the innersoles until week 3.
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Figure 2. Subject set up for the walking trials
Week 3: In this session in the fir s t tria l data will be collected with innersoles and the 
second tria l without innersoles using the same procedure as in week 2. After this 
session the innersoles will not be worn any longer.
Week 4: One session without innersoles data will be collected in the same procedure. 
Week 5: An exact repeat of week 4.
The two week period between week 3 and week 5 are considered to be a washout 
period.
No data will be collected if the subject is feeling tired or unwell.
7. Questionnaire
A questionnaire will be given to each participant at the end o f week 2. It aims to 
measure the subject’s perception o f comfort and performance when using the 
innersoles.
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8. Statistical analysis and study evaluation
Study evaluation will be by analysis of the gait data and the questionnaire. The 
differences in gait parameters will be calculated within each subject and averaged 
across the group.
The statistical results together with those from the questionnaire will be used to 
quantify the effects of the innersoles on gait and to provide preliminary prescription 
guidelines.
9. Details of the collected data
(i) Kinematics and kinetic data will be collected.
(ii) The collected data will be sampled at 200Hz.
(iii) The walking range will be 10m.
(iv) The start point for the foot hitting the force plate will be determined per subject 
per foot.
(v) Anthropometric measurements will be taken to be used by the analysis software 
(Visual 3D).
(vi) Setting up the subject for the trials will be in the following order: 
a- Change into Lycra shorts.
b- Application of retroreflective markers.
(vii) The volunteers will walk at their normal self-selected speed.
(viii) Trial area: The trials will be for level walking (Gait laboratory).
(ix) Data backup: Data will be backed up to an external hard drive kept in a locked 
cupboard.
10. Project duration and timing
The project will be conducted during the period from December 2005 until September 
2006.
11. Investigators and clinical competence
Both investigators are familiar with the clinical examination and gait measurement of 
patients. The primary investigator is a Consultant Clinical Scientist and has been, for a 
number of years, carrying out gait clinical sessions on patients at Queen Mary’s 
Hospital. The second investigator is a Prosthetist / Orthotist who has been fitting 
patients with artificial limbs and braces for 15 years.
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Appendix C 3. Volunteer information sheet 
University of Surrey
Please Contact: Mr Issam Flaieh, Rm 7DK 03, Centre for Biomedical Engineering 
School of Engineering
Tel 01483 684573; e-mail i.flaieh@surrev.ac.uk
UniS
THE EFFECTS OF “OFF THE SHELF” INNERSOLES ON GAIT
VOLUNTEERS IN FO RM A TIO N  SH EET
You are invited to take part in a research study on non-prescription innersoles 
conducted by the University o f Surrey. Please take a moment to read this information 
sheet and if there is anything that is not clear or if you would like more information 
please do not hesitate to contact us on the above address.
What are “off the shelf’ innersoles?
Innersoles (fig.l) are basically shoes insoles that can be made from different materials 
and come in different shapes and thicknesses. Called “Off the shelf’ because they can 
be bought from retailer stores, e.g. sports shops and chemists, without the need for a 
medical prescription. These innersoles range from simple flat shape to a complex 
shape which conforms to the foot. These innersoles are aimed to support the foot 
structures to give extra comfort to the feet and lower limbs.
i
Figure 1: Examples of “off the shelf’ Innersoles
C.9
Appendices C
Why investigate those innersoles?
People’s feet and lower limbs respond differently to innersoles, this can range from 
excellent comfort to extreme discomfort.
Limited information is available on the benefits of “off the shelf’ innersoles; This 
project aims to:
• Measure the changes in the walking pattern produced by these innersoles.
•  Analyze these changes to reach a conclusion as to their possible effects on 
the lower limbs and body.
The results from this study will contribute to the decision making process for 
specifying the type o f innersoles that may be dispensed without the need for a medical 
prescription. It should also help clinicians in the prescription of innersoles.
Who will carry out these tests?
The gait trials will be carried out by a PhD student, Mr Issam Flaieh, with a clinical 
background in Prosthetics and Orthotics, Mr Flaieh will be supervised by Dr David 
Ewins, Senior Lecturer at the University and a Consultant Clinical Scientist at Queen 
Mary’s Hospital, London.
Who is a candidate for these tests?
Screening will be conducted to ensure the suitability of the volunteers for the 
experiment. The selection criteria are:
(i) Good health and satisfying the physical examination chart (carried out at the 
screening session; see testing procedure)
(ii) Age between 20-30 years old
(iii) Males
(iv) The right is the dominant side for both hand and leg
(v) Height between 1700-1800mm
(vi) Body mass index between 18.5-24.9, calculated = Weight (kg)/ (height in 
metres)2.
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Do I have to take part?
Taking part is entirely voluntary. It is up to you to decide whether or not to take part. 
If you do decide to take part you will be given this information sheet to keep and be 
asked to sign a consent form. If you decide to take part you are still free to withdraw 
at any time and without giving a reason.
What is the testing procedure?
The total duration of the tests will be 5 weeks; however the period of wearing the 
innersoles will be only one week, during this week you are expected to be wearing the 
innersoles in your shoes as you perform your normal daily activities. The tests will be 
timed and designed as shown in table 1.
Table 1. NS = no innersoles, WS = with innersoles
Week 1 Week 2 Week 3 Week 4 Week 5
Screening & 
anthropometry
A l- Data NS 
A2- DataWS
Bl-DataW S  
B2- Data NS
C- DataNS D- Data NS
The first week will be designated for screening and physical measurements. The tests 
will be body height, weight and assessment of lower limb mobility and measurement 
of joint width and leg length. Once these tests and measurements have been 
completed we will be able to confirm your eligibility for the main data collection.
The second week will be for collecting data with and without the innersoles. This will 
be performed in the following way: you will wear Lycra shorts and your usual shoes. 
Markers (19mm0 retroreflective spheres) will be attached to your skin by double­
sided tape as in figure 2. Once accustomed you will perform 10 walks inside the Gait 
Laboratory, during which data will be collected. Then a pair of innersoles will be 
placed inside your shoes and data will be collected from another 10 walks. The 
innersoles will remain in the shoes and you will be asked to keep wearing the shoes 
with the innersoles until the third week, at this time data will be collected with, then 
without the innersoles. Then you will be asked to complete a questionnaire for your 
feedback on the innersoles.
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In the 4th and 5th weeks one further set of data will be collected (without the 
innersoles) each week.
Figure 2 Retroreflective markers attachment 
Are there any risks to me from these tests?
There are no risks that we are aware of. However, if  at any stage you have concerns or 
if pain or discomfort develops, wearing the innersoles must be stopped and the 
researchers contacted.
Will my personal information and photographs be kept confidential?
The application, consent form, video footage, photographs, anthropometric and 
experimental data (kinetics and kinematics) will be stored on a disc and kept in a 
locked cabinet. Participants will be referenced by a code that will be written on the 
relevant application form, and this will be the only means of identifying the personal 
and experimental data with the participants. This code will be kept in separate locked 
cabinet. Unless prior permission is given (see below), only the anthropometric and 
experimental data will be used in any published material. For this anonymity will be 
preserved.
With your consent, photographs or video records may be used for teaching or research 
purposes. There is a section on the consent form for you to give your permission or 
not for this.
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What will happen to the results of the research study?
The results of the work may be taken for a PhD thesis, journal publications and 
publicity material.
Will I receive any reimbursement for my time?
On completion of the study you will receive payment of £50. If you have to withdraw 
from the study through problems directly associated with your involvement, e.g. if 
you find the inner-soles uncomfortable to wear, then a pro-rata payment will be made. 
We will not be able to make a pro-rate payment if you need to withdraw for other 
reasons, e.g. difficulties with finding the time to attend the measurement sessions.
Who is organising the research?
a. Investigators
Mr Issam Flaieh PhD Student
Dr David Ewins Senior Lecturer
b. Funding Body
University of Surrey and the Jordanian Government
These bodies are supporting PhD fees/maintenance, consumables and payment to 
volunteers
Who has reviewed the study?
University of Surrey Ethics Committee
Contact for further information
Mr Issam Flaieh
Centre for Biomedical Engineering 
Duke of Kent Building 
University of Surrey 
Guildford 
Surrey GU2 7TE ,
Tel: 01483 684573 
Fax: 01483 689395 
email, i.flaieh@surrev.co.uk
Thank you for taking part in the study. If you require any further information please 
do not hesitate to contact us.
University of Surrey 
University of Surrey
C.13
Appendices C
Appendix C 4. Volunteer consent form
Consent form
•  I the undersigned voluntarily agree to take part in the above study.
•  I have read and understood the Information Sheet provided. I have been given a foil 
explanation by the investigators o f the nature, purpose, location and likely duration 
o f the study, and o f what I will be expected to do. I have been given the opportunity 
to ask questions on all aspects of the study and have understood the advice and 
information given as a result.
•  I agree to comply with any instruction given to me during the study and to co­
operate folly with the investigators. I shall inform them immediately if I suffer any 
deterioration of any kind in my health or well-being, or experience any unexpected or 
unusual symptoms.
• I understand that all personal data relating to volunteers is held and processed in the 
strictest confidence, and in accordance with the Data Protection Act (1998). I agree 
that I will not seek to restrict the use of the results o f the study on the understanding 
that my anonymity is preserved.
•  I do/do not (delete as appropriate) give permission for videos or photographs of 
tests in which I feature to be used in the PhD thesis, peer reviewed journal 
publications and publicity material (brochures and WebPages).
• I understand that I am free to withdraw from the study at any time without needing 
to justify my decision and without prejudice.
•  I understand that in the event o f my suffering a significant and enduring injury 
(including illness or disease) as a direct result o f my participation in the study, 
compensation will be paid to me by the University subject to certain provisos and 
limitations. The amount of compensation will be appropriate to the nature, severity 
and persistence o f the injury and will, in general terms, be consistent with the amount 
of damages commonly awarded for similar injury by an English court in cases where 
the liability has been admitted.
•  I confirm that I have read and understood the above and freely consent to 
participating in this study. I have been given adequate time to consider my 
participation and agree to comply with the instructions and restrictions o f the study.
• I understand that on completion o f my involvement I will receive a payment o f £50 
or pro-rata.
Name of volunteer..................... Name of witness......................Name of.Investigator......................
(BLOCK CAPITALS) (BLOCK CAPITALS) (BLOCK CAPITALS)
Signed.......................................Signed......................................Signed......................................
Date ......................................D a te ........................................Date.......................................
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Appendix C 5. Anthropometry of the selected subjects for the FO tests.
Group 1 using FOl (S = Subject)
Mass
(kg)
Height
(mm)
BMI LLD
(mm)
Age
0 0
Gender Dominant
side
SI 55 1720 18.6 5 21 M Rt
S2 73 1750 23.8 10 26 M Rt
S3 59 1670 21.2 5 24 M Rt
S4 59 1790 18.5 10 20 M Rt
S5 70 1680 24.8 10 19 M Rt
S6 58 1770 18.5 5 21 M Rt
MEAN
(Range)
62.3
(55-73)
1730
(1760-1790
20.9
(18.5-24.8)
7.5
(5-10)
21.8
(19-24)
Group 2 using F02 (S = Subject)
Mass
(kg)
Height
(mm)
BMI LLD
(mm)
Age
0 0
Gender Dominant
side
S7 70 1760 22.6 5 31 M Rt
S8 68 1670 24.2 15 24 M Rt
S9 69 1660 24.9 0 23 M Rt
S10 64 1680 22.7 10 22 M Rt
S ll 68 1790 21.2 0 22 M Rt
S12 66 1800 20.4 5 23 M Rt
MEAN
(Range)
67.5
(64-70)
1727
(1660-1800)
22.7
(20.4-24.9)
5.8
(0-15)
24.2
(22-31)
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Appendix D l. Temporal-spatial changes for all participants for FOl and F02. Table 
A speed, B cadence, C step length, (n = 6 per FO condition)
(A) Speed
Walking speed F01
sp e e d  (m /s)
SUB 1 SU B 2 SU B 3 SU B 4 SU B 5 SU B 6
A1 1.29 1.18 1.28 1.33 1.22 1.49
A2 1.35 1.22 1.35 1.40 1.26 1.45
B1 1.39 1.28 1.35 1.36 1.26 1.52
B2 1.29 1.26 1.33 1.33 1.24 1.59
C normal variability 1.26 1.24 1.37 1.35 1.40 1.53
D m ean 1.33 1.34 1.31 1.28 1.31 1.54 overall positives
[SD] m ean m ean
A2-A1 within 4.0% 3.4% 5.5% 5.3% 3.4% -2.5% 3.2% 4.3%
B1-B2 1.7% -7.1% -2.0% -1.2% -2.0% -1.7% 4.4% -1.6% -2.8%
B1-A1 [1.4%] 7.2% 8.7% 5.2% 2.0% 3.5% 2.4% 4.9% 4.9%
B2-A1 betw een -0.4% 6.5% 4.0% 0.0% 1.7% 6.9% 3.1% 3.8%
C-A1 2.1% -2.4% 5.2% 6.9% 1.4% 14.8% 3.2% 4.9% 6.3%
D-A1 [1%] 2.7% 13.9% 2.1% -3.4% 7.1% 3.8% 4.4% 5.9%
F02
sp ee d  (m /s)
SU B 7 SUB 8 SU B  9 SU B 10 SU B 11 SU B 12
A1 1.25 1.37 1.03 1.22 1.43 1.22
A2 1.37 1.40 1.06 1.35 1.44 1.24
B1 1.29 1.36 1.22 1.30 1.26 1.21
B2 1.32 1.42 1.18 1.32 1.21 1.19
C normal variability 1.34 1.45 1.20 1.28 1.25 1.23
D m ean 1.33 1.40 1.21 1.25 1.22 1.18 overall positives
[SD] m ean m ean
A2-A1 within 9.2% 2.2% 2.7% 11.3% 1.0% 2.0% 4.7% 4.7%
B2-B1 1.7% 2.6% 4.7% -3.0% 1.4% -4.2% -1.2% 0.1% 2.9%
B1-A1 [1.4%] 3.0% -0.9% 18.3% 7.2% -11.6% -0.7% 2.5% 9.5%
B2-A1 betw een 5.7% 3.8% 14.8% 8.6% -15.3% -2.0% 2.6% 8.2%
C-A1 2.1% 6.9% 5.6% 16.7% 5.2% -12.2% 1.4% 3.9% 7.2%
D-A1 [1%] 6.4% 1.9% 17.2% 2.5% -14.4% -2.6% 1.8% 7.0%
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(B) Cadence
Cadence F01
c a d e n c e  (s te p s /m in )
S U B  1 S U B  2 S U B  3 S U B  4 S U B  5 S U B  6
A1 1 1 4 .5 1 0 4 .6 1 1 3 .7 1 1 7 1 1 3 .8 1 1 6 .3
A2 1 1 2 .8 1 0 6 .7 1 1 2 1 1 9 .5 1 1 4 .6 1 1 3 .8
B1 1 1 8 .6 1 1 2 .4 1 1 4 .1 121 1 1 5 .4 1 1 8 .2
B2 1 1 1 .2 1 1 2 1 1 2 .8 1 1 8 .2 1 1 8 .9 1 1 8 .6
C 1 0 9 .9 1 1 2 .4 1 1 4 .5 1 2 3 1 2 9 .8 11 5
D norm al variability 1 1 4 .6 1 1 5 1 1 3 .2 1 1 9 .9 1 1 8 .6 1 1 9 .6 overall
m e a n  [SD ] m e a n
A2-A1 within -1 .5 % 2 .0 % -1 .5% 2.1% 0.7% -2.1% 0.0%
B 2-B 1 1.2% -6 .2 % -0 .4% -1 .1% -2 .3 % 3 .0% 0.3% -1 .1 %
B1-A1 [1.2% ] 3.6% 7.5% 0.4% 3.4% 1.4% 1.6% 3.0%
B2-A1 b e tw e e n -2 .9 % 7.1% -0 .8 % 1.0% 4 .5 % 2.0% 1.8%
C-A1 1.5% -4 .0 % 7.5% 0.7% 5.1% 14 .1 % -1.1% 3.7%
D-A1 [0.5% ] 0.1% 9.9% -0 .4% 2 .5% 4 .2 % 2.8% 3.2%
F02
c a d e n c e  (s te p s /m in )
S U B  7 S U B  8 S U B  9 S U B  10 S U B  11 S U B  12
A1 1 0 4 .5 1 0 9 .1 1 0 7 .6 9 6 .8 1 1 0 .2 1 0 4 .9
A2 1 1 2 1 0 8 1 0 6 1 0 2 1 0 9 .7 1 0 4 .8
B1 1 0 6 .4 1 0 7 .2 1 0 9 .9 1 0 0 .7 1 0 3 .9 1 0 3 .8
B 2 1 1 0 .2 1 0 9 .5 1 1 1 .1 1 0 2 .4 1 0 1 .5 1 0 3 .9
C 1 0 6 .7 1 1 2 .4 1 1 2 .2 1 0 4 .9 1 0 2 .1 1 0 7 .6
D norm al variability 1 0 7 .9 1 0 8 .3 1 1 2 .8 1 0 5 1 0 3 .5 1 0 6 .8
m e a n  [SD ] m e a n
A2-A1 within 7.2% -1 .0 % -1 .5% 5.4% -0 .5 % -0.1% 1.6%
B 2-B 1 1.2% 3.6% 2 .1% 1.1% 1.7% -2 .3 % 0.1% 1.0%
B1-A1 [1.2% ] 1.8% -1 .7 % 2.1% 4 .0% -5 .7 % -1.0% -0 .1 %
B2-A1 b e tw e e n 5.5% 0.4% 3.3% 5.8% -7 .9 % -1.0% 1.0%
C-A1 1.5% 2.1% 3.0% 4.3% 8.4% -7 .4 % 2.6% 2.2 %
D-A1 [0.5% ] 3.3% -0 .7 % 4 .8 % 8.5% -6 .1 % 1.8% 1.9%
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(C) Step length
Step length FOl
step  length (m)
SUB 1 SUB 2 SUB 3 SUB 4 SUB 5 SUB 6
A1 0.69 0 .68 0 .68 0 .69 0.66 0 .79
A2 0.73 0 .69 0 .73 0.71 0.67 0.79
B1 0.72 0 .70 0.71 0.69 0 .68 0.80
B2 0.70 0.68 0 .7 2 0.68 0.65 0.81
C 0.69 0 .66 0 .73 0.67 0.65 0.83
D normal vari 0 .70 0 .70 0 .70 0.65 0 .67 0.80 overall positives
m ean [SD] m ean m ean
A2-A1 within 5.6% 2.2% 6.8% 3.6% 1.5% -0.8% 3.2% 4.0%
B2-B1 0.7% -3.3% -1.6% 0.8% -1.2% -4.0% 1.6% -1.3% -2.5%
B1-A1 [0.5%] 3.9% 2.8% 4.3% 0.0% 2.7% 1.3% 2.5% 2.5%
B2-A1 betw een 0.4% 1.2% 5.1% -1.2% -1.4% 2.9% 1.2% 2.4%
C-A1 1.5% 0.3% -3.1% 6.8% -2.2% -2.4% 4.6% 0.6% 3.9%
D-A1 [0.8%] 0.4% 3.6% 3.1 % -5.4% 0.9% 1.1% 0.6% 1.8%
F02
step  length (m)
SUB 7 SUB 8 SUB 9 SUB 10 SUB 11 SUB 12
A1 0.73 0 .76 0 .55 0 .74 0.78 0.69
A2 0.75 0 .78 0 .58 0 .77 0.78 0.71
CD __J
k 0.74 0 .77 0 .65 0 .76 0.73 0.69
B2 0.74 0.79 0.63 0 .77 0.71 0.69
C 0.78 0.77 0 .62 0 .73 0.73 0 .69
D normal vari; 0 .76 0 .76 0.62 0 .70 0.70 0 .67 overall positives
m ean [SD] m ean m ean
A2-A1 within 2.2% 1.4% 4.5% 4.8% 0.0% 2.8% 2.6% 2.6%
B2-B1 0.7% 0.3% 2.7% -3.7% 1.0% -2.9% -0.6% -0.5% -1.5%
B1-A1 [0.5%] 1.2% 1.2% 17.9% 3.7% -6.5% 0.4% 3.0% 4.9%
B2-A1 betw een 1.5% 3.9% 13.6% 4.8% -9.2% -0.1% 2.4% 5.9%
C-A1 1.5% 6.4% 1.3% 12.1% -0.5% -6.3% 0.7% 2.3% 5.1%
D-A1 [0.8%] 3.7% -0.3% 13.0% -4.4% -9.9% -3.1% -0.1% 8.4%
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Appendix D 2. Kinematic and kinetic changes during LR.
(A) Maximum eversion angle changes during LR. +ve values indicate increased 
eversion, and -ve values indicate reduced eversion. (n = 6 per FO condition)
MAX EV REDUCTION (LR) F 01
normal S1 S 2 S 3 S 4 S 5 S 6 all m ean positives m ean
A1-A2 variability -0 .6 2 .4 2.1 -3.1 -1.1 2 .3 0 .3 -1 .6
B1-B2 within -5 .3 -3 .3 -2 .4 -8 .6 -0 .6 1.0 -3 .2 -4 .0
A1-B1 0.9 (0 .5 ) -7 .8 2 .5 1.6 -4 .3 -0 .7 0 .7 -1 .3 -4 .3
A1-B2 betw een -2 .5 5 .8 4 .0 4 .2 -0.1 -0 .3 1.8 -1 .0
A1-C 2 .1 (1 .3 ) -1 .0 3 .4 4 .6 2 .6 0 .4 3 .8 2 .3 -1 .0
A1-D -0 .7 2 .8 1.3 0.1 1.7 2.1 1.2 -0 .7
F 0 2
normal S 7 S 8 S 9 S 1 0 S11 S 1 2 all m ean p ositives m ean
A1-A2 variability -2.1 1.9 -1.1 -0 .2 -5 .7 0 .7 -1.1 -2 .3
B1-B2 within -3.1 -1.1 -0 .9 -4 .3 -2 .2 -2 .7 -2 .4 -2 .4
A1-B1 0 .9 (0 .5 ) -5.1 2 .2 1.0 -1 .9 -6 .6 0 .2 -1 .7 -4 .5
A 1-B2 betw een -2 .0 3 .2 1.9 2 .4 -4 .5 2 .9 0 .7 -3 .2
A1-C 2.1 (1 .3 ) -1 .6 2 .3 -1 .4 3 .4 -1 .4 3 .4 0 .8 -1 .5
A1-D 0.9 1.9 -0 .4 0 .3 1.1 4 .0 1.3 -0 .4
(B) Maximum inversion angle changes during LR. +ve values indicate increased 
inversion, -ve values indicate reduction, (n = 6 per FO condition)
MAX INV INCREASE (LR) F 0 1
normal S1 S 2 S 3 S 4 S 5 S 6 all m ean p ositives m ean
A1-A2 variability -4 .2 0 .0 2 .7 0 .4 -1 .6 2 .5 0 .0 -0 .6
B1-B2 within 5 .6 1.1 2 .0 5 .8 0 .9 -1 .9 2 .2 3 .3
A1-B1 1 .6 (1 8 ) -8 .4 0 .3 3.1 -2 .5 -3 .6 2 .3 -1 .5 -4 .8
A1-B2 betw een -2 .9 1.4 5.1 3 .3 -2 .7 0 .4 0 .8 -2 .8
A1-C 1 .7 (1 1 ) -1 .4 0 .7 6 .3 3.1 -1 .6 -2 .0 0 .9 0 .0
A1-D 0.4 3.1 2 .3 -2 .7 0.1 0 .0 0 .5 -2 .7
F 0 2
normal S 7 S 8 S 9 S 1 0 S11 S 1 2 all m ean positives m ean
A1-A2 variability -0 .7 1.6 1.3 0.1 -8 .5 -0 .5 -1.1 -4 .5
B1-B2 within -1 .4 0 .5 0 .3 1.6 1.0 3 .6 0 .9 1.7
A1-B1 1 .6 (1 8 ) -0 .4 2 .9 2 .7 0 .3 -8 .7 0 .8 -0 .4 -1 .5
A1-B2 betw een -1 .8 3 .4 3 .0 1.9 -7 .7 4 .4 0 .5 -2 .2
A1-C 1 .7 (1 1 ) 1.8 -2 .4 -1 .2 2 .7 -4 .7 -2 .0 -0 .9 -4 .7
A1-D 1.3 2 .3 -2.1 -1 .6 -3 .6 0 .5 -0 .5 -2 .6
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Appendix D 3. Inversion/ eversion angle during the FOl and F02 testing for all 12 
subjects (S I-S I2).
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Appendix D 4. Joint angles CMC over the GC of all subjects between sessions (n = 6 
per FO condition)
CMC pelvic tilt FOl CMC pelvic obliq FOl
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 72.5% 65.6% 0.0% 0.0% 87.6% 94.0% S1 97.6% 99.2% 92.2% 92.0% 56.0% 89.8%
S2 95.7% 97.6% 98.0% 95.4% 83.6% 94.0% S2 99.7% 99.9% 82.9% 80.4% 90.3% 92.5%
S3 96.8% 93.1% 30.7% 0.0% 60.2% 69.1% S3 99.6% 99.4% 93.7% 94.6% 89.5% 98.6%
S4 0.0% 42.3% 0.0% 0.0% 0.0% 0.0% S4 99.5% 99.8% 92.5% 91.9% 99.6% 99.3%
S5 85.2% 94.5% 0.0% 0.0% 0.0% 81.7% S5 99.7% 99.2% 96.2% 96.6% 79.5% 91.5%
S6 39.2% 60.4% 58.2% 84.1% 0.0% 0.0% S6 99.6% 99.1% 73.5% 75.3% 87.8% 90.2%
mean 64.9% 75.6% 31.1% 29.9% 38.6% 56.4% mean 99.3% 99.4% 88.5% 88.5% 83.8% 93.7%
SD 38.3% 22.8% 40.3% 46.5% 43.3% 44.7% SD 0.8% 0.3% 8.6% 8.6% 15.0% 4.2%
F02 F02
S7 96.3% 95.7% 44.1% 55.0% 0.0% 0.0% S7 97.6% 99.7% 96.8% 96.5% 66.7% 78.0%
S8 99.0% 97.0% 89.0% 82.4% 92.1% 0.0% S8 99.8% 99.7% 98.3% 98.6% 95.8% 80.8%
S9 97.7% 84.4% 0.0% 0.0% 0.0% 0.0% S9 99.6% 99.7% 83.4% 84.2% 90.6% 98.1%
S10 86.6% 89.4% 0.0% 0.0% 0.0% 0.0% S10 98.3% 99.5% 92.3% 89.7% 90.4% 83.6%
S11 68.4% 0.0% 0.0% 0.0% 0.0% 76.7% S11 98.6% 98.0% 92.9% 90.3% 82.8% 99.5%
S12 36.7% 94.5% 0.0% 0.0% 49.1% 65.2% S12 99.7% 99.6% 96.1% 96.8% 66.9% 99.0%
mean 80.8% 76.8% 22.2% 22.9% 23.5% 23.7% mean 98.9% 99.4% 93.3% 92.7% 82.2% 89.8%
SD 24.5% 37.9% 37.2% 36.5% 38.9% 36.8% SD 0.9% 0.7% 5.4% 5.5% 12.6% 10.0%
CMC pelvic rot FOl CMC hip flex FOl
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 93.4% 96.3% 97.1% 93.1% 91.9% 95.7% S1 99.9% 99.7% 98.9% 99.0% 99.5% 99.8%
S2 99.1% 99.6% 99.0% 98.6% 97.4% 99.6% S2 99.8% 99.9% 99.4% 99.0% 98.8% 99.3%
S3 99.1% 96.9% 88.1% 75.4% 87.6% 63.5% S3 99.9% 99.9% 98.1% 98.3% 99.6% 99.4%
S4 99.0% 97.7% 74.9% 60.3% 68.5% 0.0% S4 99.6% 99.8% 99.4% 99.0% 98.7% 98.4%
S5 99.8% 99.3% 75.9% 73.9% 95.4% 97.2% S5 99.7% 99.7% 98.8% 98.7% 97.9% 99.9%
S6 94.2% 91.2% 67.6% 65.3% 86.4% 43.3% S6 99.7% 99.7% 99.9% 99.8% 96.2% 98.5%
mean 97.4% 96.8% 83.8% 77.8% 87.9% 66.6% mean 99.8% 99.8% 99.1% 99.0% 98.5% 99.2%
SD 2.8% 3.0% 12.9% 15.2% 10.4% 39.7% SD 0.1% 0.1% 0.6% 0.5% 1.2% 0.6%
F02 F02
S7 99.2% 96.5% 96.7% 93.0% 98.3% 98.6% S7 99.7% 99.9% 98.2% 98.6% 94.3% 99.0%
S8 99.3% 98.3% 98.7% 95.3% 97.5% 97.6% S8 100.0% 100.0% 98.8% 98.9% 99.3% 99.6%
S9 99.4% 98.6% 88.9% 88.8% 96.9% 92.0% S9 99.9% 99.9% 93.9% 94.8% 91.8% 95.7%
S10 98.2% 94.3% 90.0% 95.9% 93.3% 86.1% S10 99.8% 100.0% 99.4% 99.1% 98.8% 97.8%
S11 98.6% 90.3% 84.7% 95.8% 96.2% 96.6% S11 99.9% 99.8% 95.6% 96.5% 99.3% 99.4%
S12 97.6% 90.5% 96.7% 77.5% 91.6% 93.9% S12 100.0% 100.0% 98.4% 98.6% 99.8% 99.8%
mean 98.7% 94.8% 92.6% 91.0% 95.6% 94.1% mean 99.9% 99.9% 97.4% 97.8% 97.2% 98.6%
SD 0.7% 3.7% 5.5% 7.2% 2.6% 4.6% SD 0.1% 0.1% 2.2% 1.7% 3.3% 1.6%
CMC hip abd FOl CMC hip rot FOl
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 98.9% 99.0% 97.9% 97.5% 71.2% 82.3% S1 24.5% 93.3% 0.0% 0.0% 0.0% 76.7%
S2 99.8% 99.8% 85.1% 82.5% 92.7% 93.6% S2 99.6% 99.7% 0.0% 0.0% 0.0% 0.0%
S3 99.7% 99.6% 98.3% 99.4% 97.8% 99.4% S3 99.6% 94.4% 82.3% 60.6% 94.7% 84.8%
S4 99.6% 99.5% 99.1% 98.8% 96.7% 97.9% S4 98.9% 99.4% 98.3% 97.1% 0.0% 10.8%
S5 99.3% 99.3% 94.8% 92.6% 88.8% 97.8% S5 99.3% 97.2% 96.4% 95.3% 80.2% 89.4%
S6 99.6% 99.3% 85.4% 84.9% 96.2% 90.9% S6 32.7% 98.9% 68.8% 69.7% 82.0% 74.4%
mean 99.5% 99.4% 93.4% 92.6% 90.6% 93.7% mean 75.8% 97.2% 57.6% 53.8% 42.8% 56.0%
SD 0.3% 0.3% 6.5% 7.3% 10.0% 6.4% SD 36.6% 2.7% 45.9% 44.0% 47.2% 39.7%
F02 F02
S7 99.3% 99.7% 99.1% 99.1% 91.6% 92.4% S7 98.1% 99.1% 66.1% 58.7% 96.6% 90.2%
S8 99.4% 99.8% 98.9% 99.2% 96.1% 70.5% S8 99.0% 99.1% 69.0% 62.8% 58.4% 95.7%
S9 99.8% 99.5% 94.6% 94.1% 89.2% 97.4% S9 99.5% 99.3% 36.8% 42.3% 90.8% 85.9%
S10 98.8% 99.7% 97.0% 97.8% 96.7% 94.2% S10 98.4% 97.3% 47.6% 62.4% 78.3% 86.6%
S11 99.6% 99.0% 97.1% 99.1% 79.7% 99.2% S11 99.2% 91.9% 96.0% 93.6% 0.0% 55.6%
S12 97.3% 99.2% 95.2% 92.7% 51.3% 99.4% S12 97.5% 96.5% 59.8% 53.8% 83.2% 79.1%
mean 99.0% 99.5% 97.0% 97.0% 84.1% 92.2% mean 98.6% 97.2% 62.5% 62.3% 67.9% 82.2%
SD 0.9% 0.3% 1.8% 2.9% 17.2% 11.0% SD 0.8% 2.8% 20.3% 17.1% 35.8% 14.1%
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CMC knee flex FOl CMC knee abd FOl
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 99.9% 98.9% 98.9% 99.1% 98.8% 99.5% S1 58.4% 88.7% 0.0% 45.4% 0.0% 52.1%
S2 99.9% 100.0% 98.7% 98.7% 98.8% 97.7% S2 99.5% 99.9% 52.6% 56.0% 0.0% 0.0%
S3 99.8% 99.8% 99.8% 99.9% 99.8% 99.9% S3 99.5% 96.2% 95.7% 85.9% 98.3% 92.1%
S4 99.8% 99.8% 99.1% 99.7% 99.8% 97.8% S4 98.3% 98.8% 96.0% 98.5% 64.5% 38.3%
S5 99.8% 99.4% 99.7% 99.9% 99.4% 99.8% S5 97.6% 97.2% 97.9% 96.3% 70.6% 78.9%
S6 99.8% 99.7% 99.8% 99.6% 99.5% 99.7% S6 75.4% 97.7% 73.3% 69.1 % 79.2% 77.2%
mean 99.8% 99.6% 99.4% 99.5% 99.3% 99.0% mean 88.1% 96.4% 69.3% 75.2% 52.1% 56.4%
SD 0.1% 0.4% 0.5% 0.5% 0.4% 1.0% SD 17.3% 4.0% 38.3% 21.9% 41.9% 33.9%
F02 F02
S7 99.4% 99.9% 99.4% 99.5% 99.2% 99.5% S7 95.3% 97.0% 86.0% 75.6% 73.4% 87.3%
S8 99.9% 99.9% 99.2% 99.2% 98.5% 99.9% S8 98.9% 99.3% 0.0% 0.0% 74.1% 78.3%
S9 100.0% 99.9% 98.9% 98.7% 99.5% 99.7% S9 99.0% 95.1% 0.0% 0.0% 95.0% 95.1%
S10 99.8% 99.8% 99.9% 99.8% 99.5% 99.5% S10 98.1% 89.8% 15.6% 58.5% 89.0% 91.5%
S11 100.0% 99.7% 99.7% 99.7% 99.6% 99.0% S11 99.4% 93.2% 98.5% 96.4% 77.0% 80.0%
S12 99.8% 99.9% 99.8% 99.9% 99.9% 99.5% S12 99.4% 98.7% 97.0% 94.3% 98.1% 96.1%
mean 99.8% 99.9% 99.5% 99.5% 99.4% 99.5% mean 98.4% 95.5% 49.5% 54.1% 84.4% 88.1%
SD 0.2% 0.1% 0.4% 0.4% 0.5% 0.3% SD 1.6% 3.6% 49.1% 44.1% 11.0% 7.6%
CMC knee rot FOl CMC ankle dorsi FOl
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 74.2% 91.7% 0.0% 32.2% 44.2% 77.0% S1 92.1% 47.7% 53.9% 99.3% 99.5% 97.8%
S2 99.4% 99.7% 91.5% 89.6% 51.2% 0.0% S2 99.3% 99.7% 95.3% 95.7% 95.0% 93.5%
S3 96.9% 86.6% 92.1% 76.8% 71.2% 95.9% S3 99.4% 97.4% 97.5% 99.2% 99.0% 98.8%
S4 97.0% 98.0% 94.6% 93.5% 93.6% 0.0% S4 97.5% 96.4% 98.6% 98.8% 93.6% 94.6%
S5 91.2% 97.0% 25.6% 32.8% 82.3% 40.0% S5 98.2% 97.7% 96.9% 94.8% 98.6% 84.3%
S6 66.4% 96.0% 80.9% 74.7% 83.0% 62.0% S6 99.6% 98.7% 99.5% 99.5% 83.1% 95.6%
mean 87.5% 94.8% 64.1% 66.6% 70.9% 45.8% mean 97.7% 89.6% 90.3% 97.9% 94.8% 94.1%
SD 13.8% 4.9% 40.8% 27.4% 19.5% 39.9% SD 2.8% 20.6% 17.9% 2.1% 6.2% 5.2%
S7 97.3% 97.8% 89.4% 83.0% 86.4% 56.5% S7 95.0% 98.3% 90.4% 96.4% 93.5% 98.2%
S8 98.5% 97.7% 94.5% 89.0% 83.8% 96.2% S8 99.1% 99.2% 97.4% 97.3% 97.7% 98.8%
S9 98.1% 95.5% 36.9% 59.5% 91.5% 83.6% S9 95.9% 98.8% 93.4% 94.5% 98.0% 95.2%
S10 94.1% 92.2% 73.1% 58.2% 30.4% 52.8% S10 97.3% 98.3% 96.3% 96.3% 94.3% 98.1%
S11 97.5% 96.4% 94.6% 94.5% 19.4% 0.0% S11 99.4% 97.1% 93.7% 97.0% 97.4% 95.2%
S12 92.6% 96.2% 0.0% 0.0% 32.6% 18.6% S12 95.3% 96.0% 96.3% 97.7% 84.3% 89.2%
mean 96.3% 96.0% 64.8% 64.0% 57.4% 51.3% mean 97.0% 97.9% 94.6% 96.5% 94.2% 95.8%
SD 2.4% 2.0% 38.5% 34.8% 33.1% 36.8% SD 1.9% 1.2% 2.6% 1.1% 5.2% 3.6%
CMC ankle abd FC1 CMC ankle inv FOl
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 63.2% 57.1% 65.8% 95.0% 75.2% 88.7% S1 95.5% 75.1% 59.2% 93.3% 93.9% 74.2%
S2 99.1% 99.4% 87.3% 85.8% 59.7% 67.3% S2 96.2% 96.1% 73.4% 59.3% 42.1% 30.8%
S3 98.5% 98.9% 95.6% 95.6% 74.6% 91.5% S3 92.7% 88.6% 91.9% 72.2% 67.0% 93.3%
S4 96.8% 88.6% 82.3% 67.7% 68.9% 79.9% S4 97.0% 33.1% 90.9% 60.9% 72.5% 86.0%
S5 95.2% 94.8% 92.7% 96.9% 81.0% 94.1% S5 92.9% 94.5% 76.6% 86.1% 93.5% 92.3%
S6 93.5% 99.1% 97.7% 97.2% 94.3% 97.0% S6 68.8% 88.4% 79.4% 75.9% 41.2% 47.4%
mean 91.0% 89.6% 86.9% 89.7% 75.6% 86.4% mean 90.5% 79.3% 78.6% 74.6% 68.4% 70.6%
SD 13.8% 16.5% 11.8% 11.6% 11.6% 11.0% SD 10.8% 23.8% 12.1% 13.5% 23.4% 25.9%
F02 F02
S7 95.0% 95.0% 95.8% 92.9% 67.1% 83.2% S7 98.8% 96.0% 82.0% 88.6% 91.9% 97.5%
S8 99.3% 98.5% 87.8% 82.7% 96.3% 98.2% S8 96.7% 97.5% 88.6% 90.4% 95.2% 94.3%
S9 97.4% 98.6% 76.0% 74.8% 97.3% 97.6% S9 97.1% 86.1% 78.2% 71.1% 97.8% 97.6%
S10 96.7% 99.1% 68.5% 74.7% 78.1% 97.9% S10 99.3% 70.5% 78.0% 90.5% 93.4% 90.9%
S11 98.9% 99.0% 91.8% 88.6% 93.0% 78.6% S11 0.0% 95.8% 20.9% 51.9% 86.7% 88.5%
S12 92.3% 91.5% 95.4% 97.0% 91.8% 71.9% S12 97.9% 92.1% 87.3% 63.9% 90.6% 86.6%
mean 96.6% 96.9% 85.9% 85.1% 87.3% 87.9% mean 81.6% 89.7% 72.5% 76.1% 92.6% 92.5%
SD 2.6% 3.1% 11.2% 9.3% 12.1% 11.5% SD 40.0% 10.3% 25.7% 16.3% 3.8% 4.6%
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Appendix D 5. Joint angles ABSD over the whole GC of all subjects between
sessions (n = 6 per FO condition)
ABSD pelvic tilt ABSD pelvic obliq
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 0.8 1.2 5.1 3.9 0.6 0.4 S1 0.8 0.4 1.3 1.4 4.3 1.7
S2 0.4 0.3 0.2 0.4 0.8 0.4 S2 0.3 0.2 2.8 3.0 2.0 1.6
S3 0.5 0.5 2.3 2.8 1.7 1.5 S3 0.3 0.4 1.2 1.2 1.7 0.5
S4 2.2 1.0 2.6 3.6 2.1 4.4 S4 0.4 0.3 2.0 2.1 0.4 0.5
S5 0.6 0.3 2.6 2.8 3.6 0.5 S5 0.3 0.4 1.0 0.9 2.4 1.2
, S6 1.0 0.7 0.8 0.4 5.4 4.4 S6 0.2 0.4 2.2 2.3 1.3 1.3
mean 0.9 0.7 2.3 2.3 2.4 1.9 mean 0.4 0.3 1.8 1.8 2.0 1.1
SD 0.7 0.4 1.7 1.6 1.8 2.0 SD 0.2 0.1 0.7 0.8 1.3 0.5
S7 0.4 0.3 1.8 1.5 5.0 2.2 S7 0.6 0.2 0.6 0.7 2.8 2.1
S8 0.2 0.4 0.8 1.1 0.6 2.8 S8 0.4 0.3 0.9 0.7 1.3 3.3
S9 0.3 0.7 5.4 4.7 7.6 6.6 S9 0.2 0.3 2.2 2.1 1.5 0.6
S10 0.4 0.4 2.0 2.4 2.5 5.6 S10 0.6 0.3 1.4 1.5 1.3 1.6
S11 0.7 1.9 6.6 4.7 3.3 0.4 S11 0.4 0.4 0.8 1.2 1.9 0.2
S12 0.5 0.2 2.8 2.8 0.6 0.4 S12 0.3 0.3 1.0 0.8 3.4 0.5
mean 0.4 0.7 3.2 2.9 3.3 3.0 mean 0.4 0.3 1.2 1.2 2.0 1.4
SD 0.2 0.6 2.3 1.5 2.7 2.6 SD 0.2 0.1 0.6 0.6 0.9 1.2
ABSD pelvic rot FOl ABSD hip flex
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 1.0 1.2 0.8 1.5 1.6 1.1 S1 1.0 1.5 3.3 2.9 2.0 1.5 ;
S2 0.8 0.5 0.8 1.0 1.1 0.4 S2 1.1 0.7 2.3 3.0 3.2 2.4
S3 0.6 1.3 2.7 3.9 2.9 4.6 S3 0.7 0.7 4.5 4.2 2.0 2.3 <
S4 0.5 0.8 3.3 4.1 3.7 6.3 S4 1.7 1.1 2.0 3.0 2.9 3.2
S5 0.3 0.6 4.4 4.4 1.6 1.1 S5 1.4 1.4 3.2 3.2 4.0 0.9
S6 0.6 1.0 2.0 2.0 1.2 1.8 S6 1.6 1.5 1.0 1.2 6.6 3.8
mean 0.6 0.9 2.3 2.8 2.0 2.6 mean 1.2 1.1 2.7 2.9 3.5 2.3
SD 0.2 0.3 1.4 1.5 1.0 2.3 SD 0.4 0.4 1.2 1.0 1.7 1.1
S7 0.4 0.8 0.8 1.1 0.5 0.5 S7 1.7 0.9 4.3 3.7 8.1 3.0
S8 0.5 1.0 1.0 1.9 1.1 1.3 S8 0.4 0.6 3.5 3.5 2.5 1.7
S9 0.5 0.8 2.5 2.4 1.1 2.0 S9 0.9 0.7 7.9 7.3 9.2 6.4
S10 0.5 0.9 1.5 0.9 1.4 1.7 S10 1.2 0.7 2.8 3.3 3.8 5.2
S11 1.0 1.8 2.3 1.3 1.5 1.2 S11 0.6 1.2 6.7 5.7 2.3 2.2
S12 0.7 1.4 1.0 2.3 1.4 1.0 S12 0.4 0.5 4.1 3.8 1.4 1.4
mean 0.6 1.1 1.5 1.6 1.2 1.3 mean 0.9 0.8 4.9 4.5 4.5 3.3
SD 0.2 0.4 0.7 0.6 0.4 0.5 SD 0.5 0.3 2.0 1.6 3.3 2.0
ABSD hip abd ABSD hip rot
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 0.6 0.6 0.8 1.0 4.3 3.2 S1 7.0 1.1 10.8 9.8 9.9 3.2
S2 0.5 0.4 4.3 4.7 3.0 2.7 S2 0.4 0.4 8.9 9.0 12.0 17.5
S3 0.4 0.4 0.9 0.5 1.1 0.6 S3 0.5 2.6 4.4 7.0 2.1 3.3 j
S4 0.5 0.6 0.8 1.1 1.5 1.1 S4 0.7 0.6 0.9 1.2 11.7 7.0
S5 0.6 0.7 1.9 2.2 3.0 1.2 S5 1.0 1.6 2.2 2.0 4.2 3.8
S6 0.4 0.6 2.9 2.8 1.2 1.7 S6 6.9 0.7 4.7 4.4 3.0 3.2
mean 0.5 0.5 1.9 2.1 2.3 1.7 mean 2.8 1.2 5.3 5.6 7.1 6.3
SD 0.1 0.1 1.4 1.6 1.3 1.0 SD 3.3 0.8 3.9 3.6 4.5 5.7
S7 0.6 0.4 0.7 0.7 2.5 2.4 S7 1.2 0.9 7.4 8.2 1.6 2.8
S8 0.7 0.3 0.8 0.7 1.8 5.4 S8 0.8 0.8 6.4 7.1 5.8 2.4
; S9 0.3 0.5 1.8 2.0 2.8 1.3 S9 0.6 0.8 9.3 8.9 2.9 3.0
S10 1.0 0.4 1.6 1.4 1.4 2.0 S10 1.0 1.5 8.1 6.6 3.7 2.6
S11 0.4 0.5 1.0 0.6 3.6 0.5 S11 0.5 1.7 1.2 1.4 6.0 4.9
S12 0.9 0.5 1.2 1.5 4.4 0.4 S12 1.1 0.9 4.2 4.6 3.7 4.0
mean 0.7 0.4 1.2 1.1 2.7 2.0 mean 0.9 1.1 6.1 6.1 3.9 3.3
SD 0.3 0.1 0.5 0.6 1.1 1.8 SD 0.3 0.4 3.0 2.8 1.7 1.0
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ABSD knee flex ABSD knee abd
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 1.3 4.0 4.4 3.3 4.5 2.7 S1 2.1 0.9 3.6 2.8 4.7 3.9
S2 1.1 0.4 4.7 4.7 4.4 5.6 S2 0.5 0.2 5.7 5.6 5.7 7.6
S3 1.5 1.6 1.6 1.3 1.9 1.4 S3 0.3 0.7 0.9 1.5 0.6 1.3
S4 1.6 1.7 3.0 1.9 1.5 5.1 S4 0.7 0.6 1.0 0.6 4.4 3.6
S5 1.8 3.0 2.2 1.4 3.3 2.1 S5 0.7 0.8 0.8 1.1 2.2 2.0
S6 1.4 1.9 1.6 2.3 2.4 2.3 S6 2.4 0.6 3.4 3.9 2.7 2.4
mean 1.5 2.1 2.9 2.5 3.0 3.2 mean 1.1 0.6 2.6 2.6 3.4 3.5
SD 0.2 1.2 1.4 1.3 1.3 1.7 SD 0.9 0.2 2.0 1.9 1.9 2.2
S7 2.4 1.3 2.7 2.4 3.3 2.2 S7 0.7 1.0 1.6 2.1 2.2 1.1
S8 1.1 0.8 3.5 3.6 4.8 1.4 S8 0.4 0.4 4.1 4.0 2.0 2.0
S9 0.8 1.0 5.3 5.6 3.3 2.5 S9 0.4 0.5 4.5 4.6 1.2 1.3
S10 1.3 1.4 1.1 1.5 2.6 2.6 S10 0.5 0.8 2.8 2.1 1.2 1.3
S11 0.8 1.9 2.2 1.9 2.6 4.1 S11 0.3 1.1 0.6 0.7 2.2 2.2
S12 1.5 0.8 1.4 1.2 1.4 2.7 S12 0.6 0.6 1.2 1.4 1.0 1.8
mean 1.3 1.2 2.7 2.7 3.0 2.6 mean 0.5 0.7 2.5 2.5 1.6 1.6
SD 0.6 0.4 1.5 1.6 1.1 0.9 SD 0.1 0.3 1.6 1.5 0.6 0.4
ABSD knee rot ABSD ankle dorsi
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 3.3 2.1 7.5 6.5 5.4 2.9 S1 2.9 12.4 11.5 0.9 0.9 2.2
S2 0.6 0.5 2.9 3.2 5.4 8.7 S2 0.9 0.7 3.1 2.9 2.8 2.9
S3 0.8 1.8 1.2 2.3 3.6 1.0 S3 0.9 2.0 1.9 0.9 1.0 1.2
S4 1.8 1.1 2.0 2.0 2.4 10.6 S4 1.8 2.2 1.3 1.2 3.2 2.6
S5 1.6 1.2 6.1 5.4 2.2 4.4 S5 1.5 1.6 2.2 2.9 1.3 5.3
S6 4.7 0.9 2.6 3.2 2.4 4.9 S6 0.6 1.7 0.9 1.0 5.9 2.8
mean 2.1 1.3 3.7 3.8 3.6 5.4 mean 1.4 3.4 3.5 1.6 2.5 2.8
SD 1.6 0.6 2.5 1.8 1.5 3.6 SD 0.8 4.4 4.0 1.0 1.9 1.4
S7 1.1 1.1 2.7 3.4 2.6 5.7 S7 2.3 1.4 3.4 2.0 2.9 1.4
S8 1.4 1.2 2.7 3.5 4.0 1.9 S8 1.2 1.5 2.3 2.2 1.9 1.6
S9 0.7 0.9 3.9 3.5 1.3 2.0 S9 2.4 1.4 2.8 3.2 1.5 2.5
S10 1.2 1.5 2.9 4.2 5.9 5.1 S10 2.4 2.0 2.7 2.6 3.4 1.7
S11 1.2 1.5 1.9 1.4 8.1 10.3 S11 0.9 2.6 3.6 2.3 2.1 2.8
S12 1.4 1.3 6.7 6.7 6.5 6.3 S12 2.4 2.2 2.0 1.7 4.4 3.8
mean 1.2 1.2 3.5 3.8 4.7 5.2 mean 1.9 1.8 2.8 2.3 2.7 2.3
SD 0.2 0.2 1.7 1.7 2.5 3.1 SD 0.7 0.5 0.6 0.5 1.1 0.9
ABSD ankle abd ABSD ankle inv
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 6.0 7.7 7.3 2.3 5.8 3.9 S1 1.5 4.6 5.8 1.9 1.9 2.7
S2 0.9 0.9 4.6 4.9 8.4 7.7 S2 1.2 1.4 3.2 4.6 4.8 4.8
S3 1.0 0.8 1.7 1.8 5.0 2.5 S3 1.7 1.9 1.5 3.4 3.7 1.2
S4 1.5 3.4 3.9 6.5 6.6 4.3 S4 0.8 6.6 1.8 4.8 3.2 2.4
S5 1.7 1.6 1.9 1.1 2.5 1.6 S5 1.3 0.8 1.9 1.4 1.0 0.8
S6 2.4 0.8 1.5 1.7 2.5 1.8 S6 3.0 1.1 1.7 1.5 3.3 3.9
mean 2.2 2.5 3.5 3.0 5.1 3.6 mean 1.6 2.7 2.6 2.9 3.0 2.6
SD 1.9 2.7 2.3 2.2 2.3 2.3 SD 0.8 2.3 1.7 1.6 1.3 1.5
S7 2.0 2.0 1.9 2.4 6.3 4.1 S7 1.0 1.3 3.4 3.3 2.0 1.5
S8 0.7 1.2 3.9 4.7 1.6 1.2 S8 1.6 0.8 2.5 2.4 2.1 2.3
S9 1.4 1.1 5.5 5.6 1.5 1.3 S9 1.2 1.5 2.6 2.8 0.9 1.0
S10 1.7 1.1 8.0 7.1 6.2 1.5 S10 0.5 3.0 2.4 2.0 2.0 2.0
S11 1.0 1.0 2.6 3.4 2.3 4.6 S11 6.6 1.4 5.8 4.7 2.3 2.1
S12 2.2 2.7 1.9 1.5 2.9 6.0 S12 0.6 2.3 2.2 4.5 1.9 2.1
mean 1.5 1.5 4.0 4.1 3.5 3.1 mean 1.9 1.7 3.1 3.3 1.9 1.8
SD 0.6 0.7 2.4 2.1 2.2 2.1 SD 2.3 0.8 1.3 1.1 0.5 0.5
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Appendix D 6. Joint angles excursion differences over the whole GC of all subjects
between sessions (n = 6 per FO condition)
EXC DIFF pelvic tilt EXC DIFF pelvic obliq
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 -0.2 0.7 -0.9 -0.2 -0.8 -0.1 S1 -2.5 -0.9 -1.9 -2.8 -4.8 -4.6
S2 -04 0.1 0.0 0.1 0.0 0.0 S2 1.0 0.5 0.0 0.5 0.6 0.8
S3 -1.2 0.2 -0.1 0.1 -0.2 -0.6 S3 -0.2 -0.8 1.1 0.3 0.4 0.5
S4 -0.7 0.9 -0.5 0.4 -0.5 0.2 S4 0.2 -0.5 -0.7 -1.1 0.5 0.6
S5 -0.5 0.6 -0.5 0.1 0.2 0.0 S5 -0.2 0.3 -0.5 -0.2 -0.1 1.1
S6 0.2 0.1 0.1 0.2 -0.4 -0.7 S6 0.3 -0.4 -0.9 -1.3 -1.3 -2.9
mean -0.5 0.4 -0.3 0.1 -0.3 -0.2 mean -0.3 -0.3 -0.5 -0.8 -0.8 -0.7
SD 0.4 0.3 0.4 0.2 0.3 0.4 SD 1.2 0.6 1.0 1.2 2.1 2.4
S7 0.3 0.0 0.7 0.8 0.9 0.9 S7 -1.1 -0.5 0.0 -0.5 -1.0 0.0
S8 0.0 -0.6 0.2 -0.4 0.7 0.0 S8 -0.6 0.2 3.0 3.2 2.8 3.4
S9 0.0 0.8 0.1 0.9 1.7 1.0 S9 -1.1 0.3 -3.6 -3.3 -2.6 -2.6
S10 -1.1 0.8 -1.5 -0.7 -1.5 -2.5 S10 -1.7 0.0 -1.3 -1.3 2.0 2.5
S11 0.4 0.4 0.8 1.2 1.9 0.2 S11 -0.8 -1.0 1.8 0.8 -0.8 0.9
S12 -0.4 0.3 -1.2 -0.8 -1.1 -0.2 S12 -0.4 0.5 -0.1 0.4 0.2 0.5
mean -0.1 0.3 -0.1 0.2 0.4 -0.1 mean -1.0 -0.1 0.0 -0.1 0.1 0.8
SD 0.6 0.5 1.0 0.9 1.4 1.3 SD 0.5 0.6 2.3 2.2 2.0 2.1
EXC DIFF pelvic rot FOl EXC DIFF hip flex
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 2.3 -3.5 -1.2 -4.7 -4.8 -3.7 S1 -2.2 2.2 -1.7 0.5 1.9 0.7
S2 -0.5 0.4 -1.7 -1.3 1.0 -0.4 S2 0.9 0.3 2.0 2.3 1.0 2.7
S3 -0.4 -0.2 -1.4 -1.6 -1.6 0.6 S3 -1.2 0.6 -2.5 -1.9 -0.4 -2.0
S4 -0.4 1.1 -0.4 0.7 -0.7 0.8 S4 0.4 -0.6 0.7 0.1 1.8 2.8
S5 -1.0 2.2 -2.4 -0.2 -4.3 1.4 S5 -1.1 0.2 0.7 0.8 -0.7 -2.4
S6 0.1 2.5 -1.8 0.8 -1.4 0.8 S6 1.2 -1.1 0.6 -0.5 1.5 1.8
mean 0.0 0.4 -1.5 -1.1 -2.0 -0.1 mean -0.3 0.3 0.0 0.2 0.8 0.6
SD 1.2 2.2 0.7 2.1 2.2 1.9 SD 1.4 1.1 1.7 1.4 1.1 2.3
S7 0.1 -0.8 1.1 0.4 -0.1 0.4 S7 -3.5 -1.3 -3.3 -4.6 -4.6 -3.8
S8 -0.5 -1.8 -0.2 -2.0 0.3 -1.0 S8 -0.6 -2.5 1.0 -1.5 0.7 -0.3
S9 0.3 0.9 -2.6 -1.7 -3.2 -3.8 S9 -2.3 1.2 -7.5 -6.4 -5.6 -2.1
S10 0.4 -1.6 1.6 0.0 -1.9 1.2 S10 -0.9 0.2 0.8 1.0 3.9 3.6
S11 -0.7 -1.1 4.4 3.3 1.2 3.9 S11 1.2 -1.3 4.4 3.1 3.9 4.4
S12 0.9 2.0 -1.7 0.2 1.3 1.5 S12 1.2 -0.8 2.0 1.2 2.0 0.4
mean 0.1 -0.4 0.4 0.0 -0.4 0.4 mean -0.8 -0.7 -0.5 -1.2 0.0 0.4
SD 0.6 1.5 2.5 1.9 1.8 2.6 SD 1.9 1.3 4.3 3.7 4.2 3.2
EXC DIFF hip abd EXC DIFF hip rot
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 -1.0 -0.7 -1.0 -1.8 -4.8 -5.0 S1 1.9 0.5 3.1 3.6 -2.2 -6.0
S2 1.4 -0.1 0.4 0.4 0.4 0.8 S2 0.0 -0.2 -2.6 -2.8 -0.2 -7.9
S3 0.3 -1.2 3.0 1.8 0.7 1.4 S3 0.2 -1.5 -1.5 -3.0 0.6 4.4
S4 0.1 -0.7 0.8 0.0 1.9 3.4 S4 0.0 -0.5 -0.4 -0.9 -0.2 4.3
S5 -1.2 -0.8 0.3 -0.5 -2.5 -1.2 S5 0.9 2.4 5.7 8.1 10.6 6.4
S6 -0.3 0.7 -3.1 -2.4 -1.8 -4.5 S6 2.4 0.3 1.3 1.7 -0.3 3.3
mean -0.1 -0.5 0.1 -0.4 -1.0 -0.9 mean 0.9 0.2 0.9 1.1 1.4 0.8
SD 1.0 0.7 2.0 1.5 2.5 3.4 SD 1.0 1.3 3.1 4.3 4.6 6.1
S7 -1.2 -0.7 -1.4 -2.1 -1.3 -1.3 S7 0.9 1.2 -2.7 -1.6 3.0 3.9
S8 -1.6 -0.3 3.1 2.8 2.2 3.0 S8 -0.2 -0.4 2.4 2.0 10.8 -3.2
S9 -1.0 0.2 -2.2 -2.0 -2.1 -1.2 S9 -0.9 -0.6 -2.4 -3.0 -0.9 5.1
S10 -0.1 -0.9 0.8 0.0 4.7 4.3 S10 0.8 1.2 -2.0 -0.8 0.2 4.1
S11 -0.3 -2.2 2.4 0.2 -0.2 0.8 S11 -0.2 -1.8 2.1 0.3 -1.4 -2.5
S12 -0.1 -0.4 -0.5 -0.9 -0.2 -0.3 S12 -0.9 3.0 0.8 3.8 -7.1 -4.4
mean -0.7 -0.7 0.4 -0.3 0.5 0.9 mean -0.1 0.4 -0.3 0.1 0.8 0.5
SD 0.6 0.8 2.1 1.8 2.5 2.3 SD 0.8 1.7 2.3 2.5 5.9 4.3
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EXC DIFF knee flex EXC DIFF knee abd
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 -0.1 1.3 -3.1 -1.8 0.7 2.7 S1 1.3 -1.0 1.9 0.9 -0.1 -2.3
S2 -1.9 -0.1 -2.2 -2.3 -0.5 -0.6 S2 0.3 -0.5 -0.3 -0.9 5.0 0.7
S3 -0.5 -0.8 2.4 1.6 -1.6 -0.1 S3 -0.2 -1.7 -0.3 -2.0 -0.7 0.4
S4 -1.3 -0.1 -1.1 -1.3 -0.1 -3.5 S4 -2.0 -0.4 -1.1 -1.5 -13.7 3.9 1
S5 0.3 1.9 -0.8 1.2 2.1 -2.0 S5 1.3 -1.7 -1.6 -3.4 0.9 -1.2
S6 0.9 -0.1 2.2 2.1 -0.4 -1.7 S6 0.6 -2.9 0.6 -2.3 -0.6 -1.3
mean -0.4 0.3 -0.4 -0.1 0.0 -0.8 mean 0.2 -1.4 -0.1 -1.5 -1.5 0.0
SD 1.0 1.0 2.3 1.9 1.3 2.1 SD 1.2 0.9 1.3 1.4 6.3 2.2
S7 -0.6 -0.9 -0.4 -1.3 -0.1 0.1 S7 -2.0 -0.9 -4.6 -5.5 -1.5 1.2
S8 1.2 0.8 -0.7 0.0 -4.8 -0.9 S8 0.7 -1.2 0.6 -0.5 3.7 2.4
S9 -0.2 -0.7 1.1 0.3 -2.0 -1.8 S9 -1.1 -1.0 3.5 2.5 0.5 -2.0
S10 -0.1 -2.7 0.4 -2.3 -4.1 -6.2 S10 1.1 -1.8 4.2 2.4 1.4 -0.5
S11 0.1 -4.5 0.8 -3.6 0.8 2.4 S11 0.1 1.6 -0.3 1.3 -2.2 -1.9
S12 2.0 -0.3 -0.3 -0.6 -1.4 1.8 S12 -1.6 2.0 3.3 5.3 -0.8 -2.3
mean 0.4 -1.4 0.1 -1.2 -2.0 -0.8 mean -0.5 -0.2 1.1 0.9 0.2 -0.5
SD 1.0 1.9 0.7 1.5 2.2 3.1 SD 1.3 1.6 3.3 3.7 2.1 1.9
EXC DIFF knee rot EXC DIFF ankle dorsi
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 -1.1 0.2 -5.6 -5.4 -3.0 -1.4 S1 5.7 0.8 -1.3 -0.5 -1.5 -4.0
S2 0.4 0.5 -3.7 -3.2 -0.5 -7.3 S2 -1.4 -0.2 0.0 -0.2 3.6 2.1
S3 -0.4 1.4 3.2 4.6 -1.6 2.0 S3 0.2 -0.2 0.8 0.5 -1.9 -1.6
S4 -2.4 0.2 0.1 0.3 -4.3 2.4 S4 -1.3 -2.5 2.3 -0.2 -2.4 2.0
S5 -4.1 2.0 -8.3 -6.2 0.1 -3.0 S5 0.3 2.8 -0.7 2.0 0.7 1.2
S6 -2.1 1.0 0.5 1.5 1.9 -1.1 S6 0.7 0.3 -1.8 -1.6 3.1 4.0
mean -1.6 0.9 -2.3 -1.4 -1.2 -1.4 mean 0.7 0.2 -0.2 0.0 0.3 0.6
SD 1.6 0.7 4.3 4.2 2.2 3.5 SD 2.6 1.7 1.5 1.2 2.6 2.9
S7 2.5 0.8 1.7 2.4 2.3 1.9 S7 1.1 -0.4 -0.9 -1.3 -3.5 -0.2
S8 0.3 3.2 0.9 4.0 6.4 6.5 S8 1.7 -3.3 -1.6 -4.9 1.2 0.5
S9 -1.9 -1.4 3.6 2.1 1.7 0.3 S9 -2.8 -4.5 -3.8 -8.4 -4.1 -3.1
S10 -2.0 -2.8 -0.2 -2.9 -5.9 -8.8 S10 -1.6 -3.6 -3.6 -7.2 -1.5 0.3
S11 -0.3 -0.3 1.6 1.3 2.1 4.3 S11 0.9 -2.1 0.1 -2.0 3.1 3.4
S12 -2.5 -0.6 -4.7 -5.4 -7.5 -6.4 S12 -0.5 0.6 0.1 0.6 -1.5 -3.8
mean -0.7 -0.2 0.5 0.3 -0.1 -0.4 mean -0.2 -2.2 -1.6 -3.8 -1.1 -0.5
SD 1.9 2.0 2.8 3.6 5.4 6.1 SD 1.8 2.0 1.7 3.5 2.7 2.6
EXC DIFF ankle abd EXC DIFF ankle inv
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 8.3 1.2 1.5 2.6 4.5 -0.3 S1 -5.6 0.2 -5.3 -5.1 -4.9 5.6
S2 -0.7 -1.2 0.3 -0.9 0.2 -1.0 S2 -2.3 -0.5 -2.0 -2.5 -3.5 -4.2
S3 1.4 -2.1 3.7 1.6 -1.1 2.7 S3 -1.2 -2.5 2.6 0.1 0.5 2.9
S4 4.2 -1.5 2.4 0.9 2.9 4.5 S4 0.2 -1.1 -0.7 -1.8 -0.1 -6.5
S5 -0.3 0.7 0.0 0.7 4.5 -1.5 S5 -0.4 -0.4 1.7 1.4 2.8 1.4
S6 -0.3 -0.3 -0.9 -1.2 -4.8 -1.1 S6 -0.6 0.6 3.3 3.9 0.0 -0.5
mean 2.1 -0.5 1.1 0.6 1.0 0.5 mean -1.7 -0.6 0.0 -0.7 -0.9 -0.2
SD 3.5 1.3 1.7 1.5 3.7 2.4 SD 2.1 1.1 3.3 3.1 2.8 4.5
S7 1.0 0.5 -2.4 -1.9 0.7 0.9 S7 1.4 -4.4 4.4 0.1 8.1 -1.2
S8 -0.9 2.0 -0.4 1.6 2.9 1.1 S8 3.0 -1.2 6.9 5.7 -1.0 0.0
S9 -2.6 -0.1 -4.1 -4.2 -1.9 1.0 S9 0.0 0.1 2.8 2.9 -4.5 -2.6
S10 4.4 -0.1 0.4 0.3 1.9 4.0 S10 2.6 -2.8 6.7 4.0 0.6 4.0
S11 -0.1 -2.0 -1.1 -3.1 -0.2 0.9 S11 -1.7 -1.0 -2.2 -3.2 -8.5 -5.6
S12 1.5 -5.0 1.2 -3.8 -5.9 -3.2 S12 1.5 -5.0 1.2 -3.8 -5.9 -3.2
mean 0.5 -0.8 -1.1 -1.9 -0.4 0.8 mean 1.1 -2.4 3.3 0.9 -1.9 -1.4
SD 2.4 2.4 2.0 2.4 3.2 2.3 SD 1.8 2.0 3.5 3.9 5.9 3.3
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Appendix D 7. FOl and F 02  GRF components excursion differences during LR 
between sessions (n = 6 per FO condition)
EXC DIFF GRFz LR F01
normal variability A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 within -13.5 8.7 1.3 10.0 55.9 36.2
S2 19(10.6) -21.6 3.1 -25.8 -22.7 -32.7 -95.6
S3 between -19.6 8.9 -24.1 -15.2 -52.5 -29.6
S4 30.8(20.2) 34.3 -15.3 48.5 33.2 -5.7 38.9
S5 -21.7 -7.1 20.9 13.7 -23.3 -34.8
S6 -20.3 -1.0 -24.5 -25.4 13.3 10.4
mean -10.4 -0.4 -0.6 -1.1 -7.5 -12.4
SD 22.1 9.5 30.4 23.6 38.4 51.4
F 02
S7 normal mean (SD) -16.3 -14.4 -1.9 -16.3 -1.4 -9.3
S8 within 34.4 5.8 16.3 22.1 -30.1 13.0
S9 19(10.6) 0.7 30.4 2.3 32.8 -34.5 -13.6
S10 between -30.0 -45.6 -4.7 -50.3 -39.2 -22.7
S11 30.8(20.2) 6.7 -1.9 32.3 30.4 -14.1 34.2
S12 21.4 -26.9 15.3 -11.6 -4.7 -14.1
mean 2.8 -8.8 9.9 1.2 -20.7 -2.1
SD 23.7 26.5 14.0 32.9 16.1 21.5
EXC DIFF GRFx LR F01
normal variability A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 within 1.5 -29.3 -7.1 -36.5 -6.3 13.0 I
S2 6.8(6.6) 9.1 -8.9 -4.4 -13.3 0.3 -26.2
S3 between -17.2 -5.4 4.4 -1.0 -25.8 -29.3
S4 9(6.4) -9.3 9.1 -6.9 2.3 -6.3 12.5
S5 -18.4 5.3 7.7 13.0 19.5 -19.7
S6 -0.1 -6.6 -9.5 -16.1 -26.1 -7.0
mean -5.7 -6.0 -2.6 -8.6 -7.5 -9.5
SD 11.0 13.5 7.0 17.3 17.2 18.8
F 0 2
S7 normal variability -6.4 -17.7 -2.9 -20.6 -10.2 2.4
S8 within 7.6 -7.5 7.1 -0.5 -18.5 -20.9
S9 6.8(6.6) -27.0 -5.5 -35.5 -41.0 -44.7 -50.8
S10 between -19.3 4.5 -23.7 -19.1 -6.7 6.6
S11 9(6.4) -9.4 -7.3 -4.8 -12.1 11.3 31.4
S12 8.3 -6.6 12.5 5.9 -3.4 -7.4
mean -7.7 -6.7 -7.9 -14.6 -12.0 -6.4
SD 14.2 7.1 18.4 16.6 18.8 27.8
EXC DIFF GRFy LR
normal variability F01
within A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 9(5.8) -12.8 -1.6 -4.2 -5.8 -5.4 -2.3
S2 between -5.2 5.4 -15.8 -10.4 -11.4 -8.0
S3 2(1.4) -5.9 -3.0 0.8 -2.1 -4.9 1.7
S4 -2.3 -6.2 0.2 -5.9 -3.2 3.1
S5 2.0 3.2 1.0 4.2 -15.6 4.4
S6 -4.5 -7.3 -16.7 -24.0 -11.2 -20.0
mean -4.8 -1.6 -5.8 -7.3 -8.6 -3.5
SD 4.8 5.0 8.4 9.5 4.8 9.2
F 02
S7 normal variability -16.7 -7.5 2.5 -5.1 3.3 6.3
S8 within 4.1 -9.8 12.7 3.0 0.8 -1.3
S9 9(5.8) 3.1 -12.7 1.7 -10.9 -7.5 -11.9
S10 between -16.4 -1.6 -16.2 -17.8 -16.1 -14.4
S11 2(1.4) -10.7 -5.9 1.9 -4.0 8.4 2.7
S12 -8.1 1.8 -7.4 -5.6 -25.9 -16.0
mean -7.4 -5.9 -0.8 -6.7 -6.1 -5.8
SD 9.2 5.3 9.9 7.0 13.0 9.5
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Appendix D 8. Moment excursion differences during LR
Moment EXC DIFF LR Hip flex EXC DIFF hip abd
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 normal -4.9 -17.6 -15.3 -32.9 -17.1 -0.7 S1 normal -3.3 -1.7 -5.7 -7.3 -7.4 -6.8
S2 mean(SD) 2.3 -9.6 3.0 -6.5 5.5 1.2 S2 mean(SD) -4.2 -3.0 -0.3 -3.3 1.1 -2.3
S3 within 2.7 -0.3 6.0 5.7 4.3 1.4 S3 within 0.3 -4.0 -6.8 -10.8 -14.3 -11.8
S4 13.6(1.3) -20.1 2.3 -15.5 -13.3 -7.4 8.0 S4 3.8(1.2) -1.9 1.3 -0.4 0.9 -5.1 1.3
S5 between -1.3 11.6 12.0 23.6 25.8 -11.9 S5 between -1.6 2.8 -0.2 2.6 -2.4 2.2
S6 8.6(23) -3.7 3.9 -20.9 -17.0 -1.7 0.1 S6 5.1(39) -3.5 4.3 -16.7 -12.4 0.4 0.7
mean -4.2 -1.6 -5.1 -6.7 1.6 -0.3 mean -2.4 0.0 -5.0 -5.1 -4.6 -2.8
SD 8.4 10.4 13.8 19.6 14.5 6.5 SD 1.6 3.4 6.5 6.2 5.8 5.5
S7 normal -1.6 -4.2 -1.0 -5.2 -5.3 2.4 S7 normal -3.7 -2.9 -7.6 -10.5 -2.2 0.2
S8 mean(SD) -3.3 -8.5 7.9 -0.6 -36.8 -28.7 S8 mean(SD) -3.9 3.2 1.2 4.4 6.1 13.2
S9 within -17.2 -1.8 -24.7 -26.4 -25.4 -18.1 S9 within -1.1 3.7 -12.9 -9.2 -14.4 -15.4
S10 13.6(1.3) -15.0 1.7 -11.3 -9.5 -3.3 9.9 S10 3.8(1.2) -3.7 -3.6 -4.1 -7.7 -13.0 -2.3
S11 between -10.9 -6.2 -4.4 -10.6 -0.2 1.5 S11 between -8.9 -8.1 2.7 -5.4 -3.4 5.2
S12 8.6(2.3) 4.9 5.3 0.1 5.3 -1.0 -0.4 S12 5.1(39) -3.7 -8.7 5.3 -3.4 -6.6 -0.2
mean -7.2 -2.3 -5.6 -7.8 -12.0 -5.6 mean -4.2 -2.7 -2.5 -5.3 -5.6 0.1
SD 8.6 5.1 11.3 10.9 15.3 14.6 SD 2.6 5.3 6.9 5.4 7.6 9.4
EXC DIFF hip rot EXC DIFF knee flex
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 normal -0.4 3.5 -7.2 -3.8 1.3 -5.8 S1 normal -1.1 -12.5 3.3 -9.2 5.0 2.3
S2 mean(SD) -1.5 1.7 5.1 6.8 6.0 2.6 S2 mean(SD) -2.6 -5.0 12.3 7.3 6.7 4.7
S3 within -0.2 -1.1 -1.8 -2.9 -5.9 -3.6 S3 within -11.9 -0.2 1.8 1.6 -4.9 -8.3
S4 2.2(1.2) -1.4 -0.4 -6.2 -6.6 -2.6 -1.7 S4 57(3.8) -5.7 -0.2 4.7 4.5 -1.2 27.8
S5 between -0.8 -0.6 1.8 1.2 -2.6 -1.1 S5 between -6.6 1.9 -9.6 -7.7 -8.6 -12.0
S6 59(3.7) -1.3 2.0 -11.7 -9.7 -7.5 -11.2 S6 6.9(2.4) 7.5 -2.9 -6.9 -9.7 -8.0 2.6
mean -0.9 0.8 -3.3 -2.5 -1.9 -3.5 mean -3.4 -3.1 0.9 -2.2 -1.8 2.8
SD 0.6 1.8 6.2 5.8 4.9 4.7 SD 6.5 5.2 8.0 7.5 6.5 13.9
S7 normal -2.2 1.3 -4.5 -3.2 -3.7 -1.6 S7 normal -7.3 -6.4 -3.9 -10.4 -13.3 -5.1
S8 mean(SD) -1.9 -1.7 0.4 -1.3 2.4 -1.0 S8 mean(SD) -5.9 -5.6 -13.8 -19.4 -10.2 -9.2
S9 within -3.5 4.1 -15.2 -11.1 -20.6 -14.8 S9 within -9.9 -2.4 -27.4 -29.9 -23.2 -21.2
S10 2.2(1.2) -3.0 0.7 -8.3 -7.6 -2.9 -3.5 S10 5.7(3.8) -14.1 1.9 -18.7 -16.8 -4.8 -4.0
S11 between -4.6 -1.2 -6.9 -8.1 -2.6 -0.1 S11 between -7.1 -4.4 9.8 5.4 20.6 25.7
S12 59(3.7) -1.7 -1.7 -1.4 -3.1 -2.7 1.8 S12 6.9(24) 1.0 -2.0 3.9 1.9 1.2 -11.9
mean -2.8 0.2 -6.0 -5.7 -5.0 -3.2 mean -7.2 -3.2 -8.4 -11.5 -4.9 -4.3
SD 1.1 2.3 5.6 3.8 7.9 5.9 SD 5.0 3.0 14.1 13.4 15.0 15.9
EXC DIFF knee abd EXC DIFF knee rot
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 normal -8.8 -1.5 -14.0 -15.5 -10.5 0.4 S1 normal -0.8 -3.4 2.0 -1.5 0.3 -1.5
S2 mean(SD) 0.0 1.9 -17.5 -15.7 -10.9 -20.5 S2 mean(SD) -0.5 -1.1 2.2 1.1 0.8 2.2
S3 within -2.8 1.5 -7.4 -5.9 -12.5 -10.3 S3 within -1.4 0.2 -0.8 -0.6 -1.1 -1.8
S4 48(1.8) 0.5 1.1 -7.2 -6.1 2.0 -18.5 S4 1.3(0.7) 0.6 -0.9 1.4 0.5 -0.1 3.7
S5 between -5.3 1.5 2.0 3.5 -2.0 2.5 S5 between -1.6 0.7 -0.1 0.5 0.7 -1.3
S6 6(2.8) -5.9 2.4 -5.3 -2.9 0.7 -5.9 S6 2.2(11) -0.1 -1.6 -3.0 -4.6 -2.5 2.3
mean -3.7 1.1 -8.2 -7.1 -5.5 -8.7 mean -0.6 -1.0 0.3 -0.7 -0.3 0.6
SD 3.6 1.4 6.8 7.4 6.5 9.5 SD 0.8 1.5 2.0 2.1 1.3 2.4
S7 normal -0.5 -2.3 -2.2 -4.5 5.1 2.1 S7 normal -1.0 -1.7 -1.1 -2.8 -2.3 0.3
S8 mean(SD) 1.7 -1.3 12.5 11.1 -7.7 3.4 S8 mean(SD) -0.4 0.8 -1.8 -1.0 2.4 4.6
S9 within -0.8 -0.8 3.3 2.5 -1.9 -3.7 S9 within -1.5 -0.3 -0.7 -0.9 -1.0 -2.2
S10 4.8(1.8) -5.0 -1.4 -1.6 -3.1 -4.9 -3.8 S10 1.3(07) -0.7 -1.0 -3.0 -4.0 -1.0 -0.7
S11 between -7.0 -0.5 -2.1 -2.7 -2.4 4.2 S11 between -0.9 -0.2 1.3 1.1 2.0 4.5
S12 6(2.8) -0.8 -6.4 5.1 -1.3 0.5 13.5 S12 2.2(11) 0.4 -0.9 0.0 -0.9 -2.9 -1.4
mean -2.1 -2.1 2.5 0.4 -1.9 2.6 mean -0.7 -0.5 -0.9 -1.4 -0.5 0.8
SD 3.2 2.2 5.8 5.8 4.4 6.4 SD 0.6 0.9 1.5 1.8 2.2 3.0
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Appendix D 8. LR moment contd.
EXC DIFF ankle dorsi EXC DIFF ankle abd
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 normal 1.3 -3.6 3.8 0.2 3.9 2.3 S1 normal 1.9 1.0 -0.9 0.1 -0.3 -0.2
S2 mean(SD) -3.1 -0.2 -3.1 -3.4 -2.8 -5.9 S2 mean(SD) -2.8 0.5 -5.0 -4.4 -1.3 -1.4
S3 within 1.9 -0.6 0.9 0.3 -2.4 1.3 S3 within 0.4 1.6 -3.4 -1.8 -0.5 -2.6
S4 3(0.8) 6.4 -4.1 4.3 0.2 1.6 6.0 S4 1.9(0.8) -0.2 -0.8 -0.9 -1.7 -1.1 -0.8
S5 between -1.7 -3.5 4.2 0.7 7.2 -9.7 S5 between 0.7 -0.4 4.7 4.3 -1.0 5.3
S6 2.7(08) -1.7 -4.0 -0.8 -4.8 -5.8 1.1 S6 4.4(27) -0.4 1.3 -5.9 -4.6 -1.7 -1.0
mean 0.5 -2.7 1.5 -1.1 0.3 -0.8 mean -0.1 0.5 -1.9 -1.4 -1.0 -0.1
SD 3.5 1.8 3.1 2.3 4.8 5.8 SD 1.6 1.0 3.8 3.3 0.5 2.8
S7 normal 2.2 -6.6 2.1 -4.4 1.2 1.7 S7 normal -2.3 0.8 -5.7 -4.9 -2.8 -2.7
S8 mean(SD) -0.6 -1.8 -3.2 -5.0 -5.9 0.8 S8 mean(SD) -0.3 0.6 0.1 0.7 -0.2 1.9
S9 within -0.8 1.2 -3.4 -2.2 -2.1 -9.0 S9 within -0.4 0.1 -4.3 -4.3 -2.3 0.4
S10 3(0.8) -2.3 -1.2 -5.5 -6.7 -2.4 -3.4 S10 1.9(08) -2.9 4.2 -4.1 0.1 -0.7 3.0
S11 between -1.3 0.0 -0.4 -0.4 -1.3 6.2 S11 between -1.7 1.2 -3.8 -2.6 0.1 3.8
S12 2.7(0.8) -2.4 1.3 -1.4 -0.1 -6.5 -2.9 S12 4.4(27) -2.3 -0.5 3.7 3.3 6.4 10.3
mean -0.9 -1.2 -1.9 -3.1 -2.8 -1.1 mean -1.7 1.1 -2.3 -1.3 0.1 2.8
SD 1.7 2.9 2.7 2.7 2.9 5.2 SD 1.1 1.7 3.6 3.2 3.3 4.3
EXC DIFF ankle inv
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 normal -1.0 0.3 -1.6 -1.3 -0.9 -1.8
S2 mean(SD) -1.0 0.0 -0.5 -0.5 -0.3 -2.9
S3 within -1.0 -0.1 -3.5 -3.6 -3.9 -3.8
S4 0.9(0.6) -0.7 0.1 -1.2 -1.2 -1.5 -1.0
S5 between -1.7 0.3 0.7 1.0 0.4 -0.5
S6 1.3(08) 0.4 -0.5 -1.5 -2.0 -1.1 -1.6
mean -0.8 0.0 -1.3 -1.3 -1.2 -1.9
SD 0.7 0.3 1.4 1.5 1.5 1.2
S7 normal -0.1 0.1 -0.9 -0.8 0.1 -0.2
S8 mean(SD) -0.7 -1.0 -0.1 -1.1 -0.6 -2.4
S9 within -0.2 -0.6 -0.3 -1.0 -2.0 -2.6
S10 09(0.6) -0.4 -1.2 1.0 -0.1 -0.1 0.6
S11 between -1.4 -0.8 -1.4 -2.2 -1.5 0.4
S12 1.3(08) 0.1 -0.9 1.8 0.8 0.9 0.9
mean -0.4 0.1 1.1 1.2 0.8 1.1
SD 1.6 1.1 1.7 1.3 1.9 2.3
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Appendix D 9a. CMC of GRF (GC)
CMC GRFz all GC
normal m ean (SD) A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 within 99.4% 97.1% 99.1% 99.1% 99.4% 99.6%
S2 99.1(0.2) 99.8% 99.9% 99.8% 99.8% 99.6% 97.5%
S3 99.0% 99.6% 99.6% 99.0% 97.9% 98.4%
S4 between 99.6% 99.7% 99.5% 99.6% 99.8% 98.8%
S5 99.5(0.2) 98.7% 98.4% 99.1% 99.6% 98.9% 99.0%
S6 99.3% 98.9% 99.8% 99.1% 98.7% 99.4%
mean 99.3% 98.9% 99.5% 99.4% 99.1% 98.8%
SD 0.4% 1.1% 0.3% 0.3% 0.7% 0.8%
S7 normal m ean (SD) 99.2% 99.0% 98.5% 99.4% 99.8% 99.6%
S8 within 99.4% 99.9% 99.8% 99.8% 98.9% 99.2%
S9 99.1(0.2) 99.9% 99.8% 99.4% 99.4% 99.3% 98.6%
S10 99.6% 99.7% 99.2% 98.8% 99.6% 99.6%
S11 between 99.7% 99.1% 98.6% 98.2% 98.6% 96.6%
S12 99.5(0.2) 99.8% 99.9% 99.8% 99.9% 99.7% 99.7%
mean 99.6% 99.5% 99.2% 99.2% 99.3% 98.9%
SD 0.3% 0.4% 0.6% 0.7% 0.5% 1.2%
CMC GRFx
normal m ean (SD) A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 within 99.9% 97.2% 99.1% 99.3% 99.6% 99.5%
S2 99.5(0.2) 99.7% 99.9% 99.9% 99.9% 99.8% 98.9%
S3 between 99.4% 99.8% 99.8% 99.5% 99.0% 99.2%
S4 99.7(0.2)% 99.7% 99.7% 99.5% 99.8% 99.7% 98.5%
S5 99.0% 98.3% 99.2% 99.4% 98.8% 99.4%
S6 99.5% 99.5% 99.9% 99.7% 99.5% 99.7%
mean 99.5% 99.1% 99.6% 99.6% 99.4% 99.2%
SD 0.3% 1.1% 0.4% 0.2% 0.4% 0.4%
S7 normal m ean (SD) 99.6% 99.4% 99.3% 99.7% 99.8% 99.7%
S8 within 99.7% 99.7% 99.9% 99.8% 99.6% 99.5%
S9 99.5(0.2) 99.4% 99.6% 97.9% 98.2% 97.7% 96.5%
S10 between 99.7% 99.9% 99.6% 99.6% 99.7% 99.4%
S11 99.7(0.2)% 99.9% 99.6% 99.4% 99.1% 99.5% 98.0%
S12 99.8% 99.9% 99.9% 99.9% 99.8% 99.8%
mean 99.7% 99.7% 99.3% 99.4% 99.4% 98.8%
SD 0.2% 0.2% 0.8% 0.6% 0.8% 1.3%
CMC GRFy F01
normal m ean (SD) A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 within 95.8% 95.2% 83.0% 91.8% 96.7% 93.6%
S2 94.8(2.2) 99.5% 99.2% 98.7% 99.1% 98.5% 97.6%
S3 between 98.0% 97.5% 97.7% 98.1% 96.6% 94.9%
S4 98.1(1.3) 97.6% 98.3% 97.1% 97.9% 97.9% 95.1%
S5 95.7% 96.6% 98.3% 97.7% 94.7% 97.3%
S6 98.6% 96.4% 98.2% 93.6% 96.3% 98.2%
mean 97.5% 97.2% 95.5% 96.4% 96.8% 96.1%
SD 1.5% 1.4% 6.1% 2.9% 1.3% 1.8%
S7 normal mean (SD) 96.2% 96.4% 95.6% 98.8% 99.3% 97.8%
S8 within 98.2% 98.6% 96.4% 98.5% 97.8% 96.9%
S9 94.8(2.2) 98.6% 95.6% 98.5% 94.9% 97.1% 96.1%
S10 between 95.1% 99.1% 96.1% 94.5% 92.5% 93.1%
S11 98.1(1.3) 96.9% 99.2% 97.4% 98.2% 98.0% 98.3%
S12 96.4% 99.7% 98.5% 98.3% 94.8% 97.4%
m ean 96.9% 98.1% 97.1% 97.2% 96.6% 96.6%
SD 1.3% 1.7% 1.2% 2.0% 2.5% 1.9%
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Appendix D 9b. ABSD of GRF components (GC)
ABSD GRFz
F01
normal mean (SD) A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 within 22.1 38.2 21.6 22.1 21.2 15.9
S2 27.4(7.4) 16.6 8.8 16.4 17.6 22.0 60.3
S3 30.9 15.2 18.8 28.5 44.2 37.7
S4 between 15.7 13.6 21.2 18.6 12.8 31.2
S5 23.6(6.9) 34.1 34.5 28.2 20.0 35.1 32.8
S6 20.6 30.7 13.0 31.5 33.5 21.6
mean 23.3 23.5 19.9 23.0 28.1 33.2
SD 7.6 12.4 5.2 5.7 11.4 15.4
F 02
S7 normal mean (SD) 31.0 30.9 44.1 27.4 14.6 22.9
S8 within 21.3 12.6 9.9 13.7 31.6 28.8
S9 27.4(7.4) 10.4 17.3 26.4 23.8 25.6 33.2
S10 22.2 19.5 27.7 35.0 20.2 19.1
S11 between 14.8 26.0 37.4 39.3 34.6 54.0
S12 23.6(6.9) 13.8 9.8 10.6 8.2 15.0 17.9
mean 18.9 19.3 26.0 24.6 23.6 29.3
SD 7.5 8.0 13.8 12.0 8.4 13.4
ABSD GRFx
F01
normal mean (SD) A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 within 3.6 11.5 6.9 6.0 4.9 5.2
S2 9 .0(20) 6.8 3.9 3.8 4.9 4.7 13.9
S3 11.0 4.0 7.0 9.8 13.3 11.6
S4 between 4.9 4.6 6.6 4.1 4.4 10.6
S5 7.1 (3.0) 9.1 11.9 6.9 7.6 10.3 7.6
S6 8.7 8.4 3.6 7.3 7.8 5.2
mean 7.3 7.4 5.8 6.6 7.6 9.0
SD 2.8 3.8 1.6 2.1 3.6 3.6
F02
S7 normal mean (SD) 8.9 9.1 11.0 8.0 5.4 6.2
S8 within 6.0 6.5 3.9 4.7 7.9 9.4
S9 9.0(2.0) 6.7 6.2 13.6 11.1 14.7 17.9
S10 7.5 4.3 7.5 7.4 6.9 10.0
S11 between 5.0 7.5 8.5 11.2 6.8 15.5
S12 7.1 (3.0) 4.6 2.7 3.5 3.0 5.1 4.9
mean 6.4 6.1 8.0 7.6 7.8 10.7
SD 1.6 2.3 3.9 3.3 3.5 5.1
ABSD GRFy
F01
normal mean (SD) A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 within 4.3 4.0 9.1 6.7 4.1 5.7
S2 6.3(1.6) 2.2 2.7 3.6 3.1 4.1 4.4
S3 2.7 3.3 2.9 3.0 4.0 4.5
S4 between 3.7 2.9 3.6 3.9 3.8 4.8
S5 3.5(1.4) 5.3 4.0 2.9 3.5 5.7 4.2
S6 3.4 6.7 3.4 7.9 4.8 3.7
mean 3.6 3.9 4.3 4.7 4.4 4.5
SD 1.1 1.5 2.4 2.1 0.7 0.7
F 02
S7 normal mean (SD) 4.2 5.0 5.2 2.8 2.2 2.9
S8 within 3.0 2.3 3.8 2.7 3.6 4.2
S9 6.3(1.6) 2.6 5.5 2.7 5.0 4.0 5.0
S10 5.5 2.4 4.4 5.3 6.3 5.7
S11 between 3.6 2.2 3.7 2.9 3.5 2.8
S12 3.5(1.4) 4.9 1.4 3.2 3.4 5.6 3.9
mean 4.0 3.1 3.8 3.7 4.2 4.1
SD 1.1 1.7 0.9 1.2 1.5 1.1
D. 17
Appendices D
Appendix D 9c. Excursion differences for GRF (GC)
EXC DIFF GRFz
F01
normal variability A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 within -32.0 -7.1 1.3 -5.8 28.5 36.2
S2 19(10.6) 0.7 14.7 -9.8 5.0 1.6 -69.2
S3 between 5.5 5.4 7.4 12.9 -13.7 -3.0
S4 30.8(20.2) 1.6 -5.0 48.6 43.6 18.3 68.2
S5 -4.5 13.5 12.5 26.0 3.3 15.4
S6 -20.0 -19.1 -24.2 -43.3 -40.4 -7.2
mean -8.1 0.4 6.0 6.4 -0.4 6.7
SD 14.7 13.2 24.7 29.8 24.4 46.4
F 0 2
S7 mal mean (SD) 4.2 -3.1 -13.2 -16.3 -18.3 -19.5
S8 within -13.3 2.2 16.1 18.3 -32.0 -22.0
S9 19(10.6) -4.9 24.8 -17.7 7.0 -13.9 -18.5
S10 between -35.4 -38.5 -16.8 -55.3 -34.8 -18.3
S11 30.8(20.2) -15.9 -36.9 28.4 -8.5 -5.7 -3.6
S12 -19.6 -9.9 5.9 -4.0 -1.8 9.3
mean -14.1 -10.2 0.5 -9.8 -17.8 -12.1
SD 13.5 24.3 19.3 25.4 13.5 12.4
EXC DIFF GRFx
F01
normal variability A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 within -0.1 -11.4 8.8 -2.6 12.7 23.9
S2 6.8(6.6) 5.5 -3.4 -11.0 -14.3 -3.7 -43.3
S3 between -26.8 -6.5 -0.4 -6.9 -32.5 -30.4
S4 9(6.4) -1.7 -2.3 13.8 11.4 6.1 27.4
S5 -5.0 14.4 10.5 24.9 -12.5 -12.1
S6 -6.7 -9.2 -9.9 -19.1 -14.5 3.9
mean -5.8 -3.1 2.0 -1.1 -7.4 -5.1
SD 11.1 9.2 10.7 16.5 16.2 28.7
F 0 2
S7 rmal variability -23.3 -26.1 -1.6 -27.6 -24.3 -13.2
S8 within 3.6 -7.2 5.3 -1.9 -19.4 -11.0
S9 6.8(6.6) -23.4 -3.1 -49.4 -52.5 -53.9 -69.1
S10 between -28.7 5.9 -4.8 1.1 13.9 32.2
S11 9(6.4) -7.7 19.4 16.4 35.8 27.6 61.0
S12 3.6 -3.7 3.6 0.0 -7.9 -7.6
mean -12.7 -2.4 -5.1 -7.5 -10.7 -1.3
SD 14.4 15.0 22.9 29.9 29.0 44.4
EXC DIFF GRFv
F01
normal variability A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 within -8.7 -2.1 -0.1 -2.2 -1.7 0.6
S2 9(5.8) -5.2 5.4 -15.8 -10.4 -11.4 -8.0
S3 between -5.4 -4.4 1.3 -3.1 -5.8 -5.5
S4 2(1.4) -5.9 -13.0 4.2 -8.8 -4.3 0.8
S5 3.9 2.7 3.0 5.7 -12.8 6.1
S6 -4.5 -7.3 -16.7 -24.0 -11.2 -20.0
mean -4.3 -3.1 -4.0 -7.1 -7.9 -4.3
SD 4.3 6.7 9.6 10.0 4.5 9.2
F 0 2
S7 -12.5 -9.4 -2.8 -12.2 1.8 -2.7
S8 normal variability 4.1 -9.8 12.7 3.0 0.8 -1.3
S9 within 1.2 -11.9 1.0 -10.9 -9.5 -12.5
S10 9(5.8) -8.8 -6.3 -3.8 -10.1 -7.1 -3.9
S11 between -10.7 -5.9 1.9 -4.0 2.3 2.7
S12 2(1.4) -11.7 1.8 -6.9 -5.1 -25.4 -15.5
mean -6.4 -6.9 0.3 -6.6 -6.2 -5.5
SD 7.2 4.8 6.9 5.7 10.6 7.0
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Appendix D 10a. FOl and F02 moment CMC for GC.
CMC hip flex moment CMC hip abd
normal A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D normal A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 mean(SD) 99.6% 92.1% 96.7% 97.1% 98.1% 98.9% S1 mean(SD) 99.4% 98.5% 99.0% 98.2% 99.1% 97.4%
S2 within 99.3% 99.7% 99.0% 99.0% 98.6% 97.5% S2 within 99.8% 99.9% 99.2% 98.8% 99.0% 97.2%
S3 98.9(0.2) 98.7% 99.4% 98.8% 98.5% 98.2% 98.2% S3 98.7(0.4) 99.8% 99.6% 99.3% 98.9% 98.6% 98.3%
S4 between 99.3% 99.8% 99.8% 99.7% 99.6% 99.3% S4 between 98.6% 99.4% 99.4% 99.5% 99.6% 99.2%
S5 98.8(0.6) 98.4% 97.4% 98.0% 98.1% 95.8% 98.8% S5 98.7(1.2) 98.9% 98.8% 99.0% 98.7% 98.3% 98.8%
S6 99.1% 98.9% 99.1% 98.7% 97.5% 99.4% S6 99.7% 99.6% 98.3% 98.4% 99.1% 99.3%
mean 99.1% 97.9% 98.6% 98.5% 98.0% 98.7% mean 99.4% 99.3% 99.0% 98.8% 99.0% 98.4%
SD 0.4% 3.0% 1.1% 0.9% 1.3% 0.7% SD 0.5% 0.5% 0.4% 0.5% 0.4% 0.9%
S7 normal 98.0% 99.2% 97.4% 97.8% 98.5% 97.9% S7 normal 99.2% 99.2% 98.8% 98.9% 99.5% 99.5%
S8 mean(SD) 99.1% 99.6% 99.6% 99.6% 98.4% 98.7% S8 mean(SD) 99.6% 99.9% 99.9% 99.9% 99.6% 98.7%
S9 within 99.4% 99.6% 98.9% 98.7% 98.2% 98.9% S9 within 99.8% 99.5% 99.3% 99.5% 99.2% 99.1%
S10 98.9(0.2) 98.6% 99.2% 99.1% 98.4% 98.2% 97.6% S10 98.7(0.4) 99.7% 99.8% 99.5% 99.4% 99.6% 99.4%
S11 between 99.8% 99.3% 98.4% 98.2% 97.9% 98.2% S11 between 99.4% 99.7% 99.0% 98.6% 97.6% 99.1%
S12 98.8(0.6) 99.1% 99.1% 98.7% 99.3% 97.2% 99.0% S12 98.7(1.2) 99.6% 99.4% 99.1% 99.8% 99.6% 98.3%
mean 99.0% 99.3% 98.7% 98.7% 98.1% 98.4% mean 99.6% 99.6% 99.3% 99.3% 99.2% 99.0%
SD 0.6% 0.2% 0.7% 0.7% 0.5% 0.6% SD 0.2% 0.3% 0.4% 0.5% 0.8% 0.4%
CMC hip rot CMC knee flex
normal A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D normal A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 mean(SD) 97.7% 97.5% 88.3% 85.2% 95.8% 93.4% S1 mean(SD) 99.0% 91.9% 85.0% 94.1% 93.9% 94.9%
S2 within 98.8% 98.7% 95.3% 91.6% 97.4% 95.3% S2 within 98.9% 99.8% 80.7% 80.9% 70.1% 58.6%
S3 98.0(0.7) 99.2% 98.6% 97.7% 97.1% 96.7% 95.8% S3 98.8(0.5) 97.3% 99.1% 99.2% 98.0% 97.7% 96.2%
S4 between 95.7% 99.0% 95.9% 95.5% 97.2% 92.5% S4 between 99.0% 99.4% 97.1% 98.8% 99.3% 82.6%
S5 95.6(3.5) 99.4% 98.8% 98.6% 98.8% 96.8% 99.2% S5 97.6(2.5) 98.4% 96.7% 93.4% 96.2% 94.7% 96.2%
S6 99.1% 99.6% 98.1% 97.9% 93.7% 95.5% S6 98.4% 99.3% 98.6% 98.3% 98.7% 97.4%
mean 98.3% 98.7% 95.7% 94.4% 96.3% 95.3% mean 98.5% 97.7% 92.3% 94.4% 92.4% 87.6%
SD 1.4% 0.7% 3.8% 5.1% 1.4% 2.3% SD 0.6% 3.1% 7.7% 6.8% 11.1% 15.3%
S7 normal 95.3% 96.9% 93.1% 96.9% 93.2% 95.3% S7 normal 98.8% 98.2% 97.4% 99.0% 98.4% 98.4%
S8 mean(SD) 99.6% 99.7% 99.3% 99.3% 98.2% 97.2% S8 mean(SD) 98.9% 99.8% 91.1% 90.3% 94.4% 98.1%
S9 within 99.2% 99.2% 90.1% 89.7% 81.4% 83.1% S9 within 99.5% 99.1% 74.7% 76.8% 97.3% 98.0%
S10 98.0(0.7) 98.9% 99.5% 97.5% 96.8% 95.9% 90.6% S10 98.8(0.5) 99.4% 99.6% 97.6% 97.6% 98.8% 98.3%
S11 between 99.1% 98.7% 87.4% 92.9% 94.0% 98.7% S11 between 99.5% 97.8% 95.9% 98.0% 93.9% 93.4%
S12 95.6(3.5) 99.0% 99.5% 97.6% 97.2% 96.7% 99.0% S12 97.6(2.5) 98.9% 99.2% 98.5% 99.3% 98.2% 97.4%
mean 98.5% 98.9% 94.2% 95.5% 93.2% 94.0% mean 99.2% 98.9% 92.6% 93.5% 96.8% 97.3%
SD 1.6% 1.0% 4.7% 3.5% 6.1% 6.1% SD 0.3% 0.8% 9.1% 8.8% 2.1% 1.9%
CMC knee abd CMC knee rot
normal A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D normal A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 mean(SD) 97.8% 98.8% 96.4% 95.8% 98.0% 99.1% S1 mean(SD) 99.2% 97.7% 97.9% 98.4% 96.9% 99.3%
S2 within 99.8% 99.9% 97.2% 97.7% 99.3% 97.3% S2 within 99.4% 99.6% 98.6% 99.0% 98.4% 94.9%
S3 99.2(0.2) 99.7% 99.7% 97.6% 96.6% 97.7% 97.6% S3 98.9(0.2) 99.4% 99.6% 98.2% 98.0% 98.5% 98.6%
S4 between 96.5% 99.6% 93.3% 94.8% 97.1% 89.3% S4 between 97.8% 99.5% 98.8% 99.6% 99.4% 96.5%
S5 98.8(0.8) 99.4% 99.2% 97.6% 97.2% 98.9% 97.7% S5 98.7(0.9) 99.0% 98.3% 99.1% 99.2% 97.2% 98.6%
S6 99.4% 99.6% 99.7% 99.4% 99.3% 98.8% S6 99.6% 99.6% 98.3% 97.9% 98.0% 98.9%
mean 98.8% 99.5% 97.0% 96.9% 98.4% 96.6% mean 99.1% 99.0% 98.5% 98.7% 98.1% 97.8%
SD 1.3% 0.4% 2.1% 1.6% 0.9% 3.6% SD 0.6% 0.8% 0.4% 0.7% 0.9% 1.7%
S7 normal 99.1% 99.0% 98.7% 98.3% 98.7% 99.4% S7 normal 98.4% 99.1 % 97.0% 97.7% 97.8% 99.3%
S8 mean(SD) 99.8% 99.8% 98.5% 98.9% 99.4% 99.7% S8 mean(SD) 99.7% 99.4% 98.1% 98.9% 97.7% 95.0%
S9 within 99.9% 99.8% 99.4% 99.5% 99.3% 99.2% S9 within 99.7% 99.3% 97.7% 99.1% 99.5% 98.7%
S10 99.2(0.2) 99.5% 99.7% 99.5% 99.4% 99.7% 98.7% S10 98.9(0.2) 99.4% 99.8% 99.2% 99.0% 99.3% 99.5%
S11 between 99.4% 99.8% 98.3% 98.6% 98.8% 98.6% S11 between 99.3% 98.4% 99.3% 98.0% 99.1% 96.9%
S12 98.8(0.8) 99.9% 99.8% 99.1% 99.5% 99.4% 97.4% S12 98.7(0.9) 99.0% 99.5% 97.6% 98.9% 95.9% 97.5%
mean 99.6% 99.7% 98.9% 99.0% 99.2% 98.8% mean 99.2% 99.3% 98.2% 98.6% 98.2% 97.8%
SD 0.3% 0.3% 0.5% 0.5% 0.4% 0.8% SD 0.5% 0.5% 0.9% 0.6% 1.4% 1.7%
D.19
Appendices D
Appendix D 10a. contd.
CMC ankle dorsi CMC ankle abd
normal A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D normal A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 mean(SD) 99.7% 99.4% 99.7% 99.8% 99.7% 99.9% S1 mean(SD) 46.9% 92.0% 72.7% 86.7% 58.2% 69.4%
S2 within 99.6% 99.9% 99.8% 99.7% 99.4% 98.4% S2 within 97.6% 99.2% 96.5% 98.3% 90.5% 82.9%
S3 99.6(0.2) 99.5% 99.8% 99.9% 99.7% 99.3% 99.4% S3 97.7(1.4) 98.7% 97.6% 0.0% 0.0% 0.0% 0.0%
S4 between 99.4% 99.7% 99.0% 99.7% 99.0% 98.9% S4 between 98.4% 95.5% 51.3% 63.3% 45.3% 57.2%
S5 99.7(0.2) 99.4% 99.5% 99.6% 99.9% 99.5% 99.1% S5 81.6(16.1) 99.4% 99.4% 95.9% 96.6% 94.9% 91.6%
S6 99.8% 99.4% 99.9% 99.7% 99.5% 99.7% S6 93.2% 98.5% 17.9% 26.9% 39.5% 93.0%
mean 99.6% 99.6% 99.6% 99.7% 99.4% 99.2% mean 89.0% 97.0% 55.7% 62.0% 54.7% 78.8%
SD 0.2% 0.2% 0.4% 0.1% 0.2% 0.5% SD 20.8% 2.8% 33.2% 30.0% 25.6% 15.3%
S7 normal 99.4% 99.6% 99.3% 99.7% 99.9% 99.9% S7 normal 92.3% 90.7% 83.1% 96.9% 0.0% 78.1%
S8 mean(SD) 99.9% 99.9% 99.6% 99.5% 99.7% 99.7% S8 mean(SD) 99.2% 99.4% 86.5% 86.6% 98.5% 98.8%
S9 within 99.9% 99.9% 99.8% 99.9% 99.7% 98.7% S9 within 98.7% 99.5% 73.6% 72.6% 86.2% 90.2%
S10 99.6(0.2) 99.9% 99.5% 99.0% 99.2% 99.8% 99.8% S10 97.7(1.4) 82.7% 97.4% 66.2% 71.7% 76.0% 92.9%
S11 between 99.9% 99.7% 99.6% 99.5% 99.9% 99.2% S11 between 99.0% 98.7% 94.7% 92.2% 98.0% 88.5%
S12 99.7(0.2) 99.4% 99.9% 99.8% 100.0% 99.6% 99.9% S12 81.6(16.1) 95.9% 99.1% 97.2% 97.6% 93.7% 77.9%
mean 99.7% 99.8% 99.5% 99.6% 99.8% 99.5% mean 94.7% 97.5% 83.6% 86.2% 75.4% 87.8%
SD 0.3% 0.2% 0.3% 0.3% 0.1% 0.5% SD 6.4% 3.4% 12.0% 11.6% 9.5% 8.3%
CMC ankle inv
normal A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 mean(SD) 99.0% 99.3% 98.5% 97.1% 98.5% 98.5%
S2 within 99.6% 99.6% 99.4% 99.8% 99.5% 97.7%
S3 99.3(0.2) 99.4% 99.7% 97.7% 96.7% 97.2% 97.4%
S4 between 96.9% 99.7% 99.4% 99.4% 99.4% 99.1%
S5 99(0.8) 99.1% 99.4% 98.8% 99.5% 99.4% 99.5%
S6 99.9% 99.4% 99.6% 98.8% 98.4% 98.3%
mean 99.0% 99.5% 98.9% 98.6% 98.7% 98.4%
SD 1.1% 0.2% 0.7% 1.3% 0.9% 0.8%
S7 normal 99.4% 99.7% 99.3% 99.8% 99.6% 99.8%
S8 mean(SD) 99.9% 99.8% 100.0% 99.8% 99.8% 98.7%
S9 within 99.9% 99.7% 99.5% 99.6% 99.4% 98.2%
S10 99.3(0.2) 99.6% 99.5% 98.9% 98.7% 99.6% 99.4%
S11 between 99.6% 99.1% 99.5% 99.0% 99.7% 99.4%
S12 99(0.8) 99.4% 99.8% 98.7% 99.4% 98.3% 98.3%
mean 99.6% 99.6% 99.3% 99.4% 99.4% 99.0%
SD 0.3% 0.3% 0.5% 0.4% 0.6% 0.7%
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ABSD hip flex moment ABSD hip abd
variability A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D variability A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 mean(SD) 1.8 6.3 5.2 3.2 3.0 3.1 S1 mean(SD) 1.8 2.9 2.1 3.2 2.0 3.7
S2 within 2.8 2.0 3.7 4.0 4.7 5.9 S2 within 1.3 1.1 3.0 3.6 3.4 5.6
S3 5.9(1.4) 3.0 2.5 3.2 3.5 3.9 3.7 S3 39(0.9) 1.4 1.7 2.5 3.2 3.3 3.6
S4 between 3.2 1.9 2.0 2.4 2.6 4.0 S4 between 3.1 1.9 2.1 1.9 1.6 2.3
S5 6.4(1.8) 5.2 5.7 5.7 4.9 7.5 4.8 S5 44(2.6) 2.9 3.1 3.1 3.3 3.6 3.7
S6 3.1 4.2 3.6 4.3 5.8 3.0 S6 1.6 2.1 4.2 3.7 3.0 2.6
mean 3.2 3.8 3.9 3.7 4.6 4.1 mean 2.0 2.1 2.8 3.2 2.8 3.6
SD 1.1 1.9 1.3 0.9 1.8 1.1 SD 0.8 0.7 0.8 0.7 0.8 1.1
S7 variability 4.7 3.3 5.8 5.7 4.5 4.8 S7 variability 2.4 2.3 3.2 2.9 2.2 2.1
S8 mean(SD) 3.6 2.5 2.4 2.6 4.4 4.0 S8 mean(SD) 2.0 1.2 1.3 1.4 2.5 3.9
S9 within 2.6 2.2 3.7 3.5 4.1 3.3 S9 within 1.5 2.5 3.2 2.3 2.9 3.3
S10 5.9(1.4) 4.0 3.3 2.8 4.4 4.9 5.5 S10 3.9(09) 2.1 1.6 2.5 3.2 2.5 3.0
S11 between 1.8 3.3 6.1 6.3 6.6 5.0 S11 between 2.6 1.8 3.2 4.0 5.3 2.8
S12 6.4(1.8) 2.8 2.8 3.7 2.4 5.7 3.1 S12 4.4(26) 2.1 2.3 2.8 1.2 2.2 4.1
mean 3.3 2.9 4.1 4.1 5.0 4.3 mean 2.1 2.0 2.7 2.5 2.9 3.2
SD 1.1 0.5 1.5 1.6 0.9 1.0 SD 0.4 0.5 0.7 1.1 1.2 0.7
ABSD hip rot ABSD knee flex
variability A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D variability A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 mean(SD) 0.7 0.9 1.9 2.2 1.1 1.4 S1 mean(SD) 2.2 4.6 7.7 5.1 4.8 4.6
S2 within 0.7 0.7 1.6 2.0 1.1 1.5 S2 within 2.3 0.8 9.2 9.2 11.8 14.4
S3 1.4(02) 0.6 0.7 0.9 1.1 1.2 1.3 S3 3.1(05) 3.0 1.6 1.6 2.3 2.8 3.3
S4 between 1.2 0.7 1.5 1.6 1.2 2.1 S4 between 2.3 1.5 2.9 2.1 1.8 7.4
S5 2.6(1.3) 1.1 1.6 1.7 1.6 2.8 1.3 S5 5.2(2.8) 2.1 2.7 4.4 3.4 4.1 3.5
S6 0.7 0.6 1.2 1.2 2.9 2.4 S6 3.0 2.1 3.1 3.4 2.8 3.8
mean 0.8 0.9 1.5 1.6 1.7 1.7 mean 2.5 2.2 4.8 4.2 4.7 6.2
SD 0.2 0.4 0.4 0.4 0.9 0.5 SD 0.4 1.3 3.0 2.7 3.6 4.3
S7 variability 0.9 0.9 1.4 1.0 1.5 1.2 S7 variability 3.0 3.6 4.3 2.4 3.4 3.0
S8 mean(SD) 0.7 0.7 1.0 0.9 1.3 1.6 S8 mean(SD) 2.0 1.3 6.9 7.4 5.0 2.9
S9 within 0.7 1.0 2.7 2.9 4.8 4.4 S9 within 1.3 1.4 8.7 8.3 2.8 2.4
S10 1.4(0.2) 0.7 0.6 1.1 1.5 1.4 2.5 S10 31(0.5) 2.0 1.8 4.1 3.8 3.0 3.4
S11 between 0.8 1.7 4.5 3.2 2.6 1.0 S11 between 1.6 3.2 4.3 2.9 5.5 5.1
S12 2.6(1.3) 0.7 0.5 1.2 1.3 1.1 0.6 S12 5.2(2.8) 2.4 2.0 2.7 1.9 3.4 4.2
mean 0.8 0.9 2.0 1.8 2.1 1.9 mean 2.1 2.2 5.2 4.4 3.9 3.5
SD 0.1 0.4 1.4 1.0 1.4 1.4 SD 0.6 0.9 2.2 2.7 1.1 1.0
ABSD knee abd ABSD knee rot
variability A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D variability A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 mean(SD) 2.3 1.8 2.9 2.9 2.3 1.3 S1 mean(SD) 0.5 0.9 0.8 0.7 1.0 0.4
S2 within 1.1 0.9 4.9 4.2 2.0 4.1 S2 within 0.5 0.5 1.0 0.8 1.0 1.8
S3 2.1 (0.2) 0.9 1.1 2.7 3.3 2.4 2.5 S3 1(0.2) 0.5 0.5 0.9 1.0 0.8 0.8
S4 between 1.9 0.9 3.2 2.8 2.5 4.2 S4 between 0.8 0.4 0.7 0.4 0.5 1.1
S5 3.2(1.4) 1.7 1.7 3.8 3.9 2.4 3.6 S5 1.1(0.5) 0.8 0.9 0.7 0.7 1.4 0.9
S6 1.9 1.5 1.2 1.7 1.9 2.6 S6 0.6 0.6 1.0 1.1 1.2 0.8
mean 1.6 1.3 3.1 3.1 2.3 3.0 mean 0.6 0.6 0.8 0.8 1.0 1.0
SD 0.5 0.4 1.2 0.9 0.2 1.1 SD 0.1 0.2 0.1 0.3 0.3 0.5
S7 variability 1.5 1.6 1.9 2.2 1.8 1.3 S7 variability 0.9 0.7 1.2 1.0 1.0 0.6
S8 mean(SD) 1.0 0.9 2.4 2.2 1.8 1.3 S8 mean(SD) 0.4 0.6 1.1 0.7 1.2 1.6
S9 within 0.7 1.1 1.9 1.6 2.0 2.3 S9 within 0.4 0.6 1.3 0.8 0.5 0.9
S10 2.1(02) 1.7 1.3 1.7 1.8 1.5 2.8 S10 1(0.2) 0.7 0.5 0.8 0.9 0.8 0.7
S11 between 1.8 0.9 3.0 2.8 2.4 2.4 S11 between 0.7 0.9 0.7 1.2 0.7 1.1
S12 3.2(1.4) 1.4 1.2 3.3 2.4 2.5 5.5 S12 11(0.5) 0.9 0.6 1.2 0.9 1.7 1.2
mean 1.3 1.2 2.4 2.2 2.0 2.6 mean 0.7 0.6 1.0 0.9 1.0 1.0
SD 0.4 0.3 0.7 0.4 0.4 1.6 SD 0.2 0.2 0.2 0.1 0.4 0.4
D.21
Appendices D
Appendix D 10b. contd.
ABSD ankle dorsi ABSD ankle abd
variability A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D variability A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 mean(SD) 1.9 2.5 1.8 1.7 1.9 1.2 S1 mean(SD) 2.2 1.2 2.0 1.4 2.5 2.9
S2 within 3.1 1.1 2.4 2.7 4.3 7.1 S2 within 1.5 0.7 1.6 1.0 2.1 3.2
S3 25(0.4) 2.7 1.6 1.4 1.9 2.9 2.6 S3 1.1(0.1) 0.4 0.5 4.7 4.2 3.4 3.9
S4 between 3.3 2.1 4.6 2.7 4.5 4.4 S4 between 0.5 0.8 2.9 2.3 4.8 3.3
S5 3.3(03) 3.4 3.0 3.1 1.8 4.1 5.5 S5 5.4(35) 0.6 0.6 1.4 1.1 1.6 1.8
S6 1.9 3.4 1.3 2.3 3.2 2.2 S6 0.5 0.5 2.6 2.3 1.7 0.6
mean 2.7 2.3 2.4 2.2 3.5 3.8 mean 1.0 0.7 2.5 2.1 2.7 2.6
SD 0.7 0.9 1.2 0.4 1.0 2.2 SD 0.7 0.3 1.2 1.2 1.2 1.2
S7 variability 3.9 3.5 4.4 2.5 1.7 1.9 S7 variability 1.8 2.3 2.8 1.2 5.0 2.9
S8 mean(SD) 1.0 1.0 2.9 3.3 2.5 2.4 S8 mean(SD) 0.6 0.7 2.4 2.2 0.8 0.7
S9 within 1.4 1.2 2.2 1.7 2.4 5.2 S9 within 0.5 0.5 3.0 3.1 1.5 1.0
S10 2.5(0.4) 1.0 2.7 4.2 2.8 1.6 1.7 S10 1.1(0.1) 2.2 1.4 3.5 2.3 2.2 1.0
S11 between 1.8 2.7 3.0 3.8 1.8 4.8 S11 between 1.0 1.2 2.4 2.7 1.4 2.7
S12 3.3(0.3) 3.0 1.4 1.8 1.0 2.6 1.5 S12 5.4(35) 1.6 0.6 1.1 0.9 1.3 2.9
mean 2.0 2.1 3.1 2.5 2.1 2.9 mean 1.3 1.1 2.5 2.1 2.0 1.9
SD 1.2 1.0 1.0 1.0 0.4 1.6 SD 0.7 0.7 0.8 0.9 1.5 1.1
ABSD ankle inv
variability A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 mean(SD) 0.5 0.6 0.8 1.0 0.7 0.6
S2 within 0.5 0.5 0.6 0.4 0.6 1.5
S3 0.6(01) 0.5 0.4 1.0 1.3 1.1 1.0
S4 between 0.7 0.2 0.4 0.4 0.4 0.5
S5 1(0.5) 0.8 0.6 0.7 0.6 0.7 0.6
S6 0.3 0.5 0.5 0.7 0.9 1.0
mean 0.5 0.5 0.7 0.7 0.7 0.9
SD 0.2 0.1 0.2 0.4 0.2 0.4
variability A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S7 mean(SD) 0.5 0.3 0.6 0.3 0.4 0.3
S8 within 0.2 0.4 0.1 0.3 0.3 0.9
S9 0.6(01) 0.3 0.5 0.6 0.5 0.6 1.2
S10 between 0.5 0.5 0.8 0.7 0.4 0.5
S11 1(0.5) 0.6 0.7 0.6 0.8 0.4 0.6
S12 0.7 0.4 1.1 0.8 1.1 1.1
mean 0.5 0.5 0.6 0.6 0.6 0.8
SD 0.2 0.1 0.3 0.2 0.3 0.4
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Moment EXC DIFF hip flex moment GC EXC DIFF hip abd
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 normal -7.2 -0.6 -24.1 -24.7 -15.0 -8.0 S1 normal -2.3 -3.2 -4.1 -7.3 -5.3 -8.5
S2 mean(SD) -0.5 -7.6 -0.2 -7.8 -1.5 -10.4 S2 mean(SD) -2.6 -2.3 2.7 0.4 3.4 1.0
S3 within -1.0 9.2 -5.0 4.2 0.9 4.6 S3 within -1.1 -4.2 -2.1 -6.2 -9.6 -10.0
S4 10.6(3.8) -18.0 7.2 -14.0 -6.8 -1.6 18.5 S4 5.9(17) 0.3 -3.0 1.8 -1.2 -2.5 1.7
S5 between 0.3 8.4 4.4 12.8 9.3 -13.5 S5 between -1.3 2.0 0.7 2.7 0.0 -0.7
S6 11.1(7.8) 1.7 -8.9 -14.4 -23.3 -9.0 -0.8 S6 7.8(10.2) -3.5 4.3 -16.7 -12.4 -5.8 -0.9
mean -4.1 1.3 -8.9 -7.6 -2.8 -1.6 mean -1.8 -1.1 -2.9 -4.0 -3.3 -2.9
SD 7.5 8.2 10.5 14.8 8.4 11.9 SD 1.3 3.4 7.2 5.6 4.6 5.0
S7 normal -14.6 -2.2 -6.1 -8.3 1.5 4.0 S7 normal -0.7 -2.1 -5.5 -7.6 -3.9 -1.9
S8 mean(SD) -10.0 -10.7 5.7 -5.0 -39.0 -21.8 S8 mean(SD) -2.4 1.1 2.6 3.7 0.7 5.1
S9 within -17.6 -2.1 -26.4 -28.5 -30.0 -18.9 S9 within -0.3 3.4 -9.5 -6.1 -13.3 -13.7
S10 10.6(3.8) -21.4 3.4 -19.3 -15.9 -7.9 -0.1 S10 5.9(17) -2.9 -0.2 3.8 3.6 -3.6 0.0
S11 between 0.4 6.4 16.1 22.5 23.3 20.9 S11 between -5.8 2.9 -2.6 0.2 -9.2 3.8
S12 11.1(7.8) 4.3 7.0 7.2 14.1 5.6 5.3 S12 7.8(10.2) -2.1 -5.7 8.9 3.2 -5.3 1.7
mean -9.8 0.3 -3.8 -3.5 -7.8 -1.8 mean -2.4 -0.1 -0.4 -0.5 -5.8 -0.8
SD 10.2 6.7 16.5 18.9 23.2 16.1 SD 1.9 3.4 6.8 5.1 4.9 6.8
EXC DIFF hip rot EXC DIFF knee flex
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 normal -1.1 3.3 -7.2 -4.0 -2.2 -5.8 S1 normal -1.1 -12.5 3.3 -9.2 5.0 2.3
S2 mean(SD) -1.5 0.1 3.3 3.3 4.7 2.6 S2 mean(SD) -2.6 -5.0 12.3 7.3 1.9 -1.7
S3 within -1.3 -1.1 -1.8 -2.9 -5.9 -3.6 S3 within -11.9 1.2 -3.6 -2.4 -7.0 -8.3
S4 1.9(0.7) -1.4 -0.4 -6.2 -6.6 -4.2 -1.7 S4 62(2.6) -5.7 -0.2 4.7 4.5 -1.2 26.6
S5 between -1.2 2.2 -0.6 1.6 -2.2 -1.7 S5 between -3.1 -3.1 -0.6 -3.7 1.6 -7.1
S6 4.9(27) -1.3 1.3 -11.7 -10.4 -11.2 -11.2 S6 6.7(2.9) 7.5 -2.9 -6.9 -9.7 -8.0 2.6
mean -1.3 0.9 -4.0 -3.2 -3.5 -3.6 mean -2.8 -3.8 1.5 -2.2 -1.3 2.4
SD 0.2 1.7 5.4 5.1 5.2 4.6 SD 6.3 4.8 6.8 7.0 5.2 12.7
S7 normal 0.6 0.3 -2.9 -2.6 -2.4 0.8 S7 normal -6.7 -6.4 -3.4 -9.8 -12.7 -8.9
S8 mean(SD) -2.5 -0.7 -0.9 -1.6 1.9 -0.9 S8 mean(SD) -5.9 -5.6 -13.8 -19.4 -10.2 -9.2
S9 within -3.5 2.3 -15.2 -12.9 -20.6 -17.3 S9 within -6.8 -2.4 -8.6 -11.0 -11.7 -13.3
S10 1.9(0.7) -1.1 0.7 -6.4 -5.7 -1.0 -1.6 S10 62(2.6) -12.7 1 9 -17.3 -15.4 -12.6 -12.9
S11 between -4.2 1.5 -9.3 -7.8 -2.3 0.3 S11 between -7.1 -4.4 9.8 5.4 20.6 25.7
S12 4.9(27) -1.6 -1.3 1.4 0.1 -2.1 0.8 S12 6.7(29) 4.7 -8.9 7.6 -1.3 4.6 -8.2
mean -2.1 0.5 -5.5 -5.1 -4.4 -3.0 mean -5.8 -4.3 -4.3 -8.6 -3.7 -4.5
SD 1.8 1.3 6.1 4.8 8.1 7.1 SD 5.7 3.7 11.1 9.2 13.6 14.9
EXC DIFF knee abd EXC DIFF knee rot
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 normal -4.2 -2.9 -8.1 -11.0 -3.1 0.6 S1 normal -0.5 -2.1 0.3 -1.8 0.7 -0.4
S2 mean(SD) -2.5 1.0 -8.6 -7.6 1.6 0.4 S2 mean(SD) -1.9 2.1 -2.4 -0.3 -1.7 -1.0
S3 within -0.2 -3.0 -3.3 -6.2 -6.9 -4.9 S3 within -1.8 -0.1 -2.8 -2.9 -2.4 -3.0
S4 2.9(11) -0.2 0.5 -10.7 -10.3 -5.1 -13.5 S4 16(0.5) 3.1 -0.6 0.4 -0.2 -0.9 1.6
S5 between -2.5 0.9 4.8 5.7 1.7 6.6 S5 between -0.9 -0.2 1.8 1.6 -2.5 -1.7
S6 52(7.7) -4.1 1.1 -3.6 -2.6 -4.7 -7.7 S6 2.5(19) -1.0 -1.8 -4.0 -5.8 -3.8 -0.3
mean -2.3 -0.4 -4.9 -5.3 -2.7 -3.1 mean -0.5 -0.4 -1.1 -1.6 -1.8 -0.8
SD 1.8 2.0 5.6 6.2 3.6 7.1 SD 1.8 1.5 2.3 2.6 1.5 1.5
S7 normal -2.7 2.1 -0.8 1.3 -4.1 0.5 S7 normal -1.6 -2.0 -2.5 -4.5 -2.9 -1.8
S8 mean(SD) -0.4 -2.1 4.5 2.4 -3.1 0.1 S8 mean(SD) -1.0 1.5 -0.2 1.3 -0.3 3.3
S9 within -1.1 1.2 -0.9 0.3 -3.4 -3.3 S9 within -1.1 0.2 0.8 0.9 -0.3 -1.2
S10 2.9(11) -5.4 2.2 0.6 2.8 2.3 5.5 S10 16(0.5) -3.6 -0.5 -1.9 -2.3 -3.4 -0.5
S11 between -0.9 1.3 -1.7 -0.4 0.2 6.9 S11 between -2.7 2.1 0.5 2.6 1.1 5.1
S12 5.2(77) -1.8 -5.4 6.7 1.4 -1.1 12.0 S12 2.5(1 9) 3.2 -2.3 4.8 2.5 2.8 4.9
mean -2.0 -0.1 1.4 1.3 -1.5 3.6 mean -1.1 -0.2 0.3 0.1 -0.5 1.6
SD 1.8 3.0 3.4 1.2 2.5 5.6 SD 2.4 1.8 2.6 2.9 2.4 3.1
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EXC DIFF ankle dorsi EXC DIFF ankle abd
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 normal -6.8 -3.0 1.5 -1.5 0.4 -1.8 S1 normal 4.3 0.1 2.6 2.8 2.6 -1.2
S2 mean(SD) -2.9 6.6 -4.2 2.4 0.5 -1.9 S2 mean(SD) 0.0 -2.6 4.6 2.0 9.6 7.8
S3 within -1.3 1.8 2.2 4.0 1.4 3.9 S3 within 1.2 1.2 0.2 1.4 1.2 0.2
S4 3.2(1.8) -1.7 -4.6 5.1 0.5 7.3 10.9 S4 2.3(07) 2.9 0.8 3.1 3.9 -8.7 -1.4
S5 between 0.2 -0.1 3.6 3.5 2.7 -4.4 S5 between -1.3 1.7 -2.0 -0.3 -5.7 -1.5
S6 3.7(2.2) 0.0 -4.4 -0.7 -5.2 -1.9 4.4 S6 4.4(2.7) -1.5 0.9 -3.2 -2.2 -0.6 -2.4
mean -2.1 -0.6 1.2 0.6 1.7 1.8 mean 0.9 0.4 0.9 1.3 -0.3 0.3
SD 2.6 4.3 3.3 3.5 3.1 5.6 SD 2.3 1.5 3.1 2.2 6.4 3.8
S7 normal -3.2 -1.6 -1.3 -2.9 -1.6 -3.4 S7 normal 1.3 -1.5 -3.3 -4.8 6.7 2.8
S8 mean(SD) 1.0 -0.5 3.2 2.8 -1.2 1.5 S8 mean(SD) -1.4 -2.1 -1.6 -3.7 -0.5 1.0
S9 within -0.5 3.4 -5.6 -2.3 -3.8 -6.4 S9 within -1.5 2.2 -11.1 -9.0 -4.6 -3.0
S10 3.2(1.8) -7.0 1.9 1.3 3.2 6.5 7.9 S10 2.3(07) -3.1 2.5 -9.7 -7.1 -4.9 2.6
S11 between -1.4 2.4 5.7 8.1 4.6 4.5 S11 between -3.6 -1.5 -4.1 -5.6 -3.6 10.6
S12 3.7(2.2) -3.1 -3.0 0.2 -2.8 -3.5 0.4 S12 4.4(27) -2.5 -0.4 3.9 3.5 6.8 4.5
mean -2.4 0.4 0.6 1.0 0.2 0.8 mean -1.8 -0.1 -4.3 -4.4 0.0 3.1
SD 2.8 2.5 3.9 4.4 4.3 5.2 SD 1.7 2.0 5.5 4.3 5.5 4.5
EXC DIFF ankle inv
A1-A2 B1-B2 A1-B1 A1-B2 A1-C A1-D
S1 normal 0.3 -1.4 -1.4 -2.7 -1.6 -1.1
S2 mean(SD) -1.5 2.6 -2.4 0.2 -1.2 -2.1
S3 within -1.1 -0.9 -1.9 -2.9 -1.6 -1.0
S4 1.7(07) 2.3 -0.3 0.1 -0.2 0.3 0.1
S5 between -0.2 -0.1 2.2 2.1 -2.0 0.0
S6 1.8(1.4) -0.3 -1.2 0.2 -1.0 -1.5 -2.1
mean -0.1 -0.2 -0.5 -0.7 -1.2 -1.0
SD 1.3 1.5 1.7 1.9 0.8 1.0
S7 normal -0.2 0.1 -0.7 -0.6 -1.0 -1.3
S8 mean(SD) -0.7 0.1 0.0 0.1 0.4 -0.8
S9 within -0.1 -0.3 1.0 0.8 0.0 -0.2
S10 1.7(0.7) -2.4 -0.5 2.3 1.8 1.0 2.1
S11 between -1.5 2.1 0.2 2.3 0.0 1.9
S12 1.8(1.4) 2.3 -1.0 3.8 2.8 4.3 4.8
mean -0.4 0.1 1.1 1.2 0.8 1.1
SD 1.6 1.1 1.7 1.3 1.9 2.3
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